Quarterlytics / Technology / Communication Equipment / Lumentum

Lumentum

lite · NASDAQ Technology
Claim this profile
Ticker lite
Exchange NASDAQ
Sector Technology
Industry Communication Equipment
Employees 5001-10,000
← All annual reports
FY2019 Annual Report · Lumentum
Sign in to download
Loading PDF…
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-K

(Mark One)
x  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June 29, 2019
 OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

to

 Commission File Number 001-36861
Lumentum Holdings Inc.
(Exact name of Registrant as specified in its charter)

Delaware

(State or other jurisdiction of
incorporation or organization)

47-3108385

(I.R.S. Employer
Identification Number)

400 North McCarthy Boulevard, Milpitas, California 95035
(Address of principal executive offices including Zip code)

(408) 546-5483
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of exchange on which registered

Common Stock, par value of $0.001 per share

LITE

Nasdaq Global Select Market

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. 
Yes o    No x    

Securities registered pursuant to Section 12(g) of the Act:
None

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o    No x

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding  12 months (or for such shorter period that the Registrant  was required  to file such reports),  and (2) has been subject to such filing requirements  for the past
90 days.  Yes x  No o

 Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-

T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes x  No o

 
 
 
 
 
 
 
 
 
 
 
 
 
 
                        
 
 
 
 
 
 
 
Table of Contents

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
growth  company.  See  definition  of  “large  accelerated  filer,”  “accelerated  filer,”  “smaller  reporting  company,”  and  “emerging  growth  company”  in  Rule  12b-2  of  the
Exchange Act.

Large accelerated filer

x

Accelerated filer

o

Non-accelerated filer

o

Smaller reporting company

Emerging Growth company

o

o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised

financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o  No x

As of December 29, 2018, the aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $2,264
million based on the closing sales price of the registrant’s common stock as reported on the NASDAQ Stock Market on December 28, 2018 of $41.57 per share. Shares of
common stock held by officers, directors and holders of more than five percent of the outstanding common stock have been excluded from this calculation because such
persons may be deemed to be affiliates.

As of August 20, 2019, the Registrant had 76.9 million shares of common stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE
Portions of the information called for by Part III of this Annual Report on Form 10-K is hereby incorporated by reference from the definitive proxy statement for the
Registrant’s annual meeting of stockholders, which will be filed with the Securities and Exchange Commission not later than 120 days after the Registrant’s fiscal year
ended June 29, 2019.

 
 
 
 
 
 
 
 
 
 
 
Table of Contents

PART I

ITEM 1.

ITEM 1A.

ITEM 1B.

ITEM 2.

ITEM 3.

ITEM 4.

PART II

ITEM 5.

ITEM 6.

ITEM 7.

TABLE OF CONTENTS

Page

BUSINESS

RISK FACTORS

UNRESOLVED STAFF COMMENTS

PROPERTIES

LEGAL PROCEEDINGS

MINE SAFETY DISCLOSURES

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES
OF EQUITY SECURITIES

SELECTED FINANCIAL DATA

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

CHANGES IN AND DISAGREEMENTS WITH ACOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

CONTROLS AND PROCEDURES

OTHER INFORMATION

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

EXECUTIVE COMPENSATION

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
MATTERS

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

PRINCIPAL ACCOUNTING FEES AND SERVICES

EXHIBITS, FINANCIAL STATEMENTS SCHEDULES

FORM 10-K SUMMARY

ITEM 8.

ITEM 9.

ITEM 9A.

ITEM 9B.

PART III

ITEM 10.

ITEM 11.

ITEM 12.

ITEM 13.

ITEM 14.

PART IV

ITEM 15.

ITEM 16.

SIGNATURES

1

2

12

28

29

30

31

32

34

36

53

54

115

115

117

118

118

118

118

118

119

123

124

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K (this “Annual Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”). These statements are based on our current expectations and involve
risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such
forward-looking  statements.  These  statements  relate  to,  among  other  things,  our  markets  and  industry,  products  and  strategy,  sales,  gross  margins,  operating  expenses,
capital expenditures and requirements, liquidity, product development and R&D efforts, manufacturing plans, litigation, effective tax rates and tax reserves, our corporate
and financial reporting structure, our plans for growth and innovation, our plans to discontinue certain operations and product lines, our expectations regarding US-China
relations and market conditions, the successful integration of Oclaro’s business (including personnel), and expected synergies and non-GAAP earnings accretion from the
acquisition of Oclaro, and are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,”
“intend,”  “may,”  “might,”  “plan,”  “project,”  “seek,”  “should,”  “target,”  “will,”  “would”  and  similar  expressions  or  variations  intended  to  identify  forward-looking
statements.  These statements  are based  on the beliefs  and assumptions  of our management,  which are in turn based on information  currently  available  to management.
Such  forward-looking  statements  are  subject  to  risks,  uncertainties  and  other  important  factors  that  could  cause  actual  results  and  the  timing  of  certain  events  to  differ
materially  from  future  results  expressed  or  implied  by  such  forward-looking  statements.  Factors  that  could  cause  or  contribute  to  such  differences  include,  but  are  not
limited to, those discussed in the section entitled “Risk Factors” included under Part I, Item 1A below. Furthermore, such forward-looking statements speak only as of the
date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such
statements.

PART I

ITEM 1.    BUSINESS

General

Overview

Lumentum  Holdings Inc. (“we”, “our”, “Lumentum”  or the “Company”)  is an industry-leading  provider of optical and photonic products defined by revenue and
market  share  addressing  a  range  of  end  market  applications  including  Optical  Communications  and  Commercial  Lasers  for  manufacturing,  inspection  and  life-science
applications. We seek to use our core optical and photonic technology and our volume manufacturing capability to expand into attractive emerging markets that benefit
from advantages that optical or photonics-based solutions provide, including 3D sensing for consumer electronics and diode light sources for a variety of consumer and
industrial applications. The majority of our customers tend to be original equipment manufacturers (“OEMs”) that incorporate our products into their products which then
address  end-market  applications.  For  example,  we  sell  fiber  optic  components  that  our  network  equipment  manufacturer  (“NEM”)  customers  assemble  into
communications networking systems, which they sell to network service providers or enterprises with their own networks. Similarly, many of our customers for our Lasers
products  incorporate  our  products  into  tools  they  produce,  which  are  used  for  manufacturing  processes  by  their  customers.  For  3D  sensing,  we  sell  diode  lasers  to
manufacturers of consumer electronics products for mobile, personal computing, and gaming who then integrate our devices within their products, for eventual resale to
consumers and also into other industrial applications.

We operate in two reportable segments: Optical Communications (“OpComms”) and Commercial Lasers (“Lasers”).

We  have  a  global  marketing  and  sales  footprint  that  enables  us  to  address  global  market  opportunities  for  our  products.  We  have  manufacturing  capabilities  and
facilities in North America, Asia-Pacific, and Europe, with employees engaged in R&D, administration, manufacturing, support and sales and marketing activities. Our
headquarters are located in Milpitas, California, and we employed approximately 5,161 full-time employees around the world as of June 29, 2019.

Lumentum  was  incorporated  in  Delaware  as  a  wholly  owned  subsidiary  of  JDS  Uniphase  Corporation  (“JDSU”)  on  February  10,  2015,  and  is  comprised  of  the
former communications and commercial optical products (“CCOP”) segment and WaveReady product lines of JDSU. In August 2015, we became an independent publicly-
traded company through the distribution by JDSU to its stockholders of 80.1% of our outstanding common stock (the “Separation”). Each JDSU stockholder of record as
of the close of business on July 27, 2015, received one share of Lumentum common stock for every five shares of JDSU common stock held on such date. JDSU was
renamed Viavi Solutions Inc. (“Viavi”) and at the time of distribution, retained ownership of 19.9% of Lumentum’s outstanding shares. Since the Separation, Viavi has
sold its shares and is no longer a shareholder of Lumentum.

2

Table of Contents

Our  business  traces  its  origins  to  Uniphase  Corporation,  which  was  formed  in  1979,  and  became  publicly  traded  in  1992.  Uniphase  was  originally  a  supplier  of
commercial lasers, and later, a leading supplier of optical transmission products. In 1999, JDS Fitel Inc., a pioneer in products for fiber optic networking which was formed
in  1981,  merged  with  Uniphase  to  become  JDSU,  a  global  leader  in  optical  networking.  Subsequent  acquisitions  by  JDSU  broadened  the  depth  and  breadth  of  the
OpComms and Lasers businesses, as well as the intellectual property, technology and product offerings, of what is now Lumentum. Notable amongst these acquisitions in
the  OpComms  business  were  Agility  Communications,  Inc.  in  2005  and  Picolight,  Inc.  in  2007  which  respectively  brought  widely  tunable,  long  wavelength  laser
technology  for  metro  and  long  haul  networking  applications  and  short  wavelength  vertical-cavity  surface-emitting  lasers  (“VCSELs”)  for  enterprise,  datacenter
networking,  and  3D  sensing  applications.  The  fundamental  laser  component  technologies  which  we  acquired  through  these  acquisitions,  form  the  basis  of  virtually  all
optical networks today, and we believe will continue to do so for the foreseeable future. These technologies will enable us to develop highly integrated products to satisfy
our  communications  customers’  ever  increasing  needs  for  smaller,  lower  power  and  lower  cost  optical  products.  Notable  acquisitions  in  the  Lasers  business  were
Lightwave Electronics Corporation in 2005 and Time-Bandwidth Products Inc. (“Time-Bandwidth”) in 2014. Both of these Lasers acquisitions brought high power pulsed
solid-state laser products and technology to our business, which address the micro laser machining market and expanded our addressable market. On December 10, 2018,
we completed a merger with Oclaro, Inc. (“Oclaro”), a provider of optical components and modules for the long-haul, metro and data center markets. Oclaro’s products
provide differentiated solutions for optical networks and high-speed interconnects driving the next wave of streaming video, cloud computing, application virtualization
and other bandwidth-intensive and high-speed applications. This acquisition has strengthened our product portfolio, including by gaining Oclaro’s indium phosphide laser
and  photonic  integrated  circuit  and  coherent  component  and  module  capabilities;  broadens  our  revenue  mix;  and  positions  us  strongly  to  meet  the  future  needs  of  our
customers.

Industry Trends and Business Risks

Our business is driven by end-market applications which benefit from the performance advantages that optical solutions enable.

The OpComms markets we serve are experiencing continually increasing needs for higher data transmission speeds, fiber optic network capacity and network agility.
This is driven by rapid growth in both the number of higher bandwidth broadband connections, notably those associated with mobile devices, such as high-definition video,
online gaming, cloud computing and the number and scale of datacenters that require fiber optic links to enable the higher speeds and increased scale necessary to deliver
high bandwidth video and other services. Our technology, which was originally developed for communications applications is also finding use in other emerging market
opportunities  including  3D  sensing  applications  that  employ  our  laser  technology  in  mobile  devices,  computers,  augmented  and  virtual  reality  and  other  consumer
electronics devices. Additionally, our products are used in emerging automotive, industrial, security, safety and surveillance applications.

In the Lasers markets, customer demand is driven by the need to enable faster, higher precision volume manufacturing techniques with lower power consumption,
reduced  manufacturing  footprint  and  increased  productivity.  These  capabilities  are  critical  as  industries  develop  products  that  are  smaller  and  lighter,  increasing
productivity and yield and lowering their energy consumption.

Our  optical  and  laser  solutions,  developed  in  close  collaboration  with  OEM  partners,  are  well-positioned  to  meet  demand  resulting  from  these  trends.  We  do,
however, expect to continue to encounter a number of industry and market risks and uncertainties. These risks and uncertainties may limit our visibility, and consequently,
our  ability  to  predict  future  revenue,  profitability  and  general  financial  performance,  and  could  create  quarter  over  quarter  variability  in  our  financial  measures.  For
example, the demand environment in China has fluctuated significantly in recent years, and has created volatility and uncertainty in our future demand. We cannot predict
when or to what extent these uncertainties will be resolved. Our revenues, profitability and general financial performance may also be affected by: (i) pricing pressures,
particularly within our OpComms markets, due to, among other things, a highly concentrated customer base, increasing competition, particularly from Asia-Pacific-based
competitors,  and  a  general  commoditization  trend  for  certain  products;  (ii)  high  product  mix  variability  which  affects  revenue  and  gross  margin;  (iii)  fluctuations  in
customer  buying  patterns,  which  cause  volatility  in  demand,  revenue  and  profitability;  and  (iv)  the  current  trend  of  communication  industry  consolidation,  which  is
expected to continue, that directly affects our customer bases and adds additional risk and uncertainty to our financial and business projections.

Reportable Segments

We  have  two  operating  segments,  OpComms  and  Lasers.  The  two  operating  segments  were  primarily  determined  based  on  how  our  Chief  Operating  Decision
Maker (“CODM”) views and evaluates our operations. Operating results are regularly reviewed by our CODM to make decisions about resources to be allocated to the
segments  and  to  assess  their  performance.  Other  factors,  including  market  separation  and  customer  specific  applications,  go-to-market  channels,  products  and
manufacturing, are considered

3

Table of Contents

in determining the formation of these operating segments. We do not track our property, plant, and equipment by operating segments. For the geographic identification of
these assets, refer to “Note 20. Operating Segments and Geographic Information”.

The table below discloses our total net revenue attributable to each of our two reportable segments. In addition, it discloses the percentage of our total net revenue
attributable to our product offerings which serve the Telecom, Datacom, and Consumer and Industrial markets which accounted for 10% or more of our total net revenue
during the periods presented (in millions, except percentage data):

OpComms:

Telecom

Datacom

Consumer and Industrial

Total OpComms

Lasers

Total Revenue

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

$

$

$

786.5

166.4

417.3

1,370.2

195.1

50.2%   $

10.6%  

26.7%  

476.3

150.4

432.5

87.5%   $

1,059.2

12.5%  

188.5

38.1%   $

12.1%  

34.7%  

84.9%   $

15.1%  

610.7

201.3

45.8

857.8

143.8

61.0%

20.0%

4.6%

85.6%

14.4%

1,565.3  

  $

1,247.7  

  $

1,001.6  

For further information regarding our operating segments, please refer to “Note 20. Operating Segments and Geographic Information” in the Notes to Consolidated

Financial Statements.

OpComms

Markets

Our  OpComms  products  address  the  following  markets:  telecommunications  (“Telecom”),  data  communications  (“Datacom”)  and  consumer  and  industrial

(“Consumer and Industrial”).

Our OpComms products  include  a wide range  of components,  modules  and  subsystems  to support  customers  including  carrier  networks  of access  (local),  metro
(intracity), long-haul (city-to-city and worldwide) and submarine (undersea) applications. Additionally, our products address enterprise, cloud, and data center applications,
including storage-access networks (“SANs”), local-area networks (“LANs”) and wide-area networks (“WANs”). These products enable the transmission and transport of
video, audio and text data over high-capacity fiber-optic cables. We maintain leading positions in these fast growing OpComms markets through our extensive product
portfolio,  including  reconfigurable  optical  add/drop  multiplexers  (“ROADMs”),  coherent  DWDM  pluggable  transceivers,  and  tunable  small  form-factor  pluggable
transceivers. We also sell laser chips for use in the manufacture of high-speed Datacom transceivers.

In  the  Consumer  and  Industrial  market,  our  OpComms  products  include  laser  light  sources,  which  are  integrated  into  3D  sensing  platforms  being  used  in
applications for mobile devices, gaming, computers, and other consumer electronics devices. New emerging applications include virtual and augmented reality, as well as
automotive and industrial segments. Our products include vertical cavity surface emitting lasers (“VCSELs”) and edge emitting lasers which are used in 3D sensing depth
imaging  systems.  These  systems  simplify  the  way  people  interact  with  technology  by  enabling  the  use  of  natural  user  interfaces.  Systems  are  used  for  biometric
identification,  surveillance,  and process  efficiency,  among  numerous  other  application  spaces.  Emerging  applications  for this technology  include  various  mobile  device
applications,  autonomous  vehicles,  self-navigating  robotics  and  drones  in  industrial  applications  and  3D  capture  of  objects  coupled  with  3D  printing.  In  addition,  our
industrial diode lasers are used primarily as pump sources for pulsed and kilowatt class fiber lasers.

Following the acquisition of Oclaro, during our fiscal 2019, we made several strategic changes to our OpComms business as follows:

First, for overlapping products as a result of the acquisition, we are transitioning to a common lower cost design and manufacturing platform, which we expect will
result in gross margin improvement over time. In addition, we are discontinuing certain Telecom product lines that we believe have muted growth and profitability trends
that are inconsistent with our long term model. We expect that these transitions will be completed in our fiscal 2021. For the Telecom product lines we are exiting, we do
not expect significant revenue declines until fiscal 2021 as in fiscal 2020 we are continuing to satisfy customers’ product needs with respect to these product lines.

Second, we announced our plan to discontinue development and manufacturing of Lithium Niobate modulators, and we plan to wind down these operations in San
Donato, Italy during fiscal year 2020. Development and manufacturing will also be discontinued in our San Jose, California manufacturing locations within the next few
quarters in order to facilitate our customer

4

 
 
 
 
 
 
   
 
   
 
Table of Contents

s’ transition to new products. We expect our Indium Phosphide photonic integrated circuits will replace Lithium Niobate modulators over time.

Third, we announced the sale of many of our Datacom transceiver module products to Cambridge Industries Group (“CIG”). This transaction closed on April 18,
2019. For further information regarding this transaction, refer to “Note 5. Business Combination”. We expect Datacom transceiver sales to ramp down to zero during fiscal
year 2020. We are investing in new Datacom chip development and expect sales of these chips to customers serving the Datacom and 5G wireless markets will grow over
time. With the exit from the business of selling Datacom transceivers, we recorded an impairment charge of $30.7 million to our Long-lived assets that were not deemed to
be useful, as they were retired from active use and classified as held-for-sale. These assets were valued at fair value less cost to sell. We also recorded inventory write
down charges of $20.8 million related to the decision to exit the Datacom module and Lithium Niobate product lines in our cost of goods sold of consolidated statements of
operations. These actions do not qualify as discontinued operations for disclosure purposes as they do not represent a strategic shift having a major effect on an entity’s
operations and financial results. For additional information, refer to “Note 15. Impairment Charges”.

Customers

Our OpComms customers include Alphabet, Apple, Ciena, Cisco Systems (which recently announced the acquisition of Acacia Communications, another customer
of ours), Huawei Technologies (including HiSilicon), Infinera, Innolight, Nokia Networks (including Alcatel-Lucent International), O-Net, and ZTE. During fiscal  2019,
2018, and 2017, net revenue generated from a single customer which represented 10% or more of our total net revenue of the applicable fiscal year is summarized in the
table below:

Apple

Huawei

Ciena

Cisco

*Represents less than 10% of total net revenue

Trends

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

21.0%  

15.2%  

13.7%  

*

30.0%  

11.0%  

11.0%  

*

*

16.7%

18.5%

12.4%

We believe the optical communications market has started to expand beyond a small number of very large service providers, and is transitioning to a variety of open
and captive networks created for in house use by large video services, search engines and companies offering a variety of cloud computing services. We believe that the
trend towards an increase in demand for optical solutions, which increase network capacity, is in response to growing bandwidth demand driven by increased transmission
of video, voice and data over optical  communications  networks. Additionally,  service  providers  also seek to decrease  the total  cost of ownership of their networks. To
remain competitive,  network operators worldwide must offer broader suites of digital services at competitive  prices. To do this, they are migrating  to Internet-protocol
(“IP”) networks and expanding long-haul, metro regional and metro access networks, which effectively deliver broadband services while lowering capital and operating
costs of dense-wavelength-division multiplexing networks.

The growing demand for capacity encourages the adoption of OpComms products across the Datacom and Telecom markets. Demand for capacity in the Datacom
market  is  driven  by  the  growing  needs  of  LANs  and  WANs.  Growth  in  Datacom  is  also  driven  by  web  and  cloud  services  companies  that  are  expanding  data  center
infrastructure, increasing the need for network capacity within and between these data centers.

Demand in the Telecom market is driven by new bandwidth-intensive applications that can result in sudden and severe changes in demand almost anywhere on the
network. Increasing agility in optical networks by employing ROADMs, wavelength selective switches, wavelength tunable transmission products and other agile optical
products provides an effective way to respond to unpredictable bandwidth demands and to manage expenses. With more agile optical networks, a network operator can add
capacity by using remote management applications rather than dispatching technicians to perform manual operations in the field.

In addition, the high-end routers, switches and cross-connect equipment that must handle legacy and internet-protocol traffic are becoming increasingly complex in
order to meet higher bandwidth, scalability, speed and reliability needs. Products must provide higher levels of functionality and performance in compact designs that must
also meet requirements for quality, reliability, and cost.

5

 
 
 
 
 
   
   
Table of Contents

Deployment  of  fiber  closer  to  the  end  user  increases  the  availability  of  high-bandwidth  services  and  we  expect  it  will  result  in  increased  demand  on  the  metro
regional and long-haul networks into which these services feed. The dynamically reconfigurable nature of today’s agile networks enables lower operating costs and other
competitive advantages, allowing service providers to use and scale network capacity more flexibly, streamline service provisioning, accelerate rerouting around points of
failure and modify network topology through simple point-and-click network management systems.

Our optical products are well positioned to meet these demands. Our innovation has resulted in products that have more functionality, are less than half the size,
require less power and are more cost-effective than our historical products, particularly in the area of photonic integrated circuits. Higher levels of integration have also led
to  development  of  our  Super  Transport  Blade,  which  delivers  all  transport  functions  (wavelength  switching,  pre-amplification,  post-amplification,  optical  supervisory
channel and monitoring) in a single, integrated platform, essentially replacing three blades with one.

Offerings

In addition to a full selection of active and passive components, we offer increasing levels of functionality and integration in modules, circuit packs and subsystems

for transmission, amplification, wavelength management and more.

In  the  Telecom  market,  we  provide  transmission  and  transport  solutions  for  optical  networks  that  make  up the  backbone  of  the  wireline  Telecom  infrastructure,
thereby enabling the internet. Transmission products, such as our tunable transponder, transceiver and transmitter modules, transmit and receive high-speed data signals at
the ingress/egress points of the network. These products use dense wavelength division multiplexing technology to enable high capacity (from 20 to over 40Tb/s in the C-
Band) links driven by increasing internet demand. We also offer components including tunable lasers, receivers and modulators to address the higher end of these same
network applications.

Our  transport  products,  such  as  ROADMs,  amplifiers  and  optical  channel  monitors  provide  switching,  routing  and  conditioning  of  signals.  We  also  make
components  for  transport,  including  980nm,  multi-mode  and  Raman  pumps  for  optical  amplifiers,  and  passive  components.  Passive  components  include  switches,
attenuators,  photodetectors,  gain  flattening  filters,  isolators,  wavelength-division  multiplexing  (“WDM”)  filters,  arrayed  waveguide  gratings  (“AWGs”),  multiplex/de-
multiplexers and integrated passive modules.

Our innovation led to the Super Transport Blade, which integrates all major optical transport functions into a single-slot blade. This all-in-one solution reduces the
size,  cost  and  power  requirements  of  optical  components,  incorporates  nano  wavelength  selective  switch  technology  and  enables  greater  chassis  density  and  a  smaller
footprint.

In the Datacom market, optical transceivers are used to connect servers, switches, routers and other information technology infrastructure critical for today’s internet
applications,  web  services,  video  streaming,  enterprise  networks  and  service  provider  solutions.  The  emerging  data  center  and  Web  2.0  markets  are  two  of  the  fastest
growing segments in optical communications, both in terms of capital network equipment investment and growth of high data rate optical transceivers. Additionally, the
increased  bandwidth  needs  for  5G  wireless  applications  will  drive  growth  in  high  speed  optical  modules.  Historically,  we  have  supplied  optical  transceivers,  but  have
shifted our strategy to supplying underlying optical components, high-speed source lasers and receiver photo diodes used in optical transceivers to address these market
segments.

For the 100G and higher data rates, we offer several source laser technologies to balance technical and commercial requirements. For high volume, short distance
applications we developed our VCSELs. VCSELs are ideal for short reach applications because they enable low power, low cost optical solutions that are highly scalable.
For  high-performance,  longer  distance  applications  we  have  our  directly  modulated  laser  (“DML”)  and  electro-absorption  modulated  laser  (“EML”)  dies  supporting
module  applications  with  speeds  from  10Gb/s  through  800Gb/s.  Our  individual  lasers  and  compact  laser  arrays  offer  an  innovative  solution  for  the  LANs,  SANs,
broadband Internet, 5G Wireless and metro-area network as well as hyperscale datacenter applications.

Our 3D sensing technology enables real time depth information to any photo or video image. This represents a fundamental transition for image capture akin to the
transition from monochrome to color and gives devices the ability to see the world around them in three dimensions. The immediate applications include full body imaging
for  gaming,  3D  scanning  for  space  mapping  and  facial  recognition  for  security.  Emerging  applications  for  this  technology  include  various  mobile  device  applications,
autonomous vehicles, self-navigating robotics and drones in industrial applications and 3D capture of objects coupled with 3D printing. 3D sensing can be applied to any
device with a camera. The technologies to achieve accurate and stable 3D sensing are converging to laser based solutions. We are a leading supplier of the critical laser
illumination sources for 3D sensing systems being used in applications for gaming, computing, mobile devices, and home entertainment.

6

Table of Contents

Strategy

In  our  OpComms  segment,  we  are  focused  on  technology  leadership  through  innovation  with  our  customers,  cost  leadership  and  functional  integration.  We
endeavor to align the latest technologies with industry leading, scalable manufacturing and operations to drive the next phase of optical communications technologies and
products for Telecom and Datacom applications that are faster, more agile and more reliable, making us a valuable business and technology partner for NEMs, consumer
electronic companies, cloud service providers and data center operators.

Competition

We compete against various companies in the markets we serve, including II-VI, Acacia Communications, Accelink, ams AG, Broadcom Inc., Finisar, Furukawa
Electric,  Mitsubishi  Electric,  Neophotonics,  and  Sumitomo  Electric  Industries  as  well  as  private  companies  and  subsidiaries  of  public  companies  providing  optical
communications components such as Fujitsu Optical Components - a subsidiary of Fujitsu, Nistica - a subsidiary of Molex, and O-Net. Additionally, II-VI has announced
its plan to acquire Finisar and Cisco has announced its plan to acquire Acacia Communications.

Lasers

Markets

Our Lasers products serve our customers in markets and applications such as sheet metal processing, general manufacturing, biotechnology, graphics and imaging,

remote sensing, and precision machining such as drilling in printed circuit boards, wafer singulation, glass cutting and solar cell scribing.

Our Lasers products are used in a variety of OEM applications including diode-pumped solid-state, fiber, diode, direct-diode and gas lasers such as argon-ion and
helium-neon  lasers.  Fiber  lasers  provide  kW-class  output  powers  combined  with  excellent  beam  quality  and  are  used  in  sheet  metal  processing  and  metal  welding
applications. Diode-pumped solid-state lasers provide excellent beam quality, low noise and exceptional reliability and are used in biotechnology, graphics and imaging,
remote sensing, materials processing and precision machining applications. Diode and direct-diode lasers address a wide variety of applications, including laser pumping,
thermal exposure, illumination,  ophthalmology, image recording, printing, plastic welding and selective  soldering. Gas lasers such as argon-ion and helium-neon lasers
provide a stable, low-cost and reliable solution over a wide range of operating conditions, making them well suited for complex, high-resolution OEM applications such as
flow cytometry, DNA sequencing, graphics and imaging and semiconductor inspection.

We also provide high-powered and ultrafast lasers for the industrial and scientific markets. Manufacturers use high-power, ultrafast lasers to create micro parts for
consumer electronics and to process semiconductor, LED, and other types of chips. Use of ultrafast lasers for micromachining applications is being driven primarily by the
increasing use of consumer electronics and connected devices globally.

Our portfolio of Lasers products includes components and subsystems used in a variety of OEM applications that range in output power from milliwatts to kilowatts
and  include  ultraviolet,  visible  and  infrared  wavelengths.  We  support  customer  applications  in  the  biotechnology,  graphics  and  imaging,  remote  sensing,  materials
processing and other precision machining areas.

Customers

Our  Lasers  customers  include  Amada,  ASML  Holding,  Beckman  Coulter,  DISCO,  Electro  Scientific  Industries  (recently  acquired  by  MKS  Instruments,  a
competitor of ours), Han’s Laser Technology, KLA-Tencor, Lasertec, Life Technologies, and NR Electric. During fiscal 2019, 2018, and 2017, we did not have any single
customer attributable to our Lasers segment that generated net revenue of 10% or more of our total net revenue for the applicable fiscal year.

Trends

As technology advances, industries such as consumer electronics manufacturing increasingly turn to lasers when they need more precision, higher productivity and
energy efficient, or “green,” alternatives  for problems that cannot be solved by mechanical, electronic or other means. For example, these industries are using lasers to
develop products that are smaller and lighter to increase productivity and yield and to lower their energy consumption. Lasers have been used for years to help achieve the
scale and precision needed in semiconductor processing. In biotech applications, lasers have been instrumental for advances (and new standard procedures) in cytology,
hematology, genome sequencing and crime scene investigations, among others. We believe the long-term trends in these industries will likely lead to increased demand for
lasers.

7

Table of Contents

Sheet metal processing and metal  welding applications  are increasingly  using kW-class  fiber lasers instead of kW-class  CO2 lasers. Fiber lasers generate  higher

productivity at lower cost in such applications because they exhibit lower power consumption, better quality and generally lower user maintenance costs.

In addition, demand continues for electronic products, as well as products and components in other industries, with greater functionality while becoming smaller,
lighter and less expensive. Innovative / Next generation product designs require precise micromachining and materials processing, such as micro bending, soldering and
welding. At the scale and processing speed needed, lasers are replacing mature mechanical tools such as drills for minute holes, or “vias,” in printed circuit boards and
saws and scribes for singulating silicon wafers, resulting in greater precision and productivity. As these trends continue, we believe that manufacturers and other industries
will increase their reliance on lasers in order to maintain or increase their competitiveness.

We believe we are well-positioned with key OEM providers of laser solutions to these industries. We continue to develop our laser portfolio to offer smaller and

more cost-effective products designed specifically for the performance, integration, reliability and support needs of our OEM customers.

Offerings

Our broad range of Lasers products includes diode-pumped solid-state, fiber, diode, direct-diode and gas lasers such as argon-ion and helium-neon lasers. Diode-
pumped  solid-state  and  fiber  lasers  that  provide  excellent  beam  quality,  low  noise  and  exceptional  reliability  are  used  in  biotechnology,  graphics  and  imaging,  remote
sensing, materials processing and precision machining applications. Diode and direct-diode lasers address a wide variety of applications, including laser pumping, thermal
exposure, illumination, ophthalmology, image recording, printing, plastic welding and selective soldering. Gas lasers such as argon-ion and helium-neon lasers provide a
stable, low-cost  and reliable  solution  over a wide range of operating  conditions,  making  them well suited  for complex, high-resolution  OEM applications  such as flow
cytometry, DNA sequencing, graphics and imaging and semiconductor inspection.

Strategy

In  our  Lasers  segment,  we  leverage  our  long-term  relationships  with  OEM  customers  to  drive  commercial  laser  innovation.  Using  established  manufacturing,

engineering, lasers and photonics expertise, we deliver products that meet cost-of-ownership and reliability needs while delivering on volume production demands.

Competition

We compete against various public and private companies in the commercial laser markets we serve including Coherent and IPG Photonics.

Acquisitions

We evaluate strategic opportunities regularly and, where appropriate,  may acquire additional businesses, products, or technologies that are complementary to, or
broaden  the  markets  for  our  products.  We  believe  we  have  strengthened  our  business  model  by  expanding  our  addressable  markets,  customer  base  and  expertise,
diversifying our product portfolio and fortifying our core businesses from acquisitions as well as through organic initiatives.

On December 10, 2018, we completed our merger with Oclaro, a provider of optical components and modules for the long-haul, metro and data center markets.
Oclaro’s  products  provide  differentiated  solutions  for  optical  networks  and  high-speed  interconnects  driving  the  next  wave  of  streaming  video,  cloud  computing,
application  virtualization  and  other  bandwidth-intensive  and  high-speed  applications.  This  acquisition  strengthened  our  product  portfolio,  including  gaining  Oclaro’s
indium phosphide laser and photonic integrated circuit and coherent component and module capabilities; broadens our revenue mix; and positions us strongly to meet the
future needs of our customers. Refer to “Note 5. Business Combination” for further discussion of the merger.

In February 2017, we completed the acquisition of a privately held company to enhance our manufacturing and vertical integration capabilities. We acquired all of
the outstanding shares of the company for a total purchase consideration of $8.7 million. In connection with the acquisition, we paid upfront cash consideration of $5.1
million, incurred liabilities of $2.7 million contingent upon the achievement of certain production targets being achieved within 36 months following the acquisition date,
and retained  $0.9 million  of the purchase  price  as security  for  the  seller’s  indemnification  obligations,  which resulted  in the  cash payment  of  $1.0 million to the seller
during fiscal 2019 (based on the exchange rate at the date of payment).

8

Table of Contents

Restructuring Programs

We continue to engage in targeted restructuring plans primarily intended to reduce costs, consolidate our operations, rationalize the manufacturing of our products
and  align  our  business  in  response  to  market  needs  and  as  a  result  of  our  acquisition  of  Oclaro.  We  have  focused  on  improving  efficiencies  and  reducing  costs  by
consolidating operations where appropriate, while taking into consideration our current investment strategy, product offerings, core competencies, opportunities to enhance
cost efficiency and the availability of alternative manufacturers, as appropriate.

Please refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Note 14. Restructuring and Related Charges” in the

Notes to Consolidated Financial Statements for information on restructuring charges.

Research and Development

During fiscal 2019, 2018 and  2017,  we  incurred  R&D  expenses  of  $184.6 million,  $156.8  million,  and  $148.3  million,  respectively.  The  number  of  employees

engaged in R&D was approximately 790 as of June 29, 2019, 587 as of June 30, 2018 and 598 as of July 1, 2017.

We devote substantial resources  to R&D for the development of new and enhanced products to serve our markets. Once the design of a product is complete, our

engineering efforts shift to enhancing both product performance and our ability to manufacture it in greater volume and at lower cost.

In our OpComms segment, we are maintaining our capability to provide products throughout the network, while focusing on several important sub-segments. We
continue to maintain strong investments in Telecom components and modules such as ROADMs and tunable devices needed for long-haul and metro markets, as well as
high performance DML, EML, and VCSEL chips for Datacom transceivers. We are also responding to our customers’ requests for higher levels of integration, including
the integration of optics, electronics and software in our modules, subsystems and circuit packs. We are providing optical technology for 3D sensing systems that simplify
the way that people interact with technology. These solutions are initially being used in computing, mobile, and industrial applications, including automotive applications.

In  our  Lasers  segment,  we continue  to  develop  new  product  offerings  in  both  solid-state  and  fiber  lasers  that  take  advantage  of  technologies  and  components  we
develop.  These  products  are  targeted  at  serving  customers  engaging  in  biotechnology,  graphics  and  imaging,  remote  sensing,  and  materials  processing  and  precision
micromachining markets.

Manufacturing

Our significant manufacturing facilities are located in the United States, Thailand, China, the United Kingdom, Slovenia, Italy, Japan, and Switzerland.

In our fiscal fourth quarter of 2019, we moved into our Slovenia factory, which we expect to be fully operational by the fiscal third quarter of 2020.

In fiscal 2019, we announced our plan to discontinue development and manufacturing of Lithium Niobate modulators, and we plan to wind down these operations in
San Donato, Italy during fiscal year 2020. Development and manufacturing will also be discontinued in our San Jose, California manufacturing locations within the next
few quarters in order to facilitate our customers’ transition to new products. We expect our Indium Phosphide photonic integrated circuits will replace Lithium Niobate
modulators over time.

In fiscal 2019, we also announced our plan to discontinue the development and manufacturing of future Datacom transceiver products which impacted our Milpitas
and Shenzhen Datacom module teams. While we expect strong growth in Datacom volumes in the future, the market at the transceiver level is gross margin challenged due
to extreme competition. Following the Oclaro acquisition, we have a differentiated leadership position across a range of photonic chips on which the Datacom, wireless,
and access markets critically rely.

Our significant contract manufacturing partners are located primarily in Thailand, Taiwan and Malaysia. We rely on the capabilities of our contract manufactures to

procure components and manage the inventory in these locations.

During fiscal 2018, we entered into a Transition Services Agreement (“TSA”) with one of our contract manufacturers to wind down the production of our products at
their  facility  in  China  and  to  facilitate  an  orderly  transition  of  manufacturing  to  our  manufacturing  facility  in  Thailand,  including  the  purchase  of  the  manufacturing
equipment.  Under  the  terms  of  the  TSA,  we  were  required  to  pay  $5.3  million  in  cash  upon  completion  of  certain  milestones  related  to  the  purchase  of  equipment.
During the year ended June 29, 2019, we paid $1.3 million and accrued $4.0 million for the manufacturing equipment acquired under this TSA. The equipment acquired is
included in machinery and equipment within property, plant and equipment in our consolidated balance

9

Table of Contents

sheet  as  of  June 29, 2019.  We  were  also  required  to  share  cost  of  retention  and  severance,  and  to  reimburse  for  certain  other  direct  and  indirect  costs  incurred  by  our
contract manufacturer for transition services provided. These costs were expensed as incurred. We have now fully exited from operations with this contract manufacturer.
Please refer to “Note 8. Asset Acquisition” in the Notes to Consolidated Financial Statements.

Sources and Availability of Raw Materials

We  use  various  suppliers  and  contract  manufacturers  to  supply  parts  and  components  for  the  manufacture  and  support  of  multiple  product  lines.  Although  our
intention is to establish at least two sources of supply for materials whenever possible, for certain components we have sole or limited source supply arrangements. We
may  not be able  to procure  these  components  from  alternative  sources  at acceptable  prices  and quality  within a  reasonable  time,  or at all;  therefore,  the  risk of loss or
interruption of such arrangements could impact our ability to deliver certain products on a timely basis.

Intellectual Property

Intellectual  property  rights  that  apply  to  our  various  products  include  patents,  trade  secrets  and  trademarks.  We  do  not  intend  to  broadly  license  our  intellectual
property rights unless we can obtain adequate consideration or enter into acceptable patent cross-license agreements. As of June 29, 2019, we owned 1,063 U.S. patents
and 798 foreign patents with expiration dates ranging from July 2019 through June 2038, and had 490 patent applications pending throughout the world.

Seasonality

Our revenue may be influenced on a quarter to quarter basis by customer demand patterns and new product introductions. Some of our products may be incorporated

into consumer electronic products, which are subject to seasonality and fluctuations in demand.

Backlog

Backlog consists of purchase orders for products for which we have assigned shipment dates.

As of June 29, 2019 and June 30, 2018, our backlog was $453.1 million and $370.6 million, respectively. Due to possible changes in product delivery schedules and
cancellation of product orders, and because our sales often reflect orders shipped in the same quarter in which they are received, our backlog at any particular date is not
necessarily indicative of actual revenue or the level of orders for any succeeding period. A portion of our revenue arises from vendor-managed inventory arrangements
where the timing and volume of customer utilization is difficult to predict.

Employees

As of June 29, 2019, we employed approximately 5,161 full-time employees, including approximately 3,748 employees in manufacturing, 790 employees in R&D and

623 employees in SG&A.

Outside of the United States, our business is subject to labor laws that differ from those in the United States. We follow the statutory requirements of those countries

where we operate. We consider our employee relations to be good.

Environmental

Our  R&D,  manufacturing  and  distribution  operations  involve  the  use  of  hazardous  substances  and  are  regulated  under  international,  federal,  state  and  local  laws
governing health and safety and the environment. We apply strict standards for protection of the environment and occupational health and safety to sites inside and outside
the United States, even if not subject to regulation imposed by foreign governments. We believe that our properties and operations at our facilities comply in all material
respects with applicable environmental laws and occupational health and safety laws. However, the risk of environmental liabilities cannot be completely eliminated and
there can be no assurance that the application of environmental and health and safety laws will not require us to incur significant expenditures. We are also regulated under
a  number  of  international,  federal,  state  and  local  laws  regarding  recycling,  product  packaging  and  product  content  requirements.  The  environmental,  product
content/disposal and recycling laws are gradually becoming more stringent and may cause us to incur significant expenditures in the future.

In connection with the Separation, we agreed to indemnify Viavi for any liability associated with contamination from past operations at all properties transferred to us

from Viavi, to the extent the resulting issues primarily related to our business. We have not been presented with any claims to date.

10

Table of Contents

International Operations

During fiscal 2019, 2018 and 2017, net revenue from customers outside the United States based on the geographic region and country where our product is initially
shipped,  represented  93.6%,  90.8%  and  85.2% of  net  revenue,  respectively.  In  certain  circumstances  customers  may  request  shipment  of  our  products  to  a  contract
manufacturer in one country, which may differ from the location of their end customers. During fiscal 2019, our net revenue from Hong Kong, Mexico, South Korea, and
Japan represented 24.8%, 13.7%, 10.4%, and 11.2% of our consolidated net revenue, respectively. During fiscal 2018, our net revenue from Hong Kong, Mexico, South
Korea,  and  Japan  represented  14.7%,  11.7%,  11.7%,  and  15.6%  of  our  consolidated  net  revenue,  respectively.  During  fiscal  2017,  our  net  revenue  from  Hong  Kong,
Mexico, and Japan represented 22.6%, 18.5% and 9.9% of our consolidated net revenue, respectively. Our net revenue is primarily denominated in U.S. dollars, including
our net revenue from customers outside the United States based on customer shipment locations as presented above.

As  of  June  29,  2019 and  June  30,  2018,  long-lived  assets,  namely  our  net  property,  plant  and  equipment,  located  outside  of  the  United  States  comprised  64.0%
and 68.2% of our total property, plant and equipment, net, respectively. As of June 29, 2019, 7.7% and 36.3% of our net property, plant and equipment were located in
China and Thailand, respectively. As of June 30, 2018, 22.8% and 35.0% of our net property, plant and equipment were located in China and Thailand, respectively.

Please  refer  to  “Note  20.  Operating  Segments  and  Geographic  Information”  in  the  Notes  to  Consolidated  Financial  Statements.  For  information  regarding  risks

associated with our international operations, see “Item 1A. Risk Factors.”

Available Information

Our website is located at www.lumentum.com, and our investor relations website is located at www.investor.lumentum.com. Copies of our Annual Reports on Form
10-K,  Quarterly  Reports  on  Form  10-Q,  Current  Reports  on  Form  8-K  and  amendments  to  these  reports  filed  or  furnished  pursuant  to  Section  13(a)  or  15(d)  of  the
Exchange Act, as amended, are available free of charge on our investor relations website as soon as reasonably practicable after we file such material electronically with or
furnish it to the Securities and Exchange Commission (the “SEC”). The SEC also maintains a website that contains our SEC filings at www.sec.gov.

Investors and others should note that we routinely use the Investors section of our website to announce material information to investors and the marketplace. While
not all  of the  information  that  the  Company  posts on  its  corporate  website  is  of a  material  nature,  some information  could be  deemed  to  be material.  Accordingly,  the
Company encourages investors, the media and others interested in the Company to review the information that it shares on www.lumentum.com. Information in, or that
can be accessed through, our website is not incorporated into this Form 10-K.

11

Table of Contents

ITEM 1A. RISK FACTORS

Investors  in  our  securities  should  carefully  consider  all  of  the  relevant  factors  disclosed  by  us,  including  the  following  factors  that  could  affect  our  results  of

operations, financial condition or stock price.

Risks Related to Our Business

Changing technology and intense competition require us to continuously innovate while controlling product costs, and our failure to do so may result in

decreased revenues and profitability.

The markets in which we operate are dynamic and complex, and our success depends upon our ability to deliver both our current product offerings and new products
and technologies on time and at acceptable prices to our customers. The markets for our products are characterized by rapid technological change, frequent new product
introductions, substantial capital investment, changes in customer requirements, continued price pressures and a constantly evolving industry. Historically, these pricing
pressures  have  led  to  a  continued  decline  of  average  selling  prices  across  our  business.  The  development  of  new,  technologically  advanced  products  is  a  complex  and
uncertain process requiring high levels of innovation and the accurate prediction of technology and market trends. The introduction of new products also often requires
significant investment to ramp up production capacity, the benefit of which may not be realized if we are not successful in the production of such products or if customer
demand does not develop as expected. Ramping of production capacity also entails risks of delays which can limit our ability to realize the full benefit of new product
introductions. We cannot assure you that we will be able to identify, develop, manufacture, market or support new or enhanced products successfully, if at all, or on a
timely basis. We also cannot assure you that potential markets for our new products will materialize on the timelines we anticipate, or at all, or that our technology will
meet  our  customers’  specifications.  Our  future  performance  will  depend  on  the  successful  development,  introduction,  deployment  and  market  acceptance  of  new  and
enhanced features and products that meet our customers’ current and future needs.

The market for optical communications products in particular has matured over time and these products have increasingly become subject to commoditization. Both
legacy  competitors  as  well  as  new  entrants,  predominantly  Asia-based  competitors,  have  intensified  market  competition  in  recent  years  leading  to  pricing  pressure.  To
preserve our revenues and product margin structures, we remain reliant on an integrated customer and market approach that anticipates end customer needs as Telecom and
Datacom  requirements  evolve.  We  also  must  continue  to  develop  more  advanced,  differentiated  products  that  command  a  premium  with  customers,  while  conversely
continuing to focus on streamlining product costs for established legacy products. If we fail to continue to develop enhanced or new products, or over time are unable to
adjust  our  cost  structure  to  continue  to  competitively  price  more  mature  products,  our  financial  condition  and  results  of  operations  could  be  materially  and  adversely
affected.

We  rely  on  a  limited  number  of  customers  for  a  significant  portion  of  our  sales;  and  the  majority  of  our  customers  do  not  have  contractual  purchase

commitments.

We have consistently relied on a small number of customers for a significant portion of our sales and in certain of our markets, such as 3D sensing and commercial
lasers, this customer concentration is particularly acute. We expect that this customer concentration will continue in the future and we expect that our growth prospects will
continue to be concentrated in a small number of customers. Many of our customers purchase products under purchase orders or under contracts that do not contain volume
purchase commitments. Some customers provide us with their expected forecasts for our products several months in advance, but these customers may decrease, cancel or
delay purchase orders already in place, including on short notice, and the impact of any such actions may be intensified given our dependence on a limited number of large
customers. In addition, changes in the business requirements, vendor selection, project prioritization, financial prospects, capital resources, and expenditures, or purchasing
behavior (including product mix purchased or timing of purchases) of our key customers, or any real or perceived quality issues related to the products that we sell to such
customers,  could  significantly  decrease  our  sales  to  such  customers  or  could  lead  to  delays  or  cancellations  of  planned  purchases  of  our  products  or  services,  which
increases the risk of quarterly fluctuations in our revenues and operating results. There are also continuing trade tensions with the U.S. and countries in Asia, which could
materially impact our sales to key customers in these regions. Further, we may be required to purchase raw materials, increase production capacity or make other changes
to  our  business  to  accommodate  certain  large  customers.  If  forecasted  orders  do  not  materialize,  we  may  need  to  reduce  investment  in  R&D  activities,  we  may  fail  to
optimize our manufacturing capacity, we may incur liabilities with our suppliers for reimbursement of capital expenditures, or we may have excess inventory. In addition,
if  we  incur  expenses  in  response  to  forecasted  demand  and  do  not  have  a  corresponding  increase  in  revenue,  our  profitability  may  suffer.  Any  of  these  factors  could
adversely affect our business, financial condition and results of operations.

Our ability to sell our products to a significant customer has been restricted.

On  May  16,  2019,  Huawei  Technologies  Co.  Ltd.  and  68  designated  non-U.S.  affiliates  (collectively,  “Huawei”)  were  added  to  the  Entity  List  of  the  Bureau  of

Industry and Security of the U.S. Department of Commerce, which imposes limitations on the

12

Table of Contents

supply  of  certain  U.S.  items  and  product  support  to  Huawei.  Sales  to  Huawei  accounted  for  15.2% of  our  total  revenue  for  the  fiscal  year  ended  June  29,  2019. We
suspended  shipments  of  all  products  to  Huawei  until  we  were  able  to  review  our  product  portfolio  and  determine  whether  our  products  are  subject  to  the  Export
Administration Regulations (“EAR”), and therefore within the scope of the Entity List restrictions. We resumed shipments of certain of our products to Huawei during the
quarter ended June 29, 2019 after determining that such products are not subject to the EAR.

Notwithstanding our determination that we are able to ship certain products in compliance with applicable law, we believe that under the current regulatory regime,
our business with Huawei may be more limited than it was in the past. For example, we may be unable to supply certain other products or be limited or unable to work with
Huawei on future product development while Huawei remains on the Entity List, which may negatively impact our financial condition and results of operations. Huawei
may seek to obtain similar or substitute products from our competitors that are not subject to these restrictions, or to develop similar or substitute products themselves.

We also cannot be certain what additional actions the U.S. government may take with respect to Huawei, including changes to the Entity List restrictions,  export
regulations, tariffs or other trade restrictions. We are unable to predict the duration of the restrictions enacted in May 2019 or of additional actions, which could have a
long-term adverse effect on our business.

We  also  manufacture  customized  products  for  Huawei,  and  therefore  may  be  unable  to  sell  certain  finished  goods  inventory  to  alternative  customers,  or  may  be

unable to utilize such manufacturing capabilities for products for alternative customers, which may result in excess and obsolete changes in future periods.

Continued competition in our markets may lead to an accelerated reduction in our prices, revenues and market share.

The end markets for optical products have experienced significant industry consolidation during the past few years. As a result, the markets for optical subsystems,
components and laser diodes are highly competitive. Our current competitors include a number of domestic and international public and private companies, many of which
may have substantially greater financial, technical, marketing and distribution resources and brand name recognition than we have. Our competitors include II-VI (which
has announced an agreement to acquire Finisar), Acacia Communications (which has entered an agreement to be acquired by Cisco), AMS, Broadcom, Coherent, Finisar,
Fujitsu  Optical  Components,  Furukawa  Electric,  IPG  Photonics,  MACOM,  Mitsubishi  Electric,  Molex,  Neophotonics,  nLight,  O-net  Communications,  OSRAM,
Sumitomo Electric Industries and Trumpf. We may not be able to compete successfully against either current or future competitors. Our competitors may continue to enter
markets or gain or retain market share through introduction of new or improved products or with aggressive low pricing strategies that may impact the efficacy of our
approach. Additionally, if significant competitors were to merge or consolidate, for example, the pending acquisitions of Finisar by II-VI and Acacia Communications by
Cisco, they may be able to offer a lower cost structure through economies of scale that we may be unable to match and which may intensify competition in the various
markets. Increased competition could result in significant price erosion, reduced revenue, lower margins or loss of market share, any of which would significantly harm our
business.

The manufacturing of our products may be adversely affected if we are unable to manufacture certain products in our manufacturing facilities or if our contract

manufacturers and suppliers fail to meet our production requirements.

We manufacture some of our finished good products as well as some of the components that we provide to our contract manufacturers, in our China, Italy, Japan,
Thailand,  U.K.,  and  San  Jose,  California  manufacturing  facilities.  For  some  of  the  components  and  finished  good  products  we  are  the  sole  manufacturer.  Our
manufacturing processes are highly complex, and issues are often difficult to detect and correct. From time to time we have experienced problems achieving acceptable
yields in our manufacturing facilities,  resulting in delays in the availability  of our products. In addition, if we experience problems with our manufacturing facilities, it
would be costly and require a long period of time to move the manufacture of these components and finished good products to a different facility or contract manufacturer
which could then result in interruptions in supply, and would likely materially impact our financial condition and results of operations.

We also rely on several independent contract manufacturers to supply us with certain products. For many products, a particular contract manufacturer may be the sole
source  of  the  finished  good  products.  We  depend  on  these  manufacturers  to  meet  our  production  and  capacity  requirements  and  to  provide  quality  products  to  our
customers. Despite rigorous testing for quality, both by us and the contract manufacturers to whom we sell products, we may receive and ship defective products. We may
incur significant costs to correct defective products which could result in the loss of future sales, indemnification costs or costs to replace or repair the defective products,
litigation  and  damage  to  our  reputation  and  customer  relations.  Defective  products  may  also  cause  diversion  of  management  attention  from  our  business  and  product
development efforts.

Additionally, our ability to fulfill our customers’ demand, or the ability of our contract manufacturers to fulfill their obligations, may be affected by natural disasters,
changes  in  legal  requirements,  labor  strikes  and  other  labor  unrest  and  economic,  political  or  other  forces  that  are  beyond  our  control.  For  example,  in  the  past  we
experienced a labor strike at one of our contract manufacturers

13

Table of Contents

which threatened the contract manufacturer’s ability to fulfill its product commitments to us and, in turn, our ability to fulfill our obligations to our customers. Further,
certain of our contract manufacturers are located in China, which exposes us to risks associated with Chinese laws and regulations and U.S. laws, regulations and policies
with respect to China, such as those related to import and export policies, tariffs, taxation and intellectual property. Chinese laws and regulations are subject to frequent
change, and if our contract manufacturers are unable to obtain or retain the requisite legal permits or otherwise to comply with Chinese legal requirements, we may be
forced to obtain products from other manufacturers or to make other operational changes, including transferring our manufacturing to another manufacturer or to our own
manufacturing facilities. Any such developments could have a material impact on our ability to meet our customers’ expectations and may materially impact our operating
results. The United States has recently imposed tariffs on the import of certain products manufactured in China, and may propose further tariffs in the future, which could
increase costs associated with the manufacturing of our products in China, and potentially other countries, and negatively impact our sales levels and profit margins.

In addition, for a variety of reasons, including changes in circumstances at our contract manufacturers or regarding our own business strategies, we may choose or be
required to transfer the manufacturing of certain products to other manufacturing sites, including to our own manufacturing facilities. For example, we are in the process of
transitioning  the  manufacturing  of  our  products  with  one  of  our  contract  manufacturers  in  China  to  our  Shenzhen  and  Thailand  manufacturing  facilities  and  to  other
contract manufacturers. As a result of such transfers, our contract manufacturers may prioritize other customers or otherwise be unable to meet our demand. There also
may be delays with the transfer of manufacturing equipment and successfully setting up that equipment at the transfer sites and training new operators. If such transfers are
unsuccessful  or  take  a  longer  period  of  time  than  expected,  it  could  result  in  interruptions  in  supply  and  would  likely  impact  our  financial  condition  and  results  of
operations.

Some of our purchase commitments with contract manufacturers are not cancellable which may impact our results of operations if customer forecasts driving these
purchase commitments do not materialize and we are unable to sell the products to other customers. Alternatively, our contract manufacturers may not be able to meet our
demand which would inhibit our ability to meet our customers’ demands and maintain or grow our revenues. Furthermore, it could be costly and require a long period of
time to move products from one contract manufacturer to another which could result in interruptions in supply and adversely impact our financial condition and results of
operations.

In addition, many of our products are sourced from suppliers based outside of the United States, primarily in Asia. Uncertainty with respect to tax and trade policies,
tariffs  and  government  regulations  affecting  trade  between  the  United  States  and  other  countries  has  recently  increased.  Major  developments  in  tax  policy  or  trade
relations, such as the imposition of tariffs on imported products, could increase our product and product-related costs or require us to seek alternative suppliers, either of
which could result in decreased sales or increased product and product-related costs.

If our customers  do not qualify our manufacturing lines  or the manufacturing lines of our subcontractors for volume  shipments, our operating results could

suffer.

Certain  of  our  customers  do  not  purchase  products,  other  than  limited  numbers  of  evaluation  units,  prior  to  qualification  of  the  manufacturing  line  for  volume
production.  Our existing manufacturing  lines,  as well as each new manufacturing  line, must pass through varying  levels of qualification  with certain  of our customers.
Some of our customers require that our manufacturing lines pass their specific qualification standards and that we, and any subcontractors that we may use, be registered
under  international  quality  standards.  We  may  encounter  quality  control  issues  as  a  result  of  setting  up  new  manufacturing  lines  in  our  facilities,  relocating  our
manufacturing lines or introducing new products to fill production. We may be unable to obtain, or we may experience delays in obtaining, customer qualification of our
manufacturing lines. If we introduce new contract manufacturing partners and move any production lines from existing internal or external facilities, the new production
lines will likely need to be re-qualified with our customers. Any delays or failure to obtain qualifications would harm our operating results and customer relationships.

We  depend  on  a  limited  number  of  suppliers  for  raw  materials,  packages  and  components,  and  any  failure  or  delay  by  these  suppliers  in  meeting  our

requirements could have an adverse effect on our business and results of operations.

We purchase raw materials, packages and components from a limited number of suppliers, who are often small and specialized. Additionally, some of our suppliers
are  our  sole  sources  for  certain  materials,  equipment  and  components.  We  depend  on  the  timely  and  continued  supply  and  quality  of  the  materials,  packages  and
components that our suppliers supply to us. We have not entered into long-term agreements with many of these suppliers. As a result, these suppliers may stop supplying
us  materials  and  equipment  at  any  time.  Our  business  and  results  of  operations  have  been,  and  could  continue  to  be,  adversely  affected  by  this  dependency.  Specific
concerns we periodically encounter with our sole suppliers or limited number of suppliers include receipt of defective parts or contaminated materials, stoppages or delays
of supply, insufficient resources to supply our requirements, substitution of more expensive or less reliable materials, increases in the price of supplies, and an inability to
obtain reduced pricing from our suppliers in response to competitive pressures. Additionally, supply of and costs of raw materials may be negatively impacted by trade
protection policies such as tariffs, or escalating trade tensions, particularly with countries in Asia. Any disruption in the

14

Table of Contents

supply of the raw materials, packaging or components used in the manufacture and delivery of our products could have a material adverse impact on our business, financial
condition and results of operations.

We contract with a number of large OEM and end-user service providers and product companies that have considerable bargaining power, which may require us

to agree to terms and conditions that could have an adverse effect on our business or ability to recognize revenues.

Large  OEM  and  end-user  service  providers  and  product  companies  comprise  a  significant  portion  of  our  customer  base.  These  customers  generally  have  greater
purchasing power than smaller entities and, accordingly, often request and receive more favorable terms from suppliers, including us. As we seek to expand our sales to
existing customers and acquire new customers, we may be required to agree to terms and conditions that are favorable to our customers and that may affect the timing of
our ability to recognize revenue, increase our costs and have an adverse effect on our business, financial condition, and results of operations. Furthermore, large customers
have increased buying power and ability to require onerous terms in our contracts with them, including pricing, warranties, and indemnification terms. If we are unable to
satisfy  the  terms  of  these  contracts,  it  could  result  in  liabilities  of  a  material  nature,  including  litigation,  damages,  additional  costs,  loss  of  market  share  and  loss  of
reputation. Additionally, the terms these large customers require, such as most-favored nation or exclusivity provisions, may impact our ability to do business with other
customers and generate revenues from such customers.

Our products  may  contain  defects  that  could  cause  us to  incur  significant  costs,  divert  our  attention  from  product  development  efforts  and result  in  a loss  of

customers.

Our products are complex and defects may be found from time to time. Networking products in particular frequently contain undetected software or hardware defects
when first introduced or as new versions are released. In addition, our products are often embedded in or deployed in conjunction with our customers’ products which
incorporate a variety of components produced by third parties. As a result, when problems occur, it may be difficult to identify the source of the problem. These problems
may cause us to incur significant damages or warranty and repair costs, divert the attention of our engineering personnel from our product development efforts and cause
significant customer relation problems or loss of customers, all of which would harm our business.

We are subject to risks arising from our international operations, which may adversely affect our business, financial condition, and results of operations.

We  derive  a  majority  of  our  revenue  from  our  international  operations,  and  we plan  to  continue  expanding  our  business  in  international  markets  in  the  future.  In
addition, we have extensive international manufacturing capabilities through third-party contract manufacturers, as well as through our own international facilities, with
employees engaged in R&D, administration, manufacturing, support and sales and marketing activities.

As a result of our international operations, in addition to similar risks we face in our U.S. operations, we are affected by economic, business, regulatory, social, and

political conditions in foreign countries, including the following:

•

•

•

•

•

•

•

•

changes in general IT spending;

the imposition of government controls, inclusive of critical infrastructure protection;

changes in or limitations imposed by trade protection laws or other regulatory orders or requirements in the United States or in other countries, including
tariffs, sanctions, or other costs or requirements which may affect our ability to import or export our products from various countries or increase the cost to
do so, including government action to restrict our ability to sell to foreign customers where sales of products may require export licenses (such as the U.S.
Department of Commerce’s addition of Huawei to the Entity List in May 2019 and the prohibition of export and sale of certain products to ZTE Corporation
in early 2018) and increased tariffs on various products that have been proposed by the U.S. government and other non-U.S. governments;

varying and potentially conflicting laws and regulations;

fluctuations in local economies;

wage inflation or a tightening of the labor market;

political developments of foreign nations; and

the  impact  of  the  following  on  service  provider  and  government  spending  patterns  as  well  as  our  contract  and  internal  manufacturing:  political
considerations,  unfavorable  changes  in  tax  treaties  or  laws,  unfavorable  events  that  affect  foreign  currencies,  natural  disasters,  epidemic  disease,  labor
unrest, earnings expatriation restrictions,

15

Table of Contents

misappropriation of intellectual property, military actions, acts of terrorism, political and social unrest and difficulties in staffing and managing international
operations.

Moreover, local laws and customs in many countries differ significantly from or conflict with those in the United States or other countries in which we operate. In
many foreign countries, particularly in those with developing economies, it is common for others to engage in business practices that are prohibited by our internal policies
and  procedures  or  U.S.  regulations  applicable  to  us.  There  can  be  no  assurance  that  our  employees,  contractors,  channel  partners  and  agents  will  not  take  actions  in
violation of our policies and procedures, which are designed to ensure compliance with U.S. and foreign laws and policies. Violations of laws or key control policies by
our employees, contractors, channel partners, or agents could result in termination of our relationships with customers and suppliers, financial reporting problems, fines
and/or penalties for us, or prohibition on the importation or exportation of our products, and could have a material adverse effect on our business, financial condition and
results of operations.

Any or all of these factors could have a material adverse impact on our business, financial condition, and results of operations.

The threat of increasing tariffs, particularly to goods traded between the United States and China, could materially and adversely affect our business and results

of operations.

Since  the  beginning  of  2018,  there  has  been  increasing  rhetoric,  in  some  cases  coupled  with  legislative  or  executive  action,  from  several  U.S.  and  foreign  leaders
regarding instituting tariffs against foreign imports of certain materials. More specifically, since 2018, the United States and China applied or proposed to apply tariffs to
certain of each other’s exports, and we expect these actions to continue for the foreseeable future. The institution of trade tariffs both globally and between the United
States  and  China  specifically  carries  the  risk  of  negatively  impacting  overall  economic  conditions,  which  could  have  negative  repercussions  on  our  industry  and  our
business. Furthermore, imposition of tariffs or new or revised export, import or doing-business regulations, including trade sanctions, could cause a decrease in the sales of
our products to customers located in China or other customers selling to Chinese end users, which would directly impact our business and results of operations.

We face a number of risks related to our strategic transactions.

We have in the past acquired several companies, including our acquisition of Oclaro in December 2018. We may continue to expand and diversify our operations with
additional  acquisitions.  We  may  be  unable  to  identify  or  complete  prospective  acquisitions  for  many  reasons,  including  increasing  competition  from  other  potential
acquirers, the effects of consolidation in our industries and potentially high valuations of acquisition candidates. In addition, applicable antitrust laws and other regulations
may limit our ability to acquire targets or force us to divest an acquired business. If we are unable to identify suitable targets or complete acquisitions, our growth prospects
may suffer, and we may not be able to realize sufficient scale and technological advantages to compete effectively in all markets.

In connection with acquisitions, risks to us and our business include:

•

•

•

•

•

•

•

•

•

diversion of management’s attention from normal daily operations of the business;    

unforeseen expenses, delays or conditions imposed upon the acquisition or transaction, including due to required regulatory approvals or consents;

unanticipated changes in the combined business due to potential divestitures or other requirements imposed by antitrust regulators;

unanticipated  changes  in  the  acquired  business,  including  due  to  regulatory  action  or  changes  in  the  operating  results  or  financial  condition  of  the
business;

the inability to retain and obtain required regulatory approvals, licenses and permits;

difficulties and costs in integrating the operations, technologies, products, IT and other systems, facilities and personnel of the purchased businesses;

loss of customers, suppliers or partners;

potential difficulties in completing projects associated with in-process R&D;

an acquisition or strategic transaction may not further our business strategy as we expected or we may overpay for, or otherwise not realize the expected
return on, our investments;

We have in the past, and may in the future, also divest or reduce its investment in certain businesses or product lines from time to time. For example, during the
third quarter of fiscal year 2019, we announced the divestiture of our Datacom module business in Japan which was completed in the fourth quarter of fiscal year 2019.
Such divestitures involve risks, such as difficulty

16

Table of Contents

separating portions of or entire businesses, distracting employees, incurring potential loss of revenue, negatively impacting margins, and potentially disrupting customer
relationships. We may also incur significant costs associated with exit or disposal activities, related impairment charges, or both.

If we are unable to successfully manage any of these risks in relation to any future acquisitions or divestitures, our business, financial condition and results of operations
could be adversely impacted.

We may be unable to successfully implement our acquisitions strategy or integrate acquired companies and personnel with existing operations.

To  the  extent  we  are  successful  in  making  acquisitions,  we  may  be  unsuccessful  in  implementing  our  acquisitions  strategy,  or  integrating  acquired  companies  or
product lines and personnel with existing operations, or the integration may be more difficult or more costly than anticipated. Some of the risks that may affect our ability
to integrate or realize any anticipated benefits from acquired companies, businesses or assets include those associated with:

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

loss of customers, suppliers or partners;

potential difficulties in completing projects associated with in-process R&D;

an acquisition or strategic transaction may not further our business strategy as we expected or we may overpay for, or otherwise not realize the expected
return on, our investments;

we may face unanticipated liabilities or our exposure for known contingencies and liabilities may exceed our estimates;

insufficient net revenue to offset increased expenses associated with acquisitions;

unexpected losses of key employees of the acquired company, or inability to maintain our company culture;

conforming  the  acquired  company’s  standards,  processes,  procedures  and  controls  with  our  operations,  including  integrating  Enterprise  Resource
Planning (“ERP”) systems and other key business applications;

coordinating new product and process development;

increasing complexity from combining operations;

increasing the scope, geographic diversity and complexity of our operations;

difficulties in consolidating facilities and transferring processes and know-how; and

diversion of management’s attention from other business concerns.

dilution of our current stockholders as a result of any issuance of equity securities as acquisition consideration;

expenditure of cash that would otherwise be available to operate our business;

incurrence of indebtedness on terms that are unfavorable to us, limit our operational flexibility or that we are unable to repay;

In addition, following an acquisition, we may have difficulty forecasting the financial results of the combined company the market price of our common stock could
be adversely affected if the effect of any acquisitions on our consolidated financial results is dilutive or is below the market's or financial analysts' expectations, or if there
are  unanticipated  changes  in  the  business  or  financial  performance  of  the  target  company  or  the  combined  company.  Any  failure  to  successfully  integrate  acquired
businesses may disrupt our business and adversely impact our business, financial condition and results of operations.

Changes in demand and customer requirements for our products may reduce manufacturing yields, which could negatively impact our profitability.

Manufacturing  yields  depend  on  a  number  of  factors,  including  the  volume  of  production  due  to  customer  demand  and  the  nature  and  extent  of  changes  in
specifications required by customers for which we perform design-in work. Changes in manufacturing processes required as a result of changes in product specifications,
changing customer needs, introduction of new product lines and changes in contract manufacturers may reduce manufacturing yields, resulting in low or negative margins
on those products. Moreover, an increase in the rejection rate of products during the quality control process, before, during or after

17

Table of Contents

manufacture,  results  in  lower  gross  margins  from  lower  yields  and  additional  rework  costs.  Any  reduction  in  our  manufacturing  yields  will  adversely  affect  our  gross
margins and could have a material impact on our operating results.

We may not be able to realize tax savings from our international tax structure, which could materially and adversely affect our operating results.

We initiated a new international corporate structure more closely aligned with our international operations during the third quarter of fiscal 2018. The new corporate
structure is intended to reduce our overall effective tax rate through changes among our wholly-owned subsidiaries in how we use our intellectual property, and how we
structure our international procurement and sales operations. The new structure includes legal entities located in jurisdictions with income tax rates lower than the U.S.
statutory tax rate. The intercompany arrangements are intended to result in income earned by such entities in accordance with arm’s-length principles and commensurate
with functions performed, risks assumed and ownership of valuable corporate assets. We have not yet operationalized the new structure to the full extent possible due to
various factors including the acquisition of Oclaro in the second quarter of fiscal 2019. We are currently in the process of assessing the Oclaro transaction’s impact to our
tax structure and, depending on the outcome, we may make modifications to the new structure in order to achieve better tax and operational efficiency. If we are unable to
fully adopt a new international structure, if substantial modifications to the new international structure or the way we operate our business are made in light of the Oclaro
acquisition or for other reasons, if changes in domestic and international tax laws negatively impact the structure, if we do not operate our business consistent with the new
structure and applicable tax provisions, if we fail to achieve our revenue and profit goals, or if it is successfully challenged by the U.S. or foreign tax authorities, we may
be unable to realize the anticipated tax savings which could materially and adversely affect our operating and financial results.

We have agreed to reimburse Viavi for certain tax liabilities and related costs that may be incurred by Viavi, under certain circumstances, as a result of implementing
the new corporate structure or a modified structure in the future. In addition, the implementation of such a structure has required us to incur expenses, and may require that
we incur additional expenses, for which we may not realize the anticipated benefit or it may take us several years to fully realize the anticipated benefit.

Changes in tax laws could have a material adverse effect on our business, cash flow, results of operations or financial conditions.

As  a  multinational  corporation,  we  are  subject  to  income  taxes  as  well  as  non-income  based  taxes,  in  both  the  U.S.  and  various  foreign  jurisdictions.  Significant
uncertainties exist with respect to the amount of our tax liabilities, including those arising from potential changes in laws in the countries in which we do business and the
possibility of adverse determinations with respect to the application of existing laws. Many judgments are required in determining our worldwide provision for income
taxes and other tax liabilities, and we are under audit by various tax authorities, which often do not agree with positions taken by us on our tax returns. Any unfavorable
resolution of these uncertainties may have a significant adverse impact on our tax rate.

Increasingly, countries around the world are actively considering or have enacted changes in relevant tax, accounting and other laws, regulations and interpretations.
In particular, the Tax Cuts and Jobs Act (the “Tax Act”) contains many significant changes to the U.S. tax laws that affected our fiscal year ended  June 29, 2019, and
which will continue to affect our fiscal years thereafter. Information regarding the Tax Act and the impact of the Tax Act on our tax profile is included in our Annual
Report on Form 10-K for our fiscal year ended June 30, 2018.

The reduction in the U.S. federal statutory rate is expected to positively impact our federal cash tax liability. However, the ultimate impact is subject to the effect of
other complex provisions in the Tax Act (including the BEAT and GILTI), and it is possible that any impact of BEAT, GILTI, or other provisions of the Tax Act could
significantly reduce, or outweigh, the benefit of the reduction in the U.S. federal statutory rate. Due to the uncertain practical and technical application of many of these
provisions,  we  made  reasonable  estimates  of  the  effects  and  recorded  provisional  amounts  where  possible  for  the  fiscal  year  ended  June  30,  2018.  The  U.S.  Treasury
Department and the Internal Revenue Service (IRS), and other standards-setting bodies may issue guidance on how the provisions of the Tax Act will be applied that is
different  from  our  interpretation.  The  Tax  Act  requires  complex  computations  not  previously  required  or  produced,  and  significant  judgments  and  assumptions  in  the
interpretation of the law were made in producing our provisional estimates. During the period ended December 29, 2018, we completed our accounting for the Tax Act
with no material adjustment to our provisional estimates. We also anticipate that uncertainty in the application of the Tax Act to our ongoing operations as well as possible
adverse future law changes attributable to changes in the U.S. political environment could have an adverse impact on our future tax rate. Other countries also continue to
enact  and  consider  enacting  new  laws,  which  could  adversely  affect  us.  The  foregoing  items  could  increase  our  future  tax  expense,  could  change  our  future  intentions
regarding reinvestment of foreign earnings, and could have a material adverse effect on our business, financial condition and results of operations.

18

Table of Contents

The income and non-income tax regimes we are subject to or operate under are unsettled and may be subject to significant change. Changes in tax laws or tax rulings,
or changes in interpretations of existing laws, could materially affect our financial position and results of operations. Many countries in Europe, as well as a number of
other countries and organizations, have recently proposed or recommended changes to existing tax laws or have enacted new laws that could increase our tax obligations
where  we  do  business  or  require  us  to  change  the  manner  in  which  we  operate  our  business.  The  Organization  for  Economic  Cooperation  and  Development  has  been
working on a set of internationally accepted tax rules as a part of a Base Erosion and Profit Sharing (BEPS) Project aimed at tax avoidance, and that the roll-out of BEPS
action steps by various jurisdictions may change aspects of the existing framework under which our tax obligations are determined in many of the countries in which we do
business.

On  June  7,  2019,  the  Ninth  Circuit  Court  of  Appeals,  reversing  a  previous  decision  of  the  U.S.  Tax  Court,  held  that  the  U.S.  Treasury  Department’s  regulations
requiring  the  inclusion  of  stock-based  compensation  expense  in  a  taxpayer’s  cost-sharing  calculations  were  valid.  We  have  a  research  and  development  cost  sharing
arrangement  with  one  of  our  foreign  affiliates.  Our  financial  statements  have  been  prepared  consistent  with  the  ruling  and  we  will  continue  to  monitor  any  ongoing
developments, including the possibility of rehearing or appeal to the U.S. Supreme Court, to determine if future changes are required.

Our subsidiary in Thailand currently operates under a tax holiday which will expire in fiscal 2025 unless extension is granted by the Thailand government and we
continue to meet the requirements thereunder. If we do not meet the tax holiday requirements, if we are not granted an extension by the Thailand government, or if we
decide not to apply for an extension of the tax holiday, income earned in Thailand will be subject to a higher statutory income tax rate, which may cause our effective tax
rate to increase and reduce our liquidity and cash flow.

Our operating results may be subject to volatility due to fluctuations in foreign currency.

We are exposed to foreign exchange risks with regard to our international operations which may affect our operating results. Since we conduct business in currencies
other  than  U.S.  dollars  but  report  our  financial  results  in  U.S.  dollars,  we  face  exposure  to  fluctuations  in  currency  exchange  rates.  Although  we  price  our  products
primarily in U.S. dollars, a portion of our operating expenses are incurred in foreign currencies. For example, a portion of our expenses are denominated in U.K. pound
sterling, Chinese yuan and Thai baht. Fluctuations in the exchange rate between these currencies and other currencies in which we collect revenues and/or pay expenses
could have a material effect on our future operating results. If the value of the U.S. dollar depreciates relative to certain other foreign currencies, it would increase our costs
as expressed in U.S. dollars. Conversely, if the U.S. dollar strengthens relative to other currencies, such strengthening could raise the relative cost of our products to non-
U.S. customers, especially as compared to foreign competitors, and could reduce demand.

Our ability to develop, market, and sell products could be harmed if we are unable to retain or hire key personnel.

Our future success depends upon our ability to recruit and retain the services of executive, engineering, sales and marketing, and support personnel. The supply of
highly qualified individuals, in particular engineers in very specialized technical areas, or sales people specializing in the service provider, enterprise and commercial laser
markets, is limited and competition for such individuals is intense. None of our officers or key employees is bound by an employment agreement for any specific term. The
loss of the services of any of our key employees, the inability to attract or retain personnel in the future or delays in hiring required personnel and the complexity and time
involved  in  replacing  or  training  new  employees,  could  delay  the  development  and  introduction  of  new  products,  and  negatively  impact  our  ability  to  market,  sell,  or
support our products.

We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.

We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges, including supporting
the  development  and  introduction  of  new  products,  addressing  new markets,  engaging  in strategic  transactions  and  partnerships,  improving  or  expanding  our  operating
infrastructure  or  acquiring  complementary  businesses  and  technologies.  On  December  10,  2018,  we  entered  into  a  credit  agreement  (the  “Credit  Agreement”)  with
Deutsche Bank AG New York Branch for a senior secured term loan facility in an aggregate principal amount of $500 million (the “Term Loan Facility”). In March 2017,
we  issued  and  sold  a  total  of  $450  million  in  aggregate  principal  amount  of  Convertible  Notes  due  in  2024  (the  “2024  Notes”)  and  we  may  in  the  future  engage  in
additional equity or debt financings to secure additional funds. If we raise additional funds through future issuances of equity, equity-linked or convertible debt securities,
our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders
of our common stock. Any debt financing we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and
operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not
be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us

19

Table of Contents

when we require it, our ability to continue to support our business growth and to respond to business challenges could be significantly impaired, and our business may be
harmed.

Our ability to hire and retain employees may be negatively impacted by changes in immigration laws, regulations and procedures.

Foreign nationals who are not U.S. citizens or permanent residents constitute an important part of our U.S. workforce, particularly in the areas of engineering and
product development. Our ability to hire and retain these workers and their ability to remain and work in the United States are impacted by laws and regulations, as well as
by procedures and enforcement practices of various government agencies. Changes in immigration laws, regulations or procedures, including those that may be enacted by
the current U.S. presidential administration and in the United Kingdom, may adversely affect our ability to hire or retain such workers, increase our operating expenses and
negatively impact our ability to deliver our products and services.

Any failure, disruption or security breach of our information technology infrastructure or information management systems could have an adverse impact on our

business and operations.

Our  business  depends  significantly  on  effective  and  efficient  information  management  systems,  and  the  reliability  and  security  of  our  information  technology
infrastructure  are  essential  to  the  health  and  expansion  of  our  business.  For  example,  the  information  gathered  and  processed  by  our  information  management  systems
assists  us  in  managing  our  supply  chain,  monitoring  customer  accounts,  and  protecting  our  proprietary  and  confidential  business  information,  plans,  trade  secrets,  and
intellectual property, among other things. In addition, these systems may also contain personal data or other protected information about our employees, our customers’
employees, or others. We must continue to expand and update this infrastructure in response to our changing requirements as well as evolving security standards and risks.

In  some  cases,  we  may  rely  upon  third-party  providers  of  hosting,  support  and  other  services  to  meet  our  information  technology  requirements.  Any  failure  to
manage, expand and update our information technology infrastructure, including our ERP system and other applications, any failure in the extension implementation or
operation of this infrastructure, or any failure by our hosting and support partners or other third-party service providers in the performance of their services could materially
harm our business. In addition, we have partnered with third parties to support our information technology systems and to help design, build, test, implement and maintain
our information management systems. Our merger, acquisition and divestiture activity, including our acquisition of Oclaro in December 2018, will also require transitions
to or from, and the integration of, various information management systems within our overall enterprise architecture, including our ERP system and other applications.
Those systems that we acquire may also pose security risks of which we are unaware or unable to mitigate, particularly during the transition of these systems.

Like  other  companies,  we are  subject  to  ongoing  attempts  by  malicious  actors,  including  through  hacking,  malware,  ransomware,  denial-of-service  attacks,  social
engineering,  exploitation  of  internet-connected  devices,  and  other  attacks,  to  obtain  unauthorized  access  or  acquisition  of  confidential  information  or  otherwise  affect
service reliability and threaten the confidentiality, integrity and availability of information on our systems. We have been in the past, and may be in the future, subject to
social engineering and other cybersecurity attacks. Further, our third party service providers may have been and may be in the future subject to such attacks. In addition,
actions by our employees, service providers, partners, contractors or others, whether malicious or in error, could affect the security of our systems. Further, a breach of our
information technology infrastructure could result in the misappropriation of intellectual property, business plans or trade secrets. Any failure of our systems or those of
our third-party service providers could result in unauthorized access or acquisition of such proprietary information, and any actual or perceived security breach could cause
significant  damage  to  our  reputation  and  adversely  impact  our  relationships  with  our  customers.  Additionally,  while  our  security  systems  are  designed  to  maintain  the
physical  security  of  our  facilities  and  information  systems,  accidental  or  willful  security  breaches  or  other  unauthorized  access  by  third  parties  to  our  facilities  or  our
information systems could lead to misappropriation of proprietary and confidential information.

Despite our implementation of security measures, our systems and those of our third-party service providers are vulnerable to damage from these types of attacks or
errors. In addition, our systems may be impacted by natural disasters, terrorism or other similar disruptions. Any system failure, accident or security breach affecting us or
our  third-party  providers  could  result  in  disruptions  to  our  operations  and  loss  of,  or  unauthorized  access  or  damage  to,  our  data  or  in  inappropriate  disclosure  of
confidential information. Any actual or alleged disruption to, or security breach affecting, our systems or those of our third-party partners could cause significant damage
to our reputation, lead to theft of our protected intellectual property and trade secrets, result in legal obligations or liability, affect our relationships with our customers, and
ultimately  harm  our  business.  In  addition,  we  may  be  required  to  incur  significant  costs  to  protect  against  or  mitigate  damage  caused  by  these  disruptions  or  security
breaches in the future.

Our revenues, operating  results,  and cash flows  may  fluctuate  from  period  to  period  due to  a number of factors  including  unfavorable  economic  and market

conditions, which makes predicting financial results difficult.

20

Table of Contents

Spending on optical communication and laser products is subject to cyclical and uneven fluctuations, which could cause our financial results to fluctuate unevenly
and unpredictably.  It  can be difficult  to predict  the  degree  to which end-customer  demand  and the seasonality  and uneven sales patterns  of our OEM partners  or other
customers will affect our business in the future, particularly as we or they release new or enhanced products. While our fourth fiscal quarters are typically strongest, future
buying patterns may differ from historical seasonality. Further, if the mix of revenue changes, it may also cause results to differ from historical seasonality. Accordingly,
our quarterly and annual revenues, operating results, cash flows, and other financial and operating metrics may vary significantly in the future, and the results of any prior
periods should not be relied upon as an indication of future performance.

Adverse changes to and uncertainty in the global economy may lead to decreased demand for our products and revenue fluctuations, increased price competition for
our  products,  and  may  increase  the  risk  of  excess  and  obsolete  inventories  and  higher  overhead  costs  as  a  percentage  of  revenue.  Declines  or  uncertainty  in  particular
geographic regions, such as China or Europe, may impact IT-related spending generally and consequently, may lead to lower growth or a decline in our markets. The loss
or delay of orders from any of our significant customers could cause our revenue and profitability to suffer. The impact of economic challenges on the global financial
markets could further negatively impact our operations by affecting the solvency of our customers, the solvency of our key suppliers or the ability of our customers to
obtain credit to finance purchases of our products. If economic conditions deteriorate or remain uncertain, our financial condition and results of operations would likely be
materially and adversely impacted.

If we have insufficient proprietary rights or if we fail to protect our rights, our business would be materially harmed.

We seek to protect our products and product roadmaps in part by developing and/or securing proprietary rights relating to those products, including patents, trade
secrets, know-how and continuing technological innovation. The steps we take to protect our intellectual property may not adequately prevent misappropriation or ensure
that  others  will  not  develop  competitive  technologies  or  products.  Other  companies  may  be  investigating  or  developing  technologies  that  are  similar  to  our  own.  It  is
possible that patents may not be issued from any of our pending applications or those we may file in the future and, if patents are issued, the claims allowed may not be
sufficiently broad to deter or prohibit others from making, using or selling products that are similar to ours, or such patents could be invalidated or ruled unenforceable. We
do not own patents in every country in which we sell or distribute our products, and thus others may be able to offer identical products in countries where we do not have
intellectual property protections. In addition, the laws of some territories in which our products are or may be developed, manufactured or sold, including Europe, Asia-
Pacific or Latin America, may not protect our products and intellectual property rights to the same extent as the laws of the United States. Any patents issued to us may be
challenged,  invalidated  or circumvented.  Additionally,  we are currently  a licensee  for a number of third-party  technologies  including software  and intellectual  property
rights from academic institutions, our competitors and others, and we are required to pay royalties to these licensors for the use thereof. In the future, if such licenses are
unavailable or if we are unable to obtain such licenses on commercially reasonable terms, we may not be able to rely on such third-party technologies which could inhibit
our development of new products, impede the sale of some of our current products, substantially increase the cost to provide these products to our customers, and could
have a significant adverse impact on our operating results.

We also seek to protect our important trademarks by endeavoring to register them in certain countries. We have not registered our trademarks in every country in
which  we  sell  or  distribute  our  products,  and  thus  others  may  be  able  to  use  the  same  or  confusingly  similar  marks  in  countries  where  we  do  not  have  trademark
registrations. We have adopted Lumentum as a house trademark and trade name for our company, and are in the process of establishing rights in this name and brand. We
have also adopted the Lumentum logo as a house trademark for our company, and are in the process of establishing rights in this brand. Trademarks associated with the
Lumentum brand have been registered in the United States or other jurisdictions, however, the efforts we take to maintain registration and protect trademarks, including the
Lumentum  brand,  may  not  be  sufficient  or  effective.  Although  we  have  registered  marks  associated  with  the  Lumentum  brand,  third  parties  may  seek  to  oppose  or
otherwise challenge these registrations. There is the possibility that, despite efforts, the scope of the protection obtained for our trademarks, including the Lumentum brand,
will be insufficient or that a registration may be deemed invalid or unenforceable in one or more jurisdictions throughout the world.

Further, a breach of our information technology infrastructure could result in the misappropriation of intellectual property, business plans or trade secrets. Any failure
of our systems or those of our third-party service providers could result in unauthorized access or acquisition of such proprietary information, and any actual or perceived
security breach could cause significant damage to our reputation and adversely impact our relationships with our customers.

21

Table of Contents

Our products may be subject to claims that they infringe the intellectual property rights of others, the resolution of which may be time-consuming and expensive,

as well as require a significant amount of resources to prosecute, defend, or make our products non-infringing.

Lawsuits and allegations of patent infringement and violation of other intellectual property rights occur regularly in our industry. We have in the past received, and
anticipate that we will receive in the future, notices from third parties claiming that our products infringe upon their proprietary rights, with two distinct sources of such
claims  becoming  increasingly  prevalent.  First,  large  technology  companies,  including  some  of  our  customers  and  competitors,  are  seeking  to  monetize  their  patent
portfolios and have developed large internal organizations that may approach us with demands to enter into license agreements. Second, patent-holding companies that do
not make or sell products (often referred to as “patent trolls”) may claim that our products infringe upon their proprietary rights. We respond to these claims in the course
of our business operations. The litigation or settlement of these matters, regardless of the merit of the claims, could result in significant expense and divert the efforts of our
technical  and  management  personnel,  regardless  of  whether  or  not  we  are  successful.  If  we  are  unsuccessful,  we  could  be  required  to  expend  significant  resources  to
develop  non-infringing  technology  or  to  obtain  licenses  to  the  technology  that  is  the  subject  of  the  litigation.  We  may  not  be  successful  in  such  development,  or  such
licenses may not be available on commercially reasonable terms, or at all. Without such a license, or if we are the subject of an exclusionary order, our ability to make our
products  could  be  limited  and  we  could  be  enjoined  from  future  sales  of  the  infringing  product  or  products,  which  could  adversely  affect  our  revenues  and  operating
results. Additionally, we often indemnify our customers against claims of infringement related to our products and may incur significant expenses to defend against such
claims. If we are unsuccessful defending against such claims, we may be required to indemnify our customers against any damages awarded.

We also face risks that third parties may assert trademark infringement claims against us in one or more jurisdictions throughout the world related to our Lumentum
and Oclaro brands and/or other trademarks. The litigation or settlement of these matters, regardless of the merit of the claims, could result in significant expense and divert
the efforts of our technical and management personnel, regardless of whether or not we are successful. If we are unsuccessful, trademark infringement claims against us
could result in significant monetary liability or prevent us from selling some or all of our products or services under the challenged trademark. In addition, resolution of
claims may require us to alter our products, labels or packaging, license rights from third parties, or cease using the challenged trademark altogether, which could adversely
affect our revenues and operating results.

We face certain litigation risks that could harm our business.

We are now, and in the future we may become, subject to various legal proceedings and claims that arise in or outside the ordinary course of business. The results of
legal proceedings are difficult to predict. Moreover, many of the complaints filed against us may not specify the amount of damages that plaintiffs seek, and we therefore
may be unable to estimate the possible range of damages that might be incurred should these lawsuits be resolved against us. While we may be unable to estimate the
potential  damages  arising  from  such  lawsuits,  certain  of  them  assert  types  of  claims  that,  if  resolved  against  us,  could  give  rise  to  substantial  damages.  Thus,  an
unfavorable outcome or settlement of one or more of these lawsuits could have a material adverse effect on our financial condition, liquidity and results of operations. Even
if these lawsuits are not resolved against us, the uncertainty and expense associated with unresolved lawsuits could seriously harm our business, financial condition and
reputation. Litigation is generally costly, time-consuming and disruptive to normal business operations. The costs of defending these lawsuits have been significant in the
past,  will  continue  to  be  costly  and  may  not  be  covered  by  our  insurance  policies.  The  defense  of  these  lawsuits  could  also  result  in  continued  diversion  of  our
management’s time and attention away from business operations, which could harm our business. For additional discussion regarding litigation, see “Part II, Item 1. Legal
Proceedings.”

Our products incorporate and rely upon licensed third-party technology, and if licenses of third-party technology do not continue to be available to us or are not

available on terms acceptable to us, our revenues and ability to develop and introduce new products could be adversely affected.

We integrate licensed third-party technology into certain of our products. From time to time, we may be required to license additional technology from third-parties
to  develop  new  products  or  product  enhancements.  Third-party  licenses  may  not  be  available  or  continue  to  be  available  to  us on  commercially  reasonable  terms.  The
failure to comply with the terms of any license, including free open source software, may result in our inability to continue to use such license. Our inability to maintain or
re-license any third-party licenses required in our products or our inability to obtain third-party licenses necessary to develop new products and product enhancements,
could potentially require us to develop substitute technology or obtain substitute technology of lower quality or performance standards or at a greater cost, any of which
could delay or prevent product shipment and harm our business, financial condition, and results of operations.

22

Table of Contents

We are subject to laws and other regulations worldwide including with respect to environmental matters, securities laws, privacy and data protection, compliance

with which could increase our expenses and harm our operating results.

Our operations and our products are subject to various federal, state and foreign laws and regulations, including those governing pollution and protection of human
health and the environment in the jurisdictions in which we operate or sell our products. These laws and regulations govern, among other things, wastewater discharges and
the handling and disposal of hazardous materials in our products. Our failure to comply with current and future environmental or health or safety requirements could cause
us to incur substantial costs, including significant capital expenditures, to comply with such environmental laws and regulations and to clean up contaminated properties
that we own or operate. Such clean-up or compliance obligations could result in disruptions to our operations. Additionally, if we are found to be in violation of these laws,
we could be subject to governmental fines or civil liability for damages resulting from such violations. These costs could have a material adverse impact on our financial
condition or operating results.

From time to time new regulations are enacted, and it is difficult to anticipate how such regulations will be implemented and enforced. We continue to evaluate the
necessary steps for compliance with regulations as they are enacted. These regulations include, for example, the Registration, Evaluation, Authorization and Restriction of
Chemicals (“REACH”), the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive (“RoHS”) and the Waste Electrical
and Electronic Equipment Directive (“WEEE”) enacted in the European Union which regulate the use of certain hazardous substances in, and require the collection, reuse
and recycling of waste from, certain products we manufacture. These regulations and similar legislation may require us to re-design our products to ensure compliance with
the applicable standards, for example by requiring the use of different types of materials, which could have an adverse impact on the performance of our products, add
greater  testing  lead-times  for  product  introductions  or  other  similar  effects.  We  believe  we  comply  with  all  such  legislation  where  our  products  are  sold  and  we
continuously monitor these laws and the regulations being adopted under them to determine our responsibilities.

In  addition,  pursuant  to  Section  1502  of  the  Dodd-Frank  Wall  Street  Reform  and  Consumer  Protection  Act,  the  SEC  has  promulgated  rules  requiring  disclosure
regarding the use of certain “conflict minerals” that are mined from the Democratic Republic of Congo and adjoining countries and procedures regarding a manufacturer’s
efforts to prevent the sourcing of such minerals. Complying with these disclosure requirements involves substantial diligence efforts to determine the source of any conflict
minerals used in our products and may require third-party auditing of our diligence process. These efforts may demand internal resources that would otherwise be directed
towards operations activities.

Since  our  supply  chain  is  complex,  we  may  face  reputational  challenges  if  we  are  unable  to  sufficiently  verify  the  origins  of  the  conflict  minerals  used  in  our
products. Additionally, if we are unable to satisfy those customers who require that all of the components of our products are determined to be conflict free, they may
choose a competitor’s products which could materially impact our financial condition and operating results.

We  are  also  subject  to  laws  and  regulations  with  respect  to  personal  data  we  collect  from  our  employees,  customers,  and  others.  These  laws  and  regulations  are
subject to frequent modifications and updates and require ongoing supervision. For example, the European Union adopted a General Data Protection Regulation (“GDPR”)
that  became  effective  in  May  2018,  and  has  established  new,  and  in  some  cases  more  stringent,  requirements  for  data  protection  in  Europe,  and  which  provides  for
substantial penalties for noncompliance. We have made certain modifications to our practices in order to comply with these or other requirements, and may be required to
make additional modifications in order to comply with these or other requirements relating to privacy and data protection in the future, each of which may require us to
incur significant costs and expenses. Additionally, California enacted legislation in June 2018, the California Consumer Privacy Act (“CCPA”), which will, among other
things, require covered companies to provide new disclosures to California consumers when it goes into effect on January 1, 2020. Legislators have stated that they intend
to  propose  amendments  to  the  CCPA  before  it  goes  into  effect,  and  it  remains  unclear  what,  if  any,  modifications  will  be  made  to  this  legislation  or  how  it  will  be
interpreted. The effects of the CCPA are potentially significant, however, and may require us to modify our data processing practices and policies and to incur substantial
costs and expenses in an effort to comply. Laws and regulations relating to privacy and data protection continue to evolve in various jurisdictions, with existing laws and
regulations subject to new and differing interpretations and new laws and regulations being proposed and adopted. It is possible that our practices may be deemed not to
comply with those privacy and data protection legal requirements that apply to us now or in the future.

Further, in June 2016, a referendum was passed in the United Kingdom to leave the European Union, commonly referred to as “Brexit.” This created an uncertain
political and economic environment in the United Kingdom and other European Union countries, even though the formal process for leaving the European Union may take
years to complete and may not ultimately be effectuated. For example, while the United Kingdom has enacted a Data Protection Bill that substantially implements GDPR,
which became law in May 2018, there remains uncertainty with regard to whether the European Union will view this regulation as adequate under GDPR and how data
transfers between the United Kingdom and the European Union will be regulated.

23

Table of Contents

Our failure  or perceived  failure  to comply  with  any of the  foregoing  legal  and  regulatory  requirements  could  result  in increased  costs for our  products,  monetary
penalties, damages to our reputation, government inquiries and investigations, and legal action. Furthermore, the legal and regulatory requirements that are applicable to
our business are subject to change from time to time, which increases our monitoring and compliance costs and the risk that we may fall out of compliance. Additionally,
we may be required to ensure that our suppliers comply with applicable laws and regulations. If we or our suppliers fail to comply with such laws or regulations, we could
face  sanctions for such noncompliance,  and our customers  may refuse to purchase  our products, which would have a material  adverse effect  on our business, financial
condition and results of operations.

Our  sales  may  decline  if  we  are  unable  to  obtain  government  authorization  to  export  certain  of  our  products,  and  we  may  be  subject  to  legal  and  regulatory

consequences if we do not comply with applicable export control laws and regulations.

Exports of certain of our products are subject to export controls imposed by the U.S. government and administered by the U.S. Departments of State and Commerce.
In  certain  instances,  these  regulations  may  require  pre-shipment  authorization  from  the  administering  department.  For  products  subject  to  the  Export  Administration
Regulations (“EAR”) administered by the Department of Commerce’s Bureau of Industry and Security, the requirement for a license is dependent on the type and end use
of the product, the final destination, the identity of the end user and whether a license exception might apply. Virtually all exports of products subject to the International
Traffic  in  Arms  Regulations  (“ITAR”)  administered  by  the  Department  of  State’s  Directorate  of  Defense  Trade  Controls,  require  a  license.  Certain  of  our  fiber  optics
products are subject to EAR and certain of our RF-over-fiber products, as well as certain products and technical data, are developed with government funding, and are
currently subject to ITAR. Products and the associated technical data developed and manufactured in our foreign locations are subject to export controls of the applicable
foreign nation.

Given the current global political climate, obtaining export licenses can be difficult and time-consuming. Failure to obtain export licenses for these shipments could
significantly reduce our revenue and materially adversely affect our business, financial condition and results of operations. Compliance with U.S. government regulations
also subjects us to additional fees and costs. The absence of comparable restrictions on competitors in other countries may adversely affect our competitive position.

Further,  there  is  increased  attention  from  the  government  and  the  media  regarding  potential  threats  to  U.S.  national  security  and  foreign  policy  relating  to  certain
foreign entities, particularly Chinese entities, and the imposition of enhanced restrictions or sanctions regarding the export of our products or on specific foreign entities
that would restrict their ability to do business with U.S. companies may materially adversely affect our business. For example, on May 16, 2019, Huawei was added to the
Entity List of the Bureau of Industry and Security of the U.S. Department of Commerce, which imposes limitations on the supply of certain U.S. items and product support
to  Huawei.  We  cannot  predict  what  additional  actions  the  U.S.  government  may  take  with  respect  to  Huawei  or  other  of  our  customers,  including  modifications  to  or
interpretations of Entity List restrictions, export restrictions, tariffs, or other trade limitations or barriers.

Our  association  with  customers  that  are  or  become  subject  to  U.S.  regulatory  scrutiny  or  export  restrictions  could  negatively  impact  our  business.  Governmental
actions such as these could subject us to actual or perceived reputational harm among current or prospective investors, suppliers or customers, customers of our customers,
other parties doing business with us, or the general public. Any such reputational harm could result in the loss of investors, suppliers or customers, which could harm our
business, financial condition, operating results or prospects.

In addition, certain of our significant customers and suppliers have products that are subject to U.S. export controls, and therefore these customers and suppliers may
also be subject to legal and regulatory consequences if they do not comply with applicable export control laws and regulations. Such regulatory consequences could disrupt
our  ability  to  obtain  components  from  our  suppliers,  or  to  sell  our  products  to  major  customers,  which  could  significantly  increase  our  costs,  reduce  our  revenue  and
materially adversely affect our business, financial condition and results of operations.

If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial

statements or comply with applicable regulations could be impaired.

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the Sarbanes-Oxley Act
of  2002,  as  amended,  or  the  Sarbanes-Oxley  Act,  and  Nasdaq  listing  requirements.  The  Sarbanes-Oxley  Act  requires,  among  other  things,  that  we  maintain  effective
disclosure  controls  and  procedures  and  internal  control  over  financial  reporting.  In  order  to  maintain  and  improve  the  effectiveness  of  our  disclosure  controls  and
procedures and internal control over financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-
related costs and significant management oversight.

Any failure to develop or maintain effective controls, or any difficulties encountered in their implementation or improvement, could cause us to delay reporting of our
financial  results,  be  subject  to  one  or  more  investigations  or  enforcement  actions  by  state  or  federal  regulatory  agencies,  stockholder  lawsuits  or  other  adverse  actions
requiring us to incur defense costs, pay fines, settlements

24

Table of Contents

or judgments. Any such failures could also cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on
the trading price of our common stock. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on the NASDAQ stock
market.

We face a number of risks related to our Separation from Viavi, including those associated with ongoing indemnification obligations and tax and accounting-

related risks, which could adversely affect our business, financial condition, results of operations and cash flows.

In August 2015, we became an independent publicly-traded company through the distribution by JDS Uniphase Corporation (“JDSU”) to its stockholders of 80.1% of
our outstanding common stock (the “Separation”). The Separation and Distribution Agreement dated as of July 31, 2015 by and among JDSU, Lumentum Holdings Inc.
and Lumentum Operations LLC (the “Separation Agreement”) requires that we indemnify Viavi, and that Viavi indemnify us, for certain specified liabilities related to the
Separation. Among other things, we are obligated to indemnify Viavi against certain tax-related liabilities that may result from the breach of any of our representations or
covenants made in connection with the Separation. Our indemnification obligations are not subject to maximum loss clauses and, if we are required to indemnify Viavi
under the circumstances set forth in the Separation Agreement, we may be subject to substantial liabilities. Furthermore, third parties could seek to hold us responsible for
any of the liabilities that Viavi has agreed to indemnify us for, and there can be no assurance that the indemnity from Viavi will be sufficient to protect us against the full
amount of such liabilities, or that Viavi will be able to fully satisfy its indemnification obligations.

Risks Related to Our Common Stock

Our stock price may be volatile and may decline regardless of our operating performance.

Our common stock is listed on NASDAQ under the symbol “LITE”. Since shares of our common stock commenced trading on the NASDAQ stock market in August
2015, the reported high and low closing prices of our common stock per the NASDAQ Global Select Market has ranged from $14.12 to $73.20, through June 29, 2019.
The market price of our common stock may fluctuate significantly due to a number of factors, some of which may be beyond our control, including:

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

actual or anticipated fluctuations in our quarterly or annual operating results;

changes in earnings estimates by securities analysts or our ability to meet those estimates;

the operating and stock price performance of other comparable companies;

a shift in our investor base;

the financial performance of other companies in our industry, and of our customers;

success or failure of our business strategy;

credit market fluctuations which could negatively impact our ability to obtain financing as needed;

changes to the regulatory and legal environment in which we operate;

announcements by us, competitors, customers, or our contract manufacturers of significant acquisitions or dispositions;

investor perception of us and our industry;

changes in accounting standards, policies, guidance, interpretations or principles;

litigation or disputes in which we may become involved;

overall market fluctuations; sales of our shares by our officers, directors, or significant stockholders;

the timing and amount of dividends and share repurchases, if any; and

general economic and market conditions and other external factors.

In addition, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities
of many technology companies. Stock prices of many technology companies have fluctuated in a manner unrelated or disproportionate to the operating performance of
those  companies.  In  the  past,  stockholders  have  instituted  securities  class  action  litigation  following  periods  of  market  volatility.  If  we  were  to  become  involved  in
securities

25

Table of Contents

litigation,  it  could  subject  us  to  substantial  costs,  divert  resources  and  the  attention  of  management  from  our  business  and  adversely  affect  our  business,  results  of
operations, financial condition and cash flows.

Servicing our 2024 Notes and the Term Loan Facility may require a significant amount of cash, and we may not have sufficient cash flow or the ability to raise
the  funds  necessary  to  satisfy  our  obligations  under  the  2024  Notes  or  the  Term  Loan  Facility,  and  our  current  and  future  indebtedness  may  limit  our  operating
flexibility or otherwise affect our business.

Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the 2024 Notes and the Term Loan Facility,
or to make cash payments in connection with any conversion of the 2024 Notes or upon any fundamental change if note holders require us to repurchase their notes for
cash, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not generate cash
flow from operations in the future sufficient to service our indebtedness and make necessary capital expenditures. If we are unable to generate such cash flow, we may be
required to adopt one or more alternatives, such as selling assets, restructuring indebtedness or obtaining additional equity capital on terms that may be onerous or highly
dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these
activities or engage in these activities on desirable terms, which could result in a default on our debt obligations. In addition, our existing and future indebtedness could
have important consequences to our stockholders and significant effects on our business. For example, it could:

•

•

•

•

•

•

make it more difficult for us to satisfy our debt obligations, including the 2024 Notes and the Term Loan Facility;

increase our vulnerability to general adverse economic and industry conditions;

require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our
cash flow to fund working capital and other general corporate purposes;

limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;

restrict us from exploiting business opportunities;

place us at a competitive disadvantage compared to our competitors that have less indebtedness; and

limit our availability to borrow additional funds for working capital, capital expenditures, acquisitions, debt service requirements, execution of our business strategy

or other general purposes.

Transactions relating to our 2024 Notes may dilute the ownership interest of existing stockholders, or may otherwise depress the price of our common stock.

If the 2024 Notes are converted by holders, we have the ability under the indenture for the 2024 Notes to deliver cash, equity, common stock, or any combination of
cash or common stock, at our election upon conversion of the 2024 Notes. If we elect to deliver common stock upon conversion of the 2024 Notes, it would dilute the
ownership interests of existing stockholders. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market
prices  of  our  common  stock.  In  addition,  certain  holders  of  the  2024  Notes  may  engage  in  short  selling  to  hedge  their  position  in  the  2024  Notes.  Anticipated  future
conversions of such 2024 Notes into shares of our common stock could depress the price of our common stock.

OurTerm Loan Facility restricts our operations, particularly our ability to respond to changes or to take certain actions regarding our business.

The definitive documents governing the Term Loan Facility provided for in the Commitment Letter contain a number of restrictive covenants that impose operating
and financial restrictions on us and limit our ability to engage in acts that may be in our long-term best interest, including restrictions on the ability to: incur indebtedness,
grant liens, undergo certain fundamental changes, dispose of assets, make investments, enter into transactions with affiliates, and make certain restricted payments, in each
case subject to limitations and exceptions to be set forth in the definitive documentation for the Term Loan Facility.

The definitive documentation governing the Term Loan Facility also contains customary events of default that include, among other things, certain payment defaults,
covenant defaults, cross-defaults to other indebtedness, change of control defaults, judgment defaults, and bankruptcy and insolvency defaults. Such events of default may
allow the creditors to accelerate the related debt and may result in the acceleration of any other debt to which a cross-acceleration or cross-default provision applies which
could  have  a  material  adverse  effect  on  our  business,  operations  and  financial  results.  Furthermore,  if  we  are  unable  to  repay  the  amounts  due  and  payable  under  the
definitive documentation governing our Term Loan Facility, those lenders could proceed against the collateral granted to them to secure that indebtedness which could
force us into bankruptcy or liquidation. In the event our lenders

26

Table of Contents

accelerated the repayment of the borrowings, we may not have sufficient assets to repay that indebtedness. Any acceleration of amounts due under the credit agreements
would likely have a material adverse effect on us. As a result of these restrictions, we may be: limited in how we conduct business; unable to raise additional debt or equity
financing to operate during general economic or business downturns; or unable to compete effectively or to take advantage of new business opportunities.

We do not expect to pay dividends on our common stock.

We  do  not  currently  expect  to  pay  dividends  on  our  common  stock.  The  payment  of  any  dividends  to  our  stockholders  in  the  future,  and  the  timing  and  amount
thereof, if any, is within the discretion of our board of directors. Our board of directors’ decisions regarding the payment of dividends will depend on many factors, such as
our  financial  condition,  earnings,  capital  requirements,  potential  debt  service  obligations  or  restrictive  covenants,  industry  practice,  legal  requirements,  regulatory
constraints and other factors that our board of directors deems relevant.

In  addition,  because  we  are  a  holding  company  with  no  material  direct  operations,  we  are  dependent  on  loans,  dividends  and  other  payments  from  our  operating
subsidiaries to generate the funds necessary to pay dividends on our common stock. However, our operating subsidiaries’ ability to make such distributions will be subject
to  their  operating  results,  cash  requirements  and  financial  condition  and  the  applicable  provisions  of  Delaware  law  that  may  limit  the  amount  of  funds  available  for
distribution. Our ability to pay cash dividends may also be subject to covenants and financial ratios related to existing or future indebtedness, and other agreements with
third parties.

Certain provisions in our charter and Delaware corporate law could hinder a takeover attempt.

We are subject to the provisions of Section 203 of the DGCL which prohibits  us, under some circumstances,  from engaging in business combinations  with some
stockholders for a specified period of time without the approval of the holders of substantially all of our outstanding voting stock. Such provisions could delay or impede
the removal of incumbent directors and could make more difficult a merger, tender offer or proxy contest involving us, even if such events could be beneficial, in the short-
term,  to  the  interests  of  our  stockholders.  In  addition,  such  provisions  could  limit  the  price  that  some  investors  might  be  willing  to  pay  in  the  future  for  shares  of  our
common stock. Our certificate of incorporation and bylaws contain provisions providing for the limitations of liability and indemnification of our directors and officers,
allowing vacancies  on our board of directors  to be filled  by the vote of a majority  of the remaining  directors,  granting our board of directors  the authority  to establish
additional series of preferred stock and to designate the rights, preferences and privileges of such shares (commonly known as “blank check preferred”) and providing that
our stockholders can take action only at a duly called annual or special meeting of stockholders, which may only be called by the chairman of the board of directors, the
chief executive officer or the board of directors. These provisions may also have the effect of deterring hostile takeovers or delaying changes in control or changes in our
management.

Our bylaws designate Delaware courts as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders,

which could discourage lawsuits against us or our directors and officers.

Our  bylaws  provide  that,  unless  we  consent  in  writing  to  an  alternative  forum,  the  state  or  federal  courts  of  Delaware  are  the  sole  and  exclusive  forum  for  any
derivative action or proceeding brought on our behalf; any action asserting breach of fiduciary duty, or other wrongdoing, by our directors, officers or other employees to
us or our stockholders; any action asserting a claim against Lumentum pursuant to the Delaware General Corporation Law or our certificate of incorporation or bylaws;
any  action  asserting  a  claim  against  Lumentum  governed  by  the  internal  affairs  doctrine;  or  any  action  to  interpret,  apply,  enforce  or  determine  the  validity  of  our
certificate of incorporation or bylaws. This exclusive forum provision may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders
find favorable for disputes with us or our directors or officers, which may discourage such lawsuits against us or our directors and officers.

Alternatively, if a court outside of Delaware were to find this exclusive forum provision inapplicable to, or unenforceable in respect of, one or more of the specified
types of actions or proceedings described above, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect
our business, financial condition or results of operations.

27

Table of Contents

ITEM 1B.    UNRESOLVED STAFF COMMENTS 

None.

28

Table of Contents

ITEM 2.    PROPERTIES 

We own and lease various properties in the United States and nine other countries around the world. We use the properties for executive and administrative offices,
data centers, product development offices, customer service offices and manufacturing facilities. Our current corporate headquarters is approximately 126,000 square feet
and located in Milpitas, California. In May 2019, we purchased a three-building campus property consisting of approximately 238,000 square feet in San Jose, California.
We plan to relocate our corporate headquarters to this new San Jose campus and consolidate another leased San Jose site to this campus by end of calendar year 2019. As
of June 29, 2019, our leased and owned properties in total are approximately 2,100,000 square feet, of which we own approximately 900,000 square feet, including the
560,000 square feet manufacturing site in Thailand and the new 238,000 square feet San Jose campus. Larger leased sites include properties located in Canada, China,
Japan and the United States. We believe our existing properties, including both owned and leased sites, are in good condition and suitable for the conduct of our business.

From  time  to  time  we  consider  various  alternatives  related  to  our  long-term  facilities’  needs.  While  we  believe  our  existing  facilities  are  adequate  to  meet  our

immediate needs, it may become necessary to lease, acquire, or sell additional or alternative space to accommodate future business needs.

29

Table of Contents

ITEM 3.    LEGAL PROCEEDINGS 

We are subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving
claims against us, individually or in the aggregate, will not have a material adverse impact on our financial position, results of operations or cash flows, these matters are
subject to inherent uncertainties and management’s view of these matters may change in the future. Should we experience an unfavorable final outcome, there exists the
possibility of a material adverse impact on our financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

Merger Litigation

In connection with our acquisition of Oclaro, seven lawsuits were filed by purported stockholders of Oclaro challenging the proposed merger (the “Merger”). Two of
the seven suits were putative class actions filed against Oclaro, its directors, Lumentum, Prota Merger Sub, Inc. and Prota Merger, LLC: Nicholas Neinast v. Oclaro, Inc.,
et al., No. 3:18-cv-03112-VC, in the United States District Court for the Northern District of California (filed May 24, 2018) (the “Neinast Lawsuit”); and Adam Franchi v.
Oclaro, Inc., et al., No. 1:18-cv-00817-GMS, in the United States District Court for the District of Delaware (filed June 9, 2018) (the “Franchi Lawsuit). Both the Neinast
Lawsuit and the Franchi Lawsuit were voluntarily dismissed with prejudice.

The other five suits, styled as Gerald F. Wordehoff v. Oclaro, Inc., et al., No. 5:18-cv-03148-NC (the “Wordehoff Lawsuit”), Walter Ryan v. Oclaro, Inc., et al., No.
3:18-cv-03174-VC (the “Ryan Lawsuit”), Jayme Walker v. Oclaro, Inc., et al., No. 5:18-cv-03203-EJD (the “Walker Lawsuit”), Kevin Garcia v. Oclaro, Inc., et al., No.
5:18-cv-03262-VKD (the “Garcia Lawsuit”), and SaiSravan B. Karri v. Oclaro, Inc., et al., No. 3:18-cv-03435-JD (the “Karri Lawsuit” and, together with the other six
lawsuits, the “Lawsuits”), were filed in the United States District Court for the Northern District of California on May 25, 2018, May 29, 2018, May 30, 2018, May 31,
2018, and June 9, 2018, respectively. These five Lawsuits named Oclaro and its directors as defendants only and did not name Lumentum. The Wordehoff, Ryan, Walker,
and Garcia Lawsuits have been voluntarily dismissed, and the Wordehoff, Ryan, and Walker dismissals were with prejudice. The Karri Lawsuit has not yet been dismissed.
The Ryan Lawsuit was, and the Karri Lawsuit is, a putative class action.

The Lawsuits generally alleged, among other things, that Oclaro and its directors violated Section 14(a) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and Rule 14a-9 promulgated thereunder by disseminating an incomplete and misleading Form S-4, including proxy statement/prospectus. The Lawsuits
further alleged that Oclaro’s directors violated Section 20(a) of the Exchange Act by failing to exercise proper control over the person(s) who violated Section 14(a) of the
Exchange Act.

The  remaining  Lawsuit  (the  Karri  Lawsuit)  currently  purports  to  seek, among  other  things,  damages  to  be  awarded  to  the  plaintiff  and  any  class  if  the  Merger  is

consummated, and litigation costs, including attorneys’ fees. The defendants intend to defend the Karri Lawsuit vigorously.

30

Table of Contents

ITEM 4.    MINE SAFETY DISCLOSURES 

None.

31

Table of Contents

PART II

ITEM 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY
SECURITIES 

Market Information for Common Stock and Stockholders

From August 4, 2015, our common stock has traded on the NASDAQ Stock Market under the symbol “LITE”. The following table sets forth the range of high and

low closing prices of our common stock per the NASDAQ Global Select Market for the periods indicated:

Fiscal 2019 Quarter Ended:

June 29, 2019

March 30, 2019

December 29, 2018

September 29, 2018

Fiscal 2018 Quarter Ended:

June 30, 2018

March 31, 2018

December 30, 2017

September 30, 2017

 High

 Low

63.74   $

56.54   $

62.36   $

68.80   $

64.50   $

73.20   $

64.75   $

67.95   $

40.47

39.01

37.50

52.10

50.20

42.60

46.40

50.80

$

$

$

$

$

$

$

$

According  to  records  of  our  transfer  agent,  we  had  2,957 stockholders  of  record  as  of  August  20,  2019 and  we  believe  there  is  a  substantially  greater  number  of

beneficial holders.

Dividends

Our subsidiary, Lumentum Inc., issued $35.8 million in Series A Preferred Stock to Viavi, which was sold to Amada following the Separation. On November 2, 2018,
all  35,805  shares  of  Series  A  Preferred  Stock,  were  converted  into  1.5 million shares  of  our  common  stock.  Up  through  the  date  of  conversion,  holders  of  Series  A
Preferred Stock, in preference to holders of common stock or any other class or series of our outstanding capital stock ranking in any such event junior to the Series A
Preferred Stock, were entitled to receive, when and as declared by the board of directors, quarterly cumulative cash dividends at the annual rate of 2.5% of the Issuance
Value per share on each outstanding share of Series A Preferred Stock. The accrued dividends were payable on March 31, June 30, September 30 and December 31 of each
year commencing on September 30, 2015. The accrued dividends as of November 2, 2018, the effective date of the conversion of all outstanding Series A Preferred Stock,
and June 30, 2018, were $0.3 million and $0.4 million, respectively. During the years ended June 29, 2019, June 30, 2018, and July 1, 2017, we paid $0.7 million, $0.7
million,  and  $0.9 million,  respectively,  in  dividends  to  the  holders  of  Series  A  Preferred  Stock.  We  do  not  expect  to  pay  cash  dividends  on  our  common  stock  in  the
foreseeable future.

32

 
 
 
   
 
   
Table of Contents

Stock Performance Graph

This  performance  graph  shall  not  be  deemed  “filed”  for  purposes  of  Section  18  of  the  Securities  Exchange  Act  of  1934,  as  amended  (the  Exchange  Act),  or
incorporated by reference into any filing of Lumentum Holdings Inc. under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set
forth by specific reference in such filing.

The  following  graph  compares  the  cumulative  total  return  of  our  common  stock  with  the  total  return  for  the  NASDAQ  Composite  Index  (the  “IXIC”)  and  the
NASDAQ 100 Technology Sector Index (the “NDXT”) from August 4, 2015 through June 29, 2019. The stock price performance on the following graph is not necessarily
indicative of future stock price performance.

Recent Sale of Unregistered Equity Securities

None.

Issuer Purchases of Equity Securities

None.

33

Table of Contents

ITEM 6. SELECTED FINANCIAL DATA 

This table sets forth selected  financial  data of Lumentum (in millions, except share and per share amounts)  for the periods indicated.  This data should be read in
conjunction with the discussion in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Item 7 of this Annual Report
and our audited consolidated financial statements included in Item 8 of this Annual Report. The selected data in this section are not intended to replace the Consolidated
Financial Statements included in this Annual Report.

Our historical consolidated financial statements for the fiscal years ended July 2, 2016 and June 27, 2015, include allocations of expenses arising from shared services
and infrastructure provided by Viavi to us, including costs of information technology, human resources, accounting, legal, real estate and facilities, corporate marketing,
insurance, treasury and other corporate and infrastructure services. The financial information included here may not necessarily reflect our financial position and results of
operations  or  what  our  financial  position  and  results  of  operations  would  have  been  had  we  been  an  independent,  publicly-traded  company  during  the  entirety  of  the
periods presented or be indicative of our future performance as an independent company. There were no allocations of expenses from Viavi for the fiscal years ended June
29, 2019, June 30, 2018, or July 1, 2017.

Consolidated Statements of Operations Data:

Net revenue

Gross profit

Income (loss) from operations

Net (loss) income

Cumulative dividends on Series A Preferred Stock

Accretion of Series A Preferred Stock

Earnings allocated to Series A Preferred Stock

Net income (loss) attributable to common stockholders

Net income (loss) per share attributable to common
stockholders (5):

   Basic

   Diluted

Shares used to compute net income (loss) per share
attributable to common stockholders (5):

   Basic

   Diluted

June 29, 2019 (1)

June 30, 2018 (2)

July 1, 2017 (3)

July 2, 2016

June 27, 2015 (4)

Years Ended

$

1,565.3   $

1,247.7   $

1,001.6   $

903.0   $

$

$

$

425.9  

(21.6)  

(36.4)  

(0.3)  

—  

(1.2)  

432.1  

139.9  

248.1  

(0.9)  

—  

(5.7)  

318.1  

47.6  

(102.5)  

(0.9)  

—  

—  

277.3  

11.5  

9.3  

(0.8)  

(11.7)  

—  

(37.9)   $

241.5   $

(103.4)   $

(3.2)   $

(0.54)   $

(0.54)   $

3.88   $

3.82   $

(1.71)   $

(1.71)   $

(0.05)   $

(0.05)   $

70.7  

70.7  

62.3  

63.3  

60.6  

60.6  

59.1  

59.1  

34

837.1

257.9

(23.4)

(3.4)

—

—

—

(3.4)

(0.06)

(0.06)

58.8

58.8

 
 
 
 
 
 
 
   
   
   
   
 
 
   
   
   
   
 
   
   
   
   
 
   
   
   
   
Table of Contents

June 29, 2019 (1)

June 30, 2018 (2)

July 1, 2017 (3)

July 2, 2016

June 27, 2015 (4)

Balance as of

Consolidated Balance Sheet Data:

Cash and cash equivalents

$

Total assets

Convertible notes

Term loan, non-current

Derivative liability

Other non-current liabilities

Total redeemable convertible preferred stock

Total stockholders’ equity

432.6   $

2,716.6  

351.9  

484.0  

—  

33.7  

—  

1,497.1  

397.3   $

272.9   $

1,581.5  

334.2  

—  

52.4  

19.0  

35.8  

926.1  

1,232.9  

317.5  

—  

51.6  

25.0  

35.8  

618.8  

157.1   $

726.3  

—  

—  

10.3  

9.1  

35.8  

497.4  

14.5

512.6

—

—

—

9.8

—

380.6

(1) On December 10, 2018, we completed the acquisition of Oclaro, a provider of optical components and modules for the long-haul, metro and data center markets,
for $1.4 billion, which was funded through the issuance of Lumentum common stock, new debt, and cash balances of the combined company. Refer to “Note 5.
Business Combination” in the notes to consolidated financial statements for further discussion of the merger. Results of operations and financial position of the
business acquired have been included in our consolidated financial statements subsequent to the date of acquisition.

(2) During the second quarter of fiscal 2018, we had a credit of $207.0 million primarily related to a release of a U.S. valuation allowance, which was offset by a
write-down of deferred tax assets in the amount of $83.0 million due to the lower corporate tax rate enacted under the 2017 “Tax Cuts and Jobs Act” reform.

(3) During the third quarter of fiscal 2017, we completed the acquisition of a privately held company. Results of operations and financial position of the business

acquired have been included in our consolidated financial statements subsequent to the date of acquisition.

(4)

In fiscal 2015, we settled an audit in a non-U.S. jurisdiction which resulted in the recognition of a $21.8 million tax benefit. In addition, we recognized $14.1
million of additional deferred tax assets which were fully offset by a corresponding increase in the deferred tax valuation allowance.

(5) On August 1, 2015, JDSU distributed 47.1 million shares, or 80.1% of the outstanding shares of Lumentum common stock to existing holders of JDSU common
stock. JDSU was renamed Viavi and at the time of distribution, retained 11.7 million shares, or 19.9% of Lumentum’s outstanding shares. Basic and diluted net
income (loss) per share for all periods through June 27, 2015 is calculated using the shares of Lumentum common stock outstanding on August 1, 2015.

35

 
 
 
 
 
 
 
   
   
   
   
Table of Contents

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion in conjunction with the audited consolidated financial statements and the corresponding notes included elsewhere in this
Annual Report. This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements. The matters discussed
in these forward-looking statements are subject to risk, uncertainties and other factors that could cause actual results to differ materially from those made, projected or
implied  in  the  forward-looking  statements.  Please  see  “Risk  Factors”  and  “Forward-Looking  Statements”  for  a  discussion  of  the  uncertainties,  risks  and  assumptions
associated with these statements.

Overview

We are an industry-leading provider of optical and photonic products defined by revenue and market share addressing a range of end-market applications including
Optical Communications,  which we refer  to as OpComms, and Lasers for manufacturing,  inspection  and life-science  applications.  We seek to use our core  optical  and
photonic  technology  and  our  volume  manufacturing  capability  to  expand  into  attractive  emerging  markets  that  benefit  from  advantages  that  optical  or  photonics-based
solutions provide,  including 3D sensing  for consumer  electronics  and diode light  sources for  a variety  of consumer and industrial  applications.  We have two operating
segments, OpComms and Lasers. The two operating segments were primarily determined based on how our CODM views and evaluates our operations. Operating results
are regularly reviewed by our CODM to make decisions about resources to be allocated to the segments and to assess their performance. Other factors, including market
separation  and  customer  specific  applications,  go-to-market  channels,  products  and  manufacturing,  are  considered  in  determining  the  formation  of  these  operating
segments.

We see the world as becoming more reliant on ever-increasing amounts of data flowing through optical networks and data centers, which demand new networks and
data  centers  to  be  built  to  satisfy  this  insatiable  demand  for  data.  As  higher  levels  of  precision,  new  materials,  factory  and  energy  efficiency  are  being  demanded  by
manufacturers,  suppliers of manufacturing  tools globally  are turning more and more to laser  based approaches, including the types of lasers Lumentum supplies. Laser
based 3D sensing is a rapidly developing market. The technology enables computer vision applications that enhance security, safety, and new functionality in the electronic
devices that people rely on every day. We believe the global markets in which Lumentum participates have fundamentally robust, long-term trends that increase the need
for our photonics products and technologies.

On December 10, 2018, we completed the acquisition of Oclaro, a provider of optical components and modules for the long-haul, metro and data center markets. In
accordance with the terms of the Merger Agreement, each issued and outstanding share of Oclaro common stock was automatically converted into the right to receive (i)
$5.60  in  cash  and  (ii)  0.0636  of  a  share  of  Lumentum  common  stock.  The  total  transaction  consideration  was  $1.4  billion,  which  was  funded  through  the  issuance  of
Lumentum common stock, new debt (refer to “Note 7. Term Loan Facility”), and cash balances of the combined company. Refer to “Note 5. Business Combination” in the
notes to consolidated financial statements for further discussion of the merger.

During our fiscal 2019, we recorded $20.9 million in restructuring and related charges in our consolidated statements of operations, attributable to severance and
employee related benefits associated with Oclaro’s executive severance and retention agreements. These retention agreements  provide, under certain circumstances,  for
payments and benefits upon an involuntary termination of employment, including following a change in control of Oclaro. The payments and benefits payable under these
arrangements in the event of a change in control of Oclaro are subject to a “double trigger,” meaning that both a change in control of Oclaro and a subsequent involuntary
termination of employment are required. In other words, the change in control of Oclaro does not by itself trigger any payments or benefits. Instead, payments and benefits
are  paid  only  if  the  employment  of  the  employee  is  subsequently  terminated  without  “cause”  (or  the  employee  resigns  for  “good  reason”)  during  a  specified  period
following the change in control. We incurred total expense of $20.9 million, of which $5.7 million relates to cash severance as part of our restructuring expense, refer to
“Note 14. Restructuring and Related Charges” and $15.2 million relates to acceleration of equity awards, refer to “Note 17. Stock-Based Compensation and Stock Plans.”

OpComms

Our OpComms products address the following markets: Telecom, Datacom and Consumer and Industrial.

Our OpComms products  include  a wide range  of components,  modules  and  subsystems  to support  customers  including  carrier  networks  of access  (local),  metro
(intracity), long-haul (city-to-city and worldwide) and submarine (undersea) applications. Additionally, our products address enterprise, cloud, and data center applications,
including storage-access networks (“SANs”), local-area networks (“LANs”) and wide-area networks (“WANs”). These products enable the transmission and transport of
video, audio and text data over high-capacity fiber-optic cables. We maintain leading positions in these fast growing OpComms markets through our extensive product
portfolio, including reconfigurable optical add/drop multiplexers (“ROADMs”), coherent DWDM

36

Table of Contents

pluggable transceivers, and tunable small form-factor pluggable transceivers. We also sell laser chips for use in the manufacture of high-speed Datacom transceivers.

In  the  Consumer  and  Industrial  market,  our  OpComms  products  include  laser  light  sources,  which  are  integrated  into  3D  sensing  platforms  being  used  in
applications for mobile devices, gaming, computers, and other consumer electronics devices. New emerging applications include virtual and augmented reality, as well as
automotive and industrial segments. Our products include vertical cavity surface emitting lasers (“VCSELs”) and edge emitting lasers which are used in 3D sensing depth
imaging  systems.  These  systems  simplify  the  way  people  interact  with  technology  by  enabling  the  use  of  natural  user  interfaces.  Systems  are  used  for  biometric
identification,  surveillance,  and process  efficiency,  among  numerous  other  application  spaces.  Emerging  applications  for this technology  include  various  mobile  device
applications,  autonomous  vehicles,  self-navigating  robotics  and  drones  in  industrial  applications  and  3D  capture  of  objects  coupled  with  3D  printing.  In  addition,  our
industrial diode lasers are used primarily as pump sources for pulsed and kilowatt class fiber lasers.

Our OpComms customers include Alphabet, Apple, Ciena, Cisco Systems (which recently announced the acquisition of Acacia Communications, another customer

of ours), Huawei Technologies (including HiSilicon), Infinera, Innolight, Nokia Networks (including Alcatel-Lucent International), O-Net, and ZTE.

Following the acquisition of Oclaro, during our fiscal 2019, we made several strategic changes to our OpComms business as follows:

First, for overlapping products as a result of the acquisition, we are transitioning to a common lower cost design and manufacturing platform, which we expect will
result in gross margin improvement over time. In addition, we are discontinuing certain Telecom product lines that we believe have muted growth and profitability trends
that are inconsistent with our long term model. We expect that these transitions will be completed in our fiscal 2021. For the Telecom product lines we are exiting, we do
not expect significant revenue declines until fiscal 2021 as in fiscal 2020 we are continuing to satisfy customers’ product needs with respect to these product lines.

Second, we announced our plan to discontinue development and manufacturing of Lithium Niobate modulators, and we plan to wind down these operations in San
Donato, Italy during fiscal year 2020. Development and manufacturing will also be discontinued in our San Jose, California manufacturing locations within the next few
quarters  in  order  to  facilitate  our  customers’  transition  to  new  products.  We  expect  our  Indium  Phosphide  photonic  integrated  circuits  will  replace  Lithium  Niobate
modulators over time.

Third, we announced the sale of many of our Datacom transceiver module products to Cambridge Industries Group (“CIG”). This transaction closed on April 18,
2019. For further information regarding this transaction, refer to “Note 5. Business Combination”. We expect Datacom transceiver sales to ramp down to zero during fiscal
year 2020. We are investing in new Datacom chip development and expect sales of these chips to customers serving the Datacom and 5G wireless markets will grow over
time. With the exit from the business of selling Datacom transceivers, we recorded an impairment charge of $30.7 million to our Long-lived assets that were not deemed to
be useful, as they were retired from active use and classified as held-for-sale. These assets were valued at fair value less cost to sell. We also recorded inventory write
down charges of $20.8 million related to the decision to exit the Datacom module and Lithium Niobate product lines in our cost of goods sold of consolidated statements of
operations. These actions do not qualify as discontinued operations for disclosure purposes as they do not represent a strategic shift having a major effect on an entity’s
operations and financial results. For additional information, refer to “Note 15. Impairment Charges”.

Lasers

Our Lasers products serve our customers in markets and applications such as sheet metal processing, general manufacturing, biotechnology, graphics and imaging,

remote sensing, and precision machining such as drilling in printed circuit boards, wafer singulation, glass cutting and solar cell scribing.

Our Lasers products are used in a variety of OEM applications including diode-pumped solid-state, fiber, diode, direct-diode and gas lasers such as argon-ion and
helium-neon  lasers.  Fiber  lasers  provide  kW-class  output  powers  combined  with  excellent  beam  quality  and  are  used  in  sheet  metal  processing  and  metal  welding
applications. Diode-pumped solid-state lasers provide excellent beam quality, low noise and exceptional reliability and are used in biotechnology, graphics and imaging,
remote sensing, materials processing and precision machining applications. Diode and direct-diode lasers address a wide variety of applications, including laser pumping,
thermal exposure, illumination,  ophthalmology, image recording, printing, plastic welding and selective  soldering. Gas lasers such as argon-ion and helium-neon lasers
provide a stable, low-cost and reliable solution over a wide range of operating conditions, making them well suited for complex, high-resolution OEM applications such as
flow cytometry, DNA sequencing, graphics and imaging and semiconductor inspection.

37

Table of Contents

We also provide high-powered and ultrafast lasers for the industrial and scientific markets. Manufacturers use high-power, ultrafast lasers to create micro parts for
consumer electronics and to process semiconductor, LED, and other types of chips. Use of ultrafast lasers for micromachining applications is being driven primarily by the
increasing use of consumer electronics and connected devices globally.

Our  Lasers  customers  include  Amada,  ASML  Holding,  Beckman  Coulter,  DISCO,  Electro  Scientific  Industries  (recently  acquired  by  MKS  Instruments,  a

competitor of ours), Han’s Laser Technology, KLA-Tencor, Lasertec, Life Technologies, and NR Electric.

Critical Accounting Policies and Estimates

Our  consolidated  financial  statements  are  prepared  in  accordance  with  U.S.  generally  accepted  accounting  principles  (“GAAP”)  as  set  forth  in  the  Financial
Accounting Standards Board’s Accounting Standards Codification (“ASC”), and we consider the various staff accounting bulletins and other applicable guidance issued by
the United States Securities and Exchange Commission (“SEC”). GAAP, as set forth within the ASC, requires us to make certain estimates, judgments and assumptions.
We  believe  that  the  estimates,  judgments  and  assumptions  upon  which  we  rely  are  reasonable  based  upon  information  available  to  us  at  the  time  that  these  estimates,
judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial
statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are differences between these estimates, judgments
or assumptions and actual results, our financial statements will be affected. The accounting policies that reflect our more significant estimates, judgments and assumptions
and which we believe are the most critical to aid in fully understanding and evaluating our reported financial results include the following:

• Inventory Valuation
• Revenue Recognition
• Income Taxes
• Long-lived Asset Valuation
• Business Combinations
• Goodwill

During fiscal year 2019, we removed valuation of derivative liability from the list of critical accounting policies and estimates due to the conversion of the Series A
Preferred Stock to common stock on November 2, 2018. Refer to “Note 12. Non-Controlling Interest Redeemable Convertible Preferred Stock and Derivative Liability”
for additional information.

Inventory Valuation

Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of net realizable value. We assess the value
of our inventory on a quarterly basis and write down those inventories which are obsolete or in excess of our forecasted usage to the lower of their cost or estimated net
realizable value. Our estimates of realizable value are based upon our analysis and assumptions including, but not limited to, forecasted sales levels and historical usage by
product, expected product lifecycle, product development plans and future demand requirements. Our product line management personnel play a key role in our excess
review  process  by  providing  updated  sales  forecasts,  managing  product  transitions  and  working  with  manufacturing  to  minimize  excess  inventory.  If  actual  market
conditions are less favorable than our forecasts or actual demand from our customers is lower than our estimates, we may be required to record additional inventory write-
downs. If actual market conditions are more favorable than anticipated, inventory previously written down may be sold, resulting in lower cost of sales and higher income
from operations than expected in that period.

Revenue Recognition

Adoption of Topic 606

Pursuant to Topic 606, our revenues are recognized upon the application of the following steps:

•

•

•

•

•

identification of the contract, or contracts, with a customer;

identification of the performance obligations in the contract;

determination of the transaction price;

allocation of the transaction price to the performance obligations in the contract; and

recognition of revenues when, or as, the contractual performance obligations are satisfied.

38

Table of Contents

The  majority  of  our  revenue  comes  from  product  sales,  consisting  of  sales  of  Lasers  and  OpComms  hardware  products  to  our  customers.  Our  revenue  contracts
generally  include  only  one  performance  obligation.  Revenues  are  recognized  at  a  point  in  time  when  control  of  the  promised  goods  or  services  are  transferred  to  our
customers upon shipment or delivery, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We have entered into
vendor managed inventory (“VMI”) programs with our customers. Under these arrangements, we receive purchase orders from our customers, and the inventory is shipped
to  the  VMI  location  upon receipt  of  the  purchase  order.  The  customer  then  pulls  the  inventory  from  the  VMI  hub based  on  its  production  needs.  Revenue  under  VMI
programs is recognized when control transfers to the customer, which is generally once the customer pulls the inventory from the hub.

Revenue from all sales types is recognized at the transaction price. The transaction price is determined based on the consideration to which we will be entitled in
exchange for transferring goods or services to the customer, adjusted for estimated variable consideration, if any. We typically estimate the impact on the transaction price
for  discounts  offered  to  the  customer  for  early  payments  on  receivables  or  net  of  accruals  for  estimated  sales  returns.  These  estimates  are  based  on  historical  returns,
analysis of credit memo data and other known factors. Actual returns could differ from these estimates. We allocate the transaction price to each distinct product based on
its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input that depicts
the price as if sold to a similar customer in similar circumstances.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a
customer and deposited with the relevant government authority, are excluded from revenue. Our revenue arrangements do not contain significant financing components as
our standard payment terms are less than one year.

If a customer pays consideration, or if we have a right to an amount of consideration that is unconditional before we transfer a good or service to the customer, those
amounts  are  classified  as  deferred  revenue  or  deposits  received  from  customers  which  are  included  in  other  current  liabilities  or  other  long-term  liabilities  when  the
payment is made or when it is due, whichever is earlier.

Transaction Price Allocated to the Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied as of the end of the
reporting period. Unsatisfied and partially unsatisfied performance obligations consist of contract liabilities and non-cancellable backlog. Non-cancellable backlog includes
goods and services for which customer purchase orders have been accepted that are scheduled or in the process of being scheduled for shipment. A portion of our revenue
arises from vendor-managed inventory arrangements where the timing and volume of customer utilization is difficult to predict.

The following table includes estimated revenue expected to be recognized in the future for backlog related performance obligations that are unsatisfied as of June 29,

2019 (in millions):

Performance Obligations

Warranty

Less than 1 year

1-2 years

Greater than 2
years

$446.1

$7.0

$—

Total

$453.1

Hardware products regularly include warranties to the end customers such that the product continues to function according to published specifications. We typically
offer a twelve-month warranty for most of our products. However, in some instances depending upon the product, specific market, product line and geography in which we
operate, and what is common in the industry, our warranties can vary and range from six months to five years. These standard warranties are assurance type warranties and
do not offer any services in addition to the assurance that the product will continue working as specified. Therefore, warranties are not considered separate performance
obligations in the arrangement. Instead, the expected cost of the warranty is accrued as expense in accordance with authoritative guidance.

We provide reserves for the estimated costs of product warranties at the time revenue is recognized. We estimate the costs of our warranty obligations based on our
historical  experience  of  known  product  failure  rates,  use  of  materials  to  repair  or  replace  defective  products  and  service  delivery  costs  incurred  in  correcting  product
failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise.

Shipping and Handling Costs

We record shipping and handling costs related to revenue transactions within cost of sales as a period cost.

39

 
Table of Contents

Contract Costs

We recognize the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the
customer.  Applying  the  practical  expedient,  we  recognize  commissions  as  expense  when  incurred,  as  the  amortization  period  of  the  commission  asset  we  would  have
otherwise recognized is less than one year.

Contract Balances

We record accounts receivable when we have an unconditional right to consideration. Contract liabilities are recorded when cash payments are received or due in
advance of performance. Contract liabilities consist of advance payments and deferred revenue, where we have unsatisfied performance obligations. Contract liabilities are
classified as deferred revenue and customer deposits, and are included in other current liabilities within our consolidated balance sheet. Payment terms vary by customer.
The time between invoicing and when payment is due is not significant.

The following table reflects the changes in contract balances as of June 29, 2019 (in millions, except percentages):

Contract balances

Balance sheet location

June 29, 2019

June 30, 2018

Change

Accounts receivable, net

Accounts receivable, net

Deferred revenue and customer deposits

Other current liabilities

$238.0

$2.9

$197.1

$2.8

$40.9

$0.1

Percentage
Change

20.8%

3.6%

Disaggregation of Revenue

We disaggregate revenue by geography and by product. Refer to “Note 20. Operating Segments and Geographic Information” for a presentation of disaggregated
revenue. We do not present other levels of disaggregation, such as by type of products, customer, markets, contracts, duration of contracts, timing of transfer of control and
sales channels, as this information is not used by our CODM to manage the business.

Income Taxes

In  accordance  with  the  authoritative  guidance  on  accounting  for  income  taxes,  we  recognize  income  taxes  using  an  asset  and  liability  approach.  This  approach
requires the recognition of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been
recognized in our consolidated financial statements or tax returns. The measurement of current and deferred taxes is based on provisions of the enacted tax law, and the
effects of future changes in tax laws or rates are not anticipated.

The authoritative guidance provides for recognition of deferred tax assets if the realization of such deferred tax assets is more likely than not to occur based on an
evaluation of both positive and negative evidence and the relative weight of the evidence. We consider future growth, forecasted earnings, future taxable income, the mix
of earnings in the jurisdictions in which we operate, historical earnings, taxable income in prior years, if carryback is permitted under the law, and prudent and feasible tax
planning strategies in determining the need for a valuation allowance. In the event we were to determine that we would not be able to realize all or part of our net deferred
tax assets in the future, an adjustment to the deferred tax assets valuation allowance would be charged to earnings in the period in which we make such a determination, or
goodwill would be adjusted at our final determination of the valuation allowance related to an acquisition within the measurement period. If we later determine that it is
more  likely  than  not  that  the  net  deferred  tax  assets  would  be  realized,  we  would  reverse  the  applicable  portion  of  the  previously  provided  valuation  allowance  as  an
adjustment to earnings at such time.

We are subject to income tax audits by the respective tax authorities of the jurisdictions in which we operate. The determination of our income tax liabilities in each
of these jurisdictions requires the interpretation and application of complex, and sometimes uncertain, tax laws and regulations. The authoritative guidance on accounting
for income taxes prescribes both recognition and measurement criteria that must be met for the benefit of a tax position to be recognized in the financial statements. If a tax
position taken,  or expected  to be taken, in a tax return  does not meet such recognition  or measurement  criteria,  an unrecognized  tax benefit  liability  is recorded.  If we
ultimately  determine  that  an  unrecognized  tax  benefit  liability  is  no  longer  necessary,  we  reverse  the  liability  and  recognize  a  tax  benefit  in  the  period  in  which  it  is
determined that the unrecognized tax benefit liability is no longer necessary.

The recognition and measurement of current taxes payable or refundable and deferred tax assets and liabilities requires that we make certain estimates and judgments.

Changes to these estimates or a change in judgment may have a material impact on our tax provision in a future period.

40

 
 
 
 
 
 
 
 
 
Table of Contents

Long-lived Asset Valuation

We  test  long-lived  assets  for  recoverability,  at  the  asset  group  level,  when  events  or  changes  in  circumstances  indicate  that  their  carrying  amount  may  not  be
recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset, significant adverse changes in
the business climate or legal factors, accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset, current
period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset, or current expectation that the
asset will more likely than not be sold or disposed significantly before the end of its estimated useful life.

Recoverability is assessed based on the difference between the carrying amount of the asset and the sum of the undiscounted cash flows expected to result from the

use and the eventual disposal of the asset. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.

Business Combinations

In accordance with the guidance for business combinations, we determine  whether a transaction or other event is a business combination, which requires that the
assets acquired and liabilities assumed constitute a business. Each business combination is then accounted for by applying the acquisition method. If the assets acquired are
not  a  business,  we  account  for  the  transaction  or  other  event  as  an  asset  acquisition.  Under  both  methods,  we  recognize  the  identifiable  assets  acquired,  the  liabilities
assumed, and any noncontrolling interest in the acquired entity. We capitalize acquisition-related costs and fees associated with asset acquisitions and immediately expense
acquisition-related costs and fees associated with business combinations.

We allocate the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair
values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the
fair  values  of  assets  acquired  and  liabilities  assumed,  we  make  significant  estimates  and  assumptions,  especially  with  respect  to  intangible  assets.  Critical  estimates  in
valuing certain intangible assets include, but are not limited to, future expected cash flows from customer relationships and acquired developed technology and discount
rates. Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results
may differ materially from estimates. Other estimates associated with the accounting for acquisitions may change as additional information becomes available regarding
the assets acquired and liabilities assumed. Any change in facts and circumstances that existed as of the acquisition date and impacts our preliminary estimates is recorded
to goodwill if identified within the measurement period. Subsequent to the measurement period or our final determination of fair value of assets and liabilities whichever is
earlier the adjustments will affect our earnings.

In addition, we estimate the economic lives of certain acquired assets and these lives are used to calculate depreciation and amortization expense. If our estimates of

the economic lives change, depreciation or amortization expenses could be accelerated or slowed.

Goodwill

Goodwill represents the excess of the purchase price of an acquired business over the fair value of the identifiable assets acquired and liabilities assumed. We test for
impairment of goodwill on an annual basis in the fourth quarter and at any other time when events occur or circumstances indicate that the carrying amount of goodwill
may not be recoverable.

An entity has the option to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. If an
entity determines that as a result of the qualitative assessment that it is more likely than not (i.e., greater than 50% likelihood) that the fair value of a reporting unit is less
than its carrying amount, then the quantitative test is required. Otherwise, no further testing is required. The two-step quantitative goodwill impairment test requires us to
estimate the fair value of our reporting units. If the carrying value of a reporting unit exceeds its fair value, the goodwill of that reporting unit is potentially impaired and
we proceed to step two of the impairment analysis. In step two of the analysis, we measure and record an impairment loss equal to the excess of the carrying value of the
reporting unit’s goodwill over its implied fair value, if any.

Application  of  the  goodwill  impairment  test  requires  judgments,  including:  identification  of  the  reporting  units,  assigning  assets  and  liabilities  to  reporting  units,
assigning goodwill to reporting units, a qualitative assessment to determine whether there are any impairment indicators, and determining the fair value of each reporting
unit. We estimate the fair value of a reporting unit using market approach, income approach or a combination of market and income approach. Significant estimates in the
market approach include: identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, and assessing
comparable revenue and operating income multiples in estimating the fair value of the reporting unit. Significant estimates in the income approach include: future cash
flows, discount rates.

41

Table of Contents

We  base  our  estimates  on  historical  experience  and  on  various  assumptions  about  the  future  that  we  believe  are  reasonable  based  on  available  information.
Unanticipated events and circumstances may occur that affect the accuracy of our assumptions, estimates and judgments. For example, if the price of our common stock
were to significantly decrease combined with other adverse changes in market conditions, thus indicating that the underlying fair value of our reporting units may have
decreased, we might be required to reassess the value of our goodwill in the period such circumstances were identified.

Based  on  the  impairment  analysis  performed  in  the  fourth  quarter  of  each  year  presented,  the  fair  value  of  our  reporting  unit  substantially  exceeded  the  carrying

value; as such, our annual qualitative assessment did not indicate that a more detailed quantitative analysis was necessary.

In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application.
There are also areas in which management’s judgment in selecting among available alternatives would not produce a materially different result. Our senior management
has reviewed our critical accounting policies and related disclosures with the Audit Committee of our board of directors.

Recently Issued Accounting Pronouncements

Refer to “Note 2. Recently Issued Accounting Pronouncements” in the notes to consolidated financial statements.

Results of Operations

The results of operations for the periods presented are not necessarily indicative of results to be expected for future periods. The following table summarizes selected

consolidated statements of operations items as a percentage of net revenue:

Segment net revenue:

OpComms

Lasers

Net revenue

Cost of sales

Amortization of acquired intangibles

Gross profit

Operating expenses:

Research and development

Selling, general and administrative

Restructuring and related charges

    Impairment charge

Total operating expenses

Income/(loss) from operations

Unrealized gain (loss) on derivative liability

Interest and other income (expense), net

Income/(loss) before income taxes

Provision for (benefit from) income taxes

Net income/(loss)

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

87.5 %  

84.9 %  

85.6 %

12.5

100.0

69.8

3.0

27.2

11.8

12.8

2.0

2.0

28.6

(1.4)

0.6

(1.3)

(2.1)

0.2

15.1

100.0

65.1

0.3

34.6

12.6

10.3

0.6

—  

23.4

11.2

(0.1)

(0.8)

10.4

(9.5)

14.4

100.0

67.6

0.6

31.8

14.8

11.0

1.2

—

27.0

4.8

(10.4)

(0.3)

(6.0)

4.3

(2.3)%  

19.9 %  

(10.2)%

42

 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents

Financial Data for Fiscal 2019, 2018 and 2017

The following table summarizes selected consolidated statements of operations items (in millions, except for percentages):

Segment net revenue:

OpComms

Lasers

Net revenue

Gross profit

Gross margin

Research and
development

Percentage of net
revenue

Selling, general and
administrative

Percentage of net
revenue

Restructuring and
related charges

Percentage of net
revenue

$

$

$

$

2019

2018

Change

  Percentage Change  

2018

2017

Change

  Percentage Change

1,370.2

  $

1,059.2

  $

311.0  

29.4 %   $

1,059.2

  $

857.8

  $

195.1

188.5

6.6  

3.5

188.5

143.8

1,565.3

  $

1,247.7

  $

317.6  

25.5 %   $

1,247.7

  $

1,001.6

  $

201.4  

44.7  

246.1  

23.5 %

31.1

24.6 %

425.9

  $

432.1

  $

(6.2)  

(1.4)%   $

432.1

  $

318.1

  $

114.0  

35.8 %

27.2%  

34.6%    

34.6%  

31.8%    

184.6

  $

156.8

  $

27.8  

17.7 %   $

156.8

  $

148.3

  $

8.5  

5.7 %

11.8%  

12.6%    

12.6%  

14.8%    

$

200.3

  $

128.2

  $

72.1  

56.2 %   $

128.2

  $

110.2

  $

18.0  

16.3 %

12.8%  

10.3%    

10.3%  

11.0%    

$

31.9

  $

7.2

  $

24.7  

343.1 %   $

7.2

  $

12.0

  $

(4.8)  

(40.0)%

2.0%  

0.6%    

0.6%  

1.2%    

Impairment charge

$

30.7

  $

—   $

30.7  

100.0 %  

Percentage of net
revenue

Net Revenue

2.0%  

—%  

—  

—%  

—   $

—  

— %

—%  

Net revenue increased by $317.6 million, or 25.5%, during fiscal 2019 compared to fiscal 2018. This increase was primarily due to the acquisition of Oclaro, which

closed in December 2018, and organic growth in our Telecom business.

OpComms net revenue increased by $311.0 million, or 29.4%, during fiscal 2019 compared to fiscal 2018, primarily driven by increased sales of Telecom Products
of $310.2 million, specifically ROADM products of $165.3 million. OpComms net revenue in fiscal 2019 includes $250.1 million from the acquisition of Oclaro from the
date of closing.

Lasers net revenue increased by $6.6 million, or 3.5%, during fiscal 2019 compared to fiscal 2018, primarily due to increased sales of our kilowatt class fiber lasers,

offset by lower sales of our solid state lasers products.

Net revenue increased by $246.1 million, or 24.6%, during fiscal 2018 compared to fiscal 2017. This increase was primarily due to record revenues in 3D sensing,

TrueFlex® ROADMs, commercial lasers, and industrial diode lasers.

OpComms  net  revenue  increased  $201.4  million,  or  23.5%,  during  fiscal  2018  compared  to  fiscal  2017,  driven  by  increased  sales  of  Consumer  and  Industrial
products  of  $386.7  million,  primarily  in  3D  sensing  for  mobile  devices  and  engage  numerous  customers  globally,  partially  offset  by  decreased  sales  of  Telecom  and
Datacom products.

43

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
   
   
   
 
   
 
   
   
   
   
   
   
   
   
 
   
 
   
   
   
   
   
   
   
   
 
   
 
   
   
   
   
   
   
   
   
 
   
 
 
   
   
   
   
   
   
   
 
 
 
Table of Contents

Lasers  net  revenue  increased  $44.7  million,  or  31.1%,  in  fiscal  2018  compared  to  fiscal  2017,  primarily  due  to  increased  sales  of  our  kilowatt  class  fiber  lasers.

Growth was driven by strong demand from customers in both the micro and macro material processing markets.

During  our  fiscal  2019,  2018,  and  2017,  net  revenue  generated  from  a  single  customer  which  represented  10%  or  greater  of  total  net  revenue  is  summarized  as

follows:

Apple

Huawei

Ciena

Cisco

*Represents less than 10% of total net revenue

Revenue by Region

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

21.0%  

15.2%  

13.7%  

*

30.0%  

11.0%  

11.0%  

*

*

16.7%

18.5%

12.4%

We  operate  in  three  geographic  regions:  Americas,  Asia-Pacific  and  EMEA.  Net  revenue  is  assigned  to  the  geographic  region  and  country  where  our  product  is
initially  shipped.  For  example,  certain  customers  may  request  shipment  of  our  product  to  a  contract  manufacturer  in  one  country,  however,  the  location  of  the  end
customers may differ. The following table presents net revenue by the three geographic regions we operate in and net revenue from countries within those regions that
represented 10% or more of our total net revenue (in millions, except for percentages):

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

Net revenue:

Americas:

United States

Mexico

Other Americas

Total Americas

Asia-Pacific:

Hong Kong

Japan

South Korea

Other Asia-Pacific

Total Asia-Pacific

EMEA

Total net revenue

$

$

$

100.9

214.9

4.3

320.1

387.9

176.0

162.4

356.1

6.4% $

13.7

0.3

115.1

145.8

7.0

9.2% $

11.7

0.6

147.9

185.1

9.2

20.4% $

267.9

21.5% $

342.2

14.8%

18.5

0.9

34.2%

24.8% $

11.2

10.4

22.7

183.0

194.7

146.1

354.2

878.0

14.7% $

226.7

22.6%

15.6

11.7

28.3

70.3% $

99.2

4.9

220.5

551.3

9.9

0.5

22.0

55.0%

$

1,082.4

69.1% $

$

$

162.8

10.5% $

101.8

8.2% $

108.1

10.8%

1,565.3

$

1,247.7

$

1,001.6

During fiscal 2019, 2018 and 2017, net revenue from customers outside the United States, based on customer shipping location, represented 93.6%, 90.8% and 85.2%
of net revenue, respectively. Our net revenue from Mexico increased in fiscal 2019 compared to 2018 due to increased demand for our ROADM products from one of our
large  customers  who  manufactures  in  Mexico,  while  net  revenue  from  Hong  Kong  grew  due  to  a  change  in  shipment  destination  of  a  large  portion  of  our  3D  sensing
products for mobile devices.

Our net revenue is primarily denominated in U.S. dollars, including our net revenue from customers outside the United States as presented above. We expect revenue
from customers outside of the United States to continue to be an important part of our overall net revenue and an increasing focus for net revenue growth opportunities.
However, regulatory and enforcement actions by U.S. and other governmental agencies, as well as changes in tax and trade policies and tariffs, may impact net revenue
from customers outside the United States in future periods.

44

 
 
 
 
 
   
   
 
 
 
   
   
   
   
   
 
   
   
   
   
   
Table of Contents

Gross Margin and Segment Gross Margin

The following table summarizes segment gross margin for fiscal 2019, 2018 and 2017 (in millions, except for percentages):

OpComms

Lasers

Segment total

Unallocated corporate items:

Stock-based compensation

Amortization of intangibles

Amortization of inventory step up

Inventory write down due to product lines exit

Integration related costs
Other charges (1)

Total

Gross Profit

Years Ended

Gross Margin

Years Ended

2019

2018

2017

2019

2018

2017

$

$

534.1   $

402.3   $

84.4  

82.8  

618.5   $

485.1   $

287.3  

59.9  

347.2  

39.0%  

43.3%  

39.5%  

38.0%  

43.9%  

38.9%  

33.5%

41.7%

34.7%

(15.1)  

(46.6)  

(54.6)  

(20.8)  

(6.6)  

(48.9)  

(12.6)  

(3.2)  

—  

—  

—  

(7.5)    

(6.5)    

—    

—    

—    

(37.2)  

(15.1)    

$

425.9   $

432.1   $

318.1  

27.2%  

34.6%  

31.8%

The unallocated corporate items for the periods presented include the effects of amortization of acquired developed technologies and other intangibles, share-based
compensation and certain other charges. We do not allocate these items to the gross margin for each segment because management does not include such information in
measuring the performance of the operating segments.

(1) The increase in “other charges” of unallocated corporate items for fiscal 2019 compared to fiscal 2018 primarily relates to set-up costs of our facility in Thailand,

including costs of transferring the manufacturing of product lines to Thailand of $45.8 million in fiscal 2019 compared to $27.0 million in fiscal 2018.

The increase in “other charges” of unallocated  corporate items for fiscal 2018 compared to fiscal 2017 primarily relates to set-up costs of our facility in Thailand,

including costs of transferring the manufacturing of product lines to Thailand of $27.0 million in fiscal 2018 compared to $1.8 million in fiscal 2017.

Gross Margin

Gross  margin  in  fiscal  2019  decreased to  27.2% from  34.6% in  fiscal  2018.  The  decrease  was  primarily  due  to  amortization  of  intangibles  and  amortization  of
inventory step up related to the acquisition of Oclaro, as well as inventory write down charges of $20.8 million due to our exit of Datacom module and Lithium Niobate
product lines.

Gross margin in fiscal 2018 increased to 34.6% from 31.8% in fiscal 2017. The increase was primarily due to increased sales in our 3D sensing and lasers products,
which have higher gross margins than the average for the Company. The increase was partially offset by underutilized capacity costs due to the decline in Telecom and
Datacom demand, higher write-downs of excess and obsolete inventory of $1.2 million, as well as set-up costs of our facility in Thailand, including costs of transferring
product lines to Thailand of $27.0 million in our fiscal 2018 compared to $1.8 million in fiscal 2017.

We sell products in certain markets that are consolidating, undergoing product, architectural and business model transitions, have high customer concentrations, are
highly competitive, are price sensitive and/or are affected by customer seasonal and mix variant buying patterns. We expect these factors to continue to result in variability
of our gross margin.

45

 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Table of Contents

Segment Gross Margin

OpComms

OpComms gross margin in fiscal 2019 increased to 39.0% from 38.0% in fiscal 2018. This increase was primarily due to increased sales of our ROADM products,
which have higher gross margins  than the average for the segment as well as increased sales of our transmission products due to the acquisition of Oclaro which have
higher gross margins than legacy transmission products. This was partially offset by decreased sales of our 3D sensing products which have higher gross margins than the
average for this segment.

OpComms gross margin in fiscal 2018 increased to 38.0% from 33.5% in fiscal 2017. This increase was primarily due to increased sales of our 3D sensing products,
which have higher gross margins than the average for the segment. The increase was partially offset by underutilized capacity costs due to the decline in Telecom and
Datacom demand.

Lasers

Lasers gross margin in fiscal 2019 decreased to  43.3% from  43.9% in fiscal  2018. This decrease  was primarily  due to decreased  sales of our solid state products
which have higher gross margins than the average for the segment. This was partially offset by increased revenue and manufacturing utilization for our kilowatt class fiber
products.

Lasers gross margin in fiscal 2018 increased to 43.9% from 41.7% in fiscal 2017. This increase was primarily due to increased sales of solid state lasers products,

which have higher gross margins than the average for the segment.

Research and Development (“R&D”)

R&D expense increased by  $27.8 million, or 17.7%,  in  fiscal  2019  compared  to  fiscal  2018.  The  increase  in  R&D  expense  was  primarily  due  to  the  increase  in

investments in key product lines and R&D materials. In addition, we had an increase in payroll related expense of $10.1 million as a result of our acquisition of Oclaro.

R&D expense increased by $8.5 million, or 5.7%, in fiscal 2018 compared to fiscal 2017. The increase in R&D expense was primarily due to the increase in stock-

based compensation of $2.6 million and payroll related expense of $4.1 million, which includes an increase in variable incentive compensation of $2.9 million.

We believe that continuing our investments in R&D is critical to attaining our strategic objectives. We plan to continue to invest in R&D and new products that we

believe will further differentiate us in the marketplace and expect our investment in R&D to increase in absolute dollars in future quarters.

Selling, General and Administrative (“SG&A”)

SG&A expense increased by  $72.1 million, or 56.2%, in fiscal 2019 compared to fiscal 2018. The increase was primarily attributable to additional costs from our
acquisition of Oclaro, including $14.6 million of payroll related expense, $2.4 million of facility related expense, $13.3 million in charges related to the acceleration of
equity awards under certain Oclaro executive severance and retention agreements, $9.0 million related to the success fee on the closing of the Oclaro transaction,  $8.0
million related to the amortization of acquired intangibles, and $3.1 million related to the incremental stock-based compensation expense of Oclaro awards. The remainder
of the increase was primarily driven by higher payroll related expense and stock-based compensation.

SG&A  expense  increased  by  $18.0  million,  or  16.3%,  in  fiscal  2018  compared  to  fiscal  2017.  The  increase  was  primarily  attributable  to  increases  in  stock-based
compensation of $6.4 million and payroll related expense of $10.5 million, which includes an increase in variable incentive compensation of $3.8 million. We also incurred
$4.8 million of costs related to the planned acquisition of Oclaro during our fiscal 2018.

We expect to experience in the future certain non-core expenses, such as mergers and acquisition-related expenses and litigation expenses, which will likely increase

our SG&A expenses and potentially impact our profitability expectations in any particular quarter.

46

Table of Contents

Restructuring and Related Charges

We have initiated various strategic restructuring events primarily intended to reduce costs, consolidate our operations, rationalize the manufacturing of our products

and align our business in response to market conditions and as a result of our acquisition of Oclaro.

During fiscal 2019, we recorded $31.9 million in restructuring and related charges in our consolidated statements of operations.

• During the first quarter of 2019, we recorded $1.3 million of severance costs primarily due to an internal re-organization in order to extend our market
leadership position by strengthening product quality, to develop new enabling technologies required to support a winning long-term portfolio roadmap, and to
develop commercial proposals and new product introduction (“NPI”) priorities to maintain and grow our position while driving new customer and eco-system
partner engagements.

• During the second quarter of 2019, we recorded $5.7 million primarily attributable to severance and employee related benefits associated with Oclaro’s
executive severance and retention agreements. These retention agreements provide, under certain circumstances, for payments and benefits upon an involuntary
termination of employment.

• During the third quarter of 2019, we recorded $21.1 million primarily attributable to severance and employee related benefits associated with the wind
down of operations  for Lithium  Niobate modulators  and Datacom  modules. We also recorded  an additional  $1.6 million  of lease  restructuring  charges for the
former Oclaro corporate headquarters. 

Refer to “Note 14. Restructuring and Related Charges” in the notes to consolidated financial statements.

During fiscal 2018, we recorded $7.2 million in restructuring and related charges in the consolidated statements of operations.

•

During the fourth quarter of fiscal 2018, we initiated a new restructuring plan in order to realign the organization and enable further investment in key priority
areas. As a result, a restructuring charge of $3.4 million was recorded for severance costs and employee benefits. In total, 52 employees in manufacturing, R&D
and SG&A functions were terminated in connection with this new restructuring plan.

• We also incurred restructuring and related charges of $3.8 million from restructuring plans approved prior to fiscal 2016 primarily related to the shut down of our
manufacturing  facility  in  Bloomfield,  Connecticut  as  a  result  of  the  transfer  of  certain  production  processes  into  existing  sites  in  the  United  States  or  to
contract manufacturers.

During fiscal 2017, we recorded $12.0 million in restructuring and related charges. Of the  $12.0 million charge recorded during fiscal 2017,  $2.1 million related to

severance, retention and employee benefits.

Impairment Charges

In fiscal 2019, we announced our plan to discontinue the development and manufacturing of future Datacom transceiver products which impacted the Milpitas and
Shenzhen Datacom module teams. While we expect strong growth in Datacom volumes in the future, the market at the transceiver level is gross margin challenged due to
extreme competition. Following the Oclaro acquisition, we have a differentiated leadership position across a range of photonic chips on which the Datacom, wireless, and
access markets critically rely. 

In fiscal 2019, we recorded $30.7 million in long lived asset impairment charges in connection with the above plan. Refer to “Note 9. Balance Sheet Details” and

“Note 15. Impairment Charges” in the notes to consolidated financial statements for additional information.

47

Table of Contents

Interest and Other Income (Expense), Net

The components of interest and other income (expense), net are as follows for the years presented (in millions):

Interest expense

Foreign exchange gains (losses), net

Interest income

Other income (expense), net

Total other income (expense), net

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

(36.3)   $

(18.2)   $

(5.5)

(0.6)  

13.9  

2.5  

15.8   $

(0.3)  

8.5  

0.3  

8.5   $

0.6

1.1

0.6

2.3

$

$

During fiscal 2019, interest and other income (expense), net increased by $10.8 million in expense as compared to fiscal 2018, mainly driven by interest expense on

our term loan and ticking fees, partially offset by higher interest income due to high interest rates owned on our investment portfolio.

During fiscal 2018, interest and other income (expense), net increased by $6.5 million in expense as compared to fiscal 2017, mainly driven by amortization of the
debt  discount  on  the  2024  Notes  of  $16.7  million  in  our  fiscal  2018  compared  to  $5.1  million  in  fiscal  2017,  partially  offset  by  interest  income  on  the  short-term
investments and cash equivalents of $8.5 million in our fiscal 2018 compared to $1.1 million in fiscal 2017.

Unrealized Gain (Loss) on Derivative Liability

Unrealized gain (loss) on Series A Preferred Stock derivative liability amounted to $8.8 million and $(0.8) million in fiscal 2019 and 2018, respectively. The change
was primarily related to the change in the price of our underlying common stock and reflected in the consolidated statements of operations as “unrealized gain (loss) on
derivative  liability”.  On  November  2,  2018,  all  35,805 shares  of  our  Series  A  Preferred  Stock  were  converted  to  common  stock  with  the  outstanding  balance  of  the
embedded  derivative  liability  reclassed  to  additional  paid  in  capital.  There  will  be  no  further  adjustments  to  “unrealized  gain  (loss)  on  derivative  liability”  due  to  this
conversion.

For  further  discussion  of  our  derivative  liability,  see  “Note  12.  Non-Controlling  Interest  Redeemable  Convertible  Preferred  Stock  and  Derivative  Liability”  in  the

notes to consolidated financial statements.

Provision for (Benefit from) Income Taxes (in millions):

Provision for (benefit from) income taxes

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

  $

3.1   $

(118.7)   $

42.7

The comparability of our operating results for fiscal 2019 compared to the corresponding prior years was impacted by the U.S. Tax Cuts and Jobs Act of 2017 (the
“Tax Act”), which was enacted on December 22, 2017. The Tax Act introduced significant changes to U.S. income tax law including reducing the U.S. federal statutory
tax rate from 35% to 21% and imposing new taxes on certain foreign-sourced earnings and certain intercompany payments. Due to the timing of the enactment and the
complexity involved in applying the provisions of the Tax Act, we made reasonable estimates of the effects and recorded provisional amounts in our financial statements as
of fiscal 2018 in accordance with SEC Staff Accounting Bulletin No. 118 (“SAB 118”). During the period ended December 29, 2018, we completed our accounting for the
Tax Act with no material adjustment to our provisional estimates recorded.

Our  provision  for  income  taxes  for  fiscal  2019  differs  from  the  21%  U.S.  statutory  rate  primarily  due  to  the  income  tax  expense  from  non-deductible  stock-based
compensation  and  the  tax  effect  of  increased  valuation  allowance  in  the  U.K.  and  Thailand,  Global  Intangible  Low-Taxed  Income  (“GILTI”),  Base  Erosion  and  Anti-
Abuse Tax (“BEAT”) and subpart F inclusion, partially offset by the income tax benefit of the earnings of our foreign subsidiaries being taxed at rates that differ from the
U.S. statutory rate as well as the U.S. federal R&D tax credit.

Our provision for income taxes for fiscal 2018 differed from the tax provision based on the U.S. statutory federal income tax rate of approximately 28% as a result of

$207.2 million of income tax benefit related to the release of valuation allowance against

48

 
 
 
 
 
 
   
   
 
 
 
 
 
 
Table of Contents

our U.S. federal and certain state deferred tax assets, partially offset by $80.5 million of income tax expense related to the remeasurement of our net deferred tax assets as a
result of reduction in the U.S. federal corporate tax rate. Our provision for income taxes was also impacted by the benefit our foreign income being taxed at lower rates
than the U.S. statutory rate, as well as the benefit of research and development tax credits.

Our provision for income taxes for fiscal 2017 differed from the tax provision based on the then-U.S. statutory federal income tax rate of 35% primarily as a result of
$36.5 million of income tax expense related to the non-deductible unrealized losses associated with the embedded derivatives for the Series A Preferred Stock and the 2024
Notes,  as  well  as  $8.4  million  of  unrecognized  tax  benefits,  $4.9  million  of  non-deductible  stock-based  compensation,  and  $21.5  million  of  changes  in  the  valuation
allowance against our deferred tax assets. Our provision for income taxes was also impacted by the benefit of our foreign income being taxed at lower rates than the U.S.
statutory rate, as well as the income tax benefit of research and development tax credits.

Contractual Obligations

The following table summarizes our contractual obligations as of June 29, 2019, and the effect such obligations are expected to have on our liquidity and cash flow

over the next five years (in millions):

Contractual Obligations
Acquisition contingencies (1)

Asset retirement obligations
Capital lease obligations (2)
Operating lease obligations (2)
Pension plan contributions (3)
Purchase obligations (4)
Term loan - principal (5)
Term loan - interest (5)
Convertible notes - principal (6)
Convertible notes - interest (7)

Total

Payments due by period

Total

  Less than 1 year  

1 - 3 years

3 - 5 years

More than 5
years

$

2.7   $

2.7   $

—   $

—   $

5.5  

0.8  

90.0  

0.5  

216.4  

497.5  

151.8  

450.0  

5.6  

1.0  

0.8  

13.9  

0.5  

209.7  

5.0  

24.2  

—  

1.1  

0.8  

—  

23.3  

—  

6.6  

10.0  

47.7  

—  

2.2  

0.6  

—  

21.1  

—  

0.1  

10.0  

46.8  

450.0  

2.3  

—

3.1

—

31.7

—

—

472.5

33.1

—

—

$

1,420.8   $

258.9   $

90.6   $

530.9   $

540.4

(1) Refer to “Note 11. Fair Value Measurements” in the notes to consolidated financial statements.

(2) Refer to “Note 19. Commitments  and Contingencies” in the notes to consolidated  financial  statements.  The amounts of operating  lease  obligations  in the table

above are net of our sublease income amounts.

In fiscal 2019, 2018 and 2017, rental expense relating to building and equipment was $15.8 million, $12.1 million and $10.1 million, respectively. Non-cancellable
sublease proceeds from our subleases were approximately $1.0 million, $0.7 million, and $0.7 million, respectively, during fiscal years 2019, 2018, and 2017. The amounts
of our rental expense for the years presented are net of these sublease income amounts.

(3)  In  connection  with  our  acquisitions  of  Oclaro  in  fiscal  2019  and  Time-Bandwidth  in  fiscal  2014,  we  assumed  defined  benefit  plans  for  Japan  and  Switzerland
employees, respectively. The Switzerland Plan is partially funded. The Japan Plan is unfunded. The amount in the preceding table represents planned contributions to our
defined benefit plans. Although additional future contributions will be required, the amount and timing of these contributions will be affected by actuarial assumptions, the
actual rate of returns on plan assets, the level of market interest rates, legislative changes, and the amount of voluntary contributions to the plan. Any contributions for the
following fiscal year and later will depend on the value of the plan assets in the future and thus are uncertain. As such, we have not included any amounts beyond 1 year in
the table above. Refer to “Note 18. Employee Benefit Plans” in the notes to consolidated financial statements.

(4)  Purchase  obligations  represent  legally-binding  commitments  to  purchase  inventory  and  other  commitments  made  in  the  normal  course  of  business  to  meet

operational requirements. Refer to “Note 19. Commitments and Contingencies” in the notes to consolidated financial statements.

49

 
 
 
 
 
   
   
   
   
Table of Contents

(5) We incurred indebtedness in an aggregate principal amount of $500.0 million pursuant to a senior secured Term Loan Facility that we entered into in connection
with the closing of the Oclaro acquisition on December 10, 2018. The amounts of interest included in the table above is based on current interest rates. Refer to “Note 7.
Term Loan Facility” in the notes to consolidated financial statements.

(6) Refer to “Note 13. Convertible Notes” in the notes to consolidated financial statements.

(7) Includes interest on our 0.25% Convertible Notes due in 2024 through March 2024 as we have the right to redeem the 2024 Notes in whole or in part at any time

on or after March 15, 2024. Refer to “Note 13. Convertible Notes” in the notes to consolidated financial statements.

As of June 29, 2019, our other  non-current  liabilities  also  include  $18.7 million of  unrecognized  tax  benefit  for  uncertain  tax  positions.  We are  unable  to  reliably

estimate the timing of future payments related to uncertain tax positions and therefore have excluded them from the preceding table.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements, as such term is defined in rules promulgated by the SEC, that have or are reasonably likely to have a current or
future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that
are material to investors.

Defined Benefit Plans

   As  a  result  of  acquiring  Time-Bandwidth  in  January  2014,  we  have  a  pension  plan  for  our  employees  in  Switzerland.  This  plan  is  open  to  new  participants  and
additional service costs are being accrued. The Switzerland Plan is partially funded. As of June 29, 2019, our pension plan was under funded by $5.0 million since the
projected benefit obligation (“PBO”) exceeded the fair value of the plan assets.

In connection with the acquisition of Oclaro in December 2018, we assumed a defined benefit plan which provides benefits to our employees in Japan. This plan is
open to new participants. Benefits are generally based upon an employee’s individual grade level and years of service. Employees are entitled to a lump sum benefit upon
retirement or upon certain instances of termination. As of June 29, 2019, there were no Japan Plan assets. The net obligation of $2.8 million as of June 29, 2019 is recorded
in our consolidated balance sheets as non-current liabilities and is reflective of the total PBO.

A key actuarial assumption in calculating the net periodic cost and the PBO is the discount rate. Changes in the discount rate impact the interest cost component of the
net periodic benefit cost calculation and PBO due to the fact that the PBO is calculated on a net present value basis. Decreases in the discount rate will generally increase
pre-tax  cost, recognized  expense and the PBO. Increases  in the discount rate tend to have the opposite effect.  We estimate  a 50 basis point decrease  or increase  in the
discount rate would cause a corresponding increase or decrease, respectively, in the PBO of $1.4 million or $(1.3) million, based upon data as of June 29, 2019.

We expect to contribute $0.5 million to our Japan and Switzerland pension plans in fiscal 2020.

Financial Condition

Liquidity and Capital Resources

As of June 29, 2019 and June 30, 2018, our cash and cash equivalents of $432.6 million and $397.3 million, respectively, were largely held in the United States. The
total amount of cash outside the United States as of June 29, 2019 was $100.5 million, which was primarily held by entities incorporated in Japan, the United Kingdom,
Thailand, the British Virgin Islands, China, and the Netherlands. Although the cash currently held in the United States as well as the cash generated in the United States
from future operations is expected to cover our normal operating requirements, a substantial amount of additional cash could be required for other purposes, such as capital
expenditures to support our business and growth, including costs associated with increasing internal manufacturing capabilities, such as our new Thailand facility, strategic
transactions  and  partnerships,  and  future  acquisitions.  Except  for  the  cash  and  cash  equivalents  held  in  the  Cayman  Islands,  Japan  and  Hong  Kong,  our  intent  is  to
indefinitely reinvest the cash and cash equivalents held outside the United States since our current plans do not demonstrate a need to repatriate them to fund our domestic
operations. However, if in the future, we encounter a significant need for liquidity domestically or at a particular location that we cannot fulfill through borrowings, equity
offerings, or other internal or external sources, or the cost to bring back the money is insignificant from a tax perspective, we may determine that cash repatriations are
necessary or desirable. Repatriation could result in material additional taxes. These factors may cause us to have an overall tax rate higher than other

50

Table of Contents

companies or higher than our tax rates have been in the past. If conditions warrant, we may seek to obtain additional financing through debt or equity sources. To the extent
we issue additional shares, our existing stockholders may be diluted. However, any such financing may not be available on terms favorable to us, or may not be available at
all.

Fiscal 2019

As of June 29, 2019, our consolidated balance of cash and cash equivalents increased by $35.3 million, to $432.6 million from $397.3 million as of June 30, 2018.
The increase in cash and cash equivalents was mainly due to cash provided by financing activities of $485.1 million, primarily related to $490.8 million in proceeds from a
term loan, net of debt issuance costs, used to fund the Oclaro acquisition, and cash provided by operating activities of $330.1 million during the year ended June 29, 2019;
which was offset by cash used in investing activities of $779.7 million, principally related to net cash of $619.8 million paid to acquire Oclaro.

Cash  provided  by  operating  activities  of  $330.1 million during  the  year  ended  June  29,  2019,  primarily  resulted  from  $314.4 million of  non-cash  items  (such  as
depreciation, stock-based compensation, amortization of intangibles, amortization of discount on the 2024 Notes, amortization of the debt issuance costs on the term loan,
amortization of fair value adjustment in connection with the acquisition of Oclaro, impairment charges, net of unrealized gain on derivative liability and other non-cash
items) and $52.1 million of changes in our operating assets and liabilities, offset by our net loss of $36.4 million.

Cash used in investing activities of $779.7 million during the year ended June 29, 2019, was primarily attributable to $619.8 million paid to acquire all outstanding
shares of common stock of Oclaro, net of cash received through the acquisition of Oclaro. In addition, we had capital expenditures of $166.0 million (mainly attributable to
the purchase of the property for $54.6 million), payment for asset acquisition of $1.3 million, purchases of short-term investments, net of sales of $18.1 million, offset by
proceeds from sales of product lines of $25.5 million.

Cash provided by financing activities of $485.1 million during the year ended June 29, 2019, primarily resulted from $490.8 million of proceeds from a term loan, net
of debt issuance costs, used to partially finance the Oclaro acquisition, offset by the repayment of a term loan of $2.5 million. In addition, we received $9.3 million from
the issuance of common stock under our employee stock plan, offset by the repayment of capital lease obligations of $8.8 million, tax payments related to restricted stock
of $2.4 million, a payment of an acquisition related holdback of $1.0 million, and dividend payments on our Series A Preferred Stock of $0.7 million.

Fiscal 2018

As of June 30, 2018, our consolidated balance of cash and cash equivalents increased by $124.4 million, to $397.3 million from $272.9 million as of July 1, 2017. The
increase  in  cash  and  cash  equivalents  was  mainly  due  to  cash  provided  by  operating  activities  of  $247.5 million during  fiscal  2018  offset  by  purchases  of  short-term
investments, net of sales of $33.8 million and capital expenditures of $93.2 million.

Cash provided by operating activities was $247.5 million for the year ended June 30, 2018, primarily resulting from $248.1 million of net income and $18.5 million of
non-cash items (such as depreciation, stock-based compensation, amortization of intangibles, amortization of discount on the 2024 Notes, net of the release of the valuation
allowance),  offset  by  $19.1  million  of  changes  in  our  operating  assets  and  liabilities.  Changes  in  our  operating  assets  and  liabilities  related  primarily  to  an  increase  in
accounts receivable of $30.8 million, offset by an increase in accrued expenses and other current and non-current liabilities of $11.9 million.

Cash used in investing activities of $127.0 million for the year ended June 30, 2018, was primarily attributable to capital expenditures of $93.2 million and purchases

of short-term investments, net of sales of $33.8 million.

Cash  provided  by  financing  activities  was  $3.8  million  for  the  year  ended  June  30,  2018,  resulting  primarily  from  the  issuance  of  common  stock  under  the  2015

Employee Stock Purchase Plan of $9.2 million offset by repayment of capital lease obligation of $6.4 million.

Fiscal 2017

As of July 1, 2017, our consolidated balance of cash and cash equivalents increased by $115.8 million, to $272.9 million from $157.1 million as of July 2, 2016. The
increase in cash and cash equivalents was mainly due to proceeds from the issuance of the 2024 Notes during fiscal 2017, offset by the purchases of short-term investments
and property, plant and equipment.

Cash provided by operating activities was $85.0 million for the year ended July 1, 2017, primarily resulting from $102.5 million of net loss and $199.4 million of non-
cash  items  such  as  depreciation,  stock-based  compensation,  amortization  of  intangibles  and  unrealized  loss  on  derivative  liabilities,  the  impact  of  which  was  offset  by
changes in excess tax benefit associated with stock-

51

Table of Contents

based  compensation.  In  addition,  changes  in  our  operating  assets  and  liabilities  of  $11.9  million  related  primarily  to  an  increase  in  inventories  of  $41.7  million  and  a
decrease in accounts payable of $16.9 million related to non-cash items such as $10.0 million unpaid property, plant and equipment, offset by a decrease in income taxes,
net of $42.7 million.

Cash  used  in  investing  activities  was  mainly  for  capital  expenditures  and  purchases  of  short-term  investments,  net  of  sales  of  $138.1  million  and  $282.5  million,

respectively, for the year ended July 1, 2017. Changes in investing cash flow in fiscal 2017 also related to the acquisition of a business for $5.1 million.

Cash provided by financing activities was $456.7 million for the year ended July 1, 2017, resulting primarily from proceeds of $442.3 million from the issuance of the

2024 Notes.

Liquidity and Capital Resources Requirements

We believe that our cash and cash equivalents as of June 29, 2019, and cash flows from our operating activities will be sufficient to meet our liquidity and capital
spending requirements for at least the next 12 months. However, if market conditions are favorable, we may evaluate alternatives to opportunistically pursue additional
financing.

There are a number of factors that could positively or negatively impact our liquidity position, including:

•

•

•

•

•

•

•

•

•

•

•

•

global economic conditions which affect demand for our products and services and impact the financial stability of our suppliers and customers; 

changes in accounts receivable, inventory or other operating assets and liabilities, which affect our working capital;

increase in capital expenditures to support our business and growth;

the tendency of customers to delay payments or to negotiate favorable payment terms to manage their own liquidity positions;

timing of payments to our suppliers;

factoring or sale of accounts receivable;

volatility in fixed income and credit, which impact the liquidity and valuation of our investment portfolios;

volatility in foreign exchange markets, which impacts our financial results;

possible investments or acquisitions of complementary businesses, products or technologies, or other strategic transactions or partnerships;

issuance of debt or equity securities, or other financing transactions, including bank debt;

potential funding of pension liabilities either voluntarily or as required by law or regulation; and

the settlement of any conversion or redemption of the 2024 Notes in cash.

In March 2018, we entered into the Merger Agreement with Oclaro. On December 10, 2018, we completed the merger. In accordance with the terms of the Merger
Agreement, each issued and outstanding share of Oclaro common stock was automatically converted into the right to receive (i) $5.60 in cash and (ii) 0.0636 of a share of
Lumentum  common  stock.  The  total  transaction  consideration  was  $1.4 billion,  funded  through  a  combination  of  the  issuance  of  Lumentum  common  stock,  new  debt
obtained through the Term Loan facility, and cash balances of the combined company.

52

Table of Contents

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign Exchange Risk

We conduct our business and sell our products to customers primarily in Asia, Europe, and North America. Due to the impact of changes in foreign currency exchange
rates between the U.S. Dollar and foreign currencies, for the fiscal years ended June 29, 2019, June 30, 2018, and July 1, 2017, we recorded unrealized gain (loss) of $(0.6)
million, $(0.3) million, and $0.6 million, respectively, in interest and other income (expense), net in the consolidated statements of operations.

Although we sell primarily in the U.S. Dollar, we have foreign currency exchange risks related to our operating expenses denominated in currencies other than the
U.S. Dollar, principally the Chinese Yuan, Canadian Dollar, Thai Baht, Japanese Yen, UK Pound, Swiss Franc and Euro. The volatility of exchange rates depends on many
factors that we cannot forecast with reliable accuracy. In the event our foreign currency denominated assets, liabilities, sales or expenses increase, our operating results
may be more greatly affected by fluctuations in the exchange rates of the currencies in which we do business.

Equity Price Risk

We are exposed to equity price risk related to the conversion options embedded in our 2024 Notes.

In March 2017, we issued the 2024 Notes in a private  placement  with an aggregate  principal  amount of $450 million.  We carry the 2024 Notes at face value less
amortized discount on the consolidated balance sheet. The 2024 Notes bear interest at a rate of 0.25% per year. Since the 2024 Notes bear interest at fixed rates, we have
no financial statement risk associated with changes in interest rates. However, the potential value of the shares to be distributed to the holders of 2024 Notes changes when
the  market  price  of  our  stock  fluctuates.  The  2024  Notes  will  mature  on  March  15,  2024,  unless  earlier  repurchased  by  us  or  converted  pursuant  to  their  terms,  at  a
conversion price of approximately $60.62 per share.

Interest Rate Fluctuation Risk

As  of  June  29,  2019,  we  had  cash,  cash  equivalents,  and  short-term  investments  of  $768.5  million.  Cash  equivalents  and  short-term  investments  are  primarily
comprised  of  highly  liquid  investment  grade  fixed  income  securities.  Our  investment  policy  and  strategy  is  focused  on  the  preservation  of  capital  and  supporting  our
liquidity requirements. We do not enter into investments for trading or speculative purposes. As of June 29, 2019, the weighted-average life of our investment portfolio
was approximately seven months.

Our fixed-income portfolio is subject to fluctuations in interest rates, which could affect our results of operations. Based on our investment portfolio balance as of
June  29,  2019,  a  hypothetical  increase  or  decrease  in  interest  rates  of  1%  (100  basis  points)  would  have  resulted  in  a  decrease  or  an  increase  in  the  fair  value  of  our
portfolio of approximately $2.2 million, and a hypothetical increase or decrease of 0.5% (50 basis points) would have resulted in a decrease or an increase in the fair value
of our portfolio of approximately $1.1 million.

A hypothetical increase or decrease of 0.5% (50 basis points) in interest rates would have resulted in an approximate $2.5 million increase or decrease in our interest

expense for the year on the Term Loan Facility.

Bank Liquidity Risk

As of June 29, 2019, we had approximately $213.8 million of unrestricted cash (excluding money market funds) in operating accounts that are held with domestic and
international financial institutions. These cash balances could be lost or become inaccessible if the underlying financial institutions fail or if they are unable to meet the
liquidity  requirements  of  their  depositors  and  if  they  are  not  supported  by  the  national  government  of  the  country  in  which  such  financial  institution  is  located.
Notwithstanding,  to  date,  we  have  not  incurred  any  losses  and  have  had  full  access  to  our  operating  accounts.  We  believe  any  failures  of  domestic  and  international
financial institutions could impact our ability to fund our operations in the short term.

53

Table of Contents

ITEM 8. FINANCIAL STATEMENTS AND SUMMARY DATA

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors of Lumentum Holdings Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Lumentum Holdings Inc. and subsidiaries (the “Company”) as of June 29, 2019 and June 30, 2018, the
related consolidated statements of operations, comprehensive income (loss), cash flows, and redeemable convertible preferred stock and stockholders’ equity for each of
the  three  years  in  the  period  ended  June  29,  2019,  and  the  related  notes  and  the  schedule  listed  in  the  Index  at  Item  15  (collectively  referred  to  as  the  “financial
statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 29, 2019 and June 30, 2018,
and  the  results  of  its  operations  and  its  cash  flows  for  each  of  the  three  years  in  the  period  ended  June  29,  2019,  in  conformity  with  accounting  principles  generally
accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control
over  financial  reporting  as  of  June  29,  2019,  based  on  criteria  established  in  Internal  Control  -  Integrated  Framework  (2013)  issued  by  the  Committee  of  Sponsoring
Organizations  of  the  Treadway  Commission  and  our  report  dated  August  27,  2019,  expressed  an  unqualified  opinion  on  the  Company's  internal  control  over  financial
reporting.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on
our  audits.  We  are  a  public  accounting  firm  registered  with  the  PCAOB  and  are  required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.
federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a
test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our
opinion.

/s/ DELOITTE & TOUCHE LLP

San Jose, California  
August 27, 2019  

We have served as the Company's auditor since 2017.

54

Table of Contents

LUMENTUM HOLDINGS INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data)

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

1,247.7   $

1,001.6

Net revenue

Cost of sales

Amortization of acquired intangibles

Gross profit

Operating expenses:

    Research and development

    Selling, general and administrative

    Restructuring and related charges

    Impairment charges

Total operating expenses

Income/(loss) from operations

Unrealized gain (loss) on derivative liability

Interest expense

Other income (expense), net

Income/(loss) before income taxes

Provision for (benefit from) income taxes

Net income/(loss)

Items reconciling net income/(loss) to net income/(loss) attributable to common stockholders:

Less: Cumulative dividends on Series A Preferred Stock

Less: Earnings allocated to Series A Preferred Stock

Net income/(loss) attributable to common stockholders - Basic

Net income/(loss) attributable to common stockholders - Diluted

Net income/(loss) per share attributable to common stockholders:

    Basic

    Diluted

Shares used to compute net income/(loss) per share attributable to common stockholders:

    Basic

    Diluted

$

$

$

$

$

$

See accompanying Notes to Consolidated Financial Statements.

55

1,565.3   $

1,092.9  

46.5  

425.9  

184.6  

200.3  

31.9  

30.7

447.5  

(21.6)  

8.8  

(36.3)  

15.8  

(33.3)  

3.1

812.4  

3.2  

432.1  

156.8  

128.2  

7.2  

—

292.2  

139.9  

(0.8)  

(18.2)  

8.5  

129.4  

(118.7)  

(36.4)   $

248.1   $

(0.3)  

(1.2)  

(37.9)   $

(37.9)   $

(0.9)  

(5.7)  

241.5   $

241.5   $

(0.54)   $

(0.54)   $

3.88   $

3.82   $

70.7  

70.7  

62.3  

63.3  

677.0

6.5

318.1

148.3

110.2

12.0

—

270.5

47.6

(104.2)

(5.5)

2.3

(59.8)

42.7

(102.5)

(0.9)

—

(103.4)

(103.4)

(1.71)

(1.71)

60.6

60.6

 
 
 
 
   
   
 
   
   
 
   
   
 
   
   
 
   
   
 
   
   
 
   
   
Table of Contents

LUMENTUM HOLDINGS INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in millions)

Net income/(loss)

Other comprehensive income (loss), net of tax:

Net change in cumulative translation adjustment

Net change in unrealized gain (loss) on available-for-sale securities

Net change in defined benefit obligations

Other comprehensive income (loss), net of tax

Comprehensive income (loss), net of tax

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

(36.4)   $

248.1   $

(102.5)

(0.6)  

2.5  

(1.2)  

0.7  

(0.2)  

(1.6)  

0.8  

(1.0)  

(1.2)

—

(0.8)

(2.0)

(35.7)   $

247.1   $

(104.5)

$

$

See accompanying Notes to Consolidated Financial Statements.

56

 
 
 
   
   
Table of Contents

LUMENTUM HOLDINGS INC.
CONSOLIDATED BALANCE SHEETS
(in millions, except share and per share data)

ASSETS

Current assets:

Cash and cash equivalents

Short-term investments

Accounts receivable, net

Inventories

Prepayments and other current assets

Total current assets

Property, plant and equipment, net

Goodwill

Other intangible assets, net

Deferred income taxes

Other non-current assets

Total assets

LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’
EQUITY

Current liabilities:

Accounts payable

Accrued payroll and related expenses

Accrued expenses

Term loan, current

Other current liabilities

Total current liabilities

Convertible notes

Term loan, non-current

Derivative liability

Deferred tax liability

Other non-current liabilities

Total liabilities

Commitments and contingencies (Note 19)

Redeemable convertible preferred stock:

$

$

Non-controlling interest redeemable convertible Series A Preferred Stock, $0.001 par value, 10,000,000
authorized shares; zero and 35,805 shares issued and outstanding as of June 29, 2019 and June 30, 2018,
respectively

Total redeemable convertible preferred stock

Stockholders’ equity:

Common stock, $0.001 par value, 990,000,000 authorized shares, 76,653,478 and 62,790,087 shares issued and
outstanding as of June 29, 2019 and June 30, 2018, respectively

Additional paid-in capital

Retained earnings

Accumulated other comprehensive income

Total stockholders’ equity

Total liabilities, redeemable convertible preferred stock, and stockholders’ equity

$

See accompanying Notes to Consolidated Financial Statements.

57

June 29, 2019

June 30, 2018

$

432.6   $

335.9  

238.0

228.8  

97.5  

1,332.8  

433.3  

368.9  

395.4  

169.6  

16.6  

2,716.6   $

160.8   $

42.3  

46.7  

5.0  

39.2  

294.0  

351.9

484.0  

—

55.9  

33.7  

1,219.5  

—  

—  

0.1  

1,360.8  

129.1  

7.1  

1,497.1  

2,716.6   $

397.3

314.2

197.1

174.1

44.5

1,127.2

306.9

11.3

7.0

125.6

3.5

1,581.5

126.5

31.5

33.9

—

22.1

214.0

334.2

—

52.4

0.3

18.7

619.6

35.8

35.8

0.1

753.2

166.4

6.4

926.1

1,581.5

 
 
 
 
 
 
 
 
 
   
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

OPERATING ACTIVITIES:

Net income/(loss)

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation expense

Stock-based compensation

Unrealized (gain) loss on derivative liability

Amortization of acquired intangibles

Loss on disposal of property, plant and equipment

Excess tax benefit associated with stock-based compensation

Impairment charges

Amortization of discount on 0.25% Convertible Notes due 2024

Amortization of debt issuance costs on term loan

Amortization of inventory fair value adjustment in connection with Oclaro acquisition

Amortization of favorable/unfavorable leases

Release of valuation allowance, net

Other non-cash (income) expenses

Changes in operating assets and liabilities:

Accounts receivable

Inventories

Prepayments and other current and non-currents assets

Income taxes, net

Accounts payable

Accrued payroll and related expenses

Accrued expenses and other current and non-current liabilities

Net cash provided by operating activities

INVESTING ACTIVITIES:

Payments for acquisition of property, plant and equipment

Proceeds from sale of product lines

Acquisition of business, net of cash acquired

Payment for asset acquisition

Purchases of short-term investments

Proceeds from maturities and sales of short-term investments

Net cash used in investing activities

FINANCING ACTIVITIES:

Proceeds from the issuance of 0.25% Convertible Senior Notes due 2024, net of issuance costs

Excess tax benefit associated with stock-based compensation

Tax payments related to restricted stock

Payment of dividends - Series A Preferred Stock

Payment of acquisition related holdback

Proceeds from employee stock plans

Proceeds from term loan, net of debt issuance costs

Repayment of term loan

Repayment of capital lease obligations

Proceeds from the exercise of stock options

58

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

$

(36.4)   $

248.1   $

(102.5)

102.9  

60.7  

(8.8)  

54.6  

2.2  

—  

30.7  

17.7  

0.8  

54.6  

0.5  

—  

(1.5)  

27.7  

40.6  

(10.8)  

(5.6)  

(10.6)  

(0.1)  

10.9  

330.1  

(166.0)  

25.5  

(619.8)  

(1.3)  

(269.7)  

251.6  

(779.7)  

—  

—  

(2.4)  

(0.7)  

(1.0)  

9.3  

490.8  

(2.5)  

(8.8)  

0.4  

74.0  

46.8  

0.8  

3.2  

0.6  

—  

—  

16.7  

—  

—  

—  

(124.0)  

0.4  

(30.8)  

(7.7)  

6.1  

(7.3)  

4.8  

3.9  

11.9  

247.5  

54.2

32.7

104.2

6.8

0.2

(3.8)

—

5.1

—

—

—

—

—

4.2

(41.7)

(7.4)

42.7

(16.9)

1.0

6.2

85.0

(93.2)  

(138.1)

—  

—  

—  

(634.3)  

600.5  

(127.0)  

—  

—  

—  

(0.7)  

—  

9.2  

—  

—  

(6.4)  

1.7  

—

(5.1)

—

(290.7)

8.2

(425.7)

442.3

3.8

—

(0.9)

—

8.1

—

—

—

3.4

 
 
 
 
 
   
   
 
   
   
 
   
   
 
   
   
 
   
   
Table of Contents

LUMENTUM HOLDINGS INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

Net cash provided by financing activities

Effect of exchange rates on cash and cash equivalents

Increase in cash and cash equivalents

Cash and cash equivalents at beginning of period

Cash and cash equivalents at end of period

Supplemental disclosure of cash flow information:

Cash paid for taxes

Cash paid for interest

Supplemental disclosure of non-cash transactions:

Unpaid property, plant and equipment in accounts payable and accrued expenses

Equipment acquired under capital lease

Issuance of common stock upon conversion of Series A Preferred Stock

Net transfer of assets from property plant and equipment to assets held-for-sale

Issuance of common stock and replacement awards in connection with Oclaro acquisition

$

$

$

485.1  

(0.2)  

35.3  

397.3  

3.8  

0.1  

124.4  

272.9  

432.6   $

397.3   $

8.7   $

15.1  

14.3   $

—  

79.4  

4.9  

460.1  

12.7  

1.3  

17.2  

15.6  

—  

—  

—  

456.7

(0.2)

115.8

157.1

272.9

9.5

—

18.4

—

—

—

—

See accompanying Notes to Consolidated Financial Statements.

59

 
   
   
 
 
   
 
 
   
   
 
   
   
Other comprehensive income
(loss)

Declared dividend for preferred
stock

Reclassification of 2024 Notes
derivative liability in connection
with cash settlement condition

Issuance of shares pursuant to
equity plans, net of tax
withholdings

  ESPP shares issued

  Stock-based compensation

Excess tax benefit associated with
stock-based compensation

Table of Contents

LUMENTUM HOLDINGS INC.
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

(in millions)

Non-Controlling Interest
Redeemable Convertible
Series A Preferred Stock  

Common Stock

Shares

  Amount

Shares

Amount

Additional
Paid-In Capital

  Retained Earnings

(Accumulated
Deficit)

Accumulated
 Other Comprehensive
Income/(Loss)

Total
Stockholders’
Equity

Balance as of July 2, 2016

—   $

35.8  

59.6   $

0.1   $

467.7   $

20.2

  $

Net income (loss)

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

(102.5)

—  

(0.9)

9.4

  $

—  

497.4

(102.5)

(2.0)

—  

(2.0)

(0.9)

—  

—  

—  

—  

192.8  

—  

—  

192.8

—  

—  

—  

—  

—  

—  

1.6  

0.3  

—  

—  

—  

—  

—  

—  

—  

—  

(12.2)  

8.1  

34.3  

3.8  

—  

—  

—  

—  

Balance as of July 1, 2017

—   $

35.8  

61.5   $

0.1   $

694.5   $

(83.2)

  $

Net income (loss)

—  

—  

—  

Other comprehensive income
(loss)

Declared dividend for preferred
stock

Issuance of shares pursuant to
equity plans, net of tax
withholdings

ESPP shares issued

Stock-based compensation

Cumulative effect of stock
compensation accounting change

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

1.1  

0.2  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

1.7  

9.2  

47.6  

0.2  

248.1

—  

(0.9)

—  

—  

—  

2.4

Balance as of June 30, 2018

—   $

35.8  

62.8   $

0.1   $

753.2   $

166.4

  $

Net income (loss)

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

(36.4)

—    

—  

(0.3)

—  

—  

—  

—  

7.4

  $

—  

(1.0)

—  

—  

—  

—  

—  

6.4

  $

—  

0.7

—  

(12.2)

8.1

34.3

3.8

618.8

248.1

(1.0)

(0.9)

1.7

9.2

47.6

2.6

926.1

(36.4)

0.7

(0.3)

—  

—  

1.1  

—  

(0.4)  

—  

—  

(0.4)

—  

—  

—  

—  

11.0  

0.3  

—  

—  

60

460.1  

9.3  

—  

—  

—  

—  

460.1

9.3

Other comprehensive income
(loss)

Declared dividend for preferred
stock

Issuance of shares pursuant to
equity plans, net of tax
withholdings

Issuance of shares pursuant to
merger agreement, net of tax
withholdings

ESPP shares issued

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

(in millions)

Stock-based compensation

Cumulative-effect adjustment for
adoption of Topic 606

Conversion of preferred stock to
common stock

—  

—  

—  

—  

—  

59.2  

—  

—  

—  

—  

—  

(35.8)  

1.5  

—  

79.4  

—  

(0.6)  

—  

—  

—  

—  

59.2

(0.6)

79.4

Balance as of June 29, 2019

—   $

—  

76.7   $

0.1   $

1,360.8   $

129.1   $

7.1   $

1,497.1

See accompanying Notes to Consolidated Financial Statements.

61

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Description of Business and Summary of Significant Accounting Policies

Description of Business

Lumentum (“we,” “us,” “our” or the “Company”) is an industry-leading provider of optical and photonic products defined by revenue and market share addressing a
range of end market applications including Optical Communications (“OpComms”) and Lasers for manufacturing, inspection and life-science applications. We seek to use
our core optical and photonic technology and our volume manufacturing capability to expand into attractive emerging markets that benefit from advantages that optical or
photonics  based  solutions  provide,  including  3D  sensing  for  consumer  electronics  and  diode  light  sources  for  a  variety  of  consumer  and  industrial  applications.  The
majority  of  our  customers  tend  to  be  Original  Equipment  Manufacturers  (“OEMs”)  that  incorporate  our  products  into  their  products  which  then  address  end-market
applications.  For  example,  we  sell  fiber  optic  components  that  Network  Equipment  Manufacturers’  (“NEMs”)  customers  assemble  into  communications  networking
systems, which they sell to network service providers or enterprises with their own networks. Similarly, many of our customers for our Lasers products incorporate our
products  into  tools  they  produce,  which  are  used  for  manufacturing  processes  by  their  customers.  For  3D  sensing,  we  sell  diode  lasers  to  manufacturers  of  consumer
electronics products for mobile, personal computing, and gaming who then integrate our devices within their products, for eventual resale to consumers and also into other
industrial applications.

Basis of Presentation

The preparation of the consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) requires management to make
estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Management bases its estimates on historical
experience and various other assumptions believed to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions
that may impact the Company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements
materially and involve difficult, subjective or complex judgments by management. Those policies are inventory valuation, revenue recognition, income taxes, long-lived
asset valuation, business combinations, and goodwill.

On  December  10,  2018,  we  completed  our  merger  with  Oclaro,  Inc.  (“Oclaro”),  a  provider  of  optical  components  and  modules  for  the  long-haul,  metro  and  data
center markets. Our consolidated financial statements include the operating results of Oclaro for the period from the date of acquisition through June 29, 2019. Refer to
“Note 5. Business Combination” for further discussion of the merger.

Fiscal Years

We  utilize  a  52-53  week  fiscal  year  ending  on  the  Saturday  closest  to  June  30th.  Our  fiscal  2019 and  2018  ended  on  June  29,  2019 and  June  30,  2018,

respectively, and were 52-week years. Our fiscal 2017 ended on July 1, 2017 and was a 53-week year.

Principles of Consolidation

The preparation of the consolidated financial statements in accordance with GAAP in the United States requires management to make estimates and assumptions that
affect the amounts reported in our consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other
assumptions believed to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company
in the future, actual results may be different from the estimates.

Certain prior period amounts have been reclassified to conform to the current year presentation. For fiscal 2018, we have reclassified  $20.5 million of capitalized
manufacturing overhead from prepayments and other current assets to inventory work in process to conform to current period presentation. Refer to “Note 9. Balance Sheet
Details”.

Related Party Transactions

Since October 2017, all transactions with Viavi were no longer related party transactions, as Viavi held less than 5% of our total shares outstanding. During fiscal
year 2017, we recognized revenue of $3.6 million from products sold to Viavi, recorded $0.5 million in research and development cost reimbursement, and $0.7 million in
sublease rental income. During fiscal year 2017, we also recorded $0.6 million in other income, which resulted from a tax indemnification agreement between Lumentum
and Viavi.

Summary of Significant Accounting Policies

Our significant accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management.

We believe that of our significant accounting policies described below, certain accounting

62

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

policies involve a greater degree of judgment and complexity and are the most critical to aid in fully understanding and evaluating our consolidated financial statements.
These policies are inventory valuation, revenue recognition, income taxes, long-lived asset valuation, business combinations, and goodwill. During fiscal year 2019, we
removed valuation of derivative liability from the list of critical accounting policies and estimates due to the conversion of the Series A Preferred Stock to common stock
on November 2, 2018. Refer to “Note 12. Non-Controlling Interest Redeemable Convertible Preferred Stock and Derivative Liability” for more details. For a description of
our critical accounting policies, also refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, Critical Accounting Policies and
Estimates.

Cash and Cash Equivalents

We consider highly-liquid fixed income securities with original maturities of three months or less at the time of purchase to be cash equivalents. As of fiscal year
ended June 29, 2019, cash and cash equivalents mainly consist of commercial papers, money market funds, and U.S. Treasury securities. As of fiscal year ended June 30,
2018, our cash and cash equivalents did not include any investments with original maturities of three months or less.

Short-term Investments

We classify our investments in debt as available-for-sale and record these investments at fair value. Investments with an original maturity of three months or less at
the date of purchase are considered cash equivalents, while all other investments are classified as short-term based on management’s intent and ability to use the funds in
current operations. Unrealized gains and losses are reported as a component of other comprehensive loss. Realized gains and losses are determined based on the specific
identification  method,  and  are  reflected  as  interest  and  other  income  (expense),  net  in  our  Consolidated  Statements  of  Operations.  We  regularly  review  our  investment
portfolio  to  identify  and  evaluate  investments  that  have  indicators  of  possible  impairment.  Factors  considered  in  determining  whether  a  loss  is  other-than-temporary
include, but are not limited to: the length of time and extent a security’s fair value has been below its cost, the financial condition and near-term prospects of the investee,
the credit quality of the security’s issuer, likelihood of recovery and our intent and ability to hold the security for a period of time sufficient to allow for any anticipated
recovery in value. For our debt instruments, we also evaluate whether we have the intent to sell the security or it is more likely than not that we will be required to sell the
security before recovery of its cost basis.

Impairment of Marketable and Non-Marketable Securities

We  periodically  review  our  marketable  and  non-marketable  securities  for  impairment.  If  we  conclude  that  any  of  these  investments  are  impaired,  we  determine
whether such impairment is other-than-temporary. We consider factors such as the duration, severity and the reason for the decline in value, the potential recovery period
and whether we intend to sell. For marketable debt securities, we also consider whether (i) it is more likely than not that we will be required to sell the debt securities
before recovery of their amortized cost basis, and (ii) the amortized cost basis cannot be recovered as a result of credit losses. If any impairment is considered other-than-
temporary, we will write-down the security to its fair value.

Fair Value of Financial Instruments

We define fair value as the price that would be received from selling an asset, or paid to transfer a liability, in an orderly transaction between market participants at
the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, we consider the principal or
most  advantageous  market  in  which  to  transact  and  the  market-based  risk.  We  apply  fair  value  accounting  for  all  financial  assets  and  liabilities  that  are  recognized  or
disclosed at fair value in the financial statements on a recurring basis. The carrying amounts reported in the consolidated financial statements approximate the fair value for
cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities due to their short-term nature.

Basic and Diluted Net Income (Loss) per Common Share

Basic  income  (loss)  per  share  is  computed  by  dividing  net  income  (loss)  available  to  common  stockholders  by  the  weighted  average  number  of  common  shares
outstanding  during  the  reporting  period.  The  weighted  average  number  of  shares  is  calculated  by  taking  the  number  of  shares  outstanding  and  weighting  them  by  the
amount  of  time  that  they  were  outstanding.    Diluted  earnings  per  share  reflects  the  potential  dilution  that  could  occur  if  stock  options,  preferred  stock,  and  other
commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company.

Diluted loss per share is the same as basic loss per share during periods where net losses are incurred since the inclusion of the potential common stock equivalents

would be anti-dilutive as a result of the net loss.

63

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Our  Series  A  Preferred  Stock  was  considered  a  participating  security  where  the  holders  of  Series  A  Preferred  Stock  had  the  right  to  participate  in  undistributed
earnings with holders of common stock. On November 2, 2018, the remaining 35,805 shares of our Series A Preferred Stock were converted into 1.5 million shares of our
common stock. Refer to “Note 12. Non-Controlling Interest Redeemable Convertible Preferred Stock and Derivative Liability” for further discussion. Prior to conversion,
the holders of our Series A Preferred Stock were entitled to share in dividends, on an as-converted basis, if the holders of our common stock were to receive dividends. Up
through  the  date  of  conversion,  we  used  the  two-class  method  to  compute  earnings  per  share.  The  two-class  method  is  an  earnings  allocation  formula  that  determines
earnings per share for each class of common stock and participating  security according to dividends declared (or accumulated) and participation rights in undistributed
earnings. In determining the amount of net earnings to allocate to common stockholders, earnings are allocated to both common and participating securities based on their
respective weighted-average shares outstanding during the period. Diluted earnings per common share is calculated similar to basic earnings per common share except that
it gives effect to all potentially dilutive common stock equivalents outstanding for the period, using the treasury stock method.

In March 2017, we issued $450 million in aggregate principal amount of  0.25% Convertible Senior Notes due in 2024 (the “2024 Notes”). We have the ability and
intent to settle the $450 million face value of the 2024 Notes in cash. Therefore, we use the treasury stock method for calculating the dilutive impact of the 2024 Notes.
The 2024 Notes will have no impact to diluted earnings per share until the average price of our common stock exceeds the conversion price of $60.62. Refer to “Note 13.
Convertible Notes” for details.

The dilutive effect of securities from the 2015 Equity Incentive Plan is reflected in diluted earnings per share by application of the treasury stock method, which
includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the
treasury stock method, the amount the employee must pay for exercising stock options and the amount of unamortized share-based compensation expense are collectively
assumed to be used to repurchase hypothetical shares. An increase in the fair value of our common stock can result in a greater dilutive effect from potentially dilutive
awards.

Anti-dilutive potential shares from 2015 Equity Incentive Plan are excluded from the calculation of diluted earnings per share if their exercise price exceeded the

average market price during the period or the share-based awards were determined to be anti-dilutive based on applying the treasury stock method.

Inventory Valuation

Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of net realizable value. We assess the value
of our inventory on a quarterly basis and write down those inventories which are obsolete or in excess of our forecasted usage to the lower of their cost or estimated net
realizable value. Our estimates of realizable value are based upon our analysis and assumptions including, but not limited to, forecasted sales levels and historical usage by
product, expected product lifecycle, product development plans and future demand requirements. Our product line management personnel play a key role in our excess
review  process  by  providing  updated  sales  forecasts,  managing  product  transitions  and  working  with  manufacturing  to  minimize  excess  inventory.  If  actual  market
conditions are less favorable than our forecasts or actual demand from our customers is lower than our estimates, we may be required to record additional inventory write-
downs. If actual market conditions are more favorable than anticipated, inventory previously written down may be sold, resulting in lower cost of sales and higher income
from operations than expected in that period.

Revenue Recognition

Adoption of Topic 606

Pursuant to Topic 606, our revenues are recognized upon the application of the following steps:

•

•

•

•

•

identification of the contract, or contracts, with a customer;

identification of the performance obligations in the contract;

determination of the transaction price;

allocation of the transaction price to the performance obligations in the contract; and

recognition of revenues when, or as, the contractual performance obligations are satisfied.

The  majority  of  our  revenue  comes  from  product  sales,  consisting  of  sales  of  Lasers  and  OpComms  hardware  products  to  our  customers.  Our  revenue  contracts

generally include only one performance obligation. Revenues are recognized at a point in

64

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

time when control of the promised goods or services are transferred to our customers upon shipment or delivery, in an amount that reflects the consideration we expect to
be entitled to in exchange for those goods or services. We have entered into vendor managed inventory (“VMI”) programs with our customers. Under these arrangements,
we receive purchase orders from our customers, and the inventory is shipped to the VMI location upon receipt of the purchase order. The customer then pulls the inventory
from the VMI hub based on its production needs. Revenue under VMI programs is recognized when control transfers to the customer, which is generally once the customer
pulls the inventory from the hub.

Revenue from all sales types is recognized at the transaction price. The transaction price is determined based on the consideration to which we will be entitled in
exchange for transferring goods or services to the customer adjusted for estimated variable consideration, if any. We typically estimate the impact on the transaction price
for  discounts  offered  to  the  customers  for  early  payments  on  receivables  or  net  of  accruals  for  estimated  sales  returns.  These  estimates  are  based  on  historical  returns,
analysis of credit memo data and other known factors. Actual returns could differ from these estimates. We allocate the transaction price to each distinct product based on
its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input that depicts
the price as if sold to a similar customer in similar circumstances.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a
customer and deposited with the relevant government authority, are excluded from revenue. Our revenue arrangements do not contain significant financing components as
our standard payment terms are less than one year.

If a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before we transfer a good or service to the customer,
those amounts are classified as deferred revenue or deposits received from customers which are included in other current liabilities or other long-term liabilities when the
payment is made or it is due, whichever is earlier.

Transaction Price Allocated to the Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to performances obligations that are unsatisfied or partially unsatisfied as of the end of
the  reporting  period.  Unsatisfied  and  partially  unsatisfied  performance  obligations  consist  of  contract  liabilities  and  non-cancellable  backlog.  Non-cancellable  backlog
includes goods and services for which customer purchase orders have been accepted that are scheduled or in the process of being scheduled for shipment. A portion of our
revenue arises from vendor managed inventory arrangements where the timing and volume of customer utilization is difficult to predict.

The following table includes estimated revenue expected to be recognized in the future for backlog related performance obligations that are unsatisfied as of June 29,

2019 (in millions):

Performance Obligations

Warranty

Less than 1 year

1-2 years

Greater than 2
years

$446.1

$7.0

$—

Total

$453.1

Hardware products regularly include warranties to the end customers such that the product continues to function according to published specifications. We typically
offer a twelve month warranty for most of our products. However, in some instances depending upon the product, specific market, product line and geography in which we
operate, and what is common in the industry, our warranties can vary and range from six months to five years. These standard warranties are assurance type warranties and
do not offer any services in addition to the assurance that the product will continue working as specified. Therefore, warranties are not considered separate performance
obligations in the arrangement. Instead, the expected cost of warranty is accrued as expense in accordance with authoritative guidance.

We provide reserves for the estimated costs of product warranties at the time revenue is recognized. We estimate the costs of our warranty obligations based on our
historical  experience  of  known  product  failure  rates,  use  of  materials  to  repair  or  replace  defective  products  and  service  delivery  costs  incurred  in  correcting  product
failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise.

Shipping and Handling Costs

65

 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

We record shipping and handling costs related to revenue transactions within cost of sales as a period cost.

Contract Costs

The  Company  recognizes  the  incremental  direct  costs  of  obtaining  a  contract,  which  consist  of  sales  commissions,  when  control  over  the  products  they  relate  to
transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission
asset the Company would have otherwise recognized is less than one year.

Contract Balances

The Company records accounts receivable when it has an unconditional right to consideration. Contract liabilities are recorded when cash payments are received or
due  in  advance  of  performance.  Contract  liabilities  consist  of  advance  payments  and  deferred  revenue,  where  the  Company  has  unsatisfied  performance  obligations.
Contract liabilities are classified as deferred revenue and customer deposits, and are included in other current liabilities within our consolidated balance sheet. Payment
terms vary by customer. The time between invoicing and when payment is due is not significant.

The following table reflects the changes in contract balances as of June 29, 2019 (in millions, except percentages):

Contract balances

Balance sheet location

June 29, 2019

June 30, 2018

Change

Accounts receivable, net

Accounts receivable, net

Deferred revenue and customer deposits

Other current liabilities

$238.0

$2.9

$197.1

$2.8

$40.9

$0.1

Percentage
Change

20.8%

3.6%

Disaggregation of Revenue

We disaggregate revenue by geography and by product. Refer to “Note 20. Operating Segments and Geographic Information” for a presentation of disaggregated
revenue. We do not present other levels of disaggregation, such as by type of products, customer, markets, contracts, duration of contracts, timing of transfer of control and
sales channels, as this information is not used by our Chief Operating Decision Maker to manage the business.

Income Taxes

In  accordance  with  the  authoritative  guidance  on  accounting  for  income  taxes,  we  recognize  income  taxes  using  an  asset  and  liability  approach.  This  approach
requires the recognition of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been
recognized in our consolidated financial statements or tax returns. The measurement of current and deferred taxes is based on provisions of the enacted tax law, and the
effects of future changes in tax laws or rates are not anticipated.

The authoritative guidance provides for recognition of deferred tax assets if the realization of such deferred tax assets is more likely than not to occur based on an
evaluation of both positive and negative evidence and the relative weight of the evidence. We consider future growth, forecasted earnings, future taxable income, the mix
of earnings in the jurisdictions in which we operate, historical earnings, taxable income in prior years, if carryback is permitted under the law, and prudent and feasible tax
planning strategies in determining the need for a valuation allowance. In the event we were to determine that we would not be able to realize all or part of our net deferred
tax assets in the future, an adjustment to the deferred tax assets valuation allowance would be charged to earnings in the period in which we make such a determination, or
goodwill would be adjusted at our final determination of the valuation allowance related to an acquisition within the measurement period. If we later determine that it is
more  likely  than  not  that  the  net  deferred  tax  assets  would  be  realized,  we  would  reverse  the  applicable  portion  of  the  previously  provided  valuation  allowance  as  an
adjustment to earnings at such time.

We are subject to income tax audits by the respective tax authorities of the jurisdictions in which we operate. The determination of our income tax liabilities in each
of these jurisdictions requires the interpretation and application of complex, and sometimes uncertain, tax laws and regulations. The authoritative guidance on accounting
for income taxes prescribes both recognition and measurement criteria that must be met for the benefit of a tax position to be recognized in the financial statements. If a tax
position taken,  or expected  to be taken, in a tax return  does not meet such recognition  or measurement  criteria,  an unrecognized  tax benefit  liability  is recorded.  If we
ultimately  determine  that  an  unrecognized  tax  benefit  liability  is  no  longer  necessary,  we  reverse  the  liability  and  recognize  a  tax  benefit  in  the  period  in  which  it  is
determined that the unrecognized tax benefit liability is no longer necessary.

66

 
 
 
 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The recognition and measurement of current taxes payable or refundable and deferred tax assets and liabilities requires that we make certain estimates and judgments.

Changes to these estimates or a change in judgment may have a material impact on our tax provision in a future period.

Property, Plant and Equipment

Property,  plant  and  equipment  are  stated  at  cost.  Depreciation  is  computed  by  the  straight-line  method  generally  over  the  following  estimated  useful  lives  of  the

assets: 10 to 40 years for building and improvements,  3 to 5 years for machinery and equipment, and  2 to 5 years for furniture, fixtures, software and office equipment.
Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful lives of the assets or the term of the lease.

Goodwill

Goodwill represents the excess of the purchase price of an acquired business over the fair value of the identifiable assets acquired and liabilities assumed. We test for
impairment of goodwill on an annual basis in the fourth quarter and at any other time when events occur or circumstances indicate that the carrying amount of goodwill
may not be recoverable.

An entity has the option to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. If an
entity determines that as a result of the qualitative assessment that it is more likely than not (i.e., greater than 50% likelihood) that the fair value of a reporting unit is less
than its carrying amount, then the quantitative test is required. Otherwise, no further testing is required. The two-step quantitative goodwill impairment test requires us to
estimate the fair value of our reporting units. If the carrying value of a reporting unit exceeds its fair value, the goodwill of that reporting unit is potentially impaired and
we proceed to step two of the impairment analysis. In step two of the analysis, we measure and record an impairment loss equal to the excess of the carrying value of the
reporting unit’s goodwill over its implied fair value, if any.

Application  of  the  goodwill  impairment  test  requires  judgments,  including:  identification  of  the  reporting  units,  assigning  assets  and  liabilities  to  reporting  units,
assigning goodwill to reporting units, a qualitative assessment to determine whether there are any impairment indicators, and determining the fair value of each reporting
unit. We estimate the fair value of a reporting unit using market approach, income approach or a combination of market and income approach. Significant estimates in the
market approach include: identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, and assessing
comparable revenue and operating income multiples in estimating the fair value of the reporting unit. Significant estimates in the income approach include: future cash
flows, discount rates.

We  base  our  estimates  on  historical  experience  and  on  various  assumptions  about  the  future  that  we  believe  are  reasonable  based  on  available  information.
Unanticipated events and circumstances may occur that affect the accuracy of our assumptions, estimates and judgments. For example, if the price of our common stock
were to significantly decrease combined with other adverse changes in market conditions, thus indicating that the underlying fair value of our reporting units may have
decreased, we might be required to reassess the value of our goodwill in the period such circumstances were identified.

Based  on  the  impairment  analysis  performed  in  the  fourth  quarter  of  each  year  presented,  the  fair  value  of  our  reporting  unit  substantially  exceeded  the  carrying

value; as such, our annual qualitative assessment did not indicate that a more detailed quantitative analysis was necessary.

Intangible Assets

Intangible  assets  consist  primarily  of  intangible  assets  purchased  through  acquisitions.  Purchased  intangible  assets  include  acquired  developed  technologies
(developed  and  core  technology),  customer  relationships,  in-process  research  and  development,  and  order  backlog.  Intangible  assets,  with  the  exception  of  customer
relationships  and  order  backlog,  are  amortized  using  the  straight-line  method  over  the  estimated  economic  useful  lives  of  the  assets,  which  is  the  period  during  which
expected cash flows support the fair value of such intangible assets. Customer relationships and order backlog are amortized using an accelerated method of amortization
over the expected customer lives, which more accurately reflects the pattern of realization of economic benefits expected to be obtained.

67

Table of Contents

Long-lived Asset Valuation

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

We  test  long-lived  assets  for  recoverability,  at  the  asset  group  level,  when  events  or  changes  in  circumstances  indicate  that  their  carrying  amount  may  not  be
recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset, significant adverse changes in
the business climate or legal factors, accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset, current
period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset, or current expectation that the
asset will more likely than not be sold or disposed significantly before the end of its estimated useful life.

Recoverability is assessed based on the difference between the carrying amount of the asset and the sum of the undiscounted cash flows expected to result from the

use and the eventual disposal of the asset. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.

Pension Benefits

The funded status of our retirement-related benefit plan is measured as the difference between the fair value of plan assets and the benefit obligation at fiscal year
end, the measurement date. The funded status of an underfunded benefit plan, of which the fair value of plan assets is less than the benefit obligation, is recognized as a
non-current net pension liability in the consolidated balance sheets unless the fair value of plan assets is not sufficient to cover the expected payments to be made over the
next year (or operating cycle, if longer) from the measurement date. For defined benefit pension plans, the benefit obligation is the projected benefit obligation (“PBO”)
which represents the actuarial present value of benefits expected to be paid upon retirement.

Net periodic pension cost (income) (“NPPC”) is recorded in the consolidated statements of operations and includes service cost, interest cost, expected return on plan
assets, amortization of prior service cost and (gains) losses previously recognized as a component of accumulated other comprehensive income. Service cost represents the
actuarial  present  value  of  participant  benefits  attributed  to  services  rendered  by  employees  in  the  current  year.  Interest  cost  represents  the  time  value  of  money  cost
associated  with  the  passage  of  time.  (Gains)  losses  arise  as  a  result  of  differences  between  actual  experience  and  assumptions  or  as  a  result  of  changes  in  actuarial
assumptions.  Prior  service  cost  (credit)  represents  the  cost  of  benefit  improvements  attributable  to  prior  service  granted  in  plan  amendments.  (Gains)  losses  and  prior
service cost (credit) that arise during the current year are first recognized as a component of accumulated other comprehensive income in the consolidated balances sheets,
net  of  tax.  Prior  service  cost  is  amortized  as  a  component  of  NPPC  over  the  average  remaining  service  period  of  active  plan  participants  starting  at  the  date  the  plan
amendment is adopted. Deferred actuarial (gains) losses are subsequently recognized as a component of NPPC if they exceed the greater of 10% of PBO or the fair value
of plan assets, with the excess amortized over the average remaining service period of active plan participants.

The measurement of the benefit obligation and NPPC is based on our estimates and actuarial valuations, provided by third-party actuaries, which are approved by
management. These valuations reflect the terms of the plans and use participant-specific information such as compensation, age and years of service, as well as certain
assumptions,  including  estimates  of  discount  rates,  expected  return  on  plan  assets,  rate  of  compensation  increases,  and  mortality  rates.  We  evaluate  these  assumptions
annually  at  a  minimum.  In  estimating  the  expected  return  on  plan  assets,  we  consider  historical  returns  on  plan  assets,  adjusted  for  forward-looking  considerations,
inflation assumptions and the impact of the active management of the plan’s invested assets.

Concentration of Credit and Other Risks

Financial instruments that potentially subject our business to concentration of credit risk consist primarily of cash and cash equivalents and trade receivables. We
perform credit evaluations of our customers’ financial condition and generally do not require collateral from our customers. These evaluations require significant judgment
and are based on a variety of factors including, but not limited to, current economic trends, payment history, bad debt write-off experience, and financial review of the
customer.

Although the Company deposits its cash with financial institutions that management believes are of high credit quality, its deposits, at times, may exceed federally
insured  limits.  The  Company’s  investment  portfolio  consists  of  investment  grade  securities  diversified  amongst  security  types,  industries,  and  issuers.  The  Company’s
investment policy limits the amount of credit exposure in the investment portfolio to a maximum of 5% to any one issuer, except for Treasury and Government Agencies
securities, and the Company believes no significant concentration risk exists with respect to these investments.

We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. When we become
aware that a specific customer is unable to meet their financial obligations, we record a specific allowance to reflect the level of credit risk in the customer’s outstanding
receivable balance. In addition, we record

68

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

additional  allowances  based  on  certain  percentages  of  aged  receivable  balances.  These  percentages  take  into  account  a  variety  of  factors  including,  but  not  limited  to,
current economic trends, payment history and bad debt write-off experience. We classify bad debt expenses as selling, general and administrative (“SG&A”) expense.

We have significant trade receivables concentrated in the telecommunications industry. While our allowance for doubtful accounts balance is based on historical loss

experience along with anticipated economic trends, unanticipated financial instability in the telecommunications industry could lead to higher than anticipated losses.

During  fiscal  2019,  2018  and  2017,  several  customers  generated  more  than  10%  of  total  net  revenue.  Refer  to  “Note  20.  Operating  Segments  and  Geographic

Information” in the Notes to Consolidated Financial Statements.

Our accounts receivable was concentrated with three customers as of June 29, 2019, who represented 17%, 17% and 10% of gross accounts receivable, respectively,

compared with two customers as of June 30, 2018, who represented 11% and 10% of gross accounts receivable, respectively.

We rely on a limited number of suppliers for a number of key components contained in our products. We also rely on a limited number of significant independent

contract manufacturers for the production of certain key components and subassemblies contained in our products.

We  generally  use  a  rolling  twelve months forecast  based  on  anticipated  product  orders,  customer  forecasts,  product  order  history  and  backlog  to  determine  our
materials requirements. Lead times for the parts and components that we order vary significantly and depend on factors such as the specific supplier, contract terms and
demand for a component at a given time. If the forecast does not meet or if it exceeds actual demand, we may have excess or shortfalls of some materials and components,
as well as excess inventory purchase commitments. We could experience reduced or delayed product shipments or incur additional inventory write-downs and cancellation
charges or penalties, which would increase costs and could have a material adverse impact on our results of operations.

Foreign Currency Translation

Concurrent with the acquisition of Oclaro on December 10, 2018, we established the functional currency for our worldwide operations as the U.S. dollar. The change
in our functional currency is a result of significant changes in economic facts and circumstances, primarily the acquisition of Oclaro, a U.S. dollar-denominated functional
currency company. The combined business, which requires the integration of our supply chain, manufacturing operations and sales organization, will predominantly use
the U.S. dollar, including when negotiating customer and major supplier contracts.

Translation adjustments reported prior to December 10, 2018, remain as a component of accumulated other comprehensive income in our consolidated balance sheet.
The translated values for any non-monetary assets and liabilities as of December 10, 2018 become the new accounting basis for those assets. Accordingly, monetary assets
and liabilities denominated in foreign currencies have been remeasured into U.S. dollars using the exchange rates in effect at the balance sheet date. Foreign currency re-
measurement gains (losses) are included in interest and other income (expense), net.

Stock-based Compensation

Compensation expense related to stock-based transactions is measured and recognized in the financial statements based on fair value at the grant date.

Restricted stock units (“RSUs”) are grants of shares of our common stock, the vesting of which is based on the requisite service requirement. Generally, our RSUs
are subject to forfeiture and expected to vest over one to four years. For new-hire grants, RSUs generally vest ratably on an annual basis over four years. For annual refresh
grants, RSUs generally vest ratably on an annual, or combination of annual and quarterly, basis over three years.

Restricted  stock  awards  (“RSAs”)  are  grants  of  shares  of  our  common  stock  that  are  subject  to  various  restrictions,  including  restrictions  on  transferability  and
forfeiture provisions. RSAs are expected to vest over one to four years, and the shares acquired may not be transferred by the holder until the vesting conditions (if any) are
satisfied.

69

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Performance  stock  units  (“PSUs”)  are  grants  of  shares  of  our  common  stock  that  vest  upon  the  achievement  of  certain  performance  and  service  conditions.  We
account  for  the  fair  value  of  PSUs  using  the  closing  market  price  of  our  common  stock  on  the  date  of  grant.  We  begin  recognizing  compensation  expense  when  we
conclude that it is probable that the performance conditions will be achieved. We reassess the probability of vesting at each reporting period and adjust our compensation
cost based on this probability assessment. Our PSUs are subject to risk of forfeiture until performance and service conditions are satisfied and generally vest over three
years.

We estimate the fair value of the rights to acquire stock under our 2015 Employee Stock Purchase Plan (the “2015 Purchase Plan”) using the Black-Scholes option
pricing formula. Our 2015 Purchase Plan provides for consecutive six-month offering periods. We recognize such compensation expense on a straight-line basis over the
requisite service period. We calculate the volatility factor based on our historical stock prices.

Restructuring Accrual

Costs associated with restructuring activities are recognized when they are obligated. However, in the case of leases, the expense is estimated and accrued when the
property is vacated. Given the significance of, and the timing of the execution of such activities, this process is complex and involves periodic reassessments of estimates
made  from  the  time  the  property  was  vacated,  including  evaluating  real  estate  market  conditions  for  expected  vacancy  periods  and  sub-lease  income.  We  recognize  a
liability for post-employment benefits for workforce reductions related to restructuring activities when payment is probable and the amount is reasonably estimable. We
continually evaluate the adequacy of the remaining liabilities under our restructuring initiatives. Although we believe that these estimates accurately reflect the costs of our
restructuring plans, actual results may differ, thereby requiring us to record additional provisions or reverse a portion of such provisions. Refer to “Note 14. Restructuring
and Related Charges” in the Notes to Consolidated Financial Statements.

Business Combinations

In accordance with the guidance for business combinations, we determine  whether a transaction or other event is a business combination, which requires that the
assets acquired and liabilities assumed constitute a business. Each business combination is then accounted for by applying the acquisition method. If the assets acquired are
not  a  business,  we  account  for  the  transaction  or  other  event  as  an  asset  acquisition.  Under  both  methods,  we  recognize  the  identifiable  assets  acquired,  the  liabilities
assumed, and any noncontrolling interest in the acquired entity. We capitalize acquisition-related costs and fees associated with asset acquisitions and immediately expense
acquisition-related costs and fees associated with business combinations.

We allocate the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair
values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the
fair  values  of  assets  acquired  and  liabilities  assumed,  we  make  significant  estimates  and  assumptions,  especially  with  respect  to  intangible  assets.  Critical  estimates  in
valuing certain intangible assets include, but are not limited to, future expected cash flows from customer relationships and acquired developed technology and discount
rates. Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results
may differ materially from estimates. Other estimates associated with the accounting for acquisitions may change as additional information becomes available regarding
the assets acquired and liabilities assumed. Any change in facts and circumstances that existed as of the acquisition date and impacts our preliminary estimates is recorded
to goodwill if identified within the measurement period. Subsequent to the measurement period or our final determination of fair value of assets and liabilities whichever is
earlier the adjustments will affect our earnings.

In addition, we estimate the economic lives of certain acquired assets and these lives are used to calculate depreciation and amortization expense. If our estimates of

the economic lives change, depreciation or amortization expenses could be accelerated or slowed.

Research and Development (“R&D”) Expense

Costs related to R&D, which primarily consists of labor and benefits, supplies, facilities, consulting and outside service fees, are charged to expense as incurred.

Loss Contingencies

We are subject to the possibility of various loss contingencies arising in the ordinary course of business. We consider the likelihood of loss or impairment of an asset
or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies. An estimated loss is accrued when it is
probable that an asset has been impaired or a

70

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

liability has been incurred and the amount of loss can be reasonably estimated. We regularly evaluate current information available to determine whether such accruals
should be adjusted and whether new accruals are required.

Asset Retirement Obligations (“ARO”)

Our ARO are legal obligations associated with the retirement of long-lived assets pertaining to leasehold improvements. These liabilities are initially recorded at fair
value and the related asset retirement costs are capitalized by increasing the carrying amount of the related assets by the same amount as the liability. Asset retirement costs
are subsequently depreciated over the useful lives of the related assets. Subsequent to initial recognition, we record period-to-period changes in the ARO liability resulting
from the passage of time and revisions to either the timing or the amount of the original estimate of undiscounted cash flows. We derecognize ARO liabilities when the
related obligations are settled.

Note 2. Recently Issued Accounting Pronouncements

Accounting Pronouncements Recently Adopted

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU 2014-09 (Topic 606), which amended the existing accounting standards for revenue
recognition. Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The guidance is effective
for  annual  reporting  periods  including  interim  reporting  periods  beginning  after  December  15,  2017.  On  July  1,  2018,  we  adopted  Topic  606  using  the  modified
retrospective method applied to all contracts that are not completed contracts at the date of initial adoption (i.e., July 1, 2018). Results for reporting periods after July 1,
2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historical accounting under Topic 605.
The adoption of Topic 606 did not have a material impact on the nature and timing of our revenues, consolidated statements of operations, cash flows and balance sheets
and  therefore,  we  do  not  present  results  for  the  year  ended  June  29,  2019 under  Topic  605.  Refer  to  “ Note  1.  Description  of  Business  and  Summary  of  Significant
Accounting Policies” for the changes in our accounting policies due to adoption of Topic 606.

Select consolidated balance sheet line items, as if we had adopted Topic 606 prior to July 1, 2018 are summarized below as of the periods presented (in millions):

Assets:

Accounts receivable, net

Inventories

Stockholders’ equity:

Retained earnings

June 30, 2018

Adjustments

July 1, 2018

$

$

197.1   $

174.1  

0.6

  $

(1.2)

197.7

172.9

166.4   $

(0.6)

  $

165.8

In August 2016, FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, which clarifies how
companies  present  and  classify  certain  cash  receipts  and  cash  payments  in  the  statement  of  cash  flows.  The  amendments  contained  in  ASU  2016-15  are  effective  for
interim and annual periods beginning after December 15, 2017. We adopted ASU 2016-15 on July 1, 2018 on a prospective basis. The application of ASU 2016-15 will
have a material impact on our consolidated financial statements if we elect to settle the principal amounts of our 2024 Notes (refer to “Note 13. Convertible Notes”) in
cash, and upon the repayment of the term loan (refer to “Note 7. Term Loan Facility”). The principal repayment will be bifurcated between (i) cash outflows for operating
activities of $146.9 million for the portion related to accreted interest attributable to debt discount, and (ii) financing activities for the remainder of $803.1 million.

In January 2017, FASB issued ASU 2017-01, Business Combinations (Topic 805), which clarifies the definition of a business. For accounting and financial reporting
purposes,  businesses  are  generally  comprised  of  three  elements:  inputs,  processes,  and  outputs.  Integrated  sets  of  assets  and  activities  capable  of  providing  these  three
elements may not always be considered a business, and the lack of one of the three elements does not always disqualify the set from being a business. The issuance of ASU
2017-01 provides a clarifying test to determine when a set of assets and activities is not a business. Primarily, the test requires that when substantially all of the fair value of
the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, the set is not a business. The amendments contained in ASU
2017-01 are effective for annual periods beginning after December 15, 2017, including interim periods within those periods. We adopted ASU 2017-01 on July 1, 2018 on
a prospective basis. The implementation of ASU 2017-01 did not have an impact on our consolidated financial statements.

71

 
 
 
 
   
   
 
 
   
   
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

In October 2016, FASB issued ASU 2016-16, Accounting for Income Taxes: Intra-Entity Asset Transfers of Assets other than Inventory. The new guidance removes
the prohibition against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The new guidance
became effective for us in the first quarter of our fiscal 2019. The adoption of ASU 2016-16 did not have a material impact on our consolidated financial statements.

In August 2018, FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation
Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. ASU 2018-15 requires an entity in a hosting arrangement that is a service contract to follow
the  guidance  in  Subtopic  350-40  to  determine  which  implementation  costs  to  capitalize  as  an  asset  related  to  the  service  contract  and  which  costs  to  expense.
Implementation costs capitalized must be expensed over the term of the hosting arrangement, including the period covered by an option to extend the arrangement. The
standard  is  effective  for  fiscal  years  beginning  after  December  15,  2019,  and  interim  periods  within  those  fiscal  years,  and  should  be  applied  either  retrospectively  or
prospectively to all implementation costs incurred after the date of adoption. Early adoption is permitted, including adoption in any interim period, for all entities. We early
adopted ASU 2018-15, which did not have a material impact on our consolidated financial statements.

In August 2018, the Securities and Exchange Commission (“SEC”) adopted amendments to certain disclosure requirements in Securities Act Release No. 33-10532,
Disclosure Update and Simplification. Among the amendments is the requirement to present the changes in stockholders’ equity in the interim financial statements (either
in a separate statement or footnote) in quarterly reports on Form 10-Q. The analysis should present a reconciliation of the beginning balance to the ending balance of each
period for which a consolidated statement of operations is required to be filed. The final rule was effective on November 5, 2018. The Company adopted the final rule in
our third quarter of fiscal 2019, and has included a reconciliation of the changes in statements of redeemable convertible preferred stock and stockholders' equity in the
Form 10-Q for the fiscal quarter ended March 30, 2019 filed with the Securities and Exchange Commission.

Accounting Pronouncements Not Yet Effective

In August 2018, FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715-20): Disclosure Framework-Changes to
the  Disclosure  Requirements  for  Defined  Benefit  Plans.  ASU  2018-14  modifies  the  disclosure  requirements  for  defined  benefit  pension  plans  and  other  postretirement
benefit  plans.  The  new  guidance  is  effective  for  fiscal  years  ending  after  December  15,  2020  and  early  adoption  is  permitted.  ASU  2018-14  should  be  applied
retrospectively to all periods presented and is effective for us in our fiscal 2021. We are currently evaluating the impact of ASU 2018-14 on our consolidated financial
statements and related disclosures.

In August 2018, FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value
Measurement. ASU 2018-13 modifies the disclosure requirements for fair value measurements. The new guidance is effective for fiscal years, and interim periods within
those fiscal years, beginning after December 15, 2019 and early adoption is permitted. ASU 2018-13 requires that certain of the amendments be applied prospectively,
while other amendments should be applied retrospectively to all periods presented. ASU 2018-13 is effective for us in our first quarter of fiscal 2021. We are currently
evaluating the impact of ASU 2018-13 on our consolidated financial statements and related disclosures.

In  February  2018,  FASB  issued  ASU  2018-02,  Income  Statement-Reporting  Comprehensive  Income  (Topic  220):  Reclassification  of  Certain  Tax  Effects  from
Accumulated Other Comprehensive Income, which allows companies to reclassify stranded tax effects resulting from the Tax Act, from accumulated other comprehensive
income to retained earnings. The guidance also requires certain new disclosures regardless of the election. The amendments in ASU 2018-02 are effective for all entities
for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. ASU 2018-02 is effective for us in the first
quarter of fiscal 2020. The implementation of ASU 2018-02 will not have a material impact on our consolidated financial statements and related disclosures.

In January 2017, FASB issued ASU 2017-04,  Intangibles - Goodwill and Other (Topic 350): Simplifying the Accounting for Goodwill Impairment. ASU 2017-04
removes the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment. A goodwill impairment charge will be the amount by which
a reporting unit's carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The amendments contained in ASU 2017-04 are effective for interim
and annual periods beginning after December 15, 2019, with early adoption permitted, which should be applied prospectively. ASU 2017-14 is effective for us in our first
quarter of fiscal 2020. The implementation of ASU 2017-04 will not have a material impact on our consolidated financial statements and related disclosures.

In  June  2016,  FASB  issued  ASU  2016-13,  Financial  Instruments  -  Credit  Losses  (Topic  326):  Measurement  of  Credit  Losses  on  Financial  Instruments  and

subsequent amendments, ASU 2018-19, ASU 2019-04 and ASU 2019-05 (collectively, Topic 326).

72

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Topic 326 requires measurement and recognition of expected credit losses for financial assets held. Topic 326 is effective for annual periods beginning after December 15,
2019, including interim periods within those periods, with early adoption permitted. ASU 2016-13 is effective for us in our fiscal 2021. We are currently evaluating the
impact of the adoption of Topic 326 on our consolidated financial statements and related disclosures.

In February 2016, FASB issued ASU 2016-02, Leases (Topic 842) and subsequent amendments to the initial guidance: ASU 2017-13, ASU 2018-10, ASU 2018-11,
ASU 2018-20 and ASU 2019-01 (collectively, Topic 842). The new guidance generally requires an entity to recognize on its balance sheet operating and financing lease
liabilities and corresponding right-of-use assets. The new guidance contained in Topic 842 is effective for annual periods beginning after December 15, 2018, including
interim periods within those periods, with early adoption permitted. The standard is effective for us in our first quarter of fiscal 2020 and provides an optional transition
method that allows entities to apply the standard prospectively, with any cumulative-effect adjustment recorded to opening retained earnings in the period of adoption. We
will adopt the new standard using this optional transition method. We have elected the practical expedients to not reassess prior conclusions related to contracts containing
leases, lease classification, and initial direct costs for contracts that existed prior to adoption date. We have also elected to combine lease and non-lease components and to
keep leases with an initial term of 12 months or less off the balance sheet and recognize the associated lease payments in the consolidated statements of operations on a
straight-line basis over the lease term. We expect to recognize operating lease right-of-use assets between $90.0 million to  $100.0 million and operating lease liabilities
between $80.0 million to $90.0 million on our condensed consolidated balance sheet as of the date of adoption, June 30, 2019. The difference between the operating lease
right-of-use assets and operating lease liabilities primarily represents the existing asset recognized in relation to the favorable terms of an operating lease acquired through
a business combination offset by our deferred rent balances. Our accounting for finance leases is not expected to change substantially from the legacy Topic 840. Other
than disclosed, we do not expect the new standard to have a material impact on our remaining consolidated financial statements.

Note 3. Earnings Per Share

The following table sets forth the computation of basic and diluted net income attributable to common stockholders per share (in millions, except per share data):

Basic Earnings per Common Share

Net income/(loss)

Less: Cumulative dividends on Series A Preferred Stock

Less: Earnings allocated to Series A Preferred Stock

Net income/(loss) attributable to common stockholders - Basic

Weighted average common shares outstanding including Series A Preferred Stock

Less: Weighted average Series A Preferred Stock

Basic weighted average common shares outstanding

Net income/(loss) per share attributable to common stockholders - Basic

Diluted Earnings per Common Share

Net income/(loss) attributable to common stockholders - Basic

Net income/(loss) attributable to common stockholders - Diluted

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

$

$

$

$

$

(36.4)   $

248.1   $

(102.5)

(0.3)  

(1.2)  

(0.9)  

(5.7)  

(0.9)

—

(37.9)   $

241.5   $

(103.4)

70.7  

—  

70.7  

63.8  

(1.5)  

62.3  

(0.54)   $

3.88   $

62.1

(1.5)

60.6

(1.71)

(37.9)   $

(37.9)   $

241.5   $

241.5   $

(103.4)

(103.4)

Weighted average common shares outstanding for basic earnings per common share

Effect of dilutive securities from 2015 Equity Incentive Plan

Effect of dilutive securities from Series A Preferred Stock

Diluted weighted average common shares outstanding

70.7  

—  

—  

70.7  

62.3  

1.0  

—  

63.3  

Net income/(loss) per share attributable to common stockholders - Diluted

$

(0.54)   $

3.82   $

60.6

—

—

60.6

(1.71)

73

 
 
 
 
 
 
 
   
 
 
   
   
 
 
   
   
 
   
   
 
 
   
   
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

For the years ended June 29, 2019 and July 1, 2017, our diluted earnings per share attributable to common stockholders is the same as basic EPS as we are in net loss
position. For the year ended June 30, 2018, our diluted earnings per share attributable to common stockholders is calculated using the “treasury stock” method because it is
more dilutive than the “if-converted” method.

Our  Series  A  Preferred  Stock  was  considered  a  participating  security  where  the  holders  of  Series  A  Preferred  Stock  had  the  right  to  participate  in  undistributed
earnings with holders of common stock. On November 2, 2018, the remaining 35,805 shares of our Series A Preferred Stock were converted into 1.5 million shares of our
common stock. Refer to “Note 12. Non-Controlling Interest Redeemable Convertible Preferred Stock and Derivative Liability” for further discussion. Prior to conversion,
the holders of our Series A Preferred Stock were entitled to share in dividends, on an as-converted basis, if the holders of our common stock were to receive dividends. Up
through  the  date  of  conversion,  we  used  the  two-class  method  to  compute  earnings  per  share.  The  two-class  method  is  an  earnings  allocation  formula  that  determines
earnings per share for each class of common stock and participating  security according to dividends declared (or accumulated) and participation rights in undistributed
earnings. In determining the amount of net earnings to allocate to common stockholders, earnings are allocated to both common and participating securities based on their
respective weighted-average shares outstanding during the period. Diluted earnings per common share is calculated similar to basic earnings per common share except that
it  gives  effect  to  all  potentially  dilutive  common  stock  equivalents  outstanding  for  the  period,  using  the  treasury  stock  method.  Diluted  earnings  per  common  share  is
computed using the more dilutive of the treasury stock method or the if-converted method.

Potentially dilutive common shares result from the assumed exercise of outstanding stock options, assumed vesting of outstanding equity awards, assumed issuance
of stock under the employee stock purchase plan, and assumed conversion of our outstanding $450 million in aggregate principal amount of 0.25% Convertible Notes due
in 2024 (the “2024 Notes”), all using the treasury stock method. We have the ability and intent to settle the $450 million face value of the 2024 Notes in cash. Therefore,
we use the treasury stock method for calculating the dilutive impact of the 2024 Notes. The 2024 Notes will have no impact on diluted earnings per share until the average
price of our common stock exceeds the conversion price of $60.62. Refer to “Note 13. Convertible Notes” for further discussion.

Anti-dilutive potential shares from the 2015 Equity Incentive Plan are excluded from the calculation of diluted earnings per share if their exercise price exceeded the

average market price during the period or the share-based awards were determined to be anti-dilutive based on applying the treasury stock method.

Note 4. Accumulated Other Comprehensive Income (Loss)

Our  accumulated  other  comprehensive  income  (loss)  consists  of  the  accumulated  net  unrealized  gains  or  losses  on  foreign  currency  translation  adjustments,  the

defined benefit obligations, and available-for-sale securities.

As of June 29, 2019 and June 30, 2018, balances for the components of accumulated other comprehensive income (loss) were as follows (in millions):

Beginning balance as of July 2, 2016

Other comprehensive income (loss)

Beginning balance as of July 1, 2017

Other comprehensive income (loss)

Ending balance as of June 30, 2018

Other comprehensive income (loss)

Ending balance as of June 29, 2019

$

$

11.7

(1.2)

10.5

(0.2)

10.3

(0.6)

9.7

  $

Foreign currency
translation adjustments,
net of tax

Defined benefit
obligations, net of tax (1)
(2.3)

  $

Unrealized gain (loss) on
available-for-sale
securities, net of tax

Total

  $

  $

—   $

—  

—  

(1.6)

(1.6)

2.5

0.9

  $

9.4

(2.0)

7.4

(1.0)

6.4

0.7

7.1

(0.8)

(3.1)

0.8

(2.3)

(1.2)

(3.5)

(1) Refer to “Note 18. Employee Benefit Plans” in the Notes to Consolidated Financial Statements on the computation of net periodic cost for pension plans. 

Note 5. Business Combination

74

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

On December 10, 2018, we acquired all of the outstanding common stock of Oclaro, a provider of optical components and modules for the long-haul, metro and data
center  markets.  Oclaro’s  products  provide  differentiated  solutions  for  optical  networks  and  high-speed  interconnects  driving  the  next  wave  of  streaming  video,  cloud
computing,  application  virtualization  and  other  bandwidth-intensive  and  high-speed  applications.  This  acquisition  strengthens  our  product  portfolio,  including  gaining
Oclaro’s indium phosphide laser and photonic integrated circuit and coherent component and module capabilities; broadens our revenue mix; and positions us strongly to
meet the future needs of our customers.

Pursuant to the merger agreement, Prota Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum (“Merger Sub”), merged with and
into Oclaro (the “Merger”), with Oclaro surviving the Merger. Each outstanding share of Oclaro common stock, par value $0.01 per share, was automatically converted
into the right to receive the following consideration (collectively, the “Merger Consideration”), without interest:

•

•

$5.60 in cash (the “Cash Consideration”) and;

0.0636 of a share of Lumentum common stock, par value $0.001 per share (the “Exchange Ratio”).

The total fair value of consideration given in connection with the acquisition of Oclaro consisted of the following:

Cash paid for outstanding Oclaro common stock

Lumentum common shares issued to Oclaro stockholders

Replacement equity awards for Oclaro equity awards

Total consideration

Shares

Per Share

Total Consideration
(in millions)

10,941,436 $

41.80

$

$

964.8

457.4

2.7

1,424.9

Each Oclaro restricted stock unit award (“Oclaro RSU”) that did not become vested at the close of the transaction was converted into a Lumentum restricted stock
unit award (a “Lumentum RSU”) with similar terms and conditions, including vesting, that were applicable to such Oclaro RSU, at a ratio of one Oclaro share to 0.1933
shares  of  Lumentum  common  stock.  The  0.1933 ratio  was  determined  based  on  the  sum  of  (i)  the  0.0636 shares  of  common  stock  received  by  Oclaro  common
stockholders  for  every  one  share  of  Oclaro  common  stock,  plus  (ii)  the  $5.60 per  share  received  by  Oclaro  common  stockholders,  divided  by  $43.189 (Lumentum’s
average closing price for the 10 trading days ending on December 4, 2018, the third trading day prior to the Closing Date).

Each Oclaro stock option (“Oclaro Option”), whether vested or unvested, was converted into a Lumentum stock option (“Lumentum Option”) with similar terms and
conditions,  including  vesting,  that  were  applicable  to  such  Oclaro  Option,  except  that  (i)  the  number  of  shares  subject  to  the  Lumentum  Option  equals  the  number  of
Oclaro shares subject to such Oclaro Option multiplied by 0.1933 and (ii) the exercise price of the Lumentum Option equals the exercise price per share of the Oclaro
Option divided by 0.1933. Any Oclaro Option that was held by non-employees was cancelled and converted into the right to receive the Merger Consideration for each net
option share covered by such Oclaro Option, subject to applicable withholding taxes.

In  addition,  each  Oclaro  restricted  stock  award  (“Oclaro  Restricted  Stock  Award”)  and  Oclaro  RSU  that  became  vested  with  the  close  of  the  transaction  was

converted into the right to receive the Merger Consideration.

The total transaction consideration was $1.4 billion, which was funded by the issuance of Lumentum common stock, new debt, and cash balances of the combined
company. We also recorded $18.3 million in acquisition-related costs in the year ended June 29, 2019, representing professional and other direct acquisition costs. These
costs  are  recorded  within  selling,  general  and  administrative  operating  expense  and  within  interest  and  other  income  (expense),  net  in  our  consolidated  statements  of
operations. The Company also incurred $9.3 million of debt financing costs which has been recorded as a contra liability. “Refer to Note 7. Term Loan Facility.”

From the acquisition date, Oclaro contributed $250.1 million of our consolidated net revenue for the year ended June 29, 2019. Due to the continued integration of the

combined businesses, it is impractical to determine Oclaro’s contribution to our net income.

75

 
 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

We  allocated  the  fair  value  of  the  purchase  consideration  to  the  tangible  assets,  liabilities  and  intangible  assets  acquired,  including  in-process  research  and
development,  or  IPR&D,  generally  based  on  their  estimated  fair  values.  The  excess  purchase  price  over  those  fair  values  is  recorded  as  goodwill.  IPR&D  is  initially
capitalized  at  fair  value  as  an  intangible  asset  with  an  indefinite  life  and  assessed  for  impairment  thereafter.  When  an  IPR&D  project  is  completed,  the  IPR&D  is
reclassified as an amortizable purchased intangible asset and amortized over the asset’s estimated useful life.  Our valuation assumptions of acquired assets and assumed
liabilities require significant estimates, especially with respect to intangible assets. Our preliminary allocation of the purchase price of Oclaro, based on the estimated fair
values of the assets acquired and liabilities assumed as of the acquisition date, is as follows (in millions):

Cash and cash equivalents

Accounts receivable, net

Inventories

Prepayments and other current assets

Property, plant and equipment, net

Intangibles

Deferred income tax asset

Other non-current assets

Accounts payable

Accrued payroll and related expenses

Accrued expenses

Other current liabilities

Deferred tax liability

Other non-current liabilities

Goodwill

Total purchase price

Purchase Price Allocation

Previously Reported
December 10, 2018
(Provisional)

Measurement Period
Adjustments

As Adjusted
June 29, 2019

$

345.0 $

— $

68.0

153.2

33.7

128.6

444.0

54.1

16.6

(57.8)

(11.4)

(8.3)

(8.1)

(55.8)

(10.3)

333.4

—

1.8

—

6.1

—

(11.5)

—

—

—

—

2.0

(20.0)

(2.6)

24.2

345.0

68.0

155.0

33.7

134.7

444.0

42.6

16.6

(57.8)

(11.4)

(8.3)

(6.1)

(75.8)

(12.9)

357.6

$

1,424.9 $

— $

1,424.9

The provisional amounts presented in the table above pertained to the preliminary purchase price allocation reported in our Form 10-Q for the quarter ended December
29, 2018. The measurement period adjustments were primarily related to the sale of several product lines within our Datacom business based in Sagamihara, Japan and the
transfer of related employees to Cambridge Industries Group (“CIG”). This business was acquired on December 10, 2018 as part of the acquisition of Oclaro. These assets
and liabilities were recorded at fair value less cost to sell and the adjustments to fair value were recorded as measurement period adjustments. The measurement period
adjustments also included tax adjustment of $31.5 million upon the completion of additional analysis involving refining the amount of Oclaro’s tax attributes that may be
utilizable going forward, deferred tax asset valuation allowances, and the effects of the Tax Act.  

The merger consideration allocation set forth herein is preliminary and may be revised as additional information becomes available during the measurement period

which could be up to 12 months from the closing date of the acquisition. Any such revisions or changes may be material.

We do not believe that the measurement period adjustments had a material impact on our consolidated statements of operations, balance sheets or cash flows in any

periods previously reported.

Goodwill and intangibles have been assigned to the OpComms segment. The preliminary goodwill of $357.6 million arising from the acquisition is attributed to the
expected synergies, including future cost efficiencies, and other benefits that are expected to be generated by combining Lumentum and Oclaro. Substantially all of the
goodwill recognized is not expected to be deductible for tax purposes. See “Note 6. Goodwill and Other Intangible Assets” for more information on goodwill and IPR&D.

During  the  second  quarter  of  fiscal  2019,  we  recorded  $20.9  million in  restructuring  and  stock-based  compensation  expense  in  our  consolidated  statements  of
operations,  attributable  to  severance  and  employee  related  benefits  associated  with  Oclaro’s  executive  severance  and  retention  agreements.  These  retention  agreements
provide, under certain circumstances, for payments

76

 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

and  benefits  upon  an  involuntary  termination  of  employment,  including  following  a  change  in  control  of  Oclaro.  The  payments  and  benefits  payable  under  these
arrangements in the event of a change in control of Oclaro are subject to a “double trigger,” meaning that both a change in control of Oclaro and a subsequent involuntary
termination  of  employment  by  Lumentum  are  required.  In  other  words,  the  change  in  control  of  Oclaro  does  not  by  itself  trigger  any  payments  or  benefits.  Instead,
payments and benefits are paid only if the employment of the employee is subsequently terminated without “cause” (or the employee resigns for “good reason”) during a
specified period following the change in control. We incurred total expense of $20.9 million during the second quarter of fiscal 2019, of which $5.7 million relates to cash
severance as part of our restructuring expense which is recorded within restructuring and related charges in our consolidated statements of operations (refer to “Note 14.
Restructuring and Related Charges”) and $15.2 million relates to the acceleration of equity awards which is recorded within both cost of sales and selling, general and
administrative expense, in our consolidated statements of operations (refer to “Note 17. Stock-Based Compensation and Stock Plans”).

We continually evaluate our existing portfolio of businesses to maximize long-term shareholder value. As discussed above, we sold several product lines within our
Datacom business based in Sagamihara, Japan along with the transfer of the related employees to CIG for $25.5 million in net cash. The disposition was completed on
April 18, 2019. This business did not meet the criteria for assets held-for-sale under the relevant accounting guidance as of December 10, 2018, the date of our acquisition
of Oclaro, in our purchase price allocation. The assets and liabilities transferred to CIG were $33.5 million and $7.0 million, respectively.

Assets and liabilities transferred as a result of this disposition on April 18, 2019 were as follows (in millions):

Assets: 

Cash

Inventories

Other Intangible assets

Property, plant and equipment, net

Total

Liabilities:

        Retirement obligation

        Capital lease obligation

        Other liabilities

Total

Net

$

$

$

$

$

1.0

4.8

1.0

26.7

33.5

4.9

0.8

1.3

7.0

26.5

As part of the transaction, we will also provide transition services to CIG for a period of up to 24 months and the cost of these services will be reimbursed to us by

CIG. The purpose of these services is to provide short-term assistance to the buyer in assuming the operations of the purchased business.

Supplemental Pro Forma Information

The supplemental pro forma financial information presented below is for illustrative purposes only and is not necessarily indicative of the financial position or results
of operations that would have been realized if the acquisition had been completed on the date indicated, does not reflect synergies that might have been achieved, nor is it
indicative of future operating results or financial position. The pro forma adjustments are based upon currently available information and certain assumptions we believe
are reasonable under the circumstances.

77

 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following supplemental pro forma information presents the combined results of operations for the years ended June 29, 2019 and June 30, 2018, as if Oclaro had
been  acquired  as  of  the  beginning  of  fiscal  year  2018.  The  supplemental  pro  forma  information  includes  adjustments  to  amortization  and  depreciation  for  acquired
intangible assets and property and equipment, adjustments to share-based compensation expense, the fair value adjustments on the inventories acquired, transaction costs,
interest  expense  and  amortization  of  the  term  loan  debt  issuance  costs.  For  fiscal  year  2018,  nonrecurring  pro  forma  adjustments  directly  attributable  to  the  Oclaro
acquisition included (i) restructuring and stock-based compensation expense of $20.9 million, (ii) the purchase accounting effect of inventories acquired of $60.3 million
and (iii) transaction costs of $25.5 million.

The unaudited supplemental pro forma financial information for the periods presented is as follows (in millions):

Net revenue

Net income

Note 6. Goodwill and Other Intangible Assets

Goodwill

Years Ended

June 29, 2019

June 30, 2018

$

1,779.4   $

21.5  

1,790.9

156.2

On December 10, 2018, we completed the merger with Oclaro. We recognized goodwill in the amount of $357.6 million for the acquisition of Oclaro and allocated it
to our OpComms segment. The following table presents the changes in goodwill by our reportable segments during the years ended June 29, 2019 and June 30, 2018 (in
millions):

Balance as of July 1, 2017

  Foreign currency translation adjustment

Balance as of June 30, 2018

  Acquisition of Oclaro
  Measurement period adjustments (1)

Balance as of June 29, 2019

Optical Communications  
$

5.9   $

Commercial Lasers
5.5

  $

Total

$

$

—  

5.9   $

333.4  

24.2  

363.5   $

(0.1)

5.4

  $

—  

—  

5.4

  $

11.4

(0.1)

11.3

333.4

24.2

368.9

(1) Refer to “Note 5. Business Combination” for details of these measurement period adjustments.

Impairment of Goodwill

We review goodwill for impairment during the fourth quarter of each fiscal year or more frequently if events or circumstances indicate that an impairment loss may
have occurred. Based on the impairment analysis performed in the fourth quarter of each year presented, the fair value of our reporting unit substantially exceeded the
carrying value; as such, our annual qualitative assessment did not indicate that a more detailed quantitative analysis was necessary.

Other Intangible Assets

In  connection  with  our  acquisition  of  Oclaro  on  December  10,  2018,  we  recorded  $443.0  million as  our  preliminary  estimate  of  the  fair  value  of  the  acquired

developed technologies and other intangible assets. The intangible assets acquired from Oclaro consist of the following:

78

 
 
 
 
 
   
   
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Intangible assets

Fair value
(in millions)

Weighted average amortization period
(in years)

Acquired developed technologies

Customer relationships
In-process research and development (1)

Order backlog

Total intangible assets (1)

  $

  $

182.0  

145.0  

94.0  

22.0  

443.0    

4.4 years

8 years

n/a

1 year

(1) The intangible assets as of June 29, 2019 exclude $1.0 million In-process research and development assets subsequently sold to CIG. Refer to “Note 5. Business

Combination”.

The intangible assets are amortized on a straight-line basis over the estimated useful lives, except for customer relationships and order backlog, which are amortized
using an accelerated method of amortization over the expected customer lives, which more accurately reflects the pattern of realization of economic benefits expected to be
obtained. Acquired developed technologies and order backlog are amortized to cost of sales and customer relationships is amortized to selling, general and administrative.
IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When an IPR&D project is completed, the
IPR&D is reclassified as an amortizable purchased intangible asset and amortized over the asset’s estimated useful life expected to range between 4 to 9 years.

The  following  tables  present  details  of  our  other  intangibles,  including  those  acquired  in  connection  with  the  Oclaro  acquisition,  as  of  the  periods  presented  (in

millions):

June 29, 2019
Acquired developed technologies

Customer relationships and order backlog

In-process research and development

Other intangibles

Total intangible assets

June 30, 2018
Acquired developed technologies

Customer relationships

Other intangibles

Total intangible assets

Gross Carrying Amount

  Accumulated Amortization  

Net

287.5   $

171.3  

94.0  

2.7  

555.5   $

(125.2)   $

(32.2)  

—  

(2.7)  

(160.1)   $

Gross Carrying Amount

  Accumulated Amortization  

Net

105.5   $

4.3  

2.7  

112.5

$

(98.5)   $

(4.3)  

(2.7)  

(105.5)

$

$

$

$

$

162.3

139.1

94.0

—

395.4

7.0

—

—

7.0

The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.

During fiscal 2019, 2018, and 2017, we recorded $54.6 million, $3.2 million, and $6.8 million, respectively, of amortization related to intangibles assets.

The following table presents details of amortization for the periods presented (in millions):

Cost of sales

Selling, general and administrative

Total

June 29, 2019

Years ended

June 30, 2018

July 1, 2017

$

$

46.6   $

8.0  

54.6   $

3.2   $

—  

3.2   $

6.5

0.3

6.8

79

 
 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Based  on  the  carrying  amount  of  our  acquired  developed  technologies  and  other  intangibles,  excluding  IPR&D,  as  of  June  29,  2019,  and  assuming  no  future

impairment of the underlying assets, the estimated future amortization is as follows (in millions):

Fiscal Years

2020

2021

2022

2023

2024

Thereafter

Total

Note 7. Term Loan Facility

$

$

71.9

66.3

63.6

40.6

21.8

37.2

301.4

On March 11, 2018, in connection with the Oclaro merger, Lumentum entered into a commitment letter with Deutsche Bank Securities Inc. and Deutsche Bank AG

New York Branch (“Deutsche Bank”), pursuant to which, Deutsche Bank committed to provide a senior secured term loan facility to finance the merger.

On  December  10,  2018  (the  “Closing  Date”),  concurrent  with  the  closing  of  the  Oclaro  merger,  Lumentum  entered  into  a  Credit  and  Guarantee  Agreement  (the
“Credit Agreement”), by and among Lumentum, certain subsidiaries of Lumentum, the lenders party thereto, and Deutsche Bank, as administrative agent and collateral
agent for the lenders. The Credit Agreement provides for a senior secured term loan facility (the “Term Loan Facility”) in an aggregate principal amount of $500.0 million.
The term loans available under the Term Loan Facility were fully drawn on the Closing Date and the proceeds of the term loans were used to consummate the merger and
pay fees and expenses in connection with the merger and the Term Loan Facility.

The term loans will mature on the seventh anniversary of the Closing Date, at which time all outstanding principal and accrued and unpaid interest on the term loans
must be repaid. Commencing on the last business day of the first full fiscal quarter after the Closing Date, the term loans will amortize in equal quarterly installments equal
to 0.25% of the original principal amount of the Term Loans, with the balance payable due on December 10, 2025, the maturity date. We are required to make mandatory
prepayments of the outstanding principal amount of term loans with the net cash proceeds from the disposition of certain assets and the receipt of insurance proceeds upon
certain casualty and condemnation events, in each case, to the extent in excess of the certain threshold amounts and to the extent not reinvested within a specified time
period. We are also required to make mandatory prepayments of the outstanding principal amount of term loans from the incurrence of certain types of indebtedness and
from any excess cash flow beyond stated threshold amounts. We have the right to prepay the term loans, in whole or in part, at any time without premium or penalty,
subject to certain limitations and a 1.00% soft call premium applicable during the first six months following the Closing Date.

The term loans bear interest at a rate equal to an applicable margin plus, at our option, either (a) a base rate equal to the highest of (i) the prime rate then in effect,
(ii) the federal funds rate, plus 0.50% and (iii) an adjusted LIBOR rate determined on the basis of a one-month interest period, plus 1.0%, subject to a floor of 0.0%, or (b)
an adjusted LIBOR rate, subject to a floor of 0.0%. The applicable margin with respect to the initial term loans is equal to 2.50% in the case of LIBOR rate loans and
1.50% in the case of base rate loans. The applicable margin is adjusted following the first full fiscal quarter after the Closing Date, if our first lien net leverage ratio is equal
to or less than 0.50:1.00, to 2.25% in the case of LIBOR rate loans and 1.25% in the case of base rate loans. During the year ended June 29, 2019, we recorded and paid a
contractual interest expense of $13.8 million related to the term loans, this amount is included in interest and other income (expense), net in our consolidated statements of
operations.

The commitment letter with Deutsche Bank required payment of a ticking fee. During the year ended June 29, 2019, we recorded a total ticking fee of $2.7 million.
This ticking fee is included in interest and other income (expense), net in our consolidated statements of operations. During the year ended June 29, 2019, we paid $2.5
million of principal on the term loan.

The  Credit  Agreement  permits  us  to  add  one  or  more  incremental  term  loan  facilities.  Incremental  loans  are  subject  to  certain  additional  conditions,  including,

without limitation, obtaining additional commitments from the lenders then party to the Credit Agreement or from new lenders.

Our  obligations  under  the  Credit  Agreement  are  required  to  be  guaranteed  by  certain  of  our  domestic  subsidiaries  meeting  materiality  thresholds  set  forth  in  the

Credit Agreement. Such obligations, including the guaranties, are secured by substantially

80

 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

all of the assets of Lumentum and Lumentum’s subsidiary guarantors (other than customarily excluded assets) pursuant to a Pledge and Security Agreement, dated as of
December 10, 2018, by and among Lumentum and Deutsche Bank.

The Credit Agreement contains customary affirmative and negative covenants, including covenants limiting the ability of Lumentum and its restricted subsidiaries to,
among other things, incur debt, grant liens, undergo certain fundamental changes, make investments, make certain restricted payments, dispose of assets, and enter into
transactions with affiliates, in each case, subject to limitations and exceptions set forth in the Credit Agreement. The Credit Agreement also contains customary events of
default that include, among other things, certain payment defaults, cross defaults to other indebtedness, covenant defaults, change of control defaults, judgment defaults,
and bankruptcy and insolvency defaults. If an event of default exists, the lenders may require the immediate payment of all obligations under the Credit Agreement, and
may exercise certain other rights and remedies provided for under the Credit Agreement, the other loan documents and applicable law. As of June 29, 2019, we were in
compliance with all of the covenants.

We  incurred  $9.3  million of  debt  issuance  costs  in  connection  with  the  Term  Loan  Facility  which  were  capitalized  and  recorded  as  a  contra  liability  in  our
consolidated balance sheet. These costs will be amortized to interest expense using the effective interest rate method from the issuance date of December 10, 2018, through
the end of the term of the loan. As of June 29, 2019, the effective interest rate is 5.20% and the stated interest rate is 4.94%.

The following table sets forth balance sheet information related to the term loan as of June 29, 2019 (in millions):

Principal

Repayment of principal

Unamortized value of the debt issuance costs

Net carrying value

Term loan, current

Term loan, non-current

$

$

$

June 29, 2019

500.0

(2.5)

(8.5)

489.0

5.0

484.0

The following table sets forth interest expense information related to the term loan, including interest expense associated with the ticking fee, for the periods presented

(in millions):

Contractual interest expense

Ticking fee

Amortization of the debt issuance costs

Total interest expense

Note 8. Asset Acquisition

Years Ended

June 29, 2019

13.8

2.7

0.8

17.3

$

$

On March 30, 2018, we entered into a Transition Services Agreement (“TSA”) with one of our contract manufacturers to wind down the production of our products at
their facility in China and to facilitate  an orderly transition of manufacturing  to either our manufacturing  facility in Thailand or our third party contract manufacturers,
including the purchase of the manufacturing equipment. Under the terms of the TSA, we are required to pay $5.3 million in cash upon completion of certain milestones
related to the purchase of equipment. During the year ended June 29, 2019, we paid $1.3 million and accrued $4.0 million for the manufacturing equipment acquired under
this TSA. Entire contract consideration of $5.3 million is included in machinery and equipment within property, plant and equipment in our consolidated balance sheet as
of June 29, 2019.

We are also required to share cost of retention and severance, and to reimburse for certain other direct and indirect costs incurred by our contract manufacturer for

transition services provided. These costs are expensed as incurred. We have now fully exited from operations with this contract manufacturer.

81

 
 
 
 
 
Table of Contents

Note 9. Balance Sheet Details

Accounts receivable allowances

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 29, 2019 and June 30, 2018, our accounts receivable allowance balance was $4.5 million and $2.6 million respectively.

Inventories

The components of inventories were as follows (in millions):

Raw materials and purchased parts
Work in process (1)

Finished goods

Inventories (2)

June 29, 2019

June 30, 2018

$

$

78.3   $

72.5  

78.0  

228.8   $

20.9

55.0

98.2

174.1

(1) For fiscal 2018, we have reclassified $20.5 million of capitalized manufacturing overhead from prepayments and other current assets to inventory work in process

to conform to current period presentation.

(2) The inventory balance as of June 29, 2019 includes $5.7 million, net of amortization, related to the inventory step-up adjustment from the Oclaro acquisition.

Prepayments and other current assets

The components of prepayments and other current assets were as follows (in millions):

Prepayments

Advances to contract manufacturers

Value added tax receivable

Vendor receivable

Assets held-for-sale
Other current assets 

Prepayments and other current assets

June 29, 2019

June 30, 2018

32.4   $

8.7  

11.9  

36.3  

4.9  

3.3  

97.5   $

19.5

14.0

4.0

4.3

—

2.7

44.5

$

$

82

 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Property, plant and equipment, net

The components of property, plant and equipment, net were as follows (in millions):

Land

Buildings and improvement
Machinery and equipment (1)

Computer equipment and software

Furniture and fixtures

Leasehold improvements

Construction in progress

Less: Accumulated depreciation (1)

Property, plant and equipment, net

June 29, 2019

June 30, 2018

44.2   $

103.7  

516.5  

25.4  

4.9  

31.2  

46.8  

772.7  

(339.4)  

433.3   $

10.6

55.1

463.6

26.3

2.2

25.8

52.6

636.2

(329.3)

306.9

$

$

(1)  Included  in  the  table  above  are  our  capital  lease  assets  of  $16.0 million,  gross  and  $11.2 million in  accumulated  depreciation  as  of  June 29, 2019, and $15.6

million, gross and $5.2 million in accumulated depreciation as of June 30, 2018.

In fiscal 2019, we purchased a property in San Jose, California for $54.6 million settled in cash. We plan to relocate our corporate headquarters to this new San Jose
location by the end of the calendar year 2019. The preliminary allocations of value were $21.7 million to buildings and improvements and $32.9 million to the land. The
total amount of $54.6 million is included in our property, plant and equipment, gross as of June 29, 2019.

During fiscal 2019, 2018 and 2017, we recorded depreciation expense of $102.9 million, $74.0 million, and $54.2 million, respectively.

Our construction in progress primarily includes machinery and equipment which we expect to place in service in the next 12 months.

Other current liabilities

The components of other current liabilities were as follows (in millions):

Warranty accrual (1)
Restructuring accrual and related charges (2)

Deferred revenue and customer deposits
Capital lease obligation (3)
Income tax payable (4)

Other current liabilities

Other current liabilities

(1) Refer to “Note 19. Commitments and Contingencies.”

(2) Refer to “Note 14. Restructuring and Related Charges.”

June 29, 2019

June 30, 2018

7.5   $

14.6  

2.9

0.4  

8.7  

5.1  

39.2   $

6.6

1.9

2.8

7.3

0.7

2.8

22.1

$

$

(3) In addition to the $0.4 million of capital lease obligations recorded within other current liabilities, we also recorded  $0.4 million within accounts payable in the

consolidated balance sheet as of June 29, 2019. Refer to “Note 19. Commitments and Contingencies”

(4) Refer to “Note 16. Income Taxes.”

83

 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Other non-current liabilities

The components of other non-current liabilities were as follows (in millions):

Asset retirement obligation
Pension and related accruals (1)

Deferred rent

Unrecognized tax benefit

Capital lease obligation

Other non-current liabilities

Other non-current liabilities

June 29, 2019

June 30, 2018

4.5   $

7.9  

2.2  

18.7  

—  

0.4  

33.7   $

2.7

3.5

2.6

6.1

0.4

3.4

18.7

$

$

(1)  In  connection  with  our  acquisitions  of  Oclaro  in  fiscal  2019  and  Time-Bandwidth  in  fiscal  2014,  we  assumed  defined  benefit  plans  for  Japan  and  Switzerland
employees, respectively. As of June 29, 2019, the projected benefit obligations for Japanese and Swiss employees were $2.8 million and  $5.0 million, respectively, and
were included in other non-current liabilities in our consolidated balance sheet. Refer to “Note 18. Employee Benefit Plans” for more details. Pension and related accruals
as of June 29, 2019 also include $0.1 million attributable to post-retirement benefits for executives.

84

 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 10. Cash, Cash Equivalents and Short-term Investments

The following table summarizes our cash, cash equivalents and short-term investments by category for the periods presented (in millions):

June 29, 2019:

Cash

Cash equivalents:

Commercial paper

Money market funds

U.S. Treasury securities

Total cash and cash equivalents

Short-term investments:

Certificates of deposit

Commercial paper

Asset-backed securities

Corporate debt securities

Municipal bonds

Mortgage-backed securities

Foreign government bonds

U.S. Agency securities

U.S. Treasury securities

Total short-term investments

June 30, 2018:

Cash

Cash equivalents:

Certificates of deposit

Commercial paper

Money market funds

U.S. Treasury securities

U.S. Agency securities

Total cash and cash equivalents

Short-term investments:

Certificates of deposit

Commercial paper

Asset-backed securities

Corporate debt securities

Municipal bonds

Mortgage-backed securities

Foreign government bonds

Total short-term investments

Amortized 
Cost

Gross 
Unrealized 
Gains

Gross 
Unrealized 
Losses

Fair Value

213.8   $

37.4  

168.1  

13.3  

432.6   $

1.9   $

22.3  

54.9  

207.6  

1.3  

6.6  

6.2  

4.6  

29.4  

334.8   $

—   $

—  

—  

—  

—   $

—   $

—  

0.2  

0.9  

—  

—  

—  

—  

0.1  

—   $

—  

—  

—  

—   $

—   $

—  

—  

(0.1)

—  

—  

—  

—  

—  

1.2   $

(0.1)

  $

103.6   $

—   $

—   $

3.0  

112.1  

0.8  

143.6  

34.2  

397.3   $

7.5   $

10.5  

68.0  

220.6  

1.6  

4.2  

3.4  

—  

—  

—  

—  

—  

—   $

—   $

—  

—  

0.1  

—  

—  

—  

—  

—  

—  

—  

—  

—   $

—   $

—  

(0.2)

(1.5)

—  

—  

—  

315.8   $

0.1   $

(1.7)

  $

213.8

37.4

168.1

13.3

432.6

1.9

22.3

55.1

208.4

1.3

6.6

6.2

4.6

29.5

335.9

103.6

3.0

112.1

0.8

143.6

34.2

397.3

7.5

10.5

67.8

219.2

1.6

4.2

3.4

314.2

$

$

$

$

$

$

$

$

85

 
 
 
 
 
   
   
   
 
   
   
   
 
   
   
   
 
 
 
   
   
   
 
   
   
   
 
   
   
   
 
   
   
   
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

We  use  the  specific-identification  method  to  determine  any  realized  gains  or  losses  from  the  sale  of  our  short-term  investments  classified  as  available-for-sale.
During fiscal 2019, 2018 and 2017, we did not realize significant gains or losses on a gross level from the sale of our short-term investments classified as available-for-
sale.

During fiscal 2019, 2018 and 2017, our other income (expense), net was $15.8 million, $8.5 million, and $2.3 million, respectively, and includes interest income on

cash equivalents and short-term investments of $13.9 million, $8.5 million, and $1.1 million, respectively.

The components of other income (expense), net are as follows for the years presented (in millions):

Foreign exchange gains (losses), net

Interest income

Other income (expense), net

Total other income (expense), net

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

(0.6)  

13.9  

2.5  

15.8   $

(0.3)  

8.5  

0.3  

8.5   $

0.6

1.1

0.6

2.3

$

The following table summarizes unrealized losses on our cash equivalents and short-term investments by category and length of time the investment has been in a

continuous unrealized loss position as of the periods presented (in millions):

June 29, 2019:

Commercial paper

Asset-backed securities

Corporate debt securities

Foreign government bonds

U.S. government bonds

Total

June 30, 2018:

Certificates of deposit

Commercial paper

Asset-backed securities

Corporate debt securities

Municipal bonds

U.S. Agency securities

Foreign government bonds

Less than 12 months

12 Months or Greater

Fair Value

  Unrealized Losses  

Fair Value

  Unrealized Losses  

Fair Value

Total
  Unrealized Losses

$

$

$

—   $

—   $

—   $

4.2  

9.6  

—  

6.9  

—  

—  

—  

—  

5.9  

35.9  

2.1  

—  

—   $

—  

(0.1)

—  

—  

—   $

10.1  

45.5  

2.1  

6.9  

20.7   $

—   $

43.9   $

(0.1)

  $

64.6   $

5.4   $

8.5  

66.6  

188.6  

0.6  

4.0  

3.4  

—   $

—  

(0.2)

(1.5)

—  

—  

—  

—   $

—   $

5.4   $

—  

0.3  

2.0  

—  

—  

—  

—  

—  

—  

—  

—  

—  

8.5  

66.9  

190.6  

0.6  

4.0  

3.4  

—

—

(0.1)

—

—

(0.1)

—

—

(0.2)

(1.5)

—

—

—

Total

$

277.1   $

(1.7)

  $

2.3   $

—   $

279.4   $

(1.7)

86

 
 
 
 
 
 
 
 
 
   
   
   
   
   
 
 
 
   
   
   
   
   
 
   
   
   
   
   
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table classifies our short-term investments by contractual maturities (in millions): 

Due in 1 year

Due in 1 year through 5 years

Due in 5 years through 10 years

Due after 10 years

June 29, 2019

June 30, 2018

Amortized Cost

Fair Value

  Amortized Cost

Fair Value

$

$

178.9   $

148.1  

6.0  

1.8  

179.1   $

149.0  

6.0  

1.8  

150.1   $

157.2  

6.1  

2.4  

149.6

156.1

6.1

2.4

334.8   $

335.9   $

315.8   $

314.2

All available-for-sale securities have been classified as current, based on management’s intent and ability to use the funds in current operations.

Note 11. Fair Value Measurements

We determine fair value based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market  participants  at  the  measurement  date.  The  fair  value  assumes  that  the  transaction  to  sell  the  asset  or  transfer  the  liability  occurs  in  the  principal  or  most
advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants
would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the
fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: 

Level 1:

Level 2:

Level 3:

Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.

Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset
or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial
instrument.

Inputs are unobservable inputs based on our assumptions.

The fair value of our Level 1 financial instruments, such as money market funds, which are traded in active markets, is based on quoted market prices for identical
instruments. The fair value of our Level 2 fixed income securities is obtained from an independent pricing service, which may use quoted market prices for identical or
comparable instruments or model driven valuations using observable market data or inputs corroborated by observable market data. Our marketable securities are held by
custodians  who  obtain  investment  prices  from  a  third-party  pricing  provider  that  incorporates  standard  inputs  in  various  asset  price  models.  Our  procedures  include
controls to ensure that appropriate fair values are recorded, including comparing the fair values obtained from our pricing service against fair values obtained from another
independent source.

Prior to the conversion of the Series A Preferred Stock in the second quarter of fiscal 2019, we estimated the fair value of the embedded derivative for the Series A
Preferred  Stock  using  the  binomial  lattice  model.  The  binomial  lattice  model  requires  various  assumptions  to  be  made  to  determine  the  fair  value  of  the  embedded
derivatives. These assumptions represent Level 3 inputs. Refer to “Note 12. Non-Controlling Interest Redeemable Convertible Preferred Stock and Derivative Liability.”

In February 2017, we completed the acquisition of a privately held company to enhance our manufacturing and vertical integration capabilities for a total purchase
consideration of $8.7 million. We estimated the fair value of our Level 3 contingent consideration related to this acquisition at the present value of the expected contingent
payments, determined using a probabilistic approach. We estimated the likelihood of meeting the production targets at 90 percent and recorded $2.7 million as fair value of
such contingent consideration in other current liabilities on the consolidated balance sheet as of June 29, 2019. This contingent consideration will result in a cash payment
of $3.0 million (based on the exchange rate as of the acquisition date), if and when the production targets are achieved, which we expect to occur within the following 12
months. We are required to reassess the fair value of contingent payments on a periodic basis. There was no change in the fair value of our contingent consideration during
fiscal 2019, 2018 or 2017.

87

 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Our pension assets consist of multiple institutional funds (“pension funds”) of which the fair values are based on the quoted prices of the underlying funds. Pension

funds are mainly classified as Level 2 assets since such funds are not directly traded in active markets. Refer to “Note 18. Employee Benefit Plans.”

Based  on  quoted  market  prices  as  of  June  29,  2019,  the  fair  value  of  the  Convertible  Notes  (“Note  13.  Convertible  Notes”)  was  approximately  $527.0  million,

determined using Level 2 inputs as they are not actively traded in markets.

Financial assets and liabilities measured at fair value on a recurring basis are summarized below (in millions):

Level 1

Level 2

Level 3

Total

June 29, 2019 (1)

Assets:

Cash equivalents:

Commercial paper

Money market funds

U.S. Treasury securities

Short-term investments:

Certificates of deposit

Commercial paper

Asset-backed securities

Corporate debt securities

Municipal bonds

Mortgage-backed securities

Foreign government bonds

U.S. Agency securities

U.S. Treasury securities

Total assets

Other accrued liabilities:

Acquisition contingencies

Total other accrued liabilities

$

—   $

37.4   $

—  

—  

1.9  

22.3  

55.1  

208.4  

1.3  

6.6  

6.2  

4.6  

—  

168.1  

13.3  

—  

—  

—  

—  

—  

—  

—  

—  

29.5  

210.9   $

—   $

—   $

$

$

$

343.8   $

—   $

—   $

—   $

2.7   $

2.7   $

—   $

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

37.4

168.1

13.3

1.9

22.3

55.1

208.4

1.3

6.6

6.2

4.6

29.5

554.7

2.7

2.7

(1) Excludes $213.8 million in cash held in our bank accounts as of June 29, 2019.

88

 
 
 
 
 
   
   
   
 
   
   
 
 
 
 
 
 
 
 
   
   
   
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2018: (1)

Assets:

Cash equivalents:

Certificates of deposit

Commercial paper

Money market funds

U.S. Treasury securities

U.S. Agency securities

Short-term investments:

Certificates of deposit

Commercial paper

Asset-backed securities

Corporate debt securities

Municipal bonds

Mortgage-backed securities

Foreign government bonds

Total assets

Other accrued liabilities:

Derivative liability

Acquisition contingencies

Total other accrued liabilities

Level 1

Level 2

Level 3

Total

$

—   $

3.0   $

—   $

—  

0.8  

143.6  

—  

—  

—  

—  

—  

—  

—  

—  

112.1  

—  

—  

34.2  

7.5  

10.5  

67.8  

219.2  

1.6  

4.2  

3.4  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

3.0

112.1

0.8

143.6

34.2

7.5

10.5

67.8

219.2

1.6

4.2

3.4

$

$

$

144.4   $

463.5   $

—   $

607.9

—   $

—  

—   $

—   $

—  

—   $

52.4   $

2.7  

55.1   $

52.4

2.7

55.1

(1) Excludes $103.6 million in cash held in our bank accounts as of June 30, 2018.

Assets Measured at Fair Value on a Non-Recurring Basis

We periodically review our intangible and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of
such assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated undiscounted cash flows resulting from use of the
asset and its eventual disposition. If not recoverable, an impairment loss would be calculated based on the excess of the carrying amount over the fair value. During the
annual impairment testing performed in fiscal 2019, we concluded that our intangible assets were not impaired.

We also valued certain long-lived assets at fair value on a non-recurring basis as of June 29, 2019 as part of our long-lived asset impairment testing and recorded an
impairment charge of $30.7 million during fiscal 2019. Fair value was determined by utilizing a market approach incorporating both observable and unobservable inputs,
and are deemed to be Level 3 fair value inputs. Refer to “Note 5. Business Combination” and “Note 15. Impairment Charges.”

Note 12. Non-Controlling Interest Redeemable Convertible Preferred Stock and Derivative Liability

On July 31, 2015, our wholly-owned subsidiary, Lumentum Inc., issued 40,000 shares of its Series A Preferred Stock to Viavi Solutions Inc. (“Viavi”). Pursuant to a
securities purchase agreement between us, Viavi and Amada Holdings Co., Ltd. (“Amada”), 35,805 shares of Series A Preferred Stock were sold by Viavi to Amada in
August 2015. The remaining 4,195 shares of the Series A Preferred Stock were canceled.

As  of  June  30,  2018,  the  Series  A  Preferred  Stock  was  referred  to  as  our  Non-Controlling  Interest  Redeemable  Convertible  Preferred  Stock  within  these

consolidated financial statements, and was recorded at $35.8 million.

On October 15, 2018, we issued a 30-day notice of intent to the holders of Series A Preferred Stock to convert all shares of Series A Preferred Stock at a conversion
price  equal  to  the  Issuance  Value  divided  by  $24.63 plus  the  accrued  and  unpaid  dividends  on  each  share  and  any  past  due  dividends,  whether  or  not  authorized  or
declared. On November 2, 2018, we received notice from Amada of their intent to convert the Series A Preferred Stock. Upon the conversion of the 35,805 shares of Series
A Preferred

89

 
 
 
 
 
   
   
   
 
   
   
   
 
   
   
   
 
   
   
   
 
   
   
   
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Stock, we issued 1.5 million shares of our common stock to Amada and recorded $79.4 million in additional paid in capital in the consolidated balance sheet.

Up through the date of conversion, the Series A Preferred Stock conversion feature is bifurcated from the Series A Preferred Stock and accounted for separately as a
derivative  liability.  The derivative  liability  is  measured  at  fair  value  each  reporting  period,  and  at  the  date  of  conversion,  with  the  change  in fair  value  recorded  in the
consolidated statements of operations. We estimated the fair value of the embedded derivative using the binomial lattice model. We applied the binomial lattice model to
value the embedded derivative using a “with-and-without method,” where the value of the Series A Preferred Stock, including the embedded derivative, is defined as the
“with”, and the value of the Series A Preferred Stock, excluding the embedded derivative, is defined as the “without”. The binomial lattice model requires the following
inputs: (i) the Company's common stock price; (ii) conversion price; (iii) term; (iv) yield; (v) recovery rate for the Series A Preferred Stock; (vi) estimated stock volatility;
and (vii) risk-free rate. The fair value of the embedded derivative was determined using Level 3 inputs under the fair value hierarchy (unobservable inputs). Changes in the
inputs into this valuation model have a material impact in the estimated fair value of the embedded derivative. For example, a decrease (increase) in the stock price and the
volatility results in a decrease (increase) in the estimated fair value of the embedded derivative. The changes in the fair value of the bifurcated embedded derivative for the
Series A Preferred Stock are primarily related to the change in the price of our common stock and are reflected in the consolidated statements of operations as “Unrealized
gain (loss) on derivative liability.”

Up through the date of conversion, holders of Series A Preferred Stock, in preference to holders of common stock or any other class or series of our outstanding
capital stock ranking in any such event junior to the Series A Preferred Stock, were entitled to receive, when and as declared by the board of directors, quarterly cumulative
cash dividends at the annual rate of 2.5% of the Issuance Value per share on each outstanding share of Series A Preferred Stock. The accrued dividends were payable on
March 31, June 30, September 30 and December 31 of each year commencing on September 30, 2015. The accrued dividends as of November 2, 2018, the effective date of
the conversion of all outstanding Series A Preferred Stock, and June 30, 2018 were $0.3 million and $0.4 million, respectively.

During the years ended June 29, 2019, June 30, 2018, and July 1, 2017, we paid $0.7 million, $0.7 million, and $0.9 million, respectively, in dividends to the holders

of Series A Preferred Stock.

Prior to the conversion of the Series A Preferred Stock on November 2, 2018, we marked to market the embedded derivative, resulting in a gain of $8.8 million in

our fiscal 2019.

The  following  table  provides  a  reconciliation  of  the  fair  value  of  the  embedded  derivative  for  the  Series  A  Preferred  Stock  for  the  years  ended  June  29,  2019,

June 30, 2018, and July 1, 2017 (in millions):

Balance as of beginning of period

Unrealized (gain) loss on the Series A Preferred Stock derivative liability up through the conversion date

Settlement of the derivative liability upon conversion of Series A Preferred Stock

Balance as of end of period

Note 13. Convertible Notes

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

$

$

52.4   $

51.6   $

(8.8)  

(43.6)  

0.8  

—  

—   $

52.4   $

10.3

41.3

—

51.6

In March 2017, we issued the 2024 Notes in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended
(the “Securities Act”). The 2024 Notes are governed by an indenture between the Company, as the issuer, and U.S. Bank National Association, as trustee (the “Indenture”).
The 2024 Notes are unsecured and do not contain any financial covenants, restrictions on dividends, incurrence of senior debt or other indebtedness, or the issuance or
repurchase of securities by us.

The 2024 Notes bear interest at a rate of 0.25% per year. Interest on the 2024 Notes is payable semi-annually in arrears on March 15 and September 15 of each year,

beginning on September 15, 2017. The 2024 Notes will mature on March 15, 2024, unless earlier repurchased by us or converted pursuant to their terms.

The  initial  conversion  rate  of  the  2024  Notes  is  16.4965 shares  of  common  stock  per  $1,000 principal  amount  of  2024  Notes,  which  is  equivalent  to  an  initial

conversion price of approximately $60.62 per share, a 132.5% premium to the fair market value

90

 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

at the date of issuance. Prior to the close of business on the business day immediately preceding December 15, 2023, the 2024 Notes will be convertible only under the
following circumstances: (1) during any fiscal quarter (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days
(whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter is greater than or
equal to 130% of the applicable conversion price, or $78.80 on each applicable trading day; (2) during the five consecutive business day period after any five consecutive
trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of such measurement period was less
than 98% of the product of the last reported sale price of our common stock and the applicable conversion rate on each such trading day; or (3) upon the occurrence of
specified corporate events. On or after December 15, 2023 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders
may convert their notes at any time. In addition, upon the occurrence of a make-whole fundamental change, we will, in certain circumstances, increase the conversion rate
by a number of additional shares for a holder that elects to convert 2024 Notes in connection with such make-whole fundamental change.

We may not redeem the 2024 Notes prior to their maturity date and no sinking fund is provided for the 2024 Notes. Upon the occurrence of a fundamental change,
holders may require us to repurchase all or a portion of their 2024 Notes for cash at a price equal to 100% of the principal amount of the 2024 Notes to be repurchased, plus
any accrued and unpaid interest.

We considered the features embedded in the 2024 Notes other than the conversion feature, including the holders’ put feature, our call feature, and the make-whole

feature, and concluded that they are not required to be bifurcated and accounted for separately from the host debt instrument.

Prior to the Tax Matters Agreement settlement condition (“TMA settlement condition”), because we could only settle the 2024 Notes in cash, we determined that the
conversion feature met the definition of a derivative liability. We separated the derivative liability from the host debt instrument based on the fair value of the derivative
liability. As of the issuance date, March 8, 2017, the derivative liability fair value of $129.9 million was calculated using the binomial valuation approach. The residual
principal amount of the 2024 Notes of $320.1 million before issuance costs was allocated to the debt component. We incurred approximately  $7.7 million in transaction
costs  in  connection  with  the  issuance  of  the  2024  Notes.  These  costs  were  allocated  to  the  debt  component  and  recognized  as  a  debt  discount.  We  amortize  the  debt
discount,  including  both  the  initial  value  of  the  derivative  liability  and  the  transaction  costs,  over  the  term  of  the  2024  Notes  using  the  effective  interest  method.  The
effective interest rate of the 2024 Notes is 5.4% per year. As of June 29, 2019, the remaining debt discount amortization period was 56 months.

During  the  year  ended  July  1,  2017,  we  satisfied  the  TMA  settlement  condition.  As  such,  the  value  of  the  conversion  option  will  no  longer  be  marked  to  market
and was reclassified to additional paid-in capital within stockholders’ equity on our consolidated balance sheet. The value of the conversion option at the time of issuance
will be treated as an original issue discount for purposes of accounting for the debt component of the notes. The debt component will accrete up to the principal amount
over the expected term of the debt. These accounting standards do not affect the actual amount we are required to repay, and the amount shown in the table below for the
notes is the aggregate principal amount of the notes and does not reflect the debt discount we will be required to recognize.

The 2024 Notes consisted of the following components as of the periods presented (in millions):

Liability component:

Principal

Unamortized debt discount

Net carrying amount of the liability component

June 29, 2019

June 30, 2018

$

$

450.0   $

(98.1)  

351.9   $

450.0

(115.8)

334.2

91

 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table sets forth interest expense information related to the 2024 Notes for the periods presented (in millions, except percentages):

Contractual interest expense

Amortization of the debt discount

Total interest expense

Effective interest rate on the liability component

June 29, 2019

June 30, 2018

July 1, 2017

$

$

1.1

  $

17.7

18.8

  $

5.4%  

1.2

  $

16.7

17.9

  $

5.4%  

0.4

5.1

5.5

5.4%

We have the ability and intent to settle the $450 million face value of the debt in cash. Therefore, we use the treasury stock method for calculating the dilutive impact

of the debt. The 2024 Notes will have no impact to diluted earnings per share until the average price of our common stock exceeds the conversion price of $60.62.

Note 14. Restructuring and Related Charges

We have initiated various strategic restructuring actions primarily intended to reduce costs, consolidate our operations, rationalize the manufacturing of our products

and align our business in response to market conditions and as a result of our acquisition of Oclaro on December 10, 2018.

The following table summarizes the activity of restructuring and related charges during the years ended June 29, 2019 and June 30, 2018 (in millions):

Balance as of beginning of period

Charges

Payments

Balance as of end of period

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

$

$

1.9   $

31.9  

(19.2)  

14.6   $

3.8   $

7.2  

(9.1)  

1.9   $

5.7

12.0

(13.9)

3.8

In  our  effort  to  continually  maximize  long-term  shareholder  value,  following  our  acquisition  of  Oclaro,  on  March  5,  2019,  we  announced  our  plan  to  discontinue
development and manufacturing of Lithium Niobate modulators. A plan to wind down operations over the next couple of quarters was announced to employees in San
Donato,  Italy.  Development  and  manufacturing  will  also  be  discontinued  in  our  San  Jose,  California  manufacturing  locations  within  the  next  few  quarters  in  order  to
facilitate our customers’ transition to new products.

We also announced our plan to discontinue the development and manufacturing of future Datacom transceiver products which impacted our Milpitas and Shenzhen
Datacom module teams. While we expect strong growth in Datacom volumes in the future, the market at the transceiver level is gross margin challenged due to extreme
competition.  Following the Oclaro acquisition, we have a differentiated leadership position across a range of photonic chips on which the Datacom, wireless, and access
markets critically rely. 

In connection with the restructuring plan and our plans to consolidate our operations, the Company calculated the fair value of the facilities-related charges of $1.6
million based on estimated future discounted cash flows which included the amount and timing of estimated sublease rental receipts that the Company could reasonably
obtain over the remaining lease term and the discount rate.

During fiscal 2019, we recorded $31.9 million in restructuring and related charges in our consolidated statements of operations.

• During the first quarter of 2019, we recorded $1.3 million of severance costs primarily due to an internal re-organization in order to extend our market
leadership position by strengthening product quality, to develop new enabling technologies required to support a winning long-term portfolio roadmap, and to
develop commercial proposals and new product introduction (“NPI”) priorities to maintain and grow our position while driving new customer and eco-system
partner engagements.

92

 
 
 
 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

• During the second quarter of 2019, we recorded $5.7 million primarily attributable to severance and employee related benefits associated with Oclaro’s
executive severance and retention agreements. These retention agreements provide, under certain circumstances, for payments and benefits upon an involuntary
termination of employment.

• During the third quarter of 2019, we recorded $21.1 million primarily attributable to severance and employee related benefits associated with the wind
down of operations  for Lithium  Niobate modulators  and Datacom  modules. We  also recorded  an additional  $1.6 million of lease restructuring charges for the
former Oclaro corporate headquarters. 

During fiscal 2018, we recorded $7.2 million in restructuring and related charges in the consolidated statements of operations.

•

During the fourth quarter of fiscal 2018, we initiated a new restructuring plan in order to realign the organization and enable further investment in key priority
areas. As a result, a restructuring charge of $3.4 million was recorded for severance costs and employee benefits. In total, 52 employees in manufacturing, R&D
and SG&A functions were terminated in connection with this new restructuring plan.

• We also incurred restructuring and related charges of $3.8 million from restructuring plans approved prior to fiscal 2016 primarily related to the shut down of our
manufacturing  facility  in  Bloomfield,  Connecticut  as  a  result  of  the  transfer  of  certain  production  processes  into  existing  sites  in  the  United  States  or  to
contract manufacturers.

During fiscal 2017, we recorded $12.0 million in restructuring and related charges. Of the  $12.0 million charge recorded during fiscal 2017,  $2.1 million related to

severance, retention and employee benefits.

Any changes in the estimates of executing our restructuring activities will be reflected in our future results of operations.

Note 15. Impairment Charges

The following table summarizes the activity of impairment charges during the years ended June 29, 2019, June 30, 2018, and July 1, 2017 (in millions):

Impairment charges

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

$

30.7

$

— $

—

As was previously discussed in “Note 14. Restructuring and Related Charges”, we have announced plans to discontinue the development and manufacturing of future
Datacom transceiver products. As a result of these actions we recorded an impairment charge of $30.7 million to our Long-lived assets that were not deemed to be useful,
were retired from active use and classified as assets held-for-sale. These assets were valued at fair value less cost to sell. We classified the assets within Level 3 of the fair
value hierarchy.

In fiscal 2019, we also recorded inventory write down charges of $20.8 million related to the decision to exit the Datacom module and Lithium Niobate product lines

in our cost of goods sold of consolidated statements of operations.

These actions do not qualify as discontinued operations for disclosure purposes as they do not represent a strategic shift having a major effect on an entity’s operations

and financial results. 

Refer to “Note 5. Business Combination”, “Note 9. Balance Sheet Details”, “Note 11. Fair Value Measurements” and “Note 14. Restructuring and Related Charges”

for details.

Note 16. Income Taxes

Our income (loss) before income taxes consisted of the following (in millions):

Domestic

Foreign

Income (loss) before income taxes

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

$

$

(21.9)   $

(11.4)  

(33.3)   $

37.8   $

91.6  

129.4   $

(78.4)

18.6

(59.8)

93

 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Our income tax (benefit) expense consisted of the following (in millions):

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

Federal:

Current

Deferred

State:

Current

Deferred

Foreign:

Current

Deferred

$

13.8   $

(0.1)  

13.7  

1.2   $

(120.4)  

(119.2)  

0.1  

0.4  

0.5  

10.3  

(21.4)  

(11.1)  

1.0  

(1.3)  

(0.3)  

1.2  

(0.4)  

0.8  

Total income tax (benefit) expense

$

3.1   $

(118.7)   $

13.7

—

13.7

0.1

—

0.1

2.1

26.8

28.9

42.7

The comparability of our operating results of fiscal 2019 compared to the corresponding prior year was impacted by the U.S. Tax Cuts and Jobs Act of 2017 (the “Tax
Act”), which was enacted on December 22, 2017. The Tax Act introduced significant changes to U.S. income tax law including reducing the U.S. federal statutory tax rate
from 35% to 21% and imposing new taxes on certain foreign-sourced earnings and certain intercompany payments. Due to the timing of the enactment and the complexity
involved in applying the provisions of the Tax Act, we made reasonable estimates of the effects and recorded provisional amounts in our financial statements as of fiscal
2018 in accordance with SEC Staff Accounting Bulletin No. 118 (“SAB 118”). During the period ended December 29, 2018, we completed our accounting for the Tax Act
with no material adjustment to our provisional estimates recorded.

The provision for income taxes differs from the amount computed by applying the U.S. Federal statutory income tax rate to our income before provision for income

taxes as follows (in millions):

Years Ended

June 29, 2019

June 30, 2018

July 1, 2017

36.3   $

(20.9)

Income tax (benefit) expense computed at federal statutory rate

$

State taxes, net of federal benefit

Foreign rate differential

Change in valuation allowance

Tax Act - tax rate change

Tax credits

Permanent items

Stock-based compensation

Fair value adjustment

Subpart F and GILTI

Unrecognized tax benefits

Prior year true-up

Other

Audit settlement

(7.0)   $

0.7  

(17.8)  

7.4  

—  

(7.1)  

(0.6)  

5.9  

0.5  

13.4  

4.8  

(0.3)  

0.2  

3.0  

(0.5)  

(24.3)  

(206.0)  

80.5  

(11.0)  

(0.8)  

(1.0)  

0.2  

2.0  

7.9  

(1.8)  

(0.2)  

—  

Total income tax (benefit) expense

$

3.1   $

(118.7)   $

0.1

(4.7)

21.5

—

(2.9)

0.3

4.9

36.5

—

8.4

(0.1)

(0.4)

—

42.7

Our provision for income taxes for fiscal 2019 increased compared to fiscal 2018 primarily as a result of $206.0 million of income tax benefit related to the release of
valuation allowance against our U.S. federal and certain state deferred tax assets and $80.5 million of income tax expense related to the remeasurement of our net deferred
tax assets as a result of reduction in the U.S.

94

 
 
 
 
 
   
   
 
 
   
   
 
 
   
   
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

federal corporate tax rate, both of which were recognized during fiscal 2018. Our provision for income taxes was also impacted by the benefit of our foreign income being
taxed at lower rates than the U.S. statutory rate, as well as the benefit of research and development tax credits.

The components of our net deferred taxes consisted of the following (in millions):

Gross deferred tax assets:

Intangibles

Tax credit carryforwards

Net operating loss carryforwards

Inventories

Accruals and reserves

Fixed assets

Capital loss carryforwards

Unclaimed research and experimental development expenditure

Stock-based compensation

Other

Gross deferred tax assets

Valuation allowance

Deferred tax assets

Gross deferred tax liabilities:

Intangible amortization

Convertible notes

Other

Deferred tax liabilities

Total net deferred tax assets

Years Ended

June 29, 2019

June 30, 2018

$

$

111.7   $

66.5  

134.6  

11.3  

19.6  

32.3  

12.1  

25.6  

3.4  

—  

417.1  

(190.3)  

226.8  

(90.8)  

(20.1)  

(2.2)  

(113.1)  

113.7   $

123.3

47.1

7.1

12.4

7.2

10.1

12.3

25.6

3.5

0.5

249.1

(99.4)

149.7

(0.8)

(23.6)

—

(24.4)

125.3

We assess our ability to realize the deferred tax assets on a quarterly basis and establish a valuation allowance if the deferred tax assets are not more-likely-than-not to
be  realized.  We  weigh  all  available  positive  and  negative  evidence,  including  our  earnings  history  and  results  of  recent  operations,  reversals  of  deferred  tax  liabilities,
projected future taxable income, and tax planning strategies.

As of each reporting date, we consider new evidence, both positive and negative, that could affect our view of the future realization of deferred tax assets. During
fiscal 2018, we determined that there is sufficient positive evidence to conclude that it is more-likely-than-not that the U.S. federal and certain states deferred tax assets are
realizable. We, therefore, released the valuation allowance against our U.S. federal and certain states resulting in an income tax benefit of $207.2 million.

Due to the weight of negative evidence, we continue to maintain a full valuation allowance on our California, Thailand, and the U.K. deferred tax assets and partial
valuation allowance on our Canadian deferred tax assets. In the event the Company determines that it will be able to realize all or part of the U.K., California, or Canada
deferred  tax  assets  in  the  future,  the  valuation  allowance  will  be  reversed  in  the  period  in  which  the  Company  makes  such  determination.  Based  on  the  information
currently available, we do not believe that a significant portion of our valuation allowance for the U.K., Thailand, California, and Canada will be released in the next 12
months.  Such  a  release  would  result  in  the  recognition  of  certain  deferred  tax  assets  and  a  decrease  in  the  income  tax  expense  for  the  period  in  which  the  release  is
recorded.

As a result of meeting certain capital funding, capital investments and hiring requirements, income from operations in Thailand was exempt from income tax in fiscal

2019 and fiscal 2018.

As of June 29, 2019, the Company had federal and foreign net operating loss carryforwards of $181.4 million and $562.0 million, respectively. These carryforwards
will begin to expire in the fiscal years ending 2020 and 2025, respectively. The federal and foreign tax attributes carried forward are subject to various rules which impose
limitations on the utilization.

95

 
 
 
 
   
 
   
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Additionally, the Company has federal, state, and foreign research and other tax credit carryforwards of $11.8 million, $36.7 million, and $49.2 million, respectively.
The federal credits will begin to expire in the fiscal year ending 2033 and California credits can be carried forward indefinitely. The foreign tax credits will begin to expire
in the fiscal year ending 2020.

The Tax Act generally provides greater flexibility for us to access and utilize our cash held by certain of our foreign subsidiaries and we intend to repatriate all or
some of the earnings of our subsidiaries in the Cayman Islands, Japan and Hong Kong. As to all other foreign subsidiaries, we intend to reinvest these earnings indefinitely
outside  of  the  U.S.  As  a  result,  U.S.  income  and  foreign  withholding  taxes  associated  with  the  repatriation  of  $27.2  million of  undistributed  earnings  of  foreign
subsidiaries,  other  than  the  Cayman  Islands,  Japan  and  Hong  Kong  subsidiaries,  have  not  been  provided  for.  We  estimate  that  an  additional  $1.8  million of  foreign
withholding taxes would have to be provided if these earnings were repatriated back to the U.S.

The aggregate changes in the balance of our unrecognized tax benefits between July 2, 2016 and June 29, 2019 are as follows (in millions):

Balance at July 1, 2017

Additions based on the tax positions related to the prior year

Additions based on tax positions related to current year

Balance at June 30, 2018

Additions based on the tax positions related to the prior year

Decreases related to settlement with Tax Authorities

Additions based on tax positions related to current year

Balance at June 29, 2019

$

$

$

13.3

1.2

11.3

25.8

3.7

(0.7)

29.2

58.0

As of June 29, 2019, we had $18.7 million of unrecognized tax benefits, which, if recognized, would affect the effective tax rate. We are subject to examination of
income tax returns by various domestic and foreign tax authorities. The timing of resolutions and closures of tax audits is highly unpredictable. Although it is possible that
certain tax audits may be concluded within the next 12 months, we cannot reasonably estimate the impact to tax expense and net income from tax exams that could be
resolved or closed within next 12 months. However, we believe that we have adequately provided under GAAP for potential audit outcomes. Subject to audit timing and
uncertainty, we expect the amount of unrecognized tax benefit that would become recognized due to expiration of the statute of limitations and affect the effective tax rate
to be $1.9 million over the next 12 months. During the three months ended March 30, 2019, we settled the Canadian income tax examination for fiscal years 2000 and
2001, which resulted in a $1.5 million decrease in unrecognized tax benefit.

Our policy is to recognize accrued interest and penalties related to unrecognized tax benefits within the income tax provision. The amount of interest and penalties

accrued as of June 29, 2019 and June 30, 2018 were $1.0 million and $0.9 million, respectively.

The major tax jurisdictions where we file tax returns are the U.S. federal government, the state of California, Japan, the United Kingdom, Thailand, China and Canada.
As of June 29, 2019, our fiscal 2009 to 2019 tax returns are open to potential examination in one or more jurisdictions. In addition, certain net operating loss and credit
carryforwards may extend the ability of the tax authorities to examine our tax returns beyond the regular limits.

On  June  7,  2019,  the  Ninth  Circuit  Court  of  Appeals,  reversing  a  previous  decision  of  the  U.S.  Tax  Court,  held  that  the  U.S.  Treasury  Department’s  regulations
requiring the inclusion of stock-based compensation expense in a taxpayer’s cost-sharing calculations were valid. Our financial statements have been prepared consistent
with this outcome, but we will continue to monitor any ongoing developments, including the possibility of rehearing or appeal to the U.S. Supreme Court, to determine if
future changes are required.

Note 17. Stock-Based Compensation and Stock Plans

Description of Lumentum Stock-Based Benefit Plans

Equity Incentive Plan

As  of  June  29,  2019,  we  had  2.4 million shares  subject  to  stock  options,  restricted  stock  units,  restricted  stock  awards,  and  performance  stock  units  issued  and

outstanding under the 2015 Equity Incentive Plan (the “2015 Plan”).

96

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Restricted stock units, restricted stock awards, and performance stock units are performance-based, time-based or a combination of both and are expected to vest over
one to four years. The fair value of these grants is based on the closing market price of our common stock on the date of award. The exercise price for stock options is
equal  to  the  fair  value  of  the  underlying  stock  at  the  date  of  grant.  We  issue  new  shares  of  common  stock  upon  exercise  of  stock  options.  Options  generally  become
exercisable over a three-year or four-year period and, if not exercised, expire from five to ten years after the date of grant.

As of June 29, 2019, 3.9 million shares of common stock under the 2015 Plan were available for grant.

Replacement Awards

In  connection  with  the  acquisition  of  Oclaro,  we  issued  equity  awards  to  Oclaro  employees,  consisting  of  stock  options  and  restricted  stock  units  (“replacement
awards”) in exchange for their Oclaro equity awards. The replacement awards consisted of less than 0.1 million stock options with a weighted average grant date fair value
of $34.34, and 1.0 million restricted stock units with a weighted average grant date fair value of $41.80. The terms of these replacement awards are substantially similar to
the original Oclaro equity awards. The fair value of the replacement awards for services rendered through December 10, 2018, the acquisition date, was recognized as a
component  of  the  merger  consideration,  with  the  remaining  fair  value  of  the  replacement  awards  related  to  the  post-combination  services  recorded  as  stock-based
compensation over the remaining vesting period.

Restricted Stock Units

Restricted stock units (“RSUs”) under the 2015 Plan are grants of shares of our common stock, the vesting of which is based on the requisite service requirement.
Generally,  our  RSUs  are  subject  to  forfeiture  and  expected  to  vest  over  one to  four years.  For  annual  refresh  grants,  RSUs  generally  vest  ratably  on  an  annual,  or
combination of annual and quarterly, basis over three years.

Restricted Stock Awards

Restricted  stock awards (“RSAs”) under the 2015 Plan are grants of shares of our common stock that are subject to various restrictions,  including restrictions  on
transferability and forfeiture provisions. RSAs are expected to vest over one to four years, and the shares acquired may not be transferred by the holder until the vesting
conditions (if any) are satisfied.

Performance Stock Units

Performance stock units (“PSUs”) under the 2015 Plan are grants of shares of our common stock that vest upon the achievement of certain performance and service
conditions.  We  begin  recognizing  compensation  expense  when  we  conclude  that  it  is  probable  that  the  performance  conditions  will  be  achieved.  We  reassess  the
probability  of  vesting  at  each  reporting  period  and  adjust  our  compensation  cost  based  on  this  probability  assessment.  Our  PSUs  are  subject  to  risk  of  forfeiture  until
performance and service conditions are satisfied and generally vest over three years.

In November 2018, our board of directors approved the grant of 0.2 million PSUs to senior members of our management team. At the beginning of fiscal 2019, we
determined that the achievement of the performance conditions was probable, and as such, began recording stock-based compensation associated with these PSUs. Based
on performance conditions actually achieved in fiscal 2019, we recorded $2.0 million expense related to these grants.

Employee Stock Purchase Plan

Our  2015  Employee  Stock  Purchase  Plan  (the  “2015  Purchase  Plan”)  provides  eligible  employees  with  the  opportunity  to  acquire  an  ownership  interest  in  the
Company through periodic payroll deductions and provides a 15% purchase price discount as well as a six-month look-back period. The 2015 Purchase Plan is structured
as a qualified employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986. However, the 2015 Purchase Plan is not intended to be a qualified
pension, profit sharing or stock bonus plan under Section 401(a) of the Internal Revenue Code of 1986 and is not subject to the provisions of the Employee Retirement
Income Security Act of 1974. The 2015 Purchase Plan will terminate upon the date on which all shares available for issuance have been sold. Of the 3.0 million shares
authorized under the 2015 Purchase Plan, 2.0 million shares remained available for issuance as of June 29, 2019.

97

Table of Contents

Stock-Based Compensation

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The impact on our results of operations of recording stock-based compensation by function during fiscal 2019, 2018, and 2017 was as follows (in millions):

Cost of sales

Research and development

Selling, general and administrative

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

$

$

$

15.1

13.8

41.8  

70.7   $

$

12.6

14.2

20.0  

46.8   $

7.5

11.6

13.6

32.7

Total income tax benefit associated with stock-based compensation recognized in our consolidated statements of operations during the years presented was as follows

(in millions):

Income tax benefit associated with stock-based compensation

$

(8.9)   $

(16.6)   $

(13.1)

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

Approximately $3.5 million and $2.6 million of stock-based compensation was capitalized to inventory as of June 29, 2019 and June 30, 2018, respectively.

In connection  with the acquisition  of Oclaro, we accelerated  certain  equity awards for Oclaro employees.  The total stock-based  compensation  expense associated
with the acceleration of equity awards was $15.2 million, out of which $10.0 million was settled in cash in our second quarter of fiscal 2019. Refer to “Note 5. Business
Combination.”

98

 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Stock Option and Stock Award Activity

We did not grant any stock options during fiscal 2019, 2018, or 2017, other than those assumed in connection with the Oclaro merger. As of  June 29, 2019, there

were less than 0.05 million stock options outstanding under the 2015 Plan, all of which were replacement awards issued in connection with the Oclaro acquisition.

The following table summarizes our awards activity in fiscal 2019, 2018, and 2017 (in millions, except per share amounts):

Stock Options

Restricted Stock Units

Restricted Stock Awards

Performance Stock Units

Number of
Shares

Weighted-
Average
Exercise
Price

Number of
Shares

Weighted-
Average Grant
Date Fair
Value per
Share

Number of
Shares

Weighted-
Average Grant
Date Fair
Value per
Share

0.3

  $

17.8  

—  

(0.3)

—  

14.3  

—  

—   $

—  

—  

—  

—   $

*

—  

*

—  

*

  $

—  

—  

—  

—  

—  

—  

34.3  

—  

26.2  

—  

38.8  

  $

  $

  $

2.5

1.0

(1.4)

(0.2)

1.9

1.1

(1.1)

(0.2)

1.7

1.0

1.0

(1.0)

(0.5)

2.2

  $

21.3  

35.6  

22.3  

23.8  

27.9  

54.5  

26.6  

38.8  

43.1  

41.8  

60.3  

41.5  

50.2  

52.4  

—   $

0.3

—  

—  

0.3

  $

—  

(0.2)

—  

0.1

  $

—  

—  

(0.1)

*

*

  $

—  

32.5  

—  

—  

32.5  

—  

32.5  

—  

32.5  

—  

—  

32.5  

32.8  

32.5  

Balance as of July 2, 2016

Granted

Vested/Exercised

Canceled

Balance as of July 1, 2017

Granted

Vested/Exercised

Canceled

Balance as of June 30, 2018

Assumed in Oclaro merger

Granted

Vested/Exercised

Canceled

Balance as of June 29, 2019

* Less than 0.05 million

Weighted-
Average Grant
Date Fair
Value per
Share

Number of
Shares (1)
0.1

  $

—  

(0.1)

—  

—   $

0.1

—  

—  

0.1

  $

—  

0.2

(0.1)

*

0.2

  $

14.4

—

14.4

—

—

52.0

—

—

52.0

—

55.9

49.0

53.8

56.0

(1) In fiscal 2018, we granted 0.1 million PSUs to senior members of our management team subject to revenue performance condition. The number of awards granted
in fiscal  2018 represented  100% of  target  goal;  under  the  terms  of  the  awards,  the  recipient  could  earn  between  0% and  200% of  the  original  grant.  The  performance
condition  was  achieved  in  fiscal  2018.  In  first  quarter  of  fiscal  2019,  our  board  of  directors  approved  an  increase  in  the  original  number  of  PSUs  based  on  the  actual
achievement.

As of June 29, 2019, $96.8 million of stock-based compensation cost related to awards granted to our employees remains to be amortized. That cost is expected to be

recognized over an estimated amortization period of 2.0 years.

99

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

A summary of awards available for grant is as follows (in millions):

Balance as of July 2, 2016

Authorized

Granted

Canceled

Balance as of July 1, 2017

Authorized

Granted

Canceled

Balance as of June 30, 2018

Replacement awards in connection with Oclaro acquisition

Granted

Canceled

Balance as of June 29, 2019

Employee Stock Purchase Plan Activity

Awards Available
for Grant

4.7

3.0

(1.3)

0.2

6.6

—

(1.2)

0.2

5.6

(1.0)

(1.2)

0.5

3.9

The 2015 Purchase Plan expense for fiscal 2019, 2018, and 2017 were $3.6 million, $3.3 million, and $2.7 million, respectively. The expense related to the 2015
Purchase Plan is recorded on a straight-line basis over the relevant subscription period. During fiscal 2019, 2018, and 2017, there were 0.3 million, 0.2 million, and 0.3
million shares issued to employees through the 2015 Purchase Plan.

We estimate the fair value of the 2015 Purchase Plan shares on the date of grant using the Black-Scholes option-pricing model. The assumptions used to estimate the

fair value of the 2015 Purchase Plan shares to be issued during the periods presented were as follows:

Expected term (years)

Expected volatility

Risk-free interest rate

Dividend yield

Note 18. Employee Benefit Plans

401(k) Plan

June 29, 2019

June 30, 2018

0.5

60.1%  

2.47%  

—%  

0.5

58.8%

2.02%

—%

In the United States, the Company sponsors the Lumentum 401(k) Retirement  Plan (the “401(k) Plan”), a defined contribution plan under ERISA, which provides
retirement  benefits  for  its  eligible  employees  through  tax  deferred  salary  deductions.  The  401(k)  Plan  allows  employees  to  contribute  up  to  50% of  their  annual
compensation, with contributions limited to $19,000 in calendar year 2019 as set by the Internal Revenue Service.

Employees are eligible for matching contributions after completing 180 days of service. The Company’s match is contributed on a per-pay-period basis and is based
on employees’ before-tax contributions and compensation each pay period. All matching contributions are made in cash and vest immediately under the 401(k) Plan. In
fiscal 2019 and 2018, we made matching contributions to the 401(k) Plan in the amount of $3.7 million and $3.4 million, respectively.

100

 
 
 
 
Table of Contents

Canada Retirement Plans

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

In Canada, the Company sponsors the Group Registered Retirement Savings Plan (the “RRSP”) and Deferred Profit Sharing Plan (the “DPSP”), defined contribution

plans which provide retirement benefits for eligible employees through tax deferred salary deductions.

The RRSP allows employees to contribute up to 5% of their eligible earnings in a pay period, with contributions limited to C$26,500 ($20,250 based on the applicable
exchange rate as of June 29, 2019) in calendar year 2019 as set by the Canada Revenue Agency. Based on the employee’s contribution to the RRSP, the Company makes a
matching contribution to the DPSP. The Company makes a 100% matching contribution on the first  3% of the employees’ before-tax contributions and a  50% matching
contribution on the following 2% of the employees’ before-tax contributions, up to an annual maximum of C$4,000. 

The Company’s match is contributed on a per-pay-period basis and is based on employees’ before-tax contributions and compensation each pay period. Employees are
eligible for matching contributions after completing 180 days of service. In fiscal 2019 and 2018, we made matching contributions in the amount of $1.0 million and $1.3
million into the DPSP.

U.K. Defined Contribution Plan

In connection with the acquisition of Oclaro in December 2018, we assumed a defined contribution plan which provides retirement benefits to employees in the U.K.

Contributions under this plan from the acquisition date were $0.9 million in fiscal 2019.

Japan Defined Contribution Plan

In connection with the acquisition of Oclaro in December 2018, we assumed a defined contribution plan which provides retirement benefits to employees in Japan.
Under the defined contribution plan, contributions are provided based on grade level and totaled $0.2 million for period from the acquisition date through June 29, 2019.
Employees can elect to receive the benefit as additional salary or contribute the benefit to the plan on a tax-deferred basis.

Switzerland Defined Benefit Plan

In  connection  with  the  acquisition  of  Time-Bandwidth  during  fiscal  2014,  we  assumed  a  defined  benefit  plan  which  covers  certain  employees  in  Switzerland  (the
“Switzerland Plan”). The Switzerland Plan is open to new participants. Benefits are generally based upon an employee’s age and compensation. As of June 29, 2019, the
Switzerland  Plan  was  partially  funded.  Our  policy  for  partially  funded  plans  is  to  make  contributions  equal  to  or  greater  than  the  requirements  prescribed  by  law  or
regulation; however, at our discretion, we can elect to make additional contributions to the plan.

We account for our obligations under the Switzerland Plan in accordance with the authoritative guidance which requires us to record our obligation to the participants,
as well as the corresponding net periodic cost. We determine our obligation to the participants and our net periodic cost principally using actuarial valuations provided by
third-party actuaries. The net obligation of $5.0 million as of June 29, 2019 is recorded in our consolidated balance sheets as non-current liabilities and is reflective of the
total projected benefit obligation (“PBO”) less the fair value of plan assets.

101

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The change in the benefit obligations and plan assets of the Switzerland Plan were as follows (in millions):

Change in projected benefit obligation:

  Benefit obligation at beginning of year

     Service cost

     Interest cost

     Plan participants’ contribution

     Actuarial (gains)/losses

     Benefits paid

     Plan amendments

     Foreign exchange impact

  Benefit obligation at end of year

Change in plan assets:

  Fair value of plan assets at beginning of year

     Actual return on plan assets

     Employer contribution

     Plan participants’ contribution

     Benefits paid

     Foreign exchange impact

  Fair value of plan assets at end of year

Funded status (1)

Changes in benefit obligations and plan assets recognized in other comprehensive income (loss):

     Prior service cost

     Amortization of accumulated net actuarial gain (loss)

     Net actuarial (gain) loss

Accumulated benefit obligation

$

$

$

$

$

$

$

2019

2018

$

12.1   $

0.9  

0.1  

0.5  

1.1  

(1.0)  

(0.6)  

0.2  

13.3   $

8.6   $

(0.3)  

0.4  

0.4  

(1.0)  

0.2  

8.3   $

(5.0)   $

(0.6)   $

(0.1)  

1.9  

1.2   $

11.0

0.9

0.1

0.5

(0.3)

0.4

—

(0.5)

12.1

7.1

0.3

0.5

0.5

0.4

(0.2)

8.6

(3.5)

—

(0.2)

(0.4)

(0.6)

11.6   $

11.0

(1) As of June 29, 2019 and June 30, 2018, $5.0 million and $3.5 million was recorded in other non-current liabilities on our consolidated balance sheets to account for

the PBO under the Switzerland Plan. Refer to “Note 9. Balance Sheet Details” in the Notes to Consolidated Financial Statements.

Net periodic pension cost associated with the Switzerland Plan in fiscal 2019, 2018 and 2017 include the following components:

Service cost

Interest cost

Expected return on plan assets

Amortization of net (gain) loss

Net periodic pension cost

2019

2018

2017

$

$

0.9   $

0.1  

(0.3)  

0.1  

0.8   $

0.9   $

0.1  

(0.2)  

0.2  

1.0   $

0.6

—

(0.1)

0.2

0.7

102

 
 
 
   
 
 
   
 
   
 
 
   
 
 
   
 
   
 
 
 
   
 
 
 
Table of Contents

Assumptions

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Underlying both the calculation of the PBO and net periodic cost are actuarial valuations. These valuations use participant-specific information such as salary, age and

assumptions about interest rates, compensation increases and other factors. At a minimum, we evaluate these assumptions annually and make changes as necessary.

The discount rate reflects the estimated rate at which the pension benefits could be effectively settled. In developing the discount rate, we consider the yield available

on an appropriate AA or AAA corporate bond index, adjusted to reflect the term of the plan’s liabilities.

The expected return on assets was estimated by using the weighted average of the real expected long-term return (net of inflation) on the relevant classes of assets

based on the target asset mix and adding the chosen inflation assumption.

The following table summarizes the assumptions used to determine net periodic cost and benefit obligation for the Switzerland Plan:

Assumptions used to determine net periodic cost:

Discount rate

Expected long-term return on plan assets

Salary increase rate

Assumptions used to determine benefit obligation at end of year:

Discount rate

Salary increase rate

Fair Value Measurement of Plan Assets

Pension Benefit Plans

2019

2018

0.5%  

3.2%  

2.3%  

0.5%  

2.3%  

0.7%

2.8%

2.3%

1.0%

2.3%

The following table sets forth the plan’s assets at fair value and the percentage of assets allocations as of June 29, 2019 (in millions, except percentage data):

Assets:

     Global equity

     Fixed income

     Alternative investment

     Cash

     Other

  Total Assets

Target Allocation

Total

  Percentage of Plan Asset  

Fair value measurement as of
June 29, 2019

Quoted Prices in Active
Markets for Identical
Assets
(Level 1)

Significant Other
Observable Inputs
(Level 2)

28%   $

30%  

21%  

1%  

20%  

100%   $

2.3  

2.6  

1.3  

0.3  

1.8  

8.3  

103

28%   $

31%  

16%  

3%  

22%  

100%   $

—   $

—  

—  

0.3  

—  

0.3   $

2.3

2.6

1.3

—

1.8

8.0

 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
   
   
   
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table sets forth the plan’s assets at fair value and the percentage of assets allocations as of June 30, 2018 (in millions, except percentage data):

Assets:

     Global equity

     Fixed income

     Alternative investment

     Cash

     Other

  Total Assets

Target Allocation

Total

  Percentage of Plan Asset  

Fair value measurement as of
June 30, 2018

Quoted Prices in Active
Markets for Identical
Assets

Significant Other
Observable Inputs
(Level 2)

28%   $

30%  

18%  

1%  

23%  

  $

2.4  

2.8  

1.5  

0.2  

1.7  

8.6  

28%   $

—   $

33%  

17%  

1%  

21%  

100%   $

—  

—  

0.2  

—  

0.2   $

2.4

2.8

1.5

—

1.7

8.4

Our pension assets consist of multiple institutional funds (“pension funds”) of which the fair values are based on the quoted prices of the underlying funds. Pension
funds are classified as Level 2 assets since such funds are not directly traded in active markets. Global equity consists of several funds that invest primarily in Swiss and
foreign  equities;  fixed  income  consists  of  several  funds  that  invest  primarily  in  investment  grade  domestic  and  overseas  bonds;  Other  consists  of  several  funds  that
primarily invest in hedge fund, private equity, global real estate and infrastructure funds.

Future Benefit Payments

We estimate our expected benefit payments to defined benefit pension plan participants based on the same assumptions used to measure our PBO at year end which
includes benefits attributable to estimated future compensation increases. Based on this approach, we expect future benefit payments to be $0.6 million during the 10 year
period between fiscal 2020 and fiscal 2029 and the remaining $4.4 million of payments in fiscal years subsequent to fiscal 2029.

Japan Defined Benefit Plan

In connection with the acquisition of Oclaro in December 2018, we assumed a defined benefit plan which provides benefits to employees in Japan (the “Japan Plan”).
The Japan Plan is open to new participants. Benefits are generally based upon an employee’s individual grade level and years of service. Employees are entitled to a lump
sum benefit upon retirement or upon certain instances of termination. As of June 29, 2019, there were no Japan Plan assets.

We account for our obligations under the Japan Plan in accordance with the authoritative guidance which requires us to record our obligation to the participants, as
well as the corresponding net periodic cost. We determine our obligation to the participants and our net periodic cost principally using actuarial valuations provided by
third-party actuaries. The net obligation of $2.8 million as of June 29, 2019 is recorded in our consolidated balance sheets as non-current liabilities and is reflective of the
total PBO.

104

 
 
 
   
 
 
 
 
 
 
   
   
   
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The change in the benefit obligations of the Japan Plan were as follows (in millions):

Change in projected benefit obligation:

  Benefit obligation at beginning of year

     Assumed pension liability in connection with Oclaro acquisition

     Service cost

     Actuarial losses

     Benefits paid

     Transfer of benefit obligation in connection with sale of net assets

     Foreign exchange impact

  Benefit obligation at end of year

Changes in benefit obligations recognized in other comprehensive income (loss):

     Net actuarial loss

Accumulated benefit obligation at end of year

Net periodic pension cost associated with the Japan Plan in fiscal 2019 includes the following components:

Service cost

Interest cost

Net periodic pension cost

* Less than $0.05 million

Assumptions

2019

2019

—

7.2

0.3

0.1

(0.1)

(4.9)

0.2

2.8

0.2

2.8

0.3

*

0.3

$

$

$

$

$

$

Underlying both the calculation of the PBO and the net periodic cost are actuarial valuations. These valuations use participant-specific information such as salary, age

and assumptions about interest rates, compensation increases and other factors. At a minimum, we evaluate these assumptions annually and make changes as necessary.

The discount rate reflects the estimated rate at which the pension benefits could be effectively settled. In calculating the discount rate, we consider the yield available

on an appropriate rates of fixed income governmental bonds, adjusted to reflect the term of the plan’s liabilities.

The following table summarizes the assumptions used to determine the net pension cost and benefit obligation for the Japan Plan:

Assumptions used to determine net periodic cost:

Discount rate

Salary increase rate

Assumptions used to determine benefit obligation at end of year:

Discount rate

Salary increase rate

105

2019

0.3%

2.1%

0.1%

2.0%

 
 
 
 
 
 
 
 
 
 
 
Table of Contents

Future Benefit Payments

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

We  estimate  our  expected  benefit  payments  to  the  Japan  Plan  participants  based  on  the  same  assumptions  used  to  measure  our  PBO  at  year  end  which  includes
benefits attributable to estimated future compensation increases. Based on this approach, we expect future benefit payments to be $1.9 million during the 10 year period
between fiscal 2020 and fiscal 2029 and the remaining $0.9 million of payments in fiscal years subsequent to fiscal 2029.

Note 19. Commitments and Contingencies

Operating Leases

We  lease  certain  real  and  personal  property  from  unrelated  third  parties  under  non-cancellable  operating  leases  that  expire  at  various  dates  through  fiscal  2033.

Certain leases require us to pay property taxes, insurance and routine maintenance, and include escalation clauses.

As of June 29, 2019, the total future minimum annual lease payments under non-cancellable operating leases, net of sublease income, were as follows (in millions):

Fiscal Years

2020

2021

2022

2023

2024

Thereafter

Total minimum operating lease payments (1)

$

$

13.9

12.1

11.2

11.3

9.8

31.7

90.0

(1) As of June 29, 2019, we sublease a floor of office space in our Ottawa location that is not fully utilized. Under this sublease, we will receive approximately $2.1
million in sublease income over the next four years. In addition, as part of our sale to CIG (refer to “Note 5. Business Combination”), we sublease certain portions of the
building until fiscal 2022, which will result in $4.5 million in sublease income over the contract term. The amounts set forth in the table above are net of these sublease
income amounts.

In fiscal 2019, 2018 and 2017, rental expense relating to building and equipment was $15.8 million, $12.1 million and $10.1 million, respectively. Non-cancellable
sublease proceeds from our subleases were approximately $1.0 million, $0.7 million, and $0.7 million, respectively,  during the fiscal years 2019, 2018, and 2017. The
amounts of our rental expense for the years presented are net of these sublease income amounts.

Capital Leases

As of June 29, 2019, equipment acquired under capital lease agreements, including those assumed as part of the Oclaro acquisition, was $16.0 million. Our capital
lease assets are included in property, plant and equipment, net in our consolidated balance sheets as of June 29, 2019. Amortization expense on these capital lease assets
are  recorded  as  depreciation  expense  and  is  included  in  cost  of  sales  in  our  consolidated  statements  of  operations  for  fiscal  2019,  2018,  and  2017.  Our  capital  lease
obligations are recorded at the lesser of the estimated fair market value of the leased property or the net present value of the aggregate future minimum lease payments and
is included in other current liabilities and other non-current liabilities in our consolidated balance sheets as of June 29, 2019. Refer to “Note 9. Balance Sheet Details” for
capital lease obligation amounts in other current liabilities and other non-current liabilities. Interest on these obligations is included in interest expense in our consolidated
statements of operations.

106

 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of June 29, 2019, the future minimum annual lease payments under our capital leases were $0.8 million, which we expect to pay within the following fiscal year.

Acquisition Contingencies

In February 2017, we incurred liabilities  in the amount of $3.6 million related  to an acquisition  of a privately  held company. The amount of up to  $3.0 million is
expected to be paid within the following 12 months contingent upon meeting certain production targets. We estimated the likelihood of meeting the production targets at 90
percent and recorded $2.7 million as fair value of contingent consideration in other current liabilities on the consolidated balance sheet as of June 29, 2019.

We  also  retained  $0.9 million of  the  purchase  price  as  security  for  any  potential  liabilities  of  the  seller  under  the  representations,  warranties  and  indemnifications

included in the purchase agreement, which resulted in the cash payment of $1.0 million to the seller during fiscal 2019 (based on exchange rate at the date of transaction).

Term Loan

The estimated future interest and principal payments related to the term loan are as follows as of June 29, 2019:

Fiscal Years

2020

2021

2022

2023

2024

Thereafter

Total term loan payments

0.25% Convertible Notes due 2024

The future interest and principal payments related to the 2024 Notes are as follows as of June 29, 2019:

Fiscal Years

2020

2021

2022

2023

2024

Thereafter

Total 2024 Notes payments

Purchase Obligations

$

$

$

$

29.2

29.0

28.7

28.6

28.2

505.6

649.3

1.1

1.1

1.1

1.1

451.2

—

455.6

Purchase obligations of $216.4 million as of June 29, 2019, represent legally-binding commitments to purchase inventory and other commitments made in the normal

course of business to meet operational requirements.

Although open purchase orders are considered enforceable and legally binding, the terms generally allow the option to cancel, reschedule and adjust the requirements
based on our business needs prior to the delivery of goods or performance of services. Obligations to purchase inventory and other commitments are generally expected to
be fulfilled within one year.

We  depend  on  a  limited  number  of  contract  manufacturers,  subcontractors  and  suppliers  for  raw  materials,  packages  and  standard  components.  We  generally
purchase  these  single  or  limited  source  products  through  standard  purchase  orders  or  one-year  supply  agreements  and  have  no  significant  long-term  guaranteed  supply
agreements with such vendors. While we seek to maintain a sufficient safety stock of such products and maintain on-going communications with our suppliers to guard
against interruptions or cessation of supply, our business and results of operations could be adversely affected by a stoppage or delay of supply, substitution

107

 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

of more expensive or less reliable products, receipt of defective parts or contaminated materials, increases in the price of such supplies, or our inability to obtain reduced
pricing from our suppliers in response to competitive pressures.

Product Warranties

We provide reserves  for the estimated  costs of product warranties  at the time  revenue  is recognized.  We typically  offer a twelve month warranty for most of our
products. However, in some instances depending upon the product, product component or application of our products by the end customer, our warranties can vary and
generally  range  from  six months to  five years.  We  estimate  the  costs  of  our  warranty  obligations  on  an  annualized  basis  based  on  our  historical  experience  of  known
product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to
time, specific warranty accruals may be made if unforeseen technical problems arise with specific products. We assess the adequacy of our recorded warranty liabilities
and adjust the amounts as necessary.

The following table presents the changes in our warranty reserve during fiscal 2019 and 2018 (in millions):

Balance as of beginning of period

Warranties assumed in Oclaro acquisition (1)
Provision for warranty (2)

Utilization of reserve

Balance as of end of period

Years Ended

June 29, 2019

June 30, 2018

$

$

  $

6.6

1.8

5.9

(6.8)

7.5

  $

9.7

—

5.0

(8.1)

6.6

(1) The amount is reduced by $2.0 million measurement period adjustment recorded in other current liabilities on our consolidated balance sheet in the fourth quarter

of fiscal 2019. Refer to “Note 5. Business Combination”.

(2) In fiscal 2018, the provision for warranty does not include a settlement payment of $5.1 million received from a vendor for a quality issue.

Environmental Liabilities

Our research and development (“R&D”), manufacturing and distribution operations involve the use of hazardous substances and are regulated under international,
federal, state and local laws governing health and safety and the environment. We apply strict standards for protection of the environment and occupational health and
safety to sites inside and outside the United States, even if not subject to regulations imposed by foreign governments. We believe that our properties and operations at our
facilities comply in all material respects with applicable environmental laws and occupational health and safety laws. However, the risk of environmental liabilities cannot
be  completely  eliminated  and  there  can  be  no  assurance  that  the  application  of  environmental  and  health  and  safety  laws  will  not  require  us  to  incur  significant
expenditures. We are also regulated under a number of international, federal, state and local laws regarding recycling, product packaging and product content requirements.
The environmental, product content/disposal and recycling laws are gradually becoming more stringent and may cause us to incur significant expenditures in the future.

Legal Proceedings

We are subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving
claims against us, individually or in the aggregate, will not have a material adverse impact on our financial position, results of operations or statements of cash flows, these
matters are subject to inherent uncertainties and management’s view of these matters may change in the future. We accrue for loss contingencies when it is both probable
that we will incur the loss and when we can reasonably estimate the amount of the loss or range of loss. As of  June 29, 2019, we did not have any material claims or
proceedings that were probable or reasonably possible.

Merger Litigation

In connection with our acquisition of Oclaro, seven lawsuits were filed by purported stockholders of Oclaro challenging the proposed merger (the “Merger”). Two of
the seven suits were putative class actions filed against Oclaro, its directors, Lumentum, Prota Merger Sub, Inc. and Prota Merger, LLC: Nicholas Neinast v. Oclaro, Inc.,
et al., No. 3:18-cv-03112-VC, in the United States District Court for the Northern District of California (filed May 24, 2018) (the “Neinast Lawsuit”); and Adam Franchi v.
Oclaro,

108

 
 
 
 
 
 
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Inc., et al., No. 1:18-cv-00817-GMS, in the United States District Court for the District of Delaware (filed June 9, 2018) (the “Franchi Lawsuit). Both the Neinast Lawsuit
and the Franchi Lawsuit were voluntarily dismissed with prejudice.

The other five suits, styled as Gerald F. Wordehoff v. Oclaro, Inc., et al., No. 5:18-cv-03148-NC (the “Wordehoff Lawsuit”), Walter Ryan v. Oclaro, Inc., et al., No.
3:18-cv-03174-VC (the “Ryan Lawsuit”), Jayme Walker v. Oclaro, Inc., et al., No. 5:18-cv-03203-EJD (the “Walker Lawsuit”), Kevin Garcia v. Oclaro, Inc., et al., No.
5:18-cv-03262-VKD (the “Garcia Lawsuit”), and SaiSravan B. Karri v. Oclaro, Inc., et al., No. 3:18-cv-03435-JD (the “Karri Lawsuit” and, together with the other six
lawsuits, the “Lawsuits”), were filed in the United States District Court for the Northern District of California on May 25, 2018, May 29, 2018, May 30, 2018, May 31,
2018, and June 9, 2018, respectively. These five Lawsuits named Oclaro and its directors as defendants only and did not name Lumentum. The Wordehoff, Ryan, Walker,
and Garcia Lawsuits have been voluntarily dismissed, and the Wordehoff, Ryan, and Walker dismissals were with prejudice. The Karri Lawsuit has not yet been dismissed.
The Ryan Lawsuit was, and the Karri Lawsuit is, a putative class action.

The Lawsuits generally alleged, among other things, that Oclaro and its directors violated Section 14(a) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and Rule 14a-9 promulgated thereunder by disseminating an incomplete and misleading Form S-4, including proxy statement/prospectus. The Lawsuits
further alleged that Oclaro’s directors violated Section 20(a) of the Exchange Act by failing to exercise proper control over the person(s) who violated Section 14(a) of the
Exchange Act.

The  remaining  Lawsuit  (the  Karri  Lawsuit)  currently  purports  to  seek, among  other  things,  damages  to  be  awarded  to  the  plaintiff  and  any  class  if  the  Merger  is

consummated, and litigation costs, including attorneys’ fees. The defendants intend to defend the Karri Lawsuit vigorously.

Indemnifications

In the normal course of business, we enter into agreements that contain a variety of representations and warranties and provide for general indemnification. Exposure
under these agreements  is unknown because  claims  may be made against us in the future  and we may record charges in the future as a result of these indemnification
obligations. As of June 29, 2019, we did not have any material indemnification claims that were probable or reasonably possible.

Audit Proceedings

We are  under audit by various  domestic  and foreign  tax authorities  with regards  to income tax  and indirect  tax matters.  In some, although not all cases,  we have
reserved  for  potential  adjustments  to  our  provision  for  income  taxes  and  accrual  of  indirect  taxes  that  may  result  from  examinations  by  these  tax  authorities  or  final
outcomes in judicial proceedings, and we believe that the final outcome of these examinations, agreements or judicial proceedings will not have a material effect on our
results of operations. If events occur which indicate payment of these amounts is unnecessary, the reversal of the liabilities would result in the recognition of benefits in the
period we determine the liabilities are no longer necessary. If our estimates of the federal, state, and foreign income tax liabilities and indirect tax liabilities are less than
the ultimate assessment, it could result in a further charge to expense.

In connection with our acquisition  of Oclaro, we recorded  $1.1 million in Malaysia Goods and Services Tax (“GST”) refund claims  within prepaid expenses and
other current assets in our consolidated balance sheet at June 29, 2019. The refund claim represents  an initial claim of $2.5 million of GST, net  of reserves,  that  were
previously denied by the Malaysian tax authorities in 2016. We are currently appealing the denial of these claims, and believe that additional options may be available to us
if  we do not  obtain  a  favorable  resolution.  Although  we  have  taken  action  to  minimize  the  impact  of  the  GST with  respect  to  our  ongoing  operations,  we believe  it  is
reasonably possible that, ultimately, we may not be able to recover some of these GST amounts.

Note 20. Operating Segments and Geographic Information

Our chief executive officer is our CODM. The CODM allocates resources to the segments based on their business prospects, competitive factors, net revenue and

gross margin. We do not track all of our property, plant and equipment by operating segments. The geographic identification of these assets is set forth below.

We are an industry leading provider of optical and photonic products defined by revenue and market share addressing a range of end-market applications including
optical  communications  and  commercial  lasers.  We  have  two operating  segments,  Optical  Communications,  which  we  refer  to  as  OpComms,  and  Commercial  Lasers,
which we refer to as Lasers. Our OpComms products address the following markets: telecommunications (“Telecom”), data communications (“Datacom”), and consumer
and industrial (“Consumer and Industrial”), and include product lines from the acquisition of Oclaro. The two operating segments were primarily determined based on how
the CODM views and evaluates our operations. Operating results are regularly reviewed by

109

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

the CODM to make decisions about resources to be allocated to the segments and to assess their performance. Other factors, including market separation and customer
specific applications, go-to-market channels, products and manufacturing, are considered in determining the formation of these operating segments.

OpComms

Our OpComms products address the following markets: Telecom, Datacom and Consumer and Industrial.

Our OpComms products  include  a wide range  of components,  modules  and  subsystems  to support  customers  including  carrier  networks  of access  (local),  metro
(intracity), long-haul (city-to-city and worldwide) and submarine (undersea) applications. Additionally, our products address enterprise, cloud, and data center applications,
including storage-access networks (“SANs”), local-area networks (“LANs”) and wide-area networks (“WANs”). These products enable the transmission and transport of
video, audio and text data over high-capacity fiber-optic cables. We maintain leading positions in these fast growing OpComms markets through our extensive product
portfolio,  including  reconfigurable  optical  add/drop  multiplexers  (“ROADMs”),  coherent  DWDM  pluggable  transceivers,  and  tunable  small  form-factor  pluggable
transceivers. We also sell laser chips for use in the manufacture of high-speed Datacom transceivers.

In  the  Consumer  and  Industrial  market,  our  OpComms  products  include  laser  light  sources,  which  are  integrated  into  3D  sensing  platforms  being  used  in
applications for mobile devices, gaming, computers, and other consumer electronics devices. New emerging applications include virtual and augmented reality, as well as
automotive and industrial segments. Our products include vertical cavity surface emitting lasers (“VCSELs”) and edge emitting lasers which are used in 3D sensing depth
imaging  systems.  These  systems  simplify  the  way  people  interact  with  technology  by  enabling  the  use  of  natural  user  interfaces.  Systems  are  used  for  biometric
identification,  surveillance,  and process  efficiency,  among numerous  other  application  spaces.  Emerging  applications  for this technology  include  various  mobile  device
applications,  autonomous  vehicles,  self-navigating  robotics  and  drones  in  industrial  applications  and  3D  capture  of  objects  coupled  with  3D  printing.  In  addition,  our
industrial diode lasers are used primarily as pump sources for pulsed and kilowatt class fiber lasers.

Lasers

Our Lasers products serve our customers in markets and applications such as sheet metal processing, general manufacturing, biotechnology, graphics and imaging,

remote sensing, and precision machining such as drilling in printed circuit boards, wafer singulation, glass cutting and solar cell scribing.

Our Lasers products are used in a variety of OEM applications including diode-pumped solid-state, fiber, diode, direct-diode and gas lasers such as argon-ion and
helium-neon  lasers.  Fiber  lasers  provide  kW-class  output  powers  combined  with  excellent  beam  quality  and  are  used  in  sheet  metal  processing  and  metal  welding
applications. Diode-pumped solid-state lasers provide excellent beam quality, low noise and exceptional reliability and are used in biotechnology, graphics and imaging,
remote sensing, materials processing and precision machining applications. Diode and direct-diode lasers address a wide variety of applications, including laser pumping,
thermal exposure, illumination,  ophthalmology, image recording, printing, plastic welding and selective  soldering. Gas lasers such as argon-ion and helium-neon lasers
provide a stable, low-cost and reliable solution over a wide range of operating conditions, making them well suited for complex, high-resolution OEM applications such as
flow cytometry, DNA sequencing, graphics and imaging and semiconductor inspection.

We also provide high-powered and ultrafast lasers for the industrial and scientific markets. Manufacturers use high-power, ultrafast lasers to create micro parts for
consumer electronics and to process semiconductor, LED, and other types of chips. Use of ultrafast lasers for micromachining applications is being driven primarily by the
increasing use of consumer electronics and connected devices globally.

We do not allocate research and development, sales and marketing, or general and administrative expenses to our segments because management does not include
the  information  in  its  measurement  of  the  performance  of  the  operating  segments.  In  addition,  we  do  not  allocate  amortization  and  impairment  of  acquisition-related
intangible assets, stock-based compensation and certain other charges impacting the gross margin of each segment because management does not include this information
in its measurement of the performance of the operating segments.

110

Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Information on reportable segments utilized by our CODM is as follows (in millions):

Net revenue:

OpComms

Lasers

Net revenue

Gross profit:

OpComms

Lasers

Total segment gross profit

Unallocated corporate items:

Stock-based compensation

Amortization of intangibles

Amortization of inventory step up

Inventory write down due to product lines exit

Integration related costs
Other charges (1)

Gross profit

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

$

$

$

$

$

$

1,370.2

195.1

1,565.3

534.1

84.4

618.5

(15.1)

(46.6)

(54.6)

(20.8)

(6.6)

(48.9)

$

425.9

$

$

$

$

1,059.2

188.5

1,247.7

402.3

82.8

485.1

(12.6)

(3.2)

—

—

—

(37.2)

432.1

$

857.8

143.8

1,001.6

287.3

59.9

347.2

(7.5)

(6.5)

—

—

—

(15.1)

318.1

(1)  The  increase  in  “other  charges”  of  unallocated  corporate  items  for  fiscal  2019  compared  to  fiscal  2018,  primarily  relates  to  set-up  costs  of  our  facility  in

Thailand, including costs of transferring the manufacturing of product lines to Thailand of $45.8 million in our fiscal 2019 compared to $27.0 million in fiscal 2018.

The increase in “other charges” of unallocated corporate items for fiscal 2018 compared to fiscal 2017, primarily relates to set-up costs of our facility in Thailand,

including costs of transferring the manufacturing of product lines to Thailand of $27.0 million in our fiscal 2018 compared to $1.8 million in fiscal 2017.

The table below discloses our total net revenue attributable to each of our two reportable segments. In addition, it discloses the percentage of our total net revenue
attributable to our product offerings which serve the Telecom, Datacom, and Consumer and Industrial markets which accounted for 10% or more of our total net revenue
during the periods presented (in millions, except percentage data):

OpComms:

Telecom

Datacom

Consumer and Industrial

Total OpComms

Lasers

Total Revenue

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

$

$

$

786.5

166.4

417.3

1,370.2

195.1

50.2%   $

10.6%  

26.7%  

87.5%   $

12.5%  

476.3

150.4

432.5

1,059.2

188.5

38.1%   $

12.1%  

34.7%  

84.9%   $

15.1%  

610.7

201.3

45.8

857.8

143.8

1,565.3  

  $

1,247.7  

  $

1,001.6  

61.0%

20.0%

4.6%

85.6%

14.4%

We operate in three geographic regions: Americas, Asia-Pacific, and EMEA (Europe, Middle East, and Africa). Net revenue is assigned to the geographic region
and country where our product is initially shipped. For example, certain customers may request shipment of our product to a contract manufacturer in one country, which
may differ from the location of their end customers. The following table presents net revenue by the three geographic regions we operate in and net revenue from countries
that represented 10% or more of our total net revenue (in millions, except percentage data):

111

 
 
 
 
 
 
   
 
   
 
Table of Contents

Net revenue:

Americas:

United States

Mexico

Other Americas

Total Americas

Asia-Pacific:

Hong Kong

Japan

South Korea

Other Asia-Pacific

Total Asia-Pacific

EMEA

Total net revenue

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

$

$

$

$

$

$

100.9  

214.9  

4.3  

320.1  

387.9  

176.0  

162.4  

356.1  

6.4%   $

13.7

0.3

115.1  

145.8  

7.0  

9.2%   $

11.7

0.6

147.9  

185.1  

9.2  

20.4%   $

267.9  

21.5%   $

342.2  

14.8%

18.5

0.9

34.2%

24.8%   $

11.2

10.4

22.7

183.0  

194.7  

146.1  

354.2  

14.7%   $

226.7  

22.6%

15.6

11.7

28.3

99.2  

4.9  

220.5  

9.9

0.5

22.0

1,082.4  

69.1%   $

878.0  

70.3%   $

551.3  

55.0%

162.8  

10.5%   $

101.8  

8.2%   $

108.1  

10.8%

1,565.3  

  $

1,247.7  

  $

1,001.6  

During fiscal 2019, 2018 and 2017, net revenue from customers outside the United States, based on customer shipping location, represented 93.6%, 90.8% and 85.2%
of net revenue, respectively. Our net revenue from Mexico increased in fiscal 2019 compared to 2018 due to increased demand for our ROADM products from one of our
large  customers  who  manufactures  in  Mexico,  while  net  revenue  from  Hong  Kong  grew  due  to  a  change  in  shipment  destination  of  a  large  portion  of  our  3D  sensing
products for mobile devices.

During the years ended June 29, 2019, June 30, 2018, and July 1, 2017, net revenue generated from a single customer which represented 10% or greater of total net

revenue is summarized as follows:

Customer A

Customer B

Customer C

Customer D

*Represents less than 10% of total net revenue

June 29, 2019

June 30, 2018

July 1, 2017

Years Ended

21.0%  

15.2%  

13.7%  

*

30.0%  

11.0%  

11.0%  

*

*

16.7%

18.5%

12.4%

Our accounts receivable was concentrated with three customers as of June 29, 2019, who represented 17%, 17% and 10% of gross accounts receivable, respectively,

compared with two customers as of June 30, 2018, who represented 11% and 10% of gross accounts receivable, respectively.

112

 
 
 
 
 
   
   
   
   
   
 
   
   
   
   
   
 
 
 
 
 
   
   
   
   
   
 
   
   
   
   
   
 
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
 
 
   
   
Table of Contents

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Long-lived assets, namely net property, plant and equipment, net, were identified based on the physical location of the assets in the corresponding geographic areas

as of the periods indicated (in millions):

Property, Plant and Equipment, net

Thailand

United States

China

Japan

Other countries

Total long-lived assets

June 29, 2019

June 30, 2018

$

$

157.1   $

156.2  

33.5  

28.3  

58.2  

433.3   $

107.4

97.6

70.0

0.5

31.4

306.9

We purchase a substantial portion of our inventory from contract manufacturers and vendors located primarily in Taiwan, Thailand, and Malaysia. During fiscal

2019, 2018 and 2017, net inventory purchased from a single contract manufacturer which represented 10% or greater of total net purchases is summarized as follows:

Vendor A

Vendor B

Vendor C

Vendor D

*Represents less than 10% of total net purchases

Note 21. Quarterly Financial Information (Unaudited)

June 29, 2019

Years Ended

June 30, 2018

July 1, 2017

47%  

17%  

11%  

*

44%  

20%  

21%  

*

50%

27%

*

14%

The following table presents our quarterly consolidated statements of operations for fiscal 2019 and 2018 (in millions, except per share data):

June 29, 2019

  March 30, 2019  

December 29,
2018

September 29,
2018

June 30, 2018

  March 31, 2018  

December 30,
2017

September 30,
2017

Net revenue

Cost of sales

$

404.6   $

304.6  

432.9   $

316.5  

373.7   $

244.5  

354.1   $

227.3  

301.1   $

204.8  

298.8   $

201.0  

404.6   $

232.7  

Amortization of
acquired intangibles

Gross profit

Operating expenses:

    Research and
development

    Selling, general
and administrative

    Restructuring and
related charges

    Impairment
charges

Total operating
expenses

13.2  

86.8  

28.1  

88.3  

4.4  

124.8  

0.8  

126.0  

0.8  

95.5  

0.8  

97.0  

0.8  

171.1  

49.5  

57.7  

42.8  

34.6  

38.5  

38.2  

43.8  

49.4  

55.2  

62.7  

33.0  

32.7  

33.2  

35.7  

1.7  

—  

21.1  

30.7  

7.8  

—  

1.3  

—  

3.4  

—  

0.1  

—  

0.8  

—  

100.6  

164.7  

113.3  

68.9  

74.6  

71.5  

80.3  

65.8

113

243.2

173.9

0.8

68.5

36.3

26.6

2.9

—

 
 
   
 
 
 
 
 
 
 
   
   
 
 
 
 
   
   
   
   
   
   
   
2.7

4.2

(3.4)

3.5

(3.6)

7.1

Table of Contents

Income/(loss) from
operations

Unrealized gain
(loss) on derivative
liability

Interest and other
income (expense),
net

Income/(loss) before
income taxes

Provision for (benefit
from) income taxes

LUMENTUM HOLDINGS INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(13.8)  

(76.4)  

11.5  

57.1  

20.9  

25.5  

90.8  

—  

—  

10.9  

(2.1)  

7.8  

(20.7)  

7.9  

(7.3)  

(6.1)  

(4.7)  

(2.4)  

(1.0)  

(2.1)  

(3.2)  

(21.1)  

(82.5)  

17.7  

52.6  

27.7  

2.7  

95.5  

Net income/(loss)

$

(25.8)   $

(74.3)   $

4.7  

(8.2)  

1.4  

16.3   $

5.2  

47.4   $

(5.8)  

33.5   $

—  

2.7   $

(109.3)  

204.8   $

Net income/(loss)
attributable to
common
stockholders - Basic $

(25.8)   $

(74.3)   $

16.1   $

46.1  

32.5  

2.4  

199.8  

6.7

Net income/(loss)
attributable to
common
stockholders -
Diluted

Net income/(loss) per
share attributable to
common
stockholders:

$

(25.8)   $

(74.3)   $

5.4   $

46.1  

25.7  

2.4  

196.9  

2.9

   Basic

   Diluted

$

$

(0.34)   $

(0.34)   $

(0.98)   $

(0.98)   $

0.24   $

0.08   $

0.73   $

0.72   $

0.52   $

0.40   $

0.04   $

0.04   $

3.21   $

3.05   $

0.11

0.04

Shares used to
compute net
income/(loss) per
share attributable to
common
stockholders:

   Basic

   Diluted

76.5  

76.5  

76.2  

76.2  

66.8  

67.8  

63.1  

63.9  

62.7  

65.0  

62.4  

63.3  

62.2  

64.6  

61.7

64.5

114

 
 
   
   
   
   
   
   
   
 
 
   
   
   
   
   
   
   
 
   
   
   
   
   
   
   
 
   
   
   
   
   
   
   
Table of Contents

ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES 

(a) Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Management, with the participation of our chief
executive officer and our chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as of June 29, 2019. The term “disclosure controls
and  procedures,”  as  defined  in  Rules  13a-15  and  15d-15  under  the  Exchange  Act,  means  controls  and  other  procedures  of  a  company  that  are  designed  to  ensure  that
information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within
the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that
information  required  to  be  disclosed  by  a  company  in  the  reports  that  it  files  or  submits  under  the  Exchange  Act  is  accumulated  and  communicated  to  the  company’s
management,  including  its  principal  executive  and  principal  financial  officers,  as  appropriate  to  allow  timely  decisions  regarding  required  disclosure.  Management
recognizes  that  any  controls  and  procedures,  no  matter  how  well  designed  and  operated,  can  provide  only  reasonable  assurance  of  achieving  their  objectives,  and
management  necessarily  applies  its  judgment  in  evaluating  the  cost-benefit  relationship  of  possible  controls  and  procedures.  Based  on  the  evaluation  of  our  disclosure
controls and procedures as of June 29, 2019, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at a
reasonable assurance level.

(b) Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange
Act). Management conducted an assessment of the effectiveness of our internal control over financial reporting based on the criteria set forth in Internal Control-Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on the assessment, management has concluded
that its internal control over financial reporting was effective as of June 29, 2019 to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements in accordance with U.S. GAAP.

On December 10, 2018, we acquired Oclaro (see “Note 5. Business Combination” to the accompanying consolidated financial statements for additional information).
Management excluded Oclaro from its assessment of internal control over financial reporting as of June 29, 2019. Total assets and revenues of Oclaro excluded from our
assessment of internal control over financial reporting, were 24% as of June 29, 2019, and 16% for the year ended June 29, 2019, respectively. We are in the process of
integrating the acquired business into our existing operations and evaluating the internal controls over financial reporting of the acquired business.

Deloitte & Touche LLP, the independent registered public accounting firm that audited the consolidated financial statements included in this Form 10-K, has issued a

report, included herein, on the effectiveness of the Company’s internal control over financial reporting as of June 29, 2019.

(c) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) and 15d-15(f), identified in connection with the
evaluation required by Exchange Act Rules 13a-15(d) or 15d-15(d) that occurred during our most recently completed fiscal quarter that have materially affected, or are
reasonably likely to materially affect, our internal control over financial reporting.

(d) Inherent Limitations on Effectiveness of Controls

Our management, including the CEO and CFO, recognizes that our disclosure controls and procedures or our internal control over financial reporting cannot prevent
or detect all possible instances of errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance
that the control system's objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be
considered relative to their costs.

115

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors of Lumentum Holdings Inc.

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Lumentum Holdings Inc.  and subsidiaries (the “Company”) as of June 29, 2019, based on criteria
established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our
opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of June 29, 2019, based on criteria established in Internal
Control - Integrated Framework (2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial
statements as of and for the year ended June 29, 2019, of the Company and our report dated August 27, 2019, expressed an unqualified opinion on those financial
statements.

As described in Management’s Report on Internal Control Over Financial Reporting, management excluded from its assessment the internal control over financial
reporting at Oclaro, Inc. (Oclaro). Oclaro was acquired on December 10, 2018 and its financial statements constitute 24% and 16% of consolidated total assets and
revenues, respectively, as of and for the year ended June 29, 2019. Accordingly, our audit did not include the internal control over financial reporting at Oclaro.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control
over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on
the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent
with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and
the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about
whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over
financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed
risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial
reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of
management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition
of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to
future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or
procedures may deteriorate.

/s/ DELOITTE & TOUCHE LLP

San Jose, California   
August 27, 2019  

116

 
Table of Contents

ITEM 9B.    OTHER INFORMATION

None.

117

Table of Contents

The SEC allows us to include information required in this report by referring to other documents or reports we have already filed or will soon be filing. This is called
“incorporation  by  reference.”  We  intend  to  file  our  definitive  proxy  statement  for  our  2019  annual  meeting  of  stockholders  (the  “Proxy  Statement”)  pursuant  to
Regulation 14A not later than 120 days after the end of the fiscal year covered by this report, and certain information to be contained therein is incorporated in this report
by reference.

PART III

ITEM 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 

The information required for this Item is set forth in the Proxy Statement and incorporated herein by reference.

ITEM 11.    EXECUTIVE COMPENSATION

The information required for this Item is set forth in the Proxy Statement and incorporated herein by reference.

ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required for this Item is set forth in the Proxy Statement and incorporated herein by reference.

ITEM 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required for this Item is set forth in the Proxy Statement and incorporated herein by reference.

ITEM 14.    PRINCIPAL ACCOUNTING FEES AND SERVICES

The information required for this Item is set forth in the Proxy Statement and incorporated herein by reference.

118

Table of Contents

ITEM 15.    EXHIBITS, FINANCIAL STATEMENTS SCHEDULES

1. Financial Statements

PART IV

The financial statements filed as part of this report are listed in the “Index to Financial Statements” under Part II, Item 8 of this report.

Report of Independent Registered Public Accounting Firm

Consolidated Statements of Operations—Years Ended June 29, 2019, June 30, 2018, and July 1, 2017

Consolidated Statements of Comprehensive Income (Loss)—Years Ended June 29, 2019, June 30, 2018, and July 1, 2017

Consolidated Balance Sheets—June 29, 2019 and June 30, 2018

Consolidated Statements of Cash Flows—Years Ended June 29, 2019, June 30, 2018, and July 1, 2017

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity—Years Ended June 29, 2019, June 30, 2018, and July 1,
2017

Notes to Consolidated Financial Statements

2. Financial Statement Schedules

Page

54

55

56

57

58

60

62

The following additional financial statement schedules should be considered in conjunction with our consolidated financial statements. All other financial statement
schedules have been omitted because the required information is not present in amounts sufficient to require submission of the schedule, not applicable, or because the
required information is included in the Consolidated Financial Statements or Notes thereto.

119

 
Table of Contents

Accounts receivable allowance:

Fiscal year ended June 29, 2019

Fiscal year ended June 30, 2018

Fiscal year ended July 1, 2017

Description

Deferred tax valuation allowance:

Fiscal year ended June 29, 2019

Fiscal year ended June 30, 2018

Fiscal year ended July 1, 2017

LUMENTUM HOLDINGS INC.

FINANCIAL STATEMENT SCHEDULES

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

Balance at 
Beginning 
of Period

Assumed in Oclaro
Acquisition

Increase (decrease) to
Income Statement

Write 
Offs and Other
Adjustments

Balance 
at End of 
Period

(in millions)

$

$

$

2.6   $

1.8   $

0.9   $

3.3   $

—   $

—   $

(0.2)   $

0.9   $

1.0   $

(1.2)

(0.1)

(0.1)

  $

  $

  $

4.5

2.6

1.8

Balance at Beginning of
Period

Additions Charged to
Expenses or Other
Accounts*

Deductions Credited to
Expenses or Other
Accounts**

  Balance at End of Period

(in millions)

  $

  $

  $

99.4   $

296.4   $

321.4   $

153.9   $

234.1   $

16.7   $

(63.0)   $

(431.1)   $

(41.7)   $

190.3

99.4

296.4

*    Additions include current year additions charged to expenses and current year build due to increases in net deferred tax assets, return to provision true-ups, other

adjustments to deferred taxes.

**    Deductions include current year releases credited to expenses and current year reductions due to decreases in net deferred tax assets, return to provision true-ups,

other adjustments to deferred taxes.

3. Exhibits

The following exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the Securities and Exchange Commission.

  Incorporated by Reference    

Filed

Exhibit No.

Exhibit Description

2.1

2.1

2.2

3.1

3.2

4.1

4.2

4.3

4.4

  Contribution Agreement

Agreement and Plan of Merger, dated as of March 11, 2018, by and
among Lumentum Holdings Inc., Oclaro, Inc., Prota Merger Sub, Inc.
and Prota Merger, LLC

  Separation and Distribution Agreement

  Amended and Restated Certificate of Incorporation

  Amended and Restated Bylaws

  Stockholder’s and Registration Rights Agreement

Indenture, dated March 8, 2017, between Lumentum Holdings Inc. and
U.S. Bank National Association

Form of 0.250% Convertible Senior Notes due 2024 (included in Exhibit
4.2)

  Description of Capital Stock

Form

8-K

8-K

8-K

8-K

8-K

8-K

8-K

8-K

  Exhibit

Filing Date

  Herewith

2.1

2.1

2.2

3.1

3.2

4.1

4.1

4.2

8/6/2015

3/12/2018

8/6/2015

8/6/2015

8/6/2015

8/6/2015

3/9/2017

3/9/2017

X

120

 
 
 
 
 
 
 
   
   
   
   
 
 
 
 
 
   
   
   
   
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
 
 
 
 
 
   
 
 
 
 
   
 
 
 
 
   
   
   
   
 
Table of Contents

10.1

10.2*

10.3

10.4

10.5

10.6*

10.7

10.8*

10.9*

10.10

10.11

10.12*

10.13

10.14*

10.15

21.1

23.1

31.1

31.2

32.1†

32.2†

  Tax Matters Agreement

  Employee Matters Agreement

  Intellectual Property Matters Agreement

  2015 Equity Incentive Plan as amended

  2015 Employee Stock Purchase Plan

  Executive Officer Performance-Based Incentive Plan

  Change in Control and Severance Benefits Plan, effective May 8, 2018

  Employment Agreement for Alan Lowe

  Form of Indemnification Agreement

Purchase Agreement, dated as of March 2, 2017, between Lumentum
Holdings Inc. and Goldman Sachs & Co., as representative of the Initial
Purchasers listed in Schedule I thereto.

Commitment Letter, dated as of March 11, 2018, by and among
Lumentum Holdings Inc., Deutsche Bank Securities Inc. and Deutsche
Bank AG New York.

Separation Agreement and General Release between Lumentum
Operations LLC and Aaron Tachibana dated July 31, 2018

Credit and Guaranty Agreement, dated as of December 10, 2018, by and
among Lumentum Holdings Inc. and Deutsche Bank AG New York
Branch

Offer Letter, by and between the Registrant and Wajid Ali, dated as of
January 11, 2019

Real Estate Purchase and Sale Agreement between MNCVAD-
Graymark Ridder Park LLC and Lumentum Operations LLC, dated May
7, 2019

  Subsidiaries of Lumentum Holdings Inc.

Consent of Independent Registered Public Accounting Firm (Deloitte &
Touche LLP)

Certification of the Chief Executive Officer pursuant to Securities
Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of the Chief Financial Officer pursuant to Securities
Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of the Chief Executive Officer pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

Certification of the Chief Financial Officer pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

121

8-K

8-K

8-K

8-K

S-8

8-K

10-K

8-K

10-K

10.1

10.2

10.3

10.2

99.2

10.3

10.6

10.4

10.8

8/6/2015

8/6/2015

8/6/2015

11/9/2016

7/29/2015

11/9/2016

8/28/2018

8/6/2015

9/25/2015

8-K

10.1

3/9/2017

8-K

10-K

8-K

10-Q

10.1

3/12/2018

10.11

8/28/2018

10.1

10.1

12/10/2018

5/7/2019

X

X

X

X

X

X

X

 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
 
   
 
 
 
 
   
 
 
 
 
   
 
 
 
 
   
 
 
 
 
   
 
   
   
   
 
   
   
   
 
 
   
   
   
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents

The following financial information from Lumentum Holdings Inc.’s
Annual Report on Form 10-K for the fiscal year ended June 29, 2019
formatted in Inline XBRL (eXtensible Business Reporting Language):
(i) Consolidated Statements of Operations for the fiscal years ended June
29, 2019, June 30, 2018 and July 1, 2017; (ii) Consolidated Statements
of Comprehensive Income (Loss) for the fiscal years ended June 29,
2019, June 30, 2018 and July 1, 2017; (iii) Consolidated Balance Sheets
as of June 29, 2019 and June 30, 2018; (iv) Consolidated Statements of
Cash Flows for the fiscal years ended June 29, 2019, June 30, 2018 and
July 1, 2017; (v) Consolidated Statements of Redeemable Convertible
Preferred Stock and Stockholders’ Equity for the fiscal years ended June
29, 2019, June 30, 2018 and July 1, 2017; and (vi) Notes to the
Consolidated Financial

The cover page from Lumentum Holdings Inc.’s Annual Report on Form
10-K for the fiscal year ended June 29, 2019, formatted in Inline XBRL
(included as Exhibit 101).

101

104

X

X

* Indicates management contract or compensatory plan or arrangement.

†  The  certifications  furnished  in  Exhibits  32.1  and  32.2  that  accompany  this  Annual  Report  on  Form  10-K,  are  not  deemed  filed  with  the  Securities  and  Exchange
Commission and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of
1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing.

122

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents

ITEM 16.    FORM 10-K SUMMARY.

None.

123

Table of Contents

SIGNATURES

 Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report on Form 10-K to be

signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 27, 2019

LUMENTUM HOLDINGS INC.

By: /s/ Wajid Ali

By: Wajid Ali

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Wajid Ali and Judy Hamel, and
each of them individually, as his or her attorney-in-fact, each with full power of substitution, for him or her in any and all capacities to sign any and all amendments to this
Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission,
hereby ratifying and confirming all that said attorney-in-fact, or his or her substitute, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of

the Registrant and in the capacities and on the dates indicated.

124

 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents

/s/ ALAN LOWE

Alan Lowe

/s/ WAJID ALI

Wajid Ali

/s/ MATTHEW SEPE

Matthew Sepe

/s/ HAROLD COVERT

Harold Covert

/s/ JULIE JOHNSON

Julie Johnson

/s/ PENELOPE HERSCHER

Penelope Herscher

/s/ BRIAN LILLIE

Brian Lillie

/s/ SAMUEL THOMAS

Samuel Thomas

/s/ IAN SMALL

Ian Small

 Signature

Title

Date

President, Chief Executive Officer and Director (principal
executive officer)

  August 27, 2019

Executive Vice President, Chief Financial Officer (principal
financial officer)

  August 27, 2019

  Chief Accounting Officer (principal accounting officer)

  August 27, 2019

  Director

  Director

  Director

  Director

  Director

  Director

125

  August 27, 2019

  August 27, 2019

  August 27, 2019

  August 27, 2019

  August 27, 2019

  August 27, 2019

 
 
 
   
   
 
   
   
 
   
   
 
   
   
 
   
   
   
   
 
   
   
   
   
 
   
   
   
   
 
   
   
   
   
 
   
   
   
   
 
   
   
   
   
 
   
   
   
   
DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

The following description  of the  capital  stock of Lumentum  Holdings Inc.  (“us”, “our”,  “we”, or the  “Company”) is a summary. This summary  is not complete  and is
subject to and qualified in its entirety by reference to the complete text of our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, each
previously filed with the Securities and Exchange Commission and incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.4 is
a  part,  as  well  as  to  the  relevant  provisions  of  the  general  corporation  law  of  the  state  of  Delaware  (the  “DGCL”).  We  encourage  you  to  read  our  certificate  of
incorporation, bylaws and the applicable provisions of the DGCL carefully.

Exhibit 4.4 

General

Our  authorized  capital  stock  consists  of  990,000,000  shares  of  common  stock,  par  value  $0.001  per  share,  and  10,000,000  shares  of  preferred  stock,  par  value
$0.001 per share, all of which shares of preferred stock are undesignated. Our board of directors may establish the rights and preferences of the preferred stock from time
to time.

Common Stock

Each holder of our common stock is entitled to one vote for each share on all matters to be voted upon by the common stockholders, and there are no cumulative
voting rights. Subject to any preferential rights of any outstanding preferred stock, holders of our common stock are entitled to receive ratably the dividends, if any, as may
be declared from time to time by our board of directors out of funds legally available for that purpose. If there is a liquidation, dissolution or winding up of the Company,
holders  of  our  common  stock  are  entitled  to  ratable  distribution  of  its  assets  remaining  after  the  payment  in  full  of  liabilities  and  any  preferential  rights  of  any  then-
outstanding preferred stock.

Holders of our common stock have no preemptive or conversion rights or other subscription rights, and there are no redemption or sinking fund provisions applicable
to the common stock. All outstanding shares of our common stock are fully paid and non-assessable. The rights, preferences and privileges of the holders of our common
stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future.

Preferred Stock

Under the terms of our amended and restated certificate of incorporation, our board of directors are authorized, subject to limitations prescribed by the DGCL and by
our amended and restated certificate of incorporation, to issue up to 10,000,000 shares of preferred stock in one or more series without further action by the holders of its
common stock. Our board of directors has the discretion, subject to limitations prescribed by the DGCL and by our amended and restated certificate of incorporation, to
determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences,
of each series of preferred stock.

Anti-Takeover Provisions

Charter and Bylaw Provisions

The provisions of Delaware law, our amended and restated certificate of incorporation and amended and restated bylaws include a number of provisions that may
have the effect of delaying, deferring or discouraging another person from acquiring control of our company and discouraging takeover bids. These provisions may also
have  the  effect  of  encouraging  persons  considering  unsolicited  tender  offers  or  other  unilateral  takeover  proposals  to  negotiate  with  our  board  of  directors  rather  than
pursue non-negotiated takeover attempts. These provisions include the items described below.

Board Vacancies

Our amended and restated bylaws provide that any vacancy on our board of directors, however occurring, including a vacancy resulting from an increase in the size

of our board of directors, may only be filled by the affirmative vote of a majority of our directors then in office even if less than a quorum.

No Cumulative Voting

The  DGCL  provides  that  stockholders  are  not  entitled  to  the  right  to  cumulate  votes  in  the  election  of  directors  unless  our  amended  and  restated  certificate  of
incorporation provides otherwise. Our amended and restated certificate of incorporation and our amended and restated bylaws provide that there shall be no cumulative
voting.

No Written Consent of Stockholders

Our amended and restated  certificate  of incorporation  provides  that  all stockholder  actions  are  required  to be taken by a vote of the  stockholders  at an annual  or

special meeting, and that stockholders may not take any action by written consent in lieu of a meeting.

Meetings of Stockholders

Our amended and restated bylaws provide that a majority of the members of our board of directors then in office, the chairman of the board of directors or the chief
executive  officer  may  call  special  meetings  of  stockholders  and  only  those  matters  set  forth  in  the  notice  of  the  special  meeting  may  be  considered  or  acted  upon  at  a
special meeting of stockholders. Our amended and restated bylaws limit the business that may be conducted at an annual meeting of stockholders to those matters properly
brought before the meeting.

Advance Notice Requirements

Our amended and restated bylaws establish advance notice procedures for stockholders seeking to bring business before an annual meeting of stockholders. These
procedures provide that notice of stockholder proposals must be timely given in writing to our corporate secretary prior to the meeting at which the action is to be taken.
Generally, to be timely, notice must be received at our principal executive offices not less than 60 days prior to the first anniversary date of the annual meeting for the
preceding year. The notice must contain certain information specified in the amended and restated bylaws.

Blank Check Preferred Stock

Our amended and restated certificate of incorporation provides for authorized shares of preferred stock. The existence of authorized but unissued shares of preferred
stock may enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest, or
otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of us
or  our  stockholders,  our  board  of  directors  could  cause  shares  of  preferred  stock  to  be  issued  without  stockholder  approval  in  one  or  more  private  offerings  or  other
transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our amended and restated
certificate  of  incorporation  grants  our  board  of  directors  broad  power  to  establish  the  rights  and  preferences  of  authorized  and  unissued  shares  of  preferred  stock.  The
issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may
also adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of us.

Delaware General Corporation Law

We are subject to the provisions of Section 203 of the DGCL. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a “business
combination”  with  an  “interested  stockholder”  for  a  three-year  period  following  the  time  that  this  stockholder  becomes  an  interested  stockholder,  unless  the  business
combination is approved in a prescribed manner. A “business combination” includes, among other things, a merger, asset or stock sale, or other transaction resulting in a
financial benefit to the interested stockholder. An “interested stockholder” is a person or entity who, together with affiliates and associates, owns, or did own within three
years prior to the determination  of interested  stockholder  status, 15% or more of the corporation’s  voting stock. Under Section 203, a business combination  between a
corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:

before the stockholder became interested, our board of directors approved either the business combination or the transaction which resulted in the
stockholder becoming an interested stockholder;

upon consummation of the transaction  which resulted in the stockholder becoming an interested  stockholder,  the interested stockholder owned at
least  85%  of  the  voting  stock  of  the  corporation  outstanding  at  the  time  the  transaction  commenced,  excluding  for  purposes  of  determining  the
voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances; or

at or after the time the stockholder became interested, the business combination was approved by our board of directors and authorized at an annual
or  special  meeting  of  the  stockholders  by  the  affirmative  vote  of  at  least  two-thirds  of  the  outstanding  voting  stock  which  is  not  owned  by  the
interested stockholder.

Any provision of our amended and restated certificate of incorporation, amended and restated bylaws or Delaware law that has the effect of delaying, preventing or
deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price
that some investors are willing to pay for our common stock.

 
 
 
 
 
 
 
 
 
Choice of Forum

Our restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding
brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us arising pursuant to the DGCL, our restated certificate  of
incorporation or our restated bylaws; or any action asserting a claim against us that is governed by the internal affairs doctrine. The enforceability  of similar choice of
forum  provisions  in  other  companies’  certificates  of  incorporation  has  been  challenged  in  legal  proceedings,  and  it  is  possible  that  a  court  could  find  these  types  of
provisions to be inapplicable or unenforceable.

Limitations of Liability; Indemnification of Directors and Officers

Reference is made to Section 102(b)(7) of the DGCL, which permits a corporation in its certificate of incorporation or an amendment thereto to eliminate or limit
the personal liability of a director for violations of the director’s fiduciary duty, except (i) for any breach of the director’s fiduciary duty of loyalty to the corporation or its
stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to Section 174 of the DGCL
(providing for liability of directors for unlawful payment of dividends or unlawful stock purchases or redemptions), or (iv) for any transaction from which the director
derived an improper personal benefit. Our amended and restated certificate of incorporation contains the provisions permitted by Section 102(b)(7) of the DGCL.

Reference  is  made  to  Section  145  of  the  DGCL,  which  provides  that  a  corporation  may  indemnify  any  persons,  including  directors  and  officers,  who  are,  or  are
threatened to be made, parties to any threatened, pending or completed legal action, suit or proceeding, whether civil, criminal, administrative or investigative (other than
an action by or in the right of such corporation), by reason of the fact that such person is or was a director, officer, employee or agent of such corporation, or is or was
serving at the request of such corporation as a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including
attorney’s  fees),  judgments,  fines  and  amounts  paid  in  settlement  actually  and  reasonably  incurred  by  such  person  in  connection  with  such  action,  suit  or  proceeding,
provided  such director,  officer,  employee  or agent  acted  in good faith  and in a manner  he or she reasonably  believed  to be in or not opposed to the corporation’s  best
interests and, with respect to any criminal actions or proceedings, had no reasonable cause to believe that his or her conduct was unlawful. A Delaware corporation may
indemnify directors and/or officers in an action or suit by or in the right of the corporation under the same conditions, except that no indemnification is permitted without
judicial approval if the director or officer is adjudged to be liable to the corporation. Where a director or officer is successful on the merits or otherwise in the defense of
any action referred to above, the corporation must indemnify him or her against the expenses which such director or officer actually and reasonably incurred.

Our amended and restated  certificate  of incorporation  provides  indemnification  of directors  and officers  to the  fullest  extent permitted  by applicable  law. We have
obtained liability insurance for each director and officer for certain losses arising from claims or charges made against them while acting in their capacities as directors or
officers  of  us.  We  have  entered  into  indemnification  agreements  with  each  of  our  executive  officers  and  directors.  These  agreements  provide  that,  subject  to  limited
exceptions and among other things, we will indemnify each of our executive officers and directors to the fullest extent permitted by law and advance expenses to each
indemnitee in connection with any proceeding in which a right to indemnification is available.

Registration Rights

Amada Holdings Co., Ltd. (“Amada”) is entitled to rights with respect to the registration of its shares under the Securities Act of 1933, as amended (the “Securities
Act”).  These  registration  rights  are  contained  in  the  Securities  Purchase  Agreement  by  and  between  the  Company,  Viavi  Solutions  Inc.  (formerly  JDS  Uniphase
Corporation),  and  Amada,  dated  May  12,  2015  (the  “Securities  Purchase  Agreement”).  The  registration  rights  provided  for  in  the  Securities  Purchase  Agreement  will
expire (i) five years following the Series A Preferred Stock’s conversion into shares of our common stock, which took place on November 2, 2018, or, (ii) immediately
prior to a “Liquidation Event” (as such term is defined in the Series A Preferred Stock certificate of designation). Subject to certain conditions, we will pay the registration
expenses of Amada. In an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions, to limit the number of shares Amada may
include in the offering.

Demand Registration Rights

Amada  can  on  one  occasion  request  that  we  register  all  or  a  portion  of  its  shares.  The  request  for  registration  must  cover  at  least  that  number  of  shares  with  an
anticipated aggregate offering price of at least $15 million. If we determine that it would be detrimental to our stockholders to effect such a demand registration, we have
the right to defer such registration once for a period of up to 90 days.

Piggyback Registration Rights

If we propose to register any of our securities under the Securities Act, in connection with the public offering of such securities solely for cash, Amada’s converted
shares of our common stock will be entitled to certain “piggyback” registration rights allowing Amada to include its converted shares in such registration, subject to certain
marketing and other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to a registration related
to  (i)  a  company  stock  plan,  (ii)  the  exchange  of  securities  in  certain  corporate  reorganizations,  or  (iii)  a  registration  in  which  the  only  stock  being  registered  is  stock
issuable upon the conversion of debt securities that are also being registered, Amada is entitled to notice of the registration and has the right, subject to limitations that the
underwriters may impose on the number of shares included in the registration, to include its converted shares in the registration.

Listing

Our common stock is listed on the Nasdaq Stock Market under the symbol “LITE.”

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Computershare Trust Company, N.A.

REAL ESTATE PURCHASE AND SALE AGREEMENT

1001 RIDDER PARK DRIVE, 1717 FOX DRIVE AND 1751 FOX DRIVE, 
SAN JOSE, CALIFORNIA

THIS REAL ESTATE PURCHASE AND SALE AGREEMENT (this "Agreement") is dated as of May 7, 2019 (the "Effective
Date"),  by  and  between MNCVAD-GRAYMARK  RIDDER  PARK  LLC ,  a  Delaware  limited  liability  company  ("Seller"),  and
LUMENTUM  OPERATIONS  LLC,  a  Delaware  limited  liability  company  ("Buyer").  Seller  and  Buyer  are  sometimes  collectively
referred to herein as "Parties" and individually as "Party."

IN CONSIDERATION of the respective agreements hereinafter set forth, and for other good and valuable consideration, the receipt

and sufficiency of which are hereby acknowledged, Seller and Buyer agree as follows:

1.

Property  Included  in  Sale.  Seller  hereby  agrees  to  sell  and  convey  to  Buyer,  and  Buyer  hereby  agrees  to  purchase  from  Seller,
subject  to  the  terms  and  conditions  set  forth  in  this  Agreement  and  the  Closing  Documents,  all  of  Seller's  right,  title  and  interest  in  and  to  the
following:

(a)        that  certain  real  property  located  at  1001  Ridder  Park  Drive,  1717  Fox  Drive,  and  1751  Fox  Drive  in  the  City  of  San  Jose
("City"), County of Santa Clara, State of California and more particularly described in Exhibit A attached hereto with APNs 237-03-068, 237-03-
067, 237-03-066, 237-03-079 and 237-03-078 (the "Real Property");

(b)        any  rights,  privileges,  and  easements  appurtenant  to  the  Real  Property,  to  the  extent  owned  by  Seller,  including,  without
limitation, to the extent owned by Seller, minerals, oil, gas, and other hydrocarbon substances on and under the Real Property, development rights,
air rights, water, water rights, riparian rights, and water stock relating to the Real Property and rights-of-way or other appurtenances benefitting the
Real Property (collectively, the "Appurtenances");

(c)    any improvements and fixtures to the extent owned by Seller and located on the Real Property, including, without limitation,
the buildings located thereon as well as any other structures located on the Real Property, all apparatus, installed equipment, and appliances to the
extent owned by Seller and located on or in and used in connection with the operation or occupancy of the Real Property, and any on-site parking
(collectively, the "Improvements");

(d)    any tangible personal property, if any, to the extent owned by Seller and located on or used in connection with the ownership,
operation,  and  maintenance  of  the  Real  Property  and  Improvements  (excluding  data  in  digital  or  computer  files  and  any  computer  software  or
hardware) (collectively, the "Personal Property");

(e)        to  the  extent  assignable,  without  third  party  consents  or  any  cost  or  expense  to  Seller  except  as  expressly  provided  in
Section  4(d),  all  right,  title,  and  interest  of  Seller  in  and  to  the  following:  "Assumed  Contracts",  licenses,  permits,  approvals,  certificates  of
occupancy,  dedications,  subdivision maps, entitlements, studies, reports, surveys, plans, marks, logos, names (excluding MNCVAD-Graymark  or
any name including MNCVAD, Graymark, New York Life, New York Life Real Estate Investors, NYL Real Estate Investors, NYL, NYLIM, NYL
Investors  and  any  name  including  such  terms  or  abbreviations),  and  telephone  numbers  used  exclusively  in  the  ownership,  use,  operation,  or
maintenance of the Real Property, Improvements, or Personal Property (collectively, the "Intangible Property"); and

(f)    Seller's rights and interest as landlord under any leases ("Leases"), including all amendments, modifications and renewals, in
effect as of the Closing (except for any past due rents or other past due monetary obligations under the Leases) (excluding data in digital or computer
files and any computer software or hardware), a right to all security deposits under the Leases and any and all guaranties of the Leases (subject to
applicable laws and the terms of the applicable Leases respecting said security deposits). For convenience, this Agreement refers to "Leases" even if
there is only one lease. If there is only one lease, the reference to "Leases" shall be deemed to refer to such lease and references to the "tenants" shall
be deemed to refer to the "tenant."

All of the items referred to in subparagraphs (a), (b), (c), (d), (e) and (f) above are collectively referred to as the "Property."

Schedule 1 attached hereto sets forth an index of defined terms used in this Agreement.

./
-/5-2-19//

3285553_2

 
2.    Purchase Price.

(a)        Contemporaneously  with  the  execution  and  delivery  of  this  Agreement,  Buyer  has  delivered  to  Seller  and  Seller  hereby
acknowledges the receipt of funds in the amount of One Hundred Dollars ($100.00) (the "Independent Contract Consideration"), which amount
the Parties bargained for and agreed to as consideration for Buyer's right to inspect and purchase the Property pursuant to this Agreement and for
Seller's execution, delivery and performance of this Agreement. The Independent Contract Consideration is in addition to and independent of any
other consideration or payment provided in this Agreement, is nonrefundable, and is fully earned and shall be retained by Seller notwithstanding any
other provision of this Agreement.

(b)    The purchase price of the Property is Fifty-Four Million Dollars ( $54,000,000.00) (the "Purchase Price") and shall be paid as

follows:

(i)    Upon the mutual execution and delivery of this Agreement, Buyer shall deposit in escrow with Chicago Title Insurance
Company (in such capacity, "Escrow Agent" and in its capacity as the issuer or prospective issuer of the Title Policy, as defined below, the "Title
Company"),  455  Market  Street,  Suite  2100,  San  Francisco,  CA  94105,  Attn:  Terina  J.  Kung,  Escrow  Officer,  phone:  (415)  291-5128,  email:
terina.kung@ctt.com, an earnest money deposit of One Million and No/100 Dollars ( $1,000,000.00) (the "Initial Deposit"). "Business Day" means

any day, other than a Saturday, Sunday, or holiday, on which commercial banks in the State of New York are open for business.

(ii)        On  or  before  the  date  of  expiration  of  the  Due  Diligence  Period,  if  this  Agreement  has  not  been  terminated  in
accordance with the provisions of Section 4(j), then Buyer shall deposit with the Escrow Agent an additional earnest money deposit in the amount of
One Million and No/100 Dollars ($1,000,000.00) (the "Additional Deposit"). The Initial Deposit together with the Additional Deposit when and if
made, and all interest earned thereon, are collectively herein called the "Deposit". Unless Buyer terminates this Agreement prior to the end of the
Due  Diligence  Period  in  accordance  with  Section  4(j),  then  the  Deposit  shall  be  nonrefundable  to  Buyer,  except  as  otherwise  set  forth  in  this
Agreement.

(iii)    Escrow Agent shall hold the Deposit in a joint escrow account for the benefit of Buyer and Seller.

(iv)    If the sale of the Property as contemplated hereunder is consummated, then the Deposit shall be credited against the
Purchase  Price.  The  balance  of  the  Purchase  Price,  as  adjusted  pursuant  to  the  express  terms  and  provisions  of  this  Agreement  below,  shall  be
deposited  into  the  joint  escrow  with  the  Escrow  Agent  in  immediately  available  funds  at  least  one  (1)  Business  Day  prior  to  the  closing  of  the
purchase and sale contemplated hereunder (the "Closing"). The Closing shall occur on May 21, 2019 (i.e., fifteen (15) days following the expiration
of the Due Diligence Period), and such date shall be referred to herein as the "Closing Date." The Closing shall be deemed to have occurred upon
the delivery and recording of the Deed unless the Parties agree to an escrow Closing based upon the Escrow Agent's irrevocable and unconditional
commitment to disburse monies due Seller and issue Buyer's Title Policy in advance of recordation of the Deed.

(c)        The  Escrow  Agent  joins  herein  below  to  evidence  its  agreement  to  hold  all  funds  deposited  with  the  Escrow  Agent  in
accordance with the terms and conditions of this Agreement. Further, the following provisions shall control with respect to the rights, duties, and
liabilities of the Escrow Agent.

(A) sufficiency, correctness, genuineness, or validity of any written

(i)    The Escrow Agent acts hereunder as a depository only and is not responsible or liable in any manner whatsoever for the

./
-/5-2-19//

3285553_2

2

instrument, notice, or evidence of a Party's receipt of any instruction or notice which is received by the Escrow Agent, or (B) identity or authority of
any person executing such instruction notice or evidence.

(ii)    The Escrow Agent shall have no responsibility hereunder except for the performance by it in good faith of the acts to
be performed by it hereunder, and the Escrow Agent shall have no liability except for its own negligence or willful misconduct or breach of this
Agreement.

(iii)    The Escrow Agent shall be reimbursed by whichever of Buyer or Seller is the losing party for any reasonable expenses
incurred by the Escrow Agent arising from a dispute with respect to the amount held in escrow, including the cost of any legal expenses, should the
Escrow Agent deem it necessary to retain an attorney with respect to the disposition of the amount held in escrow.

(d)    If there is a dispute between Buyer and Seller concerning whether or not Buyer or Seller is entitled to the Deposit following a
termination of this Agreement, then either Party may have such dispute, claim, or controversy determined by arbitration (the "Arbitration") in the
JAMS  office  nearest  the  Property,  before  a  single  arbitrator  (the  "Arbitrator").  The  Party  requesting  arbitration  shall  advance  any  initial
administrative  fees  and  costs  of  JAMS  necessary  for  JAMS  immediately  to  commence  the  arbitration,  but  shall  be  reimbursed  for  the  same  if
determined to be the prevailing party. The arbitration shall be administered by JAMS pursuant to its Streamlined Arbitration Rules and Procedures
except that the Parties shall use commercially reasonable efforts to cause the Arbitration to be concluded and the award (the "Award") given to the
Parties in writing within twenty (20) days after either Party requests Arbitration (the "Outside Date"). JAMS shall choose a retired judge  as the
Arbitrator from its real property panel of Arbitrators, on the first (1st) Business Day after the Arbitration is requested and the Parties waive the right
to select the Arbitrator. If the Arbitrator so selected is not acceptable to either of the Parties, for good cause, the Party to whom the Arbitrator is not
acceptable shall have one (1) Business Day, after the selection is made by JAMS, to reject the Arbitrator and to state the cause for rejection. The
Parties waive any provision of law which would give the Parties a longer period to reject the Arbitrator selected by JAMS. If either Party rejects the
first Arbitrator selected by JAMS, then JAMS shall, within one (1) Business Day after the rejection, select another retired judge as the Arbitrator and
the process outlined above shall be repeated until an Arbitrator is selected and not rejected. If Seller rejects an Arbitrator selected by JAMS, then the
Outside Date shall be extended two (2) Business Days for each instance that an Arbitrator selected by JAMS is rejected by Seller. Discovery shall be
allowed  pursuant  to  California  Code  of  Civil  Procedure  Section  1283.05.  The  Parties  shall  cooperate  in  taking  commercially  reasonable  actions
required to cause the arbitration to be concluded within such twenty (20) day period but not later than the Outside Date. The arbitration shall be
concluded even if it is not completed by the Outside Date. Judgment on the Award may be entered in any court having jurisdiction. The Arbitrator
may, in the Award, allocate all or part of the costs of the Arbitration, including the fees of the Arbitrator and the reasonable attorneys' fees of the
prevailing party.

NOTICE: BY INITIALING IN THE SPACE BELOW YOU ARE AGREEING TO HAVE ANY DISPUTE ARISING OUT OF
THE  MATTERS  INCLUDED  IN  THIS  SECTION  2(d) DECIDED  BY  NEUTRAL  ARBITRATION  AS  PROVIDED  BY
CALIFORNIA  LAW  AND  YOU  ARE  GIVING  UP  ANY  RIGHTS  YOU  MIGHT  POSSESS  TO  HAVE  THE  DISPUTE
LITIGATED  IN  A  COURT  OR  JURY  TRIAL.  BY  INITIALING  IN  THE  SPACE  BELOW  YOU  ARE  GIVING  UP  YOUR
JUDICIAL RIGHTS TO DISCOVERY AND APPEAL, UNLESS THOSE RIGHTS ARE SPECIFICALLY INCLUDED IN THE
"ARBITRATION OF DISPUTES" PROVISION. IF YOU REFUSE TO SUBMIT TO ARBITRATION AFTER AGREEING TO
THIS PROVISION, YOU MAY BE

./
-/5-2-19//

3285553_2

3

COMPELLED TO ARBITRATE UNDER THE AUTHORITY OF THE CALIFORNIA CODE OF CIVIL PROCEDURE. YOUR
AGREEMENT TO THIS ARBITRATION PROVISION IS VOLUNTARY.

WE HAVE READ AND UNDERSTAND THE FOREGOING AND AGREE TO SUBMIT DISPUTES ARISING OUT OF THE
MATTERS INCLUDED IN THE "ARBITRATION OF DISPUTES" PROVISION TO NEUTRAL ARBITRATION.

/s/ RB
SELLER'S INITIALS

/s/ JH
BUYER'S INITIALS

3.    Transfer of Title to the Property.

(a)        At  the  Closing,  Seller  shall  convey  to  Buyer  title  to  the  Real  Property,  the  Appurtenances  and  the  Improvements  by  duly
executed  and  acknowledged  Grant  Deed  in  the  form  attached  hereto  as  Exhibit  B (the  " Deed").  Evidence  of  delivery  of  title  shall  be  the  Title
Company's irrevocable commitment to issue to the Buyer, effective as of the date and time the Deed is recorded, a CLTA Owner's Policy of Title
Insurance with coverage in the amount of the Purchase Price, insuring that fee simple title to the Real Property and the Improvements and title to the
Appurtenances is vested in Buyer subject only to the Permitted Exceptions (the "Title Policy").

(b)    At the Closing, Seller shall transfer all of Seller's right, title and interest, if any, in and to any Personal Property and Intangible
Property (other than the Leases) by a Bill of Sale and Assignment of Contracts and Intangible Property in the form attached hereto as Exhibit C (the
"Assignment of Intangible Property").

(c)    At the Closing, Seller shall assign to Buyer all of Seller's right, title and interest in and to the Leases and Buyer shall assume all
of Seller's obligations under the Leases by an Assignment and Assumption of Leases in the form attached hereto as Exhibit D (the "Assignment and
Assumption of Leases"). The Leases in effect as of the Effective Date are more fully described on the schedule attached hereto as Exhibit E (the
"Schedule of Leases").

4.    Due Diligence Period; As-Is Purchase.

(a)    Due Diligence Period. Buyer, or its designees, shall have until 5:00 p.m. (Pacific Daylight Time) on May 6, 2019 (the "Due
Diligence  Period"),  to  conduct  its  due  diligence  review  with  respect  to  the  Property,  including,  without  limitation,  conducting  examinations,
inspections,  testing,  studies  and  investigations  of  the  Property  (collectively,  the  "Due  Diligence")  in  the  manner  and  subject  to  the  limitations
contained herein.

(b)        Due  Diligence  Deliveries.  Buyer  and  Seller  acknowledge  that  Buyer  shall  review  and  inspect  all  documents  and  other
information  described  on  Exhibit  I attached  hereto  (collectively,  the  " Due  Diligence  Documents")  and  any  other  documents  provided  or  made
available by or on behalf of Seller or obtained by Buyer with respect to the Property. Except as otherwise expressly provided herein, Seller makes no
representation or warranty as to the truth, accuracy, or completeness of the Due Diligence Documents or any other studies, documents, reports, or
other information provided to Buyer by or on behalf of Seller.

(c)    Further Document Review. Subject to the provisions of this Section 4(c), Seller shall provide Buyer with reasonable access to
Seller's relevant files with respect to the Property located at NYL Investors LLC, One Front Street, Suite 550, San Francisco, California 94111 for
inspection and copying, but in no event shall any originals of files be removed. On two (2) Business Days advance written notice from Buyer to
Seller,  Seller  shall,  to  the  extent  in  Seller's  actual  possession  or  under  Seller's  actual  control,  provide  access  to  all  of  Seller's  books  and  records
relating  exclusively  to  the  Property,  but  excluding  any  books,  records  and  files  that  Seller  deems  confidential,  proprietary  or  privileged,  or  other
information  prepared  for  internal  purposes,  including  budgets,  correspondence  or  documents  relating  to  Buyer's  acquisition  of  the  Property,  or
information relating to prior prospective sales of the Property, work product, marketing studies, appraisals of the Property, and information relating
to Seller itself for inspection and copying.

(d)    Contracts. All unrecorded contracts in Seller's possession relating to Seller's ownership or operation of the Property in effect on
the Effective Date and that may be assignable to Buyer at Closing are as specified on Exhibit F attached hereto ("Contracts"), excluding, however,
all property management contracts with Seller, all insurance policies, and all sale or leasing brokerage listing agreements (collectively, "Excluded
Contracts"), none of which Excluded Contracts will be assigned to Buyer at the Closing. The Leases are neither Contracts nor Excluded Contracts.
Prior  to  the  expiration  of  the  Due  Diligence  Period,  Buyer  shall  notify  Seller  in  writing  of  any  Contracts  specified  on  Exhibit F attached hereto
Buyer disapproves and does not want to assume at Closing. Seller shall (i) terminate at Closing all Contracts disapproved by Buyer in writing prior
to the end of the Due Diligence Period, and pay any damages, penalty or fee imposed by any party to any such Contract in connection with such
termination,  and  (ii)  terminate  all  Excluded  Contracts  as  of  the  Closing.  Only  those  Contracts  specified  on  Exhibit F attached  hereto  that  Buyer
approves  of  in  writing  prior  to  the  end  of  the  Due  Diligence  Period  shall  be  assigned  to,  and  assumed  by,  Buyer  at  Closing  (the  "Assumed
Contracts"),  with  Seller  being  responsible  for  the  payment  of  any  fee  or  other  charge  imposed  by  any  party  to  any  such  Assumed  Contract  in
connection with such transfer. The list of Assumed Contracts will be attached to the Assignment of Intangible Property.

(e)    Title Matters; Buyer's Objections; Seller's Right to Cure.

(i)        Buyer  hereby  confirms  receipt  of  (a)  the  existing  survey  of  the  Real  Property,  if  any  (the  "Survey"),  and  (b)  a

 
 
preliminary title report for the Real Property issued by the Title Company and copies of or hyperlinks to all documents referenced as exceptions
therein (the "PTR"). Buyer may obtain, at its sole cost and expense, an updated survey of the Property (the "Updated Survey"). Within two (2)
Business Days after Buyer's receipt of the Updated Survey, Buyer shall deliver a copy of the same to Seller and the Title Company.

(ii)    Buyer shall be obligated to accept title to the Property, subject solely to the following matters: (i) as of the Closing
Date, the lien of any real property taxes and assessments not yet due and payable including any supplementary taxes and assessments relating to the
period after Closing which may be imposed as a result of Buyer's purchase of the Property from Seller; (ii) all matters of record which are approved
or deemed approved by Buyer in accordance with Section 4(f); (iii) matters disclosed by the Survey or the Updated Survey which are approved or
deemed  approved  by  Buyer  in  accordance  with  Section  4(f);  (iv)  the  rights  of  tenants  under  the  Leases;  (v)  zoning  regulations  and  ordinances,
building restrictions and regulations of governmental agencies having jurisdiction over the Property; and (vi) matters created by, through or under
Buyer. All of the foregoing shall be, collectively, the "Permitted Exceptions."

(iii)        Seller  agrees  to  pay  and  remove,  or,  at  Seller's  election  to  cause  the  Title  Company  to  insure  over  to  Buyer's
reasonable satisfaction, any mechanic's lien or other monetary lien recorded against title to the Property, but excluding those caused by any tenant
under the Leases, any new liens or encumbrances recorded against title to the Property after the Effective Date and voluntarily created by Seller, and
any property taxes and assessments that become delinquent prior to Closing (collectively referred to as the "Removed Liens").

(f)    Title Review. In the event Buyer objects to any matters affecting title which are not Permitted Exceptions, Buyer shall, on or
before the tenth (10th) day following the Effective Date deliver a title objection letter to Seller and Title Company identifying any such objections
(the "Title Objection Letter"). Any matters affecting title that are not timely objected to in the Title Objection Letter shall be deemed approved by
Buyer and shall constitute additional Permitted Exceptions. In the event Buyer timely delivers the Title Objection Letter, Seller shall have until the
date  which  is  five  (5)  Business  Days  after  receipt  of  the  Title  Objection  Letter  within  which  to  notify  Buyer  in  writing  (the  "Seller  Response
Notice")  whether  Seller  elects  to  endeavor  to  eliminate  or  modify  any  such  identified  objections.  If  Seller  delivers  the  Seller  Response  Notice
indicating its election to endeavor to eliminate or modify any such identified objections, then it shall be a condition precedent to Buyer's obligation
to purchase the Property that such identified objections are eliminated or modified to Buyer's reasonable satisfaction. If no such Seller Response
Notice  is  given,  Seller  shall  be  deemed  to  have  elected  not  to  eliminate  or  to  modify  any  matters  affecting  title  to  the  Property  other  than  the
Removed Liens. Seller shall have no obligation to so eliminate or modify any unacceptable exceptions or matters affecting title to the Property or to
incur any cost or expense in connection therewith other than with respect to the Removed Liens. In the event that Seller has not agreed to endeavor
to  eliminate  or  modify  a  Buyer's  title  objection,  other  than  Removed  Liens,  Buyer  shall,  prior  to  the  end  of  the  Due  Diligence  Period,  either
(a) waive in writing such objections and accept title to the Property subject to such title objections, or (b) terminate this Agreement by notice to
Seller, in which event the Deposit shall be paid to Buyer and, thereafter, the Parties shall have no further rights or obligations hereunder except for
those  obligations  which  expressly survive  the  termination  of  this  Agreement. Unless  Buyer  timely  delivers  a  Termination Notice,  Buyer  shall  be
deemed  to  have  waived  all  objections  to  title  to  the  Property  other  than  those  (i)  that  Seller  has  agreed  to  endeavor  to  eliminate  or  modify  and
(ii) Removed Liens. If after the end of the Due Diligence Period and prior to the Closing Date any new title exceptions ("New Exceptions") are first
disclosed in writing to Buyer and Buyer timely objects to such New Exceptions, then subject to the provisions of this Section 4(f), Seller shall have
five  (5)  Business  Days  following  the  giving  of  written  notice  by  Buyer  to  Seller  objecting  to  such  New  Exception(s)  to  notify  Buyer  in  writing
whether or not Seller elects to endeavor, at Seller's sole option, to cause such exceptions to be removed as exceptions or insured against to Buyer's
reasonable satisfaction at no expense to Buyer, which, in either case, shall be deemed the cure of such title defect. If Seller elects to endeavor to
cause such exceptions to be removed or insured against, then it shall be a condition precedent to Buyer's obligation to purchase the Property that
such identified objections are eliminated or modified to Buyer's reasonable satisfaction. If such five (5) Business Day period extends beyond the
then  scheduled  Closing  Date,  the  Closing  Date  shall  be  extended  until  the  first  Business  Day  following  the  expiration  of  such  period.  If  such
exceptions  are  not  so  cured,  Buyer  may  (i)  waive  in  writing  such  objectionable  title  exceptions  and  proceed  to  Closing,  or  (ii)  terminate  this
Agreement and obtain a return of the Deposit within three (3) Business Days and, thereafter, the Parties shall have no further rights or obligations
hereunder except for those obligations which expressly survive the termination of this Agreement. If Buyer fails to object to or waive in writing any
New Exceptions within three (3) Business Days after Buyer first discovers or learns about such New Exceptions as described above, then such New
Exceptions shall be deemed to be additional Permitted Exceptions.

(i)    Seller shall be entitled to one or more extensions of the Closing Date (not to exceed thirty (30) days in the aggregate) for

the purposes of removal of any exceptions to title.

(g)    Site Visits.

(i)        Access to Property.  Buyer  and  its  Licensee  Parties  shall  have  access  to  the  Property  pursuant  to  the  April  16,  2019
Access Agreement. As used herein, the term "Licensee Parties" shall mean Buyer's current and prospective lenders and investors, and each of their
principals,  directors,  employees,  partners,  accountants,  advisors,  agents,  contractors,  consultants,  or  representatives  and  their  respective  agents,
subcontractors, consultants, and representatives of any tier, who inspect, investigate, test, or evaluate the Property on behalf of Buyer or its current
and prospective lenders and investors.

(ii)    Contents of Notice; Seller Representative. The notice to be given to the Seller prior to any entry onto the Property shall
describe generally the scope of any Due Diligence which Buyer intends to conduct during Buyer's access to the Property. Seller shall have the right
to have a representative present during any visits to or inspections of the Property by Buyer or any Licensee Parties.

(iii)    Physically Intrusive Due Diligence. If Buyer desires to conduct any physically intrusive Due Diligence such as, but not
limited to, sampling of soils or the like, Buyer shall provide not less than two (2) Business Days prior written notice thereof to Seller, which notice
shall identify exactly what procedures Buyer desires to perform and shall request Seller's express written consent thereto. Seller may withhold or

condition its consent to any physically intrusive Due Diligence in Seller's sole and absolute discretion.

(iv)    Third Party Consents Required for Due Diligence Activity. If Buyer desires to undertake any Due Diligence activity
which would require the approval of any governmental or quasi-governmental body or agency having jurisdiction over Seller or the Property (each a
"Governmental Entity"), or of a tenant, and provided that Seller has approved such Due Diligence, Seller, at no cost or expense to Seller, shall
contact  such  entity,  as  applicable,  and  request  consent  with  respect  to  such  Due  Diligence  and  shall  diligently  pursue  obtaining  such  consent,  at
Buyer's expense, with expenses reasonably paid or incurred by Seller to be reimbursed by Buyer within five (5) Business Days after written request.
In no event shall Seller be liable to Buyer as a result of the withholding of any such consent by any such entity.

(v)    Compliance With Law, Leases and Available Documents in Conducting Due Diligence. Buyer and all Licensee Parties
shall, in performing such Due Diligence, (i) comply in all material respects with the agreed upon procedures, (ii) comply in all material respects with
any and all laws, ordinances, rules, and regulations applicable to the Property, and (iii) will not engage in any activities which would violate any
Lease  or  any  publicly  available  documents,  including,  but  not  limited  to,  recorded  documents  or  any  licenses,  permits,  approvals,  certificates  of
occupancy, dedications, subdivision maps or entitlements. All Due Diligence shall be conducted to avoid any unreasonable disturbance of occupants
of the Property or of properties adjacent to or in the vicinity of the Property.

(vi)    Insurance. Prior to any of the Licensee Parties entering the Real Property to conduct the inspections and tests described
in this Section 4, Buyer shall obtain and maintain, on behalf of itself and the other Licensee Parties, or shall cause each of the other Licensee Parties
who  enter  the  Property  to  maintain  (and  shall  deliver  to  Seller  evidence  thereof),  at  Buyer's  or  the  Licensee  Parties'  sole  cost  and  expense,
(a)  commercial  general  liability  insurance,  from  an  insurer  reasonably  acceptable  to  Seller,  in  the  amount  of  not  less  than  $2,000,000  aggregate
liability,  with  such  policies  to  name  Seller,  the  property  manager,  and  any  of  their  respective  affiliates  specified  by  any  of  them  in  writing  as
additional insureds, which insurance shall provide coverage against any claim for personal liability or physical property damage caused by any of
the  Licensee  Parties  in  connection  with  such  inspections  and  tests  and/or  the  entry  or  activities  of  the  Licensee  Parties  upon  the  Property,  and
(b) workers' compensation insurance having limits no less than those required by state statute and federal statute, if applicable. In addition, Buyer
shall obtain excess (umbrella) liability insurance, meeting the requirements above, with limits of not less than Five Million Dollars ($5,000,000) per
occurrence.

(vii)    Payment for Inspections and Examinations and Restoration. Buyer shall promptly pay when due the costs of all entry
and inspections and examinations done with regard to the Property. Buyer shall promptly restore the Property to substantially the same condition in
which the Property was found before any such entry, inspection, or examination was undertaken.

(viii)    Mechanics Liens. Buyer covenants and agrees not to suffer or permit any lien of mechanics or materialmen or others
to be placed against the Real Property or any part thereof with respect to work or services claimed to have been performed for or materials claimed
to have been furnished to Buyer or the Licensee Parties at the Real Property or any part thereof. In the event such lien or claim of lien is not released
and removed within five (5) days after written notice from Seller, Seller, at its sole option and in addition to any of its other rights and remedies,
may take any and all action necessary to release and remove such lien or claim of lien (it being agreed by Buyer that Seller shall have no duty to
investigate the validity thereof), and Buyer shall promptly upon notice thereof reimburse Seller for  all sums, costs and expenses, including court
costs and attorneys' and expenses, incurred by Seller in connection with such lien or claim of lien. The terms and provisions of this clause (viii) shall
survive the termination of this Agreement.

(h)    Discussions and Interviews. Any discussions or interviews with any officer, director, shareholder, member, manager, employee
or  agent  of  Seller,  of  any  tenant  of  the  Property,  or  of  any  Governmental  Entity  shall  be  conducted,  at  Seller's  election,  in  the  presence  of  the
Designated Representative, or an agent or employee of Seller approved by the Designated Representative. Seller shall make either the Designated
Representative  or  another  agent  or  employee  approved  by  the  Designated  Representative  available  to  Buyer  for  such  discussions  or  interviews,
provided that Buyer gives Seller written notice of Buyer's intent to conduct such interview or discussions at least one (1) Business Days prior to the
date Buyer intends to conduct such interviews or discussions. Notwithstanding the foregoing provisions of this Section, Buyer shall not be required
to notify Seller prior to contacting any Governmental Entity in connection with obtaining information that is publicly available or of a ministerial or
administrative nature, including, without limitation, routine inquiries about current zoning and the Property's compliance.

./
-/5-2-19//

3285553_2

4

(i)        As-Is Purchase.  Buyer  acknowledges  that  prior  to  expiration  of  the  Due  Diligence  Period,  subject  to  the  limitations  of  this
Agreement, Buyer will have had the opportunity to inspect the Property and observe the physical characteristics and condition of the Property and
any and all other matters, as to, concerning or with respect to any matter whatsoever relating to the Property or this Agreement or of concern to
Buyer ("Property Conditions"), including, but not limited to: title; the environmental condition of the Property, including the presence or absence
of  Hazardous  Materials  in,  on,  or  about  the  Property;  pest  and  geological  conditions  of  the  Property;  the  Leases;  the  Contracts;  the  financial
condition of the Property; the suitability of the Property for any and all activities and/or uses which may be conducted thereon; the compliance of or
by the Property with any and all laws, rules, ordinances or regulations of any applicable governmental authority or body (including environmental,
zoning, building codes, and the status of any development or use rights respecting the Property); the availability of permits, licenses and approvals
respecting the Property; the economic or engineering feasibility of any alteration or renovation of the Property that may be contemplated by Buyer;
the  habitability,  merchantability,  marketability,  profitability  or  fitness  for  a  particular  purpose  of  the  Property;  and  the  physical  condition  of  the
Improvements, including construction defects, deferred maintenance, and other adverse physical conditions or defects. Buyer further acknowledges
and agrees that, except for any express representations, warranties, or agreements made by Seller in this Agreement or in the Closing Documents
("Seller's Representations"), neither Seller nor any of Seller's employees, agents, or representatives have made any representations, warranties, or
agreements, express or implied, by or on behalf of Seller as to any matters concerning the Property Condition. Except for Seller's Representations,
Seller  disclaims  any  and  all  such  representations,  warranties,  and  agreements  and  Buyer  agrees  that,  except  for  Seller's  Representations,  any
inaccuracy or deficiency in information, advice, or documents given to Buyer shall be solely the responsibility and risk of Buyer, and shall not be
chargeable in any respect to Seller. Buyer acknowledges that, except for Seller's Representations, it is not relying on any statement or representation,
whether express or implied, oral or written, that has been made or that in the future may be made by Seller or any of Seller's employees, agents,
attorneys or representatives concerning the Property Condition.

Buyer  hereby  acknowledges  and  agrees,  except  for  Seller's  Representations,  that  the  Property  is  to  be  purchased,  conveyed,  and

accepted by Buyer in its present condition, "AS IS," "WHERE IS" and "WITH ALL FAULTS".

By  the  end  of  the  Due  Diligence  Period,  subject  to  the  limitations  of  this  Agreement,  Buyer  will  have  examined,  reviewed,  and
inspected the Property Conditions and other matters which, in Buyer's judgment, bear upon the Property and its value and suitability for
Buyer's purposes. Upon Closing, Buyer will acquire the Property solely on the basis of Buyer's own examinations, reviews, and inspections
and the title insurance protection afforded by the Title Policy and Seller's Representations.

Upon  Closing,  Buyer  shall  assume  the  risk  that  Property  Conditions  may  not  have  been  revealed  by  Buyer's  investigations.  The
release  and  waiver  of  claims  set  forth  below  shall  be  referred  to  as  the  "Release."  Upon  the  Closing,  except  with  respect  to  Seller's
Representations, Buyer, on its own behalf and on behalf of each of its successors and assigns and each and all of its and their respective
agents,  representatives,  trustees,  property  managers  (whether  agents  or  independent  contractors),  investment  managers,  investment
advisors,  attorneys,  consultants,  contractors,  partners,  managers,  members,  shareholders,  parents,  subsidiaries,  affiliates,  joint  ventures,
directors,  officers  and  employees  and  each  of  their  agents,  representatives,  trustees,  property  managers  (whether  agents  or  independent
contractors), investment managers, investment advisors, attorneys,

./
-/5-2-19//

3285553_2

5

consultants, contractors, partners, managers, members, shareholders, parents, subsidiaries, affiliates, joint ventures, directors, officers and
employees of any tier (collectively, "Waiver Parties") releases Seller and its agents, representatives, trustees, property managers (whether
agents  or  independent  contractors),  investment  managers,  investment  advisors,  attorneys,  consultants,  contractors,  partners,  managers,
members,  shareholders,  beneficiaries,  parents,  subsidiaries,  affiliates,  joint  ventures,  directors,  officers  and  employees  and  each  of  their
agents,  representatives,  trustees,  property  managers  (whether  agents  or  independent  contractors),  investment  managers,  investment
advisors, attorneys, consultants, contractors, partners, managers, members, shareholders, beneficiaries, parents, subsidiaries, affiliates, joint
ventures,  directors,  officers  and  employees  of  any  tier  and  each  of  their  respective  successors  and  assigns  (collectively,  "Released
Parties") from, and waives any and all liability, claims, demands, damages and costs (including attorneys' fees and expenses) of any and
every  kind  or  character,  known  or  unknown,  for,  arising  from,  or  attributable  to,  any  and  all  Property  Conditions,  including,  without
limitation, any and all actual, threatened or potential claims, claims for contribution under Environmental Laws, suits, proceedings, actions,
causes  of  action,  demands,  liabilities,  losses,  obligations,  orders,  requirements  or  restrictions,  liens,  penalties,  fines,  charges,  debts,
damages, costs, and expenses of every kind and nature, whether now known or unknown, whether foreseeable or unforeseeable, whether
under any foreign, federal, state or local law (both statutory and non-statutory), and, whether asserted or demanded by a third party against
any of the Waiver Parties or incurred directly or indirectly by any of the Waiver Parties themselves (collectively, "Claims"), which any of
the Waiver Parties has or may have arising from or related to the following (collectively, "Released Claims"): (i) the physical condition of
the Property, the financial condition of the Property, or the financial condition of the tenants under the Leases, the value of the Property or
its suitability for Buyer's use, the status of any of the Leases or of the tenants thereunder, the ownership, management or operation of the
Property,  including  any  claim  or  demand  by  any  tenant  for  the  refund  or  return  of  any  security  deposit  or  other  deposit  to  the  extent
credited to Buyer at Closing, or the accuracy or completeness of any information reviewed by Buyer in connection with its investigations
of  the  Property  and  which  may  have  been  relied  upon  by  Buyer  in  deciding  to  purchase  the  Property,  (ii)  any  Handling  of  any  Waste
Materials or Hazardous Materials at, beneath, to, from, or about the Property, (iii) any compliance or non-compliance with Environmental
Laws  regarding  any  Waste  Materials,  Hazardous  Materials  or  any  Handling  related  thereto  at,  beneath,  to,  from,  or  about  the  Property,
(iv)  any  acts,  omissions,  services  or  other  conduct  related  to  any  of  the  foregoing  items  "(i)"  through  "(iii),"  inclusive,  and/or  (v)  any
condition, activity, or other matter respecting the Property that is not addressed by any of the foregoing items "(i)" through "(iv)," inclusive,
and  that  is  related  to  pollution  or  protection  of  the  environment,  natural  resources,  or  public  health;  provided,  however,  the  Released
Claims shall not include claims for breach of Seller's Representations or intentional fraud. Buyer acknowledges that any condition of the
Property which Buyer discovers or desires to correct or improve prior to or after the Closing Date shall be at Buyer's sole expense. This
Release shall survive the Closing and the recording of the Deed conveying the Property from Seller to Buyer.

TO  THE  FULLEST  EXTENT  NOT  PROHIBITED  BY  LAW,  BUYER  HEREBY  EXPRESSLY  AND  SPECIFICALLY
WAIVES  THE  BENEFITS  OF  SECTION  1542  OF  THE  CALIFORNIA  CIVIL  CODE  ("SECTION  1542")  AND  ANY
SUCCESSOR LAWS. SECTION 1542 PROVIDES AS FOLLOWS:

./
-/5-2-19//

3285553_2

6

"A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES
NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND
THAT,  IF  KNOWN  TO  HIM  OR  HER,  WOULD  HAVE  MATERIALLY  AFFECTED  HIS  OR  HER  SETTLEMENT
WITH THE DEBTOR OR RELEASED PARTY."

BUYER ACKNOWLEDGES THAT THIS WAIVER AND RELEASE IS VOLUNTARY AND WITHOUT ANY DURESS
OR  UNDUE  INFLUENCE,  AND  IS  GIVEN  AS  PART  OF  THE  CONSIDERATION  FOR  THE  AGREEMENTS  SET  FORTH
HEREIN. BUYER EXPRESSLY ACKNOWLEDGES THAT IT MAY HEREAFTER DISCOVER FACTS DIFFERENT FROM
OR  IN  ADDITION  TO  THOSE,  WHICH  IT  NOW  BELIEVES  TO  BE  TRUE  WITH  RESPECT  TO  THE  RELEASE  OF
CLAIMS.  BUYER  AGREES  THAT  THE  FOREGOING  RELEASE  SHALL  BE  AND  REMAIN  EFFECTIVE  IN  ALL
RESPECTS NOTWITHSTANDING SUCH DIFFERENT OR ADDITIONAL FACTS.

BUYER  HAS  BEEN  ADVISED  BY  ITS  LEGAL  COUNSEL  AND  UNDERSTANDS  THE  SIGNIFICANCE  OF  THIS
WAIVER  OF  SECTION  1542  RELATING  TO  UNKNOWN,  UNSUSPECTED  AND  CONCEALED  CLAIMS,  AND  BUYER
HEREBY  SPECIFICALLY  ACKNOWLEDGES  THAT  BUYER  HAS  CAREFULLY  REVIEWED  THIS  SUBSECTION  AND
DISCUSSED  ITS  IMPORT  WITH  LEGAL  COUNSEL  AND  THAT  THE  PROVISIONS  OF  THIS  SUBSECTION  ARE  A
MATERIAL  PART  OF  THIS  AGREEMENT.  BY  ITS  INITIALS  BELOW,  BUYER  ACKNOWLEDGES  THAT  IT  FULLY
UNDERSTANDS, APPRECIATES AND ACCEPTS ALL OF THE TERMS OF THIS SUBSECTION AND RELEASE.

NOTWITHSTANDING  ANY  OTHER  PROVISION  IN  THIS  AGREEMENT  TO  THE  CONTRARY,  THE  WAIVERS,
RELEASES,  ACQUITTALS,  AND  DISCHARGES  REFERRED  TO  ABOVE  SHALL  NOT  BE  APPLICABLE  TO:  (I)  ANY
CLAIMS  ARISING  OUT  OF  ANY  BREACH  OF  COVENANTS,  REPRESENTATIONS,  OR  WARRANTIES  OF  SELLER
THAT ARE EXPRESSLY SET FORTH IN THE AGREEMENT; (II) DAMAGE TO PERSONAL PROPERTY OR PERSONAL
OR  BODILY  INJURY  WHICH  OCCURRED  ON  THE  REAL  PROPERTY,  OR  ANY  PART  THEREOF,  PRIOR  TO  THE
CLOSE  OF  ESCROW,  THROUGH  NO  ACT  OR  OMISSION  ON  THE  PART  OF  BUYER  AND/OR  BUYER'S  AGENTS,
EMPLOYEES, CONSULTANTS OR CONTRACTORS; (III) ANY OBLIGATIONS OF SELLER UNDER THIS AGREEMENT
OR ANY DOCUMENT DELIVERED BY SELLER TO BUYER AS OF THE CLOSING HEREUNDER THAT SURVIVE THE
CLOSING HEREUNDER; (IV) AND ANY INTENTIONAL FRAUD COMMITTED BY SELLER.

As used in this Agreement, the following terms have the following definitions:

________/s/ JH__________ 
BUYER'S INITIALS

./
-/5-2-19//

3285553_2

7

(1)        "Environmental  Laws"  means  any  applicable  foreign,  federal,  state  or  local  law,  statute,  regulation,  rule,
ordinance,  permit,  prohibition,  restriction,  license,  requirement,  agreement,  consent,  or  approval,  or  any  determination,  directive,
judgment,  decree  or  order  of  any  executive,  administrative  or  judicial  authority  at  any  federal,  state  or  local  level  (whether  now
existing  or  subsequently  adopted  or  promulgated)  relating  to  pollution  or  the  protection  of  the  environment,  natural  resources  or
public health and safety.

(2)        "Handling"  means,  at  any  time  and  to  any  extent  and  in  any  manner  whatsoever,  any  presence  of  or  any
handling, storing, transferring, transporting, treating, using, recycling, separating, sorting, incinerating, transforming, reconstituting,
containing,  containerizing,  packaging,  manufacturing,  generating,  abandoning,  covering,  capping,  dumping,  closing,  maintaining,
disposing,  placing,  discarding,  encapsulating,  filling,  landfilling,  investigating,  monitoring,  remediating,  removing,  responding  to,
reporting on, testing, releasing, contamination resulting from, spilling, leaking, pouring, emitting, emptying, discharging, injecting,
escaping, migrating, or leaching.

(3)        "Hazardous Materials"  means  any  material,  waste,  chemical,  compound,  substance,  mixture,  or  byproduct
that  is  identified,  defined,  designated,  listed,  restricted  or  otherwise  regulated  under  Environmental  Laws  as  a  "hazardous
constituent," "hazardous substance," "hazardous material," "extremely hazardous material," "hazardous waste," "acutely hazardous
waste,"  "hazardous  waste  constituent,"  "infectious  waste,"  "medical  waste,"  "biohazardous  waste,"  "extremely  hazardous  waste,"
"pollutant," "toxic pollutant," or "contaminant," or any other formulation intended to classify substances by reason of properties that
are  deleterious  to  the  environment,  natural  resources  or  public  health  or  safety  including,  without  limitation,  ignitability,
corrosiveness, reactivity, carcinogenicity, toxicity, and reproductive toxicity. The term Hazardous Materials shall include, without
limitation, the following:

i.        a  "Hazardous  Substance,"  "Hazardous  Material,"  "Hazardous  Waste,"  or  "Toxic  Substance"  under  the  Comprehensive
Environmental Response, Compensation and Liability Act of 1980, 42 U.S.C. Section 9601, et seq., the Hazardous Materials Transportation Act, 49
U.S.C. Section 5101, et seq. or the Solid Waste Disposal Act, 42 U.S.C. Section 6901, et seq., including any regulations promulgated thereunder, as
any of the foregoing may be amended;

ii.    "Oil" or a "Hazardous Substance" under Section 311 of the Federal Water Pollution Control Act, 33 U.S.C. Section 1321, as

may be amended, as well as any other hydrocarbonic substance, fraction, distillate or by-product;

iii.    an "Acutely Hazardous Waste," "Extremely Hazardous Waste," "Hazardous Waste," or "Restricted Hazardous Waste," under
Section 25110.02, 25115, 25117 or 25122.7 of the California Health and Safety Code, or listed pursuant to Section 25140 of the California Health
and Safety Code, as any of the foregoing may be amended;

iv.    a "Hazardous Material," "Hazardous Substance" or "Hazardous Waste" under Section 25117, 25260, 25281, 25316, 25501, or

25501.1 of the California Health and Safety Code, as any of the foregoing may be amended;

v.        any  substance  or  material  defined,  identified  or  listed  as  an  "Acutely  Hazardous  Waste,"  "Extremely  Hazardous  Material,"

"Extremely Hazardous Waste," "Hazardous Constituent,"

./
-/5-2-19//

3285553_2

8

"Hazardous Material," "Hazardous Waste," "Hazardous Waste Constituent," or "Toxic Waste" pursuant to Division 4.5, Chapters 10 or 11 of Title
22 of the California Code of Regulations, as may be amended;

vi.    any substance or material listed by the State of California as a chemical known by the State to cause cancer or reproductive

toxicity pursuant to Section 25249.8 of the California Health and Safety Code, as may be amended;

vii.    a "Biohazardous Waste" or "Medical Waste" under Sections 117635 or 117690 of the California Health and Safety Code, as

may be amended;

viii.    mold;

ix.    asbestos and any asbestos containing material; and

x.        a  substance  that,  due  to  its  characteristics  or  interaction  with  one  or  more  other  materials,  wastes,  chemicals,  compounds,
substances, mixtures, or byproducts, damages or threatens to damage the environment, natural resources or public health or safety, or is required by
any  law  or  public  entity  to  be  remediated,  including  remediation  which  such  law  or  public  entity  requires  in  order  for  property  to  be  put  to  any
lawful purpose.

(4)    "Waste Materials" means any putrescible or nonputrescible solid, semisolid, liquid or gaseous waste of any

type whatsoever, including, without limitation:

i.    any garbage, trash, refuse, paper, rubbish, ash, industrial or commercial or residential waste, demolition or construction wastes,
abandoned  vehicles  or  parts  thereof,  discarded  home  and  industrial  appliances,  sewage,  sewage  sludge,  manure,  vegetable  or  animal  solid  and
semisolid  waste,  and  any  other  item  intended  to  be  or  actually  dumped,  abandoned,  discarded,  treated,  transformed,  incinerated,  disposed  of  or
recycled;

ii.        any  "solid  waste"  as  defined  in  the  Solid  Waste  Disposal  Act,  42  U.S.C.  Section  6901,  et  seq.,  including  any  regulations

promulgated thereunder, as any of the foregoing may be amended;

iii.    any "solid waste" as defined in the California Integrated Waste Management Act of 1989, California Public Resources Code

Sections 40000, et seq., including any regulations promulgated thereunder, as any of the foregoing may be amended; and

iv.        any  "waste"  as  defined  in  the  Porter  Cologne  Water  Quality  Control  Act,  California  Water  Code  Sections  13000  et  seq.,

including any regulations promulgated thereunder, as any of the foregoing may be amended.

(j)    Expiration of Due Diligence Period. Unless Buyer delivers a notice (the "Termination Notice") to Seller before the end of the
Due  Diligence  Period  that  Buyer  elects  to  terminate  this  Agreement,  Buyer  shall  be  deemed  to  have  elected  to  proceed  with  the  transactions
contemplated  in  this  Agreement  and  to  waive  further  diligence  and  investigation  without  any  conditions  or  qualifications.  If  this  Agreement  is
terminated in accordance with this Section 4(j), Buyer shall obtain a return of the Deposit within three (3) Business Days and neither Party shall
have  any  rights  or  obligations  hereunder  (except  to  the  extent  otherwise  provided  herein  with  respect  to  obligations  and  liabilities  that  expressly
survive the termination of this Agreement). If Buyer does not timely deliver the Termination Notice, the Deposit shall be deemed nonrefundable to
Buyer, except in instances of Seller default under this Agreement, failure of the Buyer's Conditions Precedent to be satisfied or waived in writing by
Buyer, or as otherwise expressly set forth in this Agreement. Buyer may determine to deliver or not to deliver a Termination Notice in its sole and
absolute discretion for any reason or no reason.

(k)    Termination of Agreement. If this Agreement is terminated  prior to Closing for any reason other than Seller's default, then,
Buyer shall return to Seller, within five (5) Business Days after termination, all original documents delivered to Buyer pursuant to Sections 4(b) and
4(c) and copies made by Buyer and its partners, attorneys, accountants, consultants, agents and prospective lenders, provided that Buyer (a) may
retain  one  copy  of  such  documents  for  compliance  purposes,  (b)  will  not  be  required  to  purge  any  electronic  documents  in  its  electronic  archive
system, and (c) may retain copies of any notes or summaries made from such documents so long as such notes or summaries are kept subject to the
terms of this Agreement. Buyer shall not deliver to Seller any third party reports and studies relating to the Property procured or

./
-/5-2-19//

3285553_2

9

obtained by Buyer, or any other person for the benefit of Buyer. The provisions of this Section 4(j) shall survive any termination of this Agreement.

(l)    Natural Hazard Disclosures. As used herein, the term "Natural Hazard Area" shall mean those areas identified as natural hazard
areas or natural hazards in the Natural Hazard Disclosure Act, California Government Code Sections 8589.3, 8589.4 and 51183.5, and California
Public Resources Code Sections 2621.9, 2694 and 4136, and any successor statutes or laws (the "Act"). Seller shall use reasonable efforts to have
the Title Company prepare and provide to Buyer a Natural Hazard Disclosure Statement (the "Disclosure Statement") in a form required by the Act
no later than ten (10) Business Days prior to the expiration of the Due Diligence Period. Buyer acknowledges that Seller shall retain the services of
the Title Company to examine the maps and other information made available to the public by government agencies for the purpose of enabling
Seller to fulfill its disclosure obligations with respect to the Act and to prepare the written report of the result of its examination (the "Report").
Buyer acknowledges that the Report fully and completely discharges Seller from its disclosure obligations under the Act and under California Civil
Code  Sections  1102  through  1102.17.  Buyer  acknowledges  and  agrees  that  nothing  contained  in  the  Disclosure  Statement  limits  Buyer  from  its
opportunity to fully investigate and satisfy itself with the condition of the Property during the Due Diligence Period, including, without limitation,
whether  the  Property  is  located  in  any  Natural  Hazard  Area.  Buyer  further  acknowledges  and  agrees  that  the  matters  set  forth  in  the  Disclosure
Statement  or  Report  may  change  on  or  prior  to  the  Closing  and  that  Seller  has  no  obligation  to  update,  modify  or  supplement  the  Disclosure
Statement or Report. Buyer is solely responsible for preparing and delivering its own Disclosure Statement to subsequent prospective purchasers of
the Property.

5.    Conditions to Closing.

(a)    Buyer's Conditions. The following conditions are precedent to Buyer's obligation to purchase the Property (the "Conditions

Precedent"):

issue the Title Policy. Buyer may request additional title policy forms or endorsements, but such shall not constitute a Condition Precedent.

(i)    Title Insurance. Title Company shall have issued or shall have irrevocably and unconditionally committed in writing to

(ii)    [Intentionally Omitted].

7(e) of this Agreement.

(iii)    Deliveries Complete. Seller shall have delivered to Buyer or Escrow Agent the documents listed in Sections 7(c) and

(iv)    Representations and Warranties. Seller's Representations shall be true and correct in all material respects on and as of
the Closing Date, as if made on and as of such date, except to the extent that they expressly relate to an earlier date. Seller shall have performed in
all material respects each and every covenant, undertaking and agreement required to be performed by Seller under this Agreement and all of Seller's
representations and warranties set forth in this Agreement shall be true and correct in all material respects as of the expiration of the Due Diligence
Period and as of the Closing Date as if made on such date, as evidenced by the delivery by Seller of certificates of Seller, in form and substance
reasonably  acceptable  to  Buyer,  updating  and  setting  forth  any  information  which  qualifies  any  of  the  Seller's  representations  and  warranties  set
forth herein no later than one (1) Business Day prior to the Closing (such certificate being referred to herein as the "Seller Closing Certificate").
Any such qualifications shall be deemed to modify the Seller's representations herein but, if the qualifications are material, shall give Buyer the right
to terminate this Agreement and recover the Deposit without recourse against Seller for such qualifications except to the extent such qualifications
were caused by Seller's knowing concealment. In addition, Seller's representations shall be deemed modified to the extent that Buyer is deemed to
know prior

./
-/5-2-19//

3285553_2

10

to the end of the Due Diligence Period that Seller's representations are inaccurate, untrue or incorrect in any way, but Buyer does not timely deliver
the Termination Notice. Buyer shall be "deemed to know" any fact, circumstance or information or shall have "deemed knowledge" of the same to
the  extent  (a)  any  Buyer's  representative  has  actual  knowledge  of  a  particular  fact  or  circumstance  or  information  that  is  inconsistent  with  any
Seller's representation, or (b) this Agreement, the closing documents executed by Seller, the documents and materials with respect to the Property
delivered  or  made available  to  any  Buyer's representative  in  connection  with the  transaction,  or  any reports  prepared  or  obtained by  any  Buyer's
representative in connection with Buyer's due diligence discloses a particular fact or circumstance or contains information which is inconsistent with
any Seller's representation. If Buyer has the right to terminate this Agreement due to any qualifications made in the Seller Closing Certificate, but
does not do so and proceeds with the Closing, then Buyer shall have no recourse against Seller due to such qualifications.

(b)    Seller's Conditions. The following conditions are conditions precedent to Seller's obligation to sell the Property (the "Seller's

Conditions"):

Section 2 and Section 7(f) of this Agreement.

(i)    Deposit of Funds. Buyer shall have deposited the Purchase Price into escrow, subject to the adjustments set forth in

Agreement.

(ii)    Deliveries Complete. Buyer shall have delivered to Seller or Escrow Agent the documents listed in Section 7(d) of this

respects on and as of the Closing Date, as if made on and as of such date, except to the extent that they expressly relate to an earlier date.

(iii)        Representations  and  Warranties.  Buyer's  representations  and  warranties  shall  be  true  and  correct  in  all  material

(c)    Waiver of Condition. At any time on or before the date specified for the satisfaction of any condition, Seller or Buyer may elect
in writing to waive the benefit of any such condition to its obligations hereunder. By closing the transaction contemplated by this Agreement, Seller
and Buyer shall be conclusively deemed to have waived the benefit of any remaining unfulfilled conditions set forth in this Section 5, except to the
extent that the same expressly survive Closing. Subject to the last sentence of this Section 5(c), in the event any of the conditions set forth in this
Section 5 are neither waived nor fulfilled, Seller or Buyer (as appropriate) may terminate this Agreement (subject to the notice and cure rights set
forth in this Agreement) and exercise such rights and remedies, if any, that such Party may pursuant to the terms of Section 6. The Parties shall be
entitled to one or more extensions of the Closing Date (not to exceed thirty (30) days in the aggregate) for the purposes of satisfying any condition to
Closing.

6.    Remedies.

(a)    If Buyer is in breach or default under this Agreement, which breach or default has not been cured by Buyer within ten (10) days
(the "Cure Period")  after  written  notice  from  Seller,  then  (i)  Seller  may  waive  such  breach  or  default  and  proceed  to  Close,  or  (ii)  Seller  may
terminate this Agreement, in which case the Deposit shall be paid to and retained by Seller as liquidated damages and as Seller's sole remedy for
such breach or default and neither Party shall have any obligation to the other hereunder, except for provisions of this Agreement which expressly
state they survive the termination of this Agreement. THE PARTIES HEREBY AGREE THAT SELLER'S ACTUAL DAMAGES IN SUCH
EVENT  WOULD  BE  EXTREMELY  DIFFICULT  OR  IMPRACTICABLE  TO  DETERMINE  AND  THAT  THE  AMOUNT  OF  THE
DEPOSIT  PLUS  ANY  INTEREST  ACCRUED  THEREON  REPRESENTS  THE  PARTIES'  REASONABLE  ESTIMATE  OF  SUCH
DAMAGES.  THE  PAYMENT  OF  SUCH  AMOUNT  AS  LIQUIDATED  DAMAGES  IS  NOT  INTENDED  AS  A  FORFEITURE  OR
PENALTY WITHIN THE MEANING OF CALIFORNIA CIVIL CODE SECTIONS 3275 OR 3369, BUT IS

./
-/5-2-19//

3285553_2

11

INTENDED  TO  CONSTITUTE  LIQUIDATED  DAMAGES  TO  SELLER  PURSUANT  TO  CALIFORNIA  CIVIL  CODE  SECTIONS
1671,  1676  AND  1677.  THEREFORE,  BY  PLACING  THEIR  INITIALS  BELOW,  THE  PARTIES  ACKNOWLEDGE  THAT  THE
DEPOSIT  HAS  BEEN  AGREED  UPON,  AFTER  NEGOTIATION,  AS  THE  PARTIES'  REASONABLE  ESTIMATE  OF  SELLER'S
DAMAGES AND AS SELLER'S EXCLUSIVE REMEDY AGAINST BUYER, AT LAW OR IN EQUITY, IN THE EVENT THE SALE
OF  THE  PROPERTY  IS  NOT  CONSUMMATED  BY  REASON  OF  A  BREACH  OR  DEFAULT  UNDER  THIS  AGREEMENT  BY
BUYER.  HOWEVER,  NOTHING  IN  THIS  SECTION  SHALL  (x)  PRECLUDE  THE  RECOVERY  OF  REASONABLE  ATTORNEYS'
FEES OR OTHER ACTUAL OUT-OF-POCKET THIRD PARTY COSTS PURSUANT TO SECTION 14(g) INCURRED BY SELLER IN
ENFORCING  THIS  AGREEMENT,  (y)  LIMIT  THE  EFFECTIVENESS  OF  THE  INDEMNIFICATION  OBLIGATIONS  OF  BUYER
UNDER  SECTION  11 AND  14(b)OF  THIS  AGREEMENT,  NOR  (z)  PRECLUDE  THE  SELLER'S  EXERCISE  OF  REMEDIES
PURSUANT TO SECTION 6(b).

/s/ RB
SELLER'S INITIALS

/s/ JH
BUYER'S INITIALS

(b)    If Seller terminates this Agreement pursuant to a right given to it hereunder and Buyer subsequently takes any action which
interferes  with  Seller's  ability  to  sell,  exchange,  transfer,  lease,  dispose  of  or  finance  the  Property  or  take  any  other  actions  with  respect  thereto,
including, without limitation, the filing of any lis pendens or other form of attachment against the Property, then notwithstanding Section 6(a), and in
addition to Seller's rights in Section 6(a), Seller shall have the right to seek, and the named Buyer, and any permitted assignee of Buyer's interest
hereunder,  shall  be  liable  for,  all  loss,  cost,  damage,  liability  or  expense  including,  without  limitation,  reasonable  attorneys'  fees,  court  costs  and
disbursements and consequential damages incurred by Seller by reason of such action to contest by Buyer.

(c)    If Seller is in breach or default under this Agreement, which breach or default has not been by Seller within the Cure Period,
then (i) Buyer may waive such breach or default and proceed to Close, or (ii) Buyer may terminate this Agreement, in which case the Deposit shall
be paid to and retained by Buyer and Buyer shall be entitled to recover its out-of-pocket expenses, which may include, but are not limited to all title,
escrow, financing, legal, environmental, architectural, engineering, professional and inspection fees and expenses incurred by Buyer and any other
expenses incurred by Buyer in connection with the performance of its due diligence review of the Property and shall not exceed One Hundred and
Fifty Thousand No/100 Dollars ($150,000.00), as Buyer's sole remedy for such breach or default and neither Party shall have any obligation to the
other hereunder, except for provisions of this Agreement which expressly state they survive the termination of this Agreement; or (iii) Buyer may
commence an action for specific performance (but not damages hereunder), provided that any action for specific performance must be commenced
within thirty (30) days after the expiration of the Cure Period. If Buyer elects to seek specific performance of this Agreement, then as a condition
precedent  to  any  suit  for  specific  performance,  Buyer  shall  have  on  or  before  the  scheduled  Closing  Date,  fully  performed  all  of  its  obligations
hereunder which are capable of being performed (other than the payment of the Purchase Price, which shall be paid as and when required by the
court  in  the  suit  for  specific  performance).  If  Seller  defaults  in  the  performance  of  any  of  its  obligations  under  this  Agreement,  Buyer  shall  not
prepare,  file  or  record  a  lis  pendens  against  the  Property  and  expressly  waives  any  and  all  rights  to  do  so.  Buyer  acknowledges  that  a  material
inducement  to  Seller's  decision  to  sell  the  Property  to  Buyer  is  the  agreement  of  Buyer  not  to  impede  or  interfere  with  a  subsequent  sale  of  the
Property  by  filing  a  lis  pendens  against  the  Property  and  that  Seller  will  be  damaged  if  Buyer  fails  to  comply  with  the  requirements  of  this
Section 6(c).

7.    Closing and Escrow.

(a)    Upon mutual execution of this Agreement, the Parties shall deposit an executed counterpart of this Agreement with Escrow
Agent as instructions to Escrow Agent as the escrow holder for consummation of the purchase and sale contemplated hereby. Seller and Buyer each
agrees to execute such additional escrow instructions as may be appropriate, or reasonably required by Escrow Agent, to enable the escrow holder to
comply with this Agreement; provided that in the event of any conflict between the provisions of this Agreement and any supplementary escrow
instructions, the terms of this Agreement shall control.

(b)    The Closing hereunder shall be held and delivery of all items to be made at the Closing shall be made at the offices of Escrow

Agent on or before 11:00 a.m. (Pacific Daylight Time) on the Closing Date.

(c)    At least one (1) Business Day prior to the Closing, Seller shall deliver to Escrow Agent, the following:

(i)    a duly executed and acknowledged Deed;

(ii)    two (2) duly executed counterparts of the Assignment of Intangible Property;

(iii)    two (2) duly executed counterparts of the Assignment and Assumption of Leases;

(iv)    executed counterparts of all transfer declarations applicable to the Property;

(v)    duly executed notices to the tenants under the Leases of the sale of the Property, in the form of Exhibit J attached hereto

(vi)        an  affidavit  pursuant  to  Section  1445(b)(2)  of  the  United  States  Internal  Revenue  Code  of  1986,  as  amended  (the

 
 
"Code")  and  on  which  Buyer  is  entitled  to  rely,  that  Seller  is  not  a  "foreign  person"  within  the  meaning  of  Section  1445(f)(3)  of  the  Code,
substantially in the form of Exhibit H attached hereto, and a California form 593-C, together with such affidavits and other documentation as may be
required pursuant to any tax withholding laws or requirements of the State where the Property is located;

satisfactory to Seller, in the event of an escrow Closing prior to recordation of the Deed pursuant to Section 2(b)(iii);

(vii)        a  gap  indemnity  in  favor  of  Title  Company  in  form  and  substance  approved  by  Title  Company  and  reasonably

(viii)    [intentionally omitted];

(ix)    the Seller Closing Certificate;

(x)    a duly executed counterpart of the Closing Statement;

to the extent in Seller's possession, provided that such items may be delivered to Buyer outside of escrow on the Closing Date;

(xi)    the originals or certified copies of any documents representing any Intangible Property being conveyed to Buyer, each

items may be delivered by Seller at the Property or to a mutually agreeable location on the Closing Date); and

(xii)    keys to all doors to the Improvements  which are in Seller's or its agents' possession  (it being understood  that such

shall be reasonably required by Title Company.

(xiii)    such resolutions and authorizations relating to Seller's authority to undertake the transaction contemplated hereby as

Buyer may waive compliance on Seller's part under any of the foregoing items by an instrument in writing.

(d)    At least one (1) Business Day prior to the Closing, Buyer shall deliver to Escrow Agent, the following:

(i)    two (2) duly executed counterparts of the Assignment of Intangible Property;

(ii)    two (2) duly executed counterparts of the Assignment and Assumption of Leases;

(iii)    a Preliminary Change of Ownership Report;

(iv)    executed counterparts of all applicable transfer declarations;

(v)    a duly executed counterpart of the Closing Statement; and

hereby as shall be reasonably required by Seller or Title Company.

(vi)    such resolutions and authorizations relating to Buyer's power and authority to undertake the transaction contemplated

In  addition,  the  Purchase  Price,  as  adjusted  for  prorations  and  costs  as  provided  herein  shall  have  been  delivered  to  Escrow  Agent,  as
escrow holder.

Seller may waive compliance on Buyer's part under any of the foregoing items by an instrument in writing.

(e)    Seller and Buyer shall each deposit such other instruments as are reasonably required by the Title Company and/or Escrow
Agent, or otherwise required to close the escrow and consummate the purchase and sale of the Property in accordance with the terms hereof. In the
event the Title Company requires Seller to provide an owner's declaration, Seller shall execute and deliver the owner's declaration in the form of
Exhibit K attached hereto. The documents and instruments to be delivered pursuant to Sections 7(c) and 7(d) and this Section 7(e) shall be referred
to herein, collectively, as the "Closing Documents".

(f)    The following are to be apportioned as of the Closing Date and the applicable adjustment(s) shall be made to the Purchase Price

delivered to Seller:

(i)        Rents.  Rent,  percentage  rent  (if  any),  operating  cost  pass-throughs  and  other  additional  rent  or  charges  payable  to
landlord under the Leases (collectively "Rent") and prepaid Rent under the Leases shall be apportioned as of the Closing Date, only to the extent
then paid, based on the actual number of days in the month or other applicable period during which the Closing occurs. Unallocated security deposits
then held by Seller shall be considered a credit due to Buyer for Closing settlement purposes. Seller shall be entitled to invoice and collect from the
tenants after the Closing any Rent payable for periods prior to Closing, provided that Seller shall not be permitted to bring any action to terminate
any Lease or evict any tenant. With respect to any Rent arrearages existing under the Leases or operating cost pass-throughs billed by or paid to
Buyer after Closing, Buyer promptly shall pay to Seller any amounts actually collected which are applicable to the period preceding the Closing
Date; provided that, all such amounts collected by Buyer or Seller after the Closing Date shall be applied first to Rent due for the month in which the
Closing occurs, then to unpaid Rent that has accrued for any month after the month of Closing, and then to any unpaid Rent that has accrued for any
month prior to the Closing Date. Buyer shall cooperate with Seller in recovering any Rent payable for periods prior to Closing by including such
amounts in Buyer's monthly billing statements for no longer than six (6) months after the Closing Date.

(ii)    Leasing Costs. At Closing, (a) Buyer and Seller shall prorate any and all Lease Expenses paid or incurred by Seller

prior  to  Closing  arising  out  of  or  in  connection  with  any  new  lease  or  modifications  of  any  Lease  entered  into  between  the  date  of  the  Access
Agreement (the "Commencement Date") and the Closing; and (b) Seller shall give Buyer a credit for any and all unpaid and due and owing Lease
Expenses  owed  to  or  for  the  benefit  of  tenants  of  the  Property  with  respect  to  Leases  as  in  effect  on  the  Commencement  Date.  For  purposes  of
determining Buyer's and Seller's pro rata share of the amounts to be prorated pursuant to  clause (a), such Lease Expenses shall be amortized over
the full term of the subject Lease or modification, as the case may be, and apportioned between Buyer and Seller as of 12:01 a.m. on the Closing
Date based upon the proportion of the affected term of the applicable Lease or modification that falls within each of Buyer's and Seller's period of
ownership of the Property. "Lease Expenses" means any and all costs, expenses, and fees paid or incurred by Seller prior to Closing in connection
with any new lease or Lease modification, including, without limitation, (i) leasing commissions, (ii) expenses incurred for tenant improvements,
(iii) legal fees, (iv) free rent, rent abatements, or rent concessions, and (v) expenses incurred to satisfy or terminate the obligations of a tenant under
another lease.

(iii)    Utility Charges. To the extent that Seller (rather than the tenants) is responsible for utility charges, utility charges will
be prorated between Buyer and Seller based on the most recently issued bills therefor, subject to adjustment after the Closing when the next bills are
available, or if current meter readings are available, on the basis of such readings. Seller will request that all utility meters for the Property be read as
close to the Closing Date as feasible.

(iv)    Other Apportionments and Closing Costs. Amounts payable under the Assumed Contracts, annual or periodic permit
and/or inspection fees, and liability for other Property operation and maintenance expenses and other recurring costs will be apportioned as of the
Closing Date.  Buyer shall pay: (A) the cost of the portion of the title insurance premiums  not paid by Seller and the cost of any endorsement(s)
Buyer may have chosen to add to the Title Policy; (B) all fees, costs and expenses incurred in connection with Buyer's due diligence activities; and,
(C) one-half of the real estate transfer taxes imposed by the City. Seller shall pay: (U) all recording fees for the recording of the Deed; (V) the cost of
the Title Policy if it were for the standard ALTA coverage without endorsement (other than endorsements to cure any title exceptions that Seller has
agreed to cure); (W) Escrow Agent's fees (except as otherwise provided by this Section 7(f)(iv)) (X) all real estate transfer tax not payable by the
Buyer;  and  (Y)  the  commission/fee  payable  to  Seller's  Broker;  and  (Z)  the  cost  of  any  endorsements  to  the  Title  Policy  obtained  to  cure  title
objections in accordance with Section 4(e). The preceding allocation of costs is consistent with the custom and practice in the County of Santa Clara.
If this Agreement is terminated due to a default of Seller hereunder, then Seller shall pay all escrow fees and charges incurred in connection with
such termination, and if this Agreement is terminated for any other reason, then Buyer shall pay all such escrow fees and charges. Each Party shall
pay  its  own  legal  fees  and  expenses  incurred  in  connection  with  the  transactions  contemplated  by  this  Agreement.  Payment  of  all  other  costs
incurred  in  connection  with  the  transaction  contemplated  by  this  Agreement  shall  be  allocated  between  Buyer  and  Seller  in  accordance  with  the
custom of the County where the Property is located, as reasonably determined by Escrow Agent.

(v)    Real Estate Taxes and Special Assessments. General real estate taxes and assessments paid by the tenants under the
Leases  shall  not  be  prorated.  Subject  to  the  preceding  sentence,  general  real  estate  taxes  and  assessments  payable  during  the  tax  year  in  which
Closing occurs will be prorated at the Closing on an accrual basis on the basis of the taxes and assessments that accrue and are due and payable
during the tax year in which the Closing occurs as follows: (i) Seller shall be responsible for that portion of such taxes and assessments equal to
(A) the total of such taxes due and payable during the tax year in which the Closing occurs, multiplied by (B) a fraction, the numerator of which
shall be the number of days in such tax year prior to the Closing Date, and the denominator of which shall be 365; and (ii) Buyer shall be responsible
for that portion of such taxes and assessments equal to (A) the total of such taxes due and payable during the tax year in which the Closing occurs,
multiplied by (B) a fraction, the numerator of which shall be the number of days in such tax year subsequent to and including the Closing Date, and
the denominator of which shall be 365. Notwithstanding anything to the contrary herein, Seller shall be entitled to any and all tax refunds relating to
the period before the Closing Date, regardless of when the refunds are received, except if and to the extent that such refunds are payable to tenants of
the Property at the time such refunds are received under the terms of their respective Leases, in which case the refundable portion of the amount
received shall be paid to such tenants. Buyer shall pay any such refund received by Buyer to Seller, less amounts paid to tenants as described above,
within  five  (5)  Business  Days  of  receipt  by  Buyer  or  its  successors-in-interest.  Seller  shall  have  the  sole  authority  to  prosecute  any  tax  protest,
challenge or appeal for a tax year ending prior to the Closing Date and Buyer shall reasonably cooperate (with Seller paying any out-of-pocket costs
incurred by Buyer in doing so) in the prosecution of any such protest, challenge or appeal.

(vi)        Closing  Statement.  Escrow  Agent  shall  prepare  a  preliminary  Closing  settlement  statement  and  shall  deliver  such
statement to Buyer and Seller for approval no less than three (3) Business Days prior to the Closing Date (the approved statement being referred to
as the "Closing Statement").

(vii)        Post-Closing  Reconciliation.  Seller  and  Buyer  hereby  agree  that  if  any  of  the  Section  7(f) prorations  cannot  be
calculated accurately as of the Closing Date, then the same shall be estimated based on current information then known, such as the most recent tax
bills, for the purposes of Closing, and within thirty (30) days after the Closing Date, or as soon as sufficient information is available to permit the
Parties to effectively calculate such prorations, but in no event later than the date which is three hundred sixty-five (365) days following the Closing
Date, the Parties shall make such adjustments to the prorations as necessary to reflect the accurate information, and the Parties shall then make such
payments to one another as necessary to correct any errors made in the prorations as of the Closing Date once such correct information is available.
Either  Party  owing  the  other  Party  a  sum  of  money  based  on  such  subsequent  prorations  shall  pay  such  sum  to  the  other  Party  within  ten  (10)
Business Days after such calculations.

(365) days following the expiration of the calendar year in which the Closing occurs.

(viii)        Survival. The provisions of Section 7(f) shall survive the Closing until the date  which  is three hundred sixty-five

8.        Representations  and  Warranties  of  Seller.  The  phrase  "to  Seller's  knowledge"  means  to  the  actual  (and  not  constructive),  present
knowledge of Andrew Jenkins (the "Seller's Designated Representative"), of Seller, without any duty of inquiry, investigation or inspection. There

shall be no personal liability on the part of the Seller's Designated Representative arising out of any of the Seller's representations. Seller hereby
represents and warrants to Buyer as follows, which representations and warranties shall be true as of the Effective Date, and as of the Closing Date,
subject to the provisions of Sections 5(a)(iv), 10 and 14(m):

(a)    Status. Seller is duly organized or formed, validly existing and qualified and empowered to conduct its business, and has full

power and authority to enter into and perform the terms of this Agreement.

(b)    Authorization. This Agreement is duly authorized and executed by Seller, and this Agreement and all documents required to be
executed by Seller in connection herewith, are and shall be, when executed, valid, legally binding obligations of Seller, enforceable in accordance
with  their  terms.  To  Seller's  Knowledge,  neither  the  execution  and  delivery  of  this  Agreement,  nor  the  performance  by  Seller  of  the  obligations
hereunder, will conflict with or result in the breach of any contract, agreement, law, rule or regulation to which Seller is a party or by which Seller is
bound.  No  action,  proceeding  or  investigation  is  pending  or,  to  Seller's  Knowledge,  threatened  against  Seller,  before  any  governmental  or  other
authority that would affect its ability to carry out its obligations under this Agreement.

(c)        Litigation.  Seller  has  not  received  any  written  notice  of  any  current,  pending,  or  threatened  litigation,  claim,  audit,  action,
proceeding before or by any court, public board or body or governmental or administrative agency or instrumentality against Seller or the Property,
including, without limitation, any condemnation proceedings, which would, in the reasonable judgment of Seller, adversely affect the Property

(d)    Condemnation. To Seller's knowledge, Seller has not received any written notice of any pending or threatened condemnation or

eminent domain action by any governmental authority with respect to all or any part of the Property.

(e)    Leases. Attached hereto as Exhibit E is a schedule of the Leases as of the Effective Date. The information set forth in said
Exhibit E is accurate in all material respects as of the Effective Date and all such Leases are in writing except as set forth on  Exhibit E and if any
such  Lease  is  not  in  writing  the  material  terms  of  the  tenancy,  to  Seller's  knowledge,  are  set  forth  in  Exhibit E.  If  there  are  any  inconsistencies
between the information set forth in Exhibit E and the provisions of such Leases or copies thereof which have been exhibited or provided to Buyer
or its representative(s), then the provisions of the Leases shall prevail and Exhibit E shall be deemed amended accordingly. To Seller's knowledge,
there are no leasing commissions payable or which will become payable with respect to the Leases.

(f)        Contracts. Seller has not entered into any service agreements, equipment leasing contracts, or other contracts relating to the
management  of  the  Property  which  will  be  in  force  after  the  Closing,  except  for  the  Leases  and  the  Contracts  and,  if  applicable,  any  document
recorded against any part of the Property. To Seller's knowledge, there is no monetary default or material non-monetary default under the Contracts.

(g)    Compliance. To Seller's knowledge, (i) Seller has not received any written notice that the Property is not in compliance with
any laws or ordinances applicable to the ownership and operation of the Property and (ii) no license or permit that has not been obtained is required
for the use, ownership or operation of the Property.

(h)        Environmental  Matters.  To  Seller's  knowledge,  the  Due  Diligence  Documents  include  all  of  the  recent  third  party  reports

relating to Hazardous Materials at the Property and issued to Seller within the last four (4) years of the Effective Date.

(i)        Non-foreign Person.  Seller  is  not  a  "foreign  person"  as  that  term  is  defined  in  Section  1445(f)  of  the  Code  and  any  similar

provisions of applicable state law, and the regulations issued thereunder.

(j)        Non-foreign  Assets.  Seller is  in  compliance  with  the  requirements  of  Executive  Order  No.  13224,  66  Fed  Reg.  49079
(September 25, 2001) (the "Order") and other similar requirements contained in the rules and regulations of the Office of Foreign Asset Control,
Department of the Treasury ("OFAC") and in any enabling legislation or other Executive Orders in respect thereof (the Order and such other rules,
regulations, legislation, or orders are collectively called the "Orders"). Seller:

(i)    is not listed on the Specially Designated Nationals and Blocked Persons List maintained by OFAC pursuant to the Order
or on any other list of terrorists or terrorist organizations maintained pursuant to any of the rules and regulations of OFAC or pursuant to any other
applicable Orders (such lists are collectively referred to as the "Lists");

(ii)    has not been determined by competent authority to be subject to the prohibitions contained in the Orders; and

entity that has been determined by competent authority to be subject to the prohibitions contained in the Orders

(iii)    is not owned or controlled by, nor acts for or on behalf of, any person or entity on the Lists or any other person or

(iv)    is not knowingly engaged in, and will not knowingly engage in, any dealings or transactions or be otherwise associated
with  such  persons  or  entities  on  the  Lists  or  that  has  been  determined  by  competent  authority  to  be  subject  to  the  prohibitions  contained  in  the
Orders; and

(v)        agrees  to  cooperate  with  Buyer  in  providing  such  additional  information  and  documentation  on  Seller's  legal  or
beneficial ownership, policies, procedures and sources of funds as Buyer reasonably deems necessary or prudent solely to enable it to comply with
Orders or anti-money laundering laws as now in existence or hereafter amended.

9.        Representations  and  Warranties  of  Buyer.  The  phrase  "to  Buyer's  knowledge"  means  to  the  actual  (and  not  constructive),  present
knowledge of Judy Hamel (the "Buyer's Designated Representative"), of Buyer, without any duty of inquiry, investigation or inspection. There

shall be no personal liability on the part of the Buyer's Designated Representative arising out of any of the Buyer's representations. Buyer hereby
represents and warrants to Seller as of the Effective Date and as of the Closing Date as follows (such representations and warranties to survive the
Closing):

(a)    Status. Buyer is duly organized or formed, validly existing and qualified and empowered to conduct its business, and has full

power and authority to enter into and perform the terms of this Agreement.

(b)    Authorization. This Agreement is duly authorized and executed by Buyer, and this Agreement and all documents required to be
executed by Buyer in connection herewith, are and shall be, when executed, valid, legally binding obligations of Buyer, enforceable in accordance
with their terms. To Buyer's knowledge, neither the execution and delivery of this Agreement, nor its performance by Buyer, will conflict with or
result in the breach of any contract, agreement, law, rule or regulation to which Buyer is a party or by which Buyer is bound. There are no actions or
proceedings  pending  or,  to  Buyer's  knowledge,  threatened  to  liquidate,  reorganize,  place  in  bankruptcy  or  dissolve  Buyer,  and  Buyer  is
contemplating no such action.

./
-/5-2-19//

3285553_2

12

(c)    Proceedings. No action, proceeding or investigation is pending or, to Buyer's knowledge, threatened against Buyer, before any

governmental or other authority that would affect its ability to carry out its obligations under this Agreement.

(d)    Non-foreign Assets. Buyer is and will remain in compliance with the requirements of the Orders. Buyer:

(i)    is not listed on the Lists;

(ii)    has not been determined by competent authority to be subject to the prohibitions contained in the Orders;

other person or entity that has been determined by competent authority to be subject to the prohibitions contained in the Orders;

(iii)    is not and will not become owned or controlled by, nor acts for or on behalf of, any person or entity on the Lists or any

(iv)    is not knowingly engaged in, and will not knowingly engage in, any dealings or transactions or be otherwise associated
with  such  persons  or  entities  on  the  Lists  or  that  has  been  determined  by  competent  authority  to  be  subject  to  the  prohibitions  contained  in  the
Orders; and

(v)        agrees  to  cooperate  with  Seller  in  providing  such  additional  information  and  documentation  on  Buyer's  legal  or
beneficial ownership, policies, procedures and sources of funds as Seller reasonably deems necessary or prudent solely to enable Buyer to comply
with Orders or anti-money laundering laws as now in existence or hereafter amended.

(e)    ERISA. Buyer is not, nor is acting on behalf of, an entity or person that is either (i) a benefit plan investor as defined under 29
CFR Section  2510.3-101, as modified by Section 3(42) of the Employee Retirement Income Security Act of 1974, as amended (the "Plan Assets
Regulation") or (ii) any other entity that holds ERISA "plan assets" under the Plan Assets Regulation. No transaction contemplated in the Agreement
will  be  subject  to  any  rules  or  regulations  applicable  to  a  "governmental  plan"  (as  defined  in  Section  3(32)  of  ERISA)  by  virtue  of  Buyer's
involvement.

10.    Warranties and Indemnifications.

(a)    Seller's Representations Deemed Modified. To the extent that Buyer knows or is deemed to know prior to the expiration of the
Due  Diligence  Period  that  Seller's  Representations  are  inaccurate,  untrue  or  incorrect  in  any  way,  such  Seller's  Representations  shall  be  deemed
modified to reflect Buyer's knowledge and deemed knowledge.

(b)        Breach Prior to Closing. If after the expiration of the Due Diligence Period but prior to the  Closing, either Buyer or Seller
obtains actual knowledge that any of the representations or warranties made herein are untrue, inaccurate of incorrect in any material respect, such
Party shall give the other Party written notice thereof within five (5) Business Days of obtaining such knowledge (but, in any event, prior to the
Closing). In  the event of  any breach of Seller's Representations, Seller shall have the right to cure such misrepresentation or breach and  shall be
entitled  to  a  reasonable  extension  of  the  scheduled  Closing  Date  (not  to  exceed  thirty  (30)  days)  for  the  purposes  of  such  cure.  The  untruth,
inaccuracy  or  incorrectness  of  Seller's  Representations  shall  be  deemed  material  for  all  purposes  of  this  Agreement  only  if  Buyer's  aggregate
damages resulting from the untruth, inaccuracy or incorrectness of Seller's Representations are reasonably estimated to exceed $100,000. If any of
Seller's Representations are untrue, inaccurate or incorrect but are not, in the aggregate, untrue, inaccurate, or incorrect in any material respect

./
-/5-2-19//

3285553_2

13

as set forth herein, Buyer shall be deemed to waive such misrepresentation or breach of warranty, and Buyer shall be required to consummate the
transaction contemplated by this Agreement without any reduction of or credit against the Purchase Price.

11.    Indemnity. Buyer hereby waives and agrees to protect, indemnify, defend and hold the Released Parties free and harmless from and
against any and all losses, damages, injuries, accidents, fires or other casualties, liabilities, claims, costs or expenses (including, but not limited to,
any and all damage to any portion of the Property and reasonable attorneys' fees and expenses) of any kind or character (i) to any person or property
relating to any personal injury, bodily injury, death or property damage resulting from due diligence activities on the Property by or for Buyer; or
(ii) for any violation of any law, ordinance or regulation resulting therefrom. Counsel retained by Buyer for purposes of this Section 11 shall be
reasonably acceptable to Seller. Buyer's obligations hereunder shall not apply to claims or liabilities to the extent caused by the willful misconduct or
gross negligence of Seller or the Released Parties seeking the benefit of this Section 11. Buyer shall have no responsibility or liability for: (a) any
adverse  condition  or  defect  on  or  affecting  the  Property  not  caused  by  Buyer  during  its  inspections;  (b)  the  discovery  of  hazardous  materials  or
substances  not  introduced  by  Buyer  except  to  the  extent  that  the  Buyer's  actions  exacerbate  any  condition  discovered;  and  (c)  the  discovery  or
legally required disclosure by Buyer of any pre-existing condition of or on the Property. The indemnification provisions of this Section 11 and the
covenants, representations and warranties provided in this Agreement shall survive the Closing or earlier termination of this Agreement.

12.        Risk  of Loss.  In  the event  any  of  the Property  is  damaged  or destroyed  prior  to  the Closing  Date,  and  such damage  or  destruction
(a) (i) would cost less than the Purchase Price to repair and is fully covered by Seller's insurance, except for the deductible amounts thereunder, or
(ii) is not insured but would cost less than One Million No/100 Dollars ($1,000,000) to repair or restore, and (b) does not materially and adversely
affect required access to or parking at the Property ("Loss of Access") and (c) does not give rise to any right of any tenant(s) representing ten percent
(10%) or more of the gross monthly rents of the Property to terminate its or their Lease(s) pursuant to the terms of such Lease(s), unless such rights
have been waived ("Loss of Tenant), then this Agreement shall remain in full force and effect, and Buyer shall acquire the Property upon the terms
and conditions set forth herein ("Immaterial Casualty"). In such event, Buyer shall receive a credit against the Purchase Price equal to the lesser of
the cost of repairs or restoration required to be completed after the Closing or the deductible amounts under Seller's insurance policies, except the
portion applied to repairs, and except to the extent reimbursable by tenants under any of the Leases), less the amount of Seller's costs in connection
with such damage or destruction, and Seller shall assign to Buyer all of Seller's right, title and interest in and to all proceeds of insurance on account
of such damage or destruction. In the event of a casualty other than an Immaterial Casualty or in the event that the Property becomes the subject of
any condemnation proceeding involving a material portion of the rentable Improvements or a substantial access to the Property or a Loss of Access
or a Loss of Tenant, then Buyer shall have the right, at its election, to terminate this Agreement by delivery of notice of termination to Seller within
ten (10) days after having been given notice of such circumstance but in any event prior to the scheduled Closing Date, whereupon Buyer and Seller
shall instruct Escrow Agent to return the Deposit to Buyer, and Buyer and Seller shall be released from all obligations hereunder pertaining to the
Property  (other  than  the  provisions  which  expressly  survive  the  termination  of  this  Agreement).  If  Buyer  elects  not  to  terminate  this  Agreement,
Seller shall assign to Buyer all of Seller's right, title, and interest in any proceeds of insurance or condemnation awards on account of such damage
or  destruction  less  Seller's  reasonable  costs  and  expenses  incurred  in  obtaining  the  proceeds  or  award,  as  applicable,  and  the  costs  and  expenses
incurred by Seller prior to Closing respecting any repairs or restoration work made by Seller as a result of the casualty or condemnation, and the
Purchase Price shall be reduced only by an amount equal to the lesser of the cost of repairs or restoration remaining to be completed or the unpaid
portion, if any, of the deductible(s) payable in connection with any insurance proceeds received. For the purpose of determining any credit to Buyer

./
-/5-2-19//

3285553_2

14

under this Section 12, the deductible applicable to any uninsured loss shall be deemed to be Zero Dollars ($0). Any repairs or restoration elected to
be made by Seller pursuant to this Section 12 shall be first paid out of insurance proceeds and the deductible and made as promptly as reasonably
possible, and at Seller's election in its sole and absolute discretion, the Closing shall be extended until the repairs or restoration are/is substantially
completed.

13.    Covenants.

(a)    Seller's Covenants. Seller hereby covenants and agrees as follows prior to Closing:

(i)        Maintenance  Duties.  Before  the  Closing,  Seller  shall  use  commercially  reasonable  efforts  to  maintain  the  Property
("Maintenance  Duties")  in  a  manner  consistent  with  past  practices.  Notwithstanding  the  above,  Seller's  Maintenance  Duties  shall  specifically
exclude the obligation: (A) to repair or correct normal wear and tear or deferred maintenance, or (B) to expend more than Ten Thousand and No/100
Dollars  ($10,000.00)  with  respect  to  Maintenance  Duties  in  the  aggregate,  excluding  amounts  clearly  reimbursable  in  full  by  tenants  under  the
Leases.

(ii)    New Leases and Contracts. Seller shall not enter into any new lease or new contract, or any amendment of any existing
lease or contract, or grant any material approval, consent (including, without limitation, any consent to assign or sublease) or waiver under any lease
or contract, to the extent such action would bind Buyer after the Closing, without (i) in the case of any leases contracts, amendments, approvals,
consents or waivers entered into during the Due Diligence Period, obtaining Buyer's prior consent thereto, which consent shall not be unreasonably
withheld, conditioned or delayed, or (ii) in the case of lease contracts, amendments, approvals, consents or waivers entered into after the end of the
Due Diligence Period, obtaining Buyer's prior consent thereto, which consent may be withheld, conditioned or delayed in Buyer's sole and absolute
discretion for any reason or no reason; provided, that nothing in the foregoing prohibits Seller from entering into any Lease or Contract amendment
which memorializes a right of the counterparty thereunder over which Seller has no discretion (such as, by way of example only, a tenant's right of
renewal). If Buyer does not reasonably disapprove Seller's request within three (3) Business Days following receipt of such written request, such
lease, contract, amendment, approval, consent or waiver shall be unconditionally and irrevocably deemed to have been approved by Buyer.

(iii)    Additional Covenants. Seller shall operate the Property in a manner consistent with past practices and perform all of its
material  obligations  as  landlord  under  the  terms  of  the  Leases  and  maintain  its  current  insurance.  Seller  shall  not,  without  Buyer's  prior  written
consent, which consent may be withheld, conditioned or delayed in Buyer's sole and absolute discretion for any reason or no reason after the end of
the Due Diligence Period (i) modify any entitlements affecting the Property, or (ii) make or permit any alterations to the Property.

14.    Miscellaneous.

(a)        Notices.  Except  as  otherwise  specifically  provided  in  this  Agreement,  any  notice,  consent,  request  or  approval  required  or
permitted to be given under this Agreement shall be in writing and shall be deemed to have been given upon (i) hand delivery, (ii) one Business Day
after being deposited with Federal Express or another reliable overnight courier service, (iii) transmission by email during regular business hours at
the  receiver's  location,  and  with  a  confirming  copy  sent  the  same  Business  Day  by  United  States  mail  or  deposited  the  same  Business  Day  with
Federal  Express  or  another  reliable  overnight  courier  service,  or  (iv)  three  (3)  Business  Days  after  being  deposited  in  the  United  States  mail,
registered or certified mail, postage prepaid, return receipt required and addressed as follows:

./
-/5-2-19//

3285553_2

15

If to Seller:    MNCVAD-Graymark Ridder Park LLC

c/o NYL Investors LLC

One Front Street, Suite 550

San Francisco, California 94111

Attention: Andrew Jenkins

Telephone: (415) 402‑4111

Facsimile: (415) 402‑4149

Email: Andrew_Jenkins@nylinvestors.com

With a copy to:    NYL Investors LLC

One Front Street, Suite 550

San Francisco, California 94111

Attention: Legal Department – Real Estate

Telephone: (415) 402-4153

Email: Lillith_E_Shilton@newyorklife.com

And a copy to:    Allen Matkins Leck Gamble Mallory & Natsis LLP

Three Embarcadero Center, Twelfth Floor

./
-/5-2-19//

3285553_2

16

San Francisco, California 94111

Attention: Lee F. Gotshall-Maxon

Telephone: (415) 273-7423

Email: lgotshallmaxon@allenmatkins.com

If to Buyer:    Lumentum Operations LLC

400 North McCarthy Blvd.

Milpitas, California 95035

Attention: Chris Ohman

Telephone: (408) 546-5483

Email: Chris.Ohman@lumentum.com

With a copy to:    Lumentum Operations LLC

400 North McCarthy Blvd.

Milpitas, California 95035

Attention: Legal Department

Telephone: (408) 546-5483

Email: judy.hamel@lumentum.com

And a copy to:    Hoge Fenton Jones & Appel

./
-/5-2-19//

3285553_2

17

60 South Market St., Suite 1400.

San Jose, California 95113-2396

Attention: Sean Cottle

Telephone: (408) 947-2404

Email: sean.cottle@hogefenton.com

If to the Escrow Agent:    Chicago Title Insurance Company

455 Market Street, Suite 2100

San Francisco, CA 94105

Attn: Terina J. Kung, Escrow Officer

Telephone No.: (415) 291-5128

Email: terina.kung@ctt.com

or such other address as any Party may from time to time specify in writing to the other. Notice of change of address shall be given by
written notice in the manner detailed in this Section 14(a). Rejection or other refusal to accept or the inability to deliver because of changed
address of which no notice was given shall be deemed to constitute receipt of the notice, demand, request or communication sent.

(b)        Brokers/Intermediaries.  Buyer  and  Seller  each  represent  that  it  has  not  had  any  conversations  or  dealings  with  any  broker,
finder or other intermediary in connection with the Property other than Colliers International ("Seller's Broker") and CBRE ("Buyer's Broker").
Seller shall pay a real estate commission to Seller's Broker pursuant to a separate agreement with Seller's Broker, and Buyer shall pay a real estate
commission to Buyer 's Broker pursuant to a separate agreement with Buyer's Broker. Buyer agrees to defend, indemnify, and hold harmless Seller,
and Seller agrees to defend, indemnify, and hold harmless Buyer from and against any and all liabilities, claims, demands, damages and costs of any
kind

./
-/5-2-19//

3285553_2

18

(including  reasonable  attorneys'  fees,  costs  and  expenses)  arising  from  or  connected  with  any  broker's  or  finder's  fee  or  commission  or  charge
claimed to be due by any person arising from or by reason of Buyer's or Seller's, as applicable, conduct with respect to this transaction (other than
the  commission  to  be  paid  to  Seller's  Broker  by  Seller  or  to  Buyer's  Broker  by  Buyer).  The  provisions  of  this  Section  shall  survive  the  Closing
hereunder or earlier termination of this Agreement

(c)        Successors  and  Assigns.  This  Agreement  shall  be  binding  upon,  and  inure  to  the  benefit  of  the  Parties  hereto  and  their
respective successors, heirs, administrators, and assigns. Buyer shall not assign this Agreement or its rights hereunder to any individual or entity
without the prior written consent of Seller, except that upon written notice to Seller, Buyer may assign all its rights and delegate its duties under this
Agreement to an entity that: (i) is controlled by or under common control with Buyer; and (ii) delivers, on or before the date that is five (5) Business
Days before the Closing Date, to Seller a duly executed assignment and assumption, in form and substance reasonably satisfactory to Seller, of all of
the duties and obligations of Buyer by the proposed assignee (including an express statement of the assumption of the representations and warranties
in Section 9); provided that such assignment document shall include a provision that Buyer shall remain liable to Seller for the performance of the
obligations  of  "Buyer"  hereunder  and  such  assignment  shall  not  relieve  Buyer  from  its  obligations  hereunder;  and  provided  further  that  the
assignment  shall  not  delay  Closing.  Seller  may  not  assign  or  otherwise  transfer  its  interest  under  this  Agreement.  Subject  to  the  foregoing,  this
Agreement shall inure to the benefit of and shall be binding upon Seller and Buyer and their respective successors and assigns.

(d)        Amendments.  Except  as  otherwise  provided  herein,  this  Agreement  may  be  amended  or  modified  only  by  an  instrument

executed by the Parties to be bound.

(e)    Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State in which the

Property is located.

(f)        Integration  of  Prior  Agreements.  The  obligations  of  the  Parties  under  the  Access  Agreement  dated  April  16,  2019  between
Seller and Buyer (the "Access Agreement") shall continue to apply to any claims or obligations arising thereunder prior to the Effective Date of this
Agreement. Except as provided in the preceding sentence, this Agreement and the exhibits hereto constitute the entire agreement between the Parties
and supersede all prior negotiations, correspondence, agreements and understandings between the Parties relating to the subject matter hereof. The
Recitals and all exhibits attached hereto are incorporated herein by reference.

(g)        Enforcement.  In  the  event  a  dispute  arises  concerning  the  performance,  meaning  or  interpretation  of  any  provision  of  this
Agreement, the defaulting party or the party not prevailing in such dispute, as the arbitrator, judicial referee, or court shall determine, shall pay any
and  all  reasonable,  third-party,  out-of-pocket  costs  and  expenses  incurred  by  the  other  Party  in  enforcing  or  establishing  its  rights  hereunder,
including, without limitation, arbitration and court costs and attorneys' and experts' fees. Any such attorneys' fees and other expenses incurred by
either  Party  in  enforcing  a  judgment  in  its  favor  under  this  Agreement  shall  be  recoverable  separately  from  and  in  addition  to  any  other  amount
included in such judgment, and such attorneys' fees obligation is intended to be severable from the other provisions of this Agreement and to survive
the Closing or earlier termination of this Agreement and not be merged into any such judgment.

(h)    Confidentiality.

(i)    Confidential Information; General Agreement Not to Disclose; Permitted Disclosures. Buyer agrees that the information
provided to or made available to Buyer by Seller or its agents is proprietary and confidential in nature and will be delivered to or made available to
Buyer solely to assist Buyer in determining the feasibility of purchasing the Property. Buyer further agrees that all studies, reports, test results or
other  information  obtained  by  Buyer  from  Seller  or  its  agent  in  connection  with  its  observations  or  inspection  of  the  Property  shall  remain
confidential. Buyer agrees not to disclose any of the foregoing information, or any of the provisions, terms or conditions thereof, to any person or
entity, or any of the terms of this Agreement or of any letter of intent or other agreement or letter pertaining to the Property, to any person or entity;
provided that Buyer shall be permitted to disclose material information with respect to the

./
-/5-2-19//

3285553_2

19

Property  or  the  terms  of  this  Agreement  to  employees,  consultants,  attorneys,  or  accountants  employed  by  Buyer  to  review  such  information  in
connection  with  Buyer's  Due  Diligence,  and  to  potential  lenders  and/or  joint  venture  partners,  provided  that,  prior  to  any  such  disclosure,  Buyer
notifies the persons and entities to whom such disclosures are made of the confidential nature of the information disclosed or discovered and the
provisions of this Section with respect to such information.

(ii)    Procedure Upon Receipt of Request or Demand for Disclosure. If Buyer receives a request, pursuant to the terms of a
subpoena, order, civil investigation, demand or similar process to disclose anything required under this Agreement to be held confidential, Buyer
agrees  to  promptly  notify  Seller,  in  writing,  of  the  existence,  terms,  and  circumstances  surrounding  such  request,  to  consult  with  Seller  on  the
advisability of taking legally available steps to resist or narrow such request, and if disclosure of such information is required, Buyer shall furnish
only that portion of the confidential information which, on the advice of its counsel, Buyer is legally compelled to disclose; provided, however, that
Seller may, at its sole cost and expense, exercise efforts to obtain an order or other reliable assurance that confidential treatment will be accorded to
any such portion of the confidential information so required to be disclosed.

(iii)    Exception to General Rule Prohibiting Disclosure. Seller agrees that portions of the confidential information need not
be treated confidentially by Buyer if such portions of the confidential information (i) are or become generally known or available publicly through
no act or failure to act of Buyer, or (ii) were already known by Buyer prior to disclosure to Buyer, or (iii) are or become available to Buyer from a
source other than Seller.

(i)    Time of the Essence; Dates. Time is of the essence in this Agreement. If any of the dates specified in this Agreement shall fall
on a Saturday, a Sunday, or a holiday, such date shall be deemed to have expired at 5:00 p.m. (Pacific Daylight Time) on the next Business Day,
notwithstanding anything to the contrary herein. Any action which is to be taken a specified number of days or Business Days before an identified
date shall be timely if taken before 5:00 p.m. (Pacific Daylight Time) on the date which is the specified number of days before the identified date,
including, in counting the specified number of days, the identified date. For example, if an action is to be taken at least two (2) Business Days before
a  date  which  falls  on  a  Wednesday  during  a  week  when  Monday  through  Wednesday,  inclusive,  are  all  Business  Days,  then  the  action  shall  be
timely if taken before 5:00 p.m. (Pacific Time) on the Monday in such week.

(j)    Severability. If any provision of this Agreement, or the application thereof to any person, place or circumstance, shall be held by
a  court  of  competent  jurisdiction  to  be  invalid,  unenforceable  or  void,  the  remainder  of  this  Agreement  and  such  provisions  as  applied  to  other
persons, places and circumstances shall remain in full force and effect.

(k)        Counterparts.  This  Agreement  may  be  executed  in  any  number  of  counterparts,  including  those  transmitted  by  .pdf  or
DocuSign, each of which will be deemed an original, but all of which taken together will constitute one and the same instrument. The signature page
of any counterpart may be detached therefrom without impairing the legal effect of the signature(s) thereon provided such signature page is attached
to any other counterpart identical thereto except having additional signature pages executed by other parties to this Agreement attached thereto. The
Parties hereby acknowledge and agree that signatures transmitted by electronic mail in so-called "pdf" or DocuSign format shall be legal and binding
and shall have the same full force and effect as if an original of this Agreement had been delivered. Buyer and Seller (i) intend to be bound by the
signatures  on  any  document  sent  by  electronic  mail,  (ii)  are  aware  that  the  other  Party  will  rely  on  such  signatures,  and  (iii)  hereby  waive  any
defenses to the enforcement of the terms of this Agreement based on the foregoing forms of signature

./
-/5-2-19//

3285553_2

20

(l)        1031 Exchange. Upon request of  a Party hereto  (the  "Requesting Party"), the other Party (the "Cooperating Party") shall
cooperate in effecting one or more tax-deferred like kind exchanges under Section 1031 of the Code in connection with the transaction contemplated
by this Agreement, including the execution of escrow instructions and other documents therefor; provided that, the Requesting Party will pay any
and all additional fees, costs or expenses connected with such exchange. Requesting Party may assign its rights in, and delegate its duties under, this
Agreement (in part or in whole), as well as transfer its interest in the Property, to an exchange intermediary, and Requesting Party may add such
intermediary  as  an  additional  party  to  the  escrow;  provided  that,  Requesting  Party  shall  remain  primarily  liable  under  this  Agreement,  such
assignment, delegation or transfer shall not delay Closing, and Cooperating Party incurs no additional expense as a result thereof. Without limiting
the  foregoing,  Cooperating  Party  shall  not  by  this  Agreement  or  acquiescence  to  any  exchange  requested  by  Requesting  Party  have  Cooperating
Party's rights under this Agreement modified or diminished in any manner or be responsible for compliance with or be deemed to have warranted to
Requesting  Party  that  any  such  exchange  in  fact  complies  with  Section  1031  of  the  Code.  Cooperating  Party  shall  have  the  right  to  review  and
approve  any  documents  to  be  executed  by  Cooperating  Party  in  connection  with  any  such  exchange  requested  by  Requesting  Party;  provided,
however,  such  approval  shall  not  be  unreasonably  withheld,  conditioned  or  delayed.  Cooperating  Party  shall  have  no  obligation  to  execute  any
documents or to undertake any action by which Cooperating Party would or might incur any liability or obligation not otherwise provided for in the
other provisions of this Agreement or to take title to any additional property. Neither the conveyance of title to the Property to Requesting Party's
designated  intermediary,  or  qualified  exchange  accommodation  title  holder  (if  applicable),  nor  any  exchange  shall  amend  or  modify  the
representations, warranties and covenants of Requesting Party to Cooperating Party under this Agreement or the survival thereof pursuant to this
Agreement in any respect, nor shall any such conveyance or exchange result in a release of Requesting Party with respect to such representations,
warranties and/or covenants. Requesting Party hereby agrees to indemnify, defend, and hold Cooperating Party harmless from and against any and
all losses,  damages,  injuries,  liabilities,  claims,  costs  or expenses  (including,  but not limited  to, reasonable  attorneys'  fees)  arising  from  any such
exchange  requested  by  Requesting  Party  (other  than  what  would  have  been  applicable  under  this  Agreement  without  such  exchange),  which
indemnification agreement shall expressly survive the Closing and not be merged therein. Requesting Party will be relying solely upon the advice
and counsel of professionals of the Requesting Party's choice in structuring, executing and consummating any such exchange.

(m)    Survival and Limitations.

(i)        The  Parties  agree  that  Seller's  Representations  shall  expire  and  shall  be  of  no  further  force  or  effect  as  of  nine  (9)
months following the Closing Date (the "Limitation Period"). If Buyer, within the Limitation Period, gives notice to Seller of any breach of such
Seller's  Representations  or  any  Post-Closing  Default  (the  "Notice"),  which  Notice  shall  not  be  effective  unless  it  sets  forth,  in  detail  and  with
particularity, the breach or default and the factual basis for asserting the same, and if Seller fails to cure such breach or Post-Closing Default, as the
case  may  be,  within  thirty  (30)  days  following  the  giving  of  such  Notice,  or,  if  such  breach  or  Post-Closing  Default  cannot  reasonably  be  cured
within  thirty  (30)  days,  Seller  shall  be  provided  with  an  additional  reasonable  time  period  to  cure  such  breach,  so  long  as  such  cure  has  been
commenced  within  such  thirty  (30)  days  and  has  been  diligently  pursued  and  is  concluded  within  one  hundred  twenty  (120)  days  following  the
giving of such Notice, then Buyer's sole remedy shall be an action at law for damages as a consequence thereof, which must be commenced, if at all,
prior to the expiration of the Overall Limitation Period. The Limitation Period shall apply to known as well as unknown breaches of such Seller's
Representations; provided that, the Closing shall be deemed to constitute a waiver of any breach of which Buyer is deemed to know or had actual
knowledge  as  of  the  Closing  Date.  Buyer  shall  not  have  the  right  to  bring  a  cause  of  action  for  a  breach  of  a  Seller's  Representation  unless  the
damage to Buyer on account of such breach (individually or when combined with damages from other breaches) equals or

./
-/5-2-19//

3285553_2

21

exceeds  Twenty-Five  Thousand  and  No/100  Dollars  ($25,000.00),  and  Buyer  agrees  that  the  post-Closing  maximum  liability  of  Seller  for  the
alleged breach of any or all Seller's Representation and/or any Post-Closing Default is limited to One Million and No/100 Dollars ($1,000,000.00) as
more particularly set forth in Section 14(m)(ii).

The  term  "Post-Closing  Defaults"  means  all  (i)  post-Closing  defaults  by  Seller  under  this  Agreement  and  the  agreements  and
instruments to be delivered by Seller at Closing including, without limitation, the Deed, and (ii) all pre-Closing Seller defaults not waived
pursuant  to  this  Agreement  and  not  known  or  deemed  to  be  known  by  Buyer  as  of  Closing.  In  the  event  of  one  or  more  Post-Closing
Defaults,  Buyer's  sole  and  exclusive  remedy  shall  be  to  seek  actual  damages  in  an  amount  (including  attorneys'  fees  and  costs)  not  to
exceed the limits set forth in this Section 14(m). The provisions of this Section 14(m) shall survive any termination of this Agreement.

(ii)    The aggregate liability of Seller to Buyer and all those claiming by or through Buyer for claims, demands, damages,
expenses (including attorneys' fees), suits, awards, judgments and liabilities asserted, awarded or otherwise recovered against Seller in connection
with  this  Agreement,  any  document  executed  by  Seller  in  connection  with  this  Agreement  and/or  the  Property,  including  claims  for  breaches  of
Seller's Representations and any and all Post-Closing Defaults, shall not exceed One Million and No/100 Dollars ($1,000,000.00). Notwithstanding
anything to the contrary, the limitations of liability of this Section 14(m)(ii) shall not apply with respect to Buyer's right to recover its attorneys' fees
and expenses in accordance with Section 13(g).

(iii)        Any  right  of  Buyer  to  bring  a  claim,  suit  or  demand  under  this  Agreement  or  any  document  executed  by  Seller
pursuant to this Agreement shall expire and shall be of no further force or effect as of the Limitation Period. Notwithstanding the foregoing, if Buyer
delivers the Notice within the Limitation Period, Buyer may bring a claim, suit or demand under this Agreement within ninety (90) days from the
Limitation Period (the "Overall Limitation Period") with respect to the breach identified in the Notice. Buyer's right to bring such claim, suit or
demand shall be subject to any applicable notice and cure rights described in Section 14(m)(i)  above; provided that, if such cure  rights and  cure
period extend beyond the Limitation Period, then the Overall Limitation Period shall be extended to the date that is ninety (90) days after Seller's
cure period has expired. The Overall Limitation Period referred to herein shall apply to known as well as unknown breaches of this Agreement or
any such document or other bases for claims that may be brought under this Agreement or any such document.

(n)    Exculpation. Buyer and Seller each agree that it does not have and will not have any claims or causes of action against any
disclosed or undisclosed officer, director, employee, trustee, shareholder, partner, principal, parent, subsidiary or other affiliate of the other, or any
officer,  director,  employee,  trustee,  shareholder,  partner,  or  principal  of  any  such  parent,  subsidiary  or  other  affiliate  (collectively,  "Affiliates"),
arising out of or in connection with this Agreement or the transactions contemplated hereby (including, without limitation, under any documents
executed pursuant hereto). Subject to the limitations set forth in this Agreement, Buyer and Seller agree to look solely to the other and its assets for
the satisfaction of any liability or obligation arising under this Agreement, the transactions contemplated hereby or the documents executed pursuant
hereto, or for the performance of any of the covenants, warranties or other agreements contained herein or therein, and further agrees not to sue or
otherwise  seek  to  enforce  any  personal  obligation  against  any  Affiliates  with  respect  to  any  matters  arising  out  of  or  in  connection  with  this
Agreement,  the  transactions  contemplated  hereby  or  the  documents  executed  pursuant  hereto.  Without  limiting  the  generality  of  the  foregoing
provisions of this Section 14(n), Buyer and Seller each hereby unconditionally and irrevocably waives any and all claims and causes of action of any
nature whatsoever it may now or hereafter have against Affiliates, and hereby unconditionally and irrevocably releases and

./
-/5-2-19//

3285553_2

22

discharges Affiliates from any and all liability whatsoever which may now or hereafter accrue in favor of Buyer or  Seller, as applicable,  against
Affiliates, in connection with or arising out of this Agreement, the transactions contemplated hereby or the documents executed pursuant hereto. The
provisions of this Section 14(n) shall survive the termination of this Agreement and the Closing.

(o)    Designation of Reporting Person. In order to assure compliance with the requirements of Section 6045 of the Code, and any

related reporting requirements of the Code, the Parties hereto agree as follows:

(i)    Provided Escrow Agent shall execute a statement in writing in form and substance reasonably acceptable to the Parties
hereunder pursuant to  which Escrow Agent agrees  to  assume  all  responsibilities  for  information  reporting  required  under  Section  6045(e)  of  the
Code, Seller and Buyer shall designate Escrow Agent as the person to be responsible for all information reporting under Section 6045(e) of the Code
(the "Reporting Person"). If Escrow Agent refuses to execute a statement pursuant to which it agrees to be the Reporting Person, Seller and Buyer
shall agree to appoint another third party as the Reporting Person.

(ii)    Seller and Buyer hereby agree:

(1)        to  provide  to  the  Reporting  Person  all  information  and  certifications  regarding  such  Party,  as  reasonably
requested  by  the  Reporting  Person  or  otherwise  required  to  be  provided  by  a  Party  to  the  transaction  described  herein  under
Section 6045 of the Code; and

(2)        to  provide  to  the  Reporting  Person  such  Party's  taxpayer  identification  number  and  a  statement  (on  Internal
Revenue Service Form W-9 or an acceptable substitute form, or on any other form the applicable current or future Code sections and
regulations  might  require  and/or  any  form  requested  by  the  Reporting  Person),  signed  under  penalties  of  perjury,  stating  that  the
taxpayer identification number supplied by such Party to the Reporting Person is correct.

(p)    Headings. The titles and headings of the various Sections hereof are intended solely for means of reference and are not intended

for any purpose whatsoever to modify, explain or place any construction on any of the provisions of this Agreement.

./
-/5-2-19//

3285553_2

23

(q)        Construction.  The  Parties  acknowledge  that  with  respect  to  the  transactions  contemplated  herein,  (A)  each  Party  and  their
counsel  have  reviewed  and  revised  this  Agreement  and  that  the  normal  rule  of  construction  to  the  effect  that  any  ambiguities  are  to  be  resolved
against the drafting party shall not be employed in the interpretation of this Agreement or any amendments or exhibits thereto; (B) neither Party has
received from the other any accounting, tax, legal or other advice, and (C) each Party has relied solely upon the advice of their own accounting, tax,
legal and other advisor.

Each Party hereto agrees to retain this Agreement for not less than four (4) years from the end of the calendar year in which the Closing
occurs, and to produce it to the Internal Revenue Service upon a valid request therefor.

[Remainder of page intentionally left blank]

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written.

SELLER:

MNCVAD-GRAYMARK RIDDER PARK LLC,

a Delaware limited liability company

By:  /s/ Ross T. Berry

Name:   Ross T. Berry

Title:   Vice President

BUYER:

LUMENTUM OPERATIONS LLC, 
a Delaware limited liability company

By:   /s/ Judy Hamel

Name:   Judy Hamel

Title:   SVP, General Counsel

Escrow Agent joins herein in order to evidence its agreement to hold the Deposit and to perform the duties and obligations of Escrow Agent

ESCROW AGENT JOINDER

set forth in this Agreement.

./
-/5-2-19//

3285553_2

24

  
 
  
  
 
  
  
 
 
 
 
 
 
 
 
Dated: May 7, 2019

CHICAGO TITLE INSURANCE COMPANY
By: /s/ Terina J. Kung 
Name: Terina J. Kung
Title: AVP, Senior Commercial Escrow Officer

LIST OF EXHIBITS

Schedule 1    Definitions

Exhibit A    Description of Real Property

Exhibit B    Form of Deed

Exhibit C    Form of Bill of Sale and Assignment of Contracts and Intangible Property

Exhibit D    Form of Assignment and Assumption of Leases

Exhibit E    Schedule of Leases

Exhibit F    Schedule of Contracts

Exhibit G    [Intentionally Omitted]

Exhibit H    Form of FIRPTA Affidavit

Exhibit I    List of Due Diligence Documents

Exhibit J    Form of Notice to Tenants

Exhibit K    Form of Owner's Declaration

Additional Deposit    Section 2(b)(ii)
Affiliates    Section 14(n)
Agreement    Preamble
Termination Notice    Section 4(i)
Appurtenances    Section 1(b)
Arbitration    Section 2(d)
Arbitrator    Section 2(d)
Assignment and Assumption of Leases    Section 3(c)
Assignment of Intangible Property    Section 3(b)
Assumed Contracts    Section 4(d)
Award    Section 2(d)
Business Day    Section 2(b)(i)
Buyer    Preamble
Buyer's Designated Representative    Section 9
Claims    Section 4(h)
Closing    Section 2(b)(iv)
Closing Date    Section 2(b)(iv)
Closing Documents    Section 7(e)
Closing Statement    Section 7(f)(vi)
Code    Section 7(c)(vi)
Commencement Date    Section 7(f)(ii)

Access Agreement    Section 13(f)

 
Conditions Precedent    Section 5(a)
Contracts    Section 4(d)
Cooperating Party    Section 13(l)
Cure Period    Section 6(c)
Deed    Section 3(a)
Deposit    Section 2(b)(ii)
Disclosure Statement    Section 4(k)
Due Diligence    Section 4(a)
Due Diligence Documents    Section 4(b)
Due Diligence Period    Section 4(a)
Effective Date    Preamble
Environmental Laws    Section 4(h)(1)
Escrow Agent    Section 2(b)(i)
Excluded Contracts    Section 4(d)
Governmental Entity    Section 4(f)(iv)
Handling    Section 4(h)(2)
Hazardous Materials    Section 4(h)(3)
Immaterial Casualty    Section 12
Improvements    Section 1(c)
Independent Contract Consideration    Section 2(a)
Initial Deposit    Section 2(b)(i)
Intangible Property    Section 1(e)
Lease Expenses    Section 7(f)(ii)
Leases    Section 1(f)
Licensee Parties    Section 4(f)(i)
Limitation Period    Section 14(m)(i)
Lists    Section 8(j)
Loss of Access    Section 12
Loss of Tenant    Section 12
Maintenance Duties    Section 12(a)(i)
New Exceptions    Section 4(f)
Notice    Section 14(m)(i)
OFAC    Section 8(j)
Order    Section 8(j)
Orders    Section 8(j)
Outside Date    Section 2(d)
Overall Limitation Period    Section 14(m)(iii)
Permitted Exceptions    Section 4(e)
Personal Property    Section 1(d)
Post-Closing Defaults    Section 14(m)(i)
Property    Section 1
Property Conditions    Section 4(h)
PTR    Section 4(e)
Purchase Price    Section 2(b)
Real Property    Section 1(a)
Release    Section 4(h)
Released Claims    Section 4(h)
Released Parties    Section 4(h)
Removed Liens    Section 4(e)
Rent    Section 7(f)(i)
Report    Section 4(k)
Reporting Person    Section 13(o)(i)
Requesting Party    Section 13(l)
Schedule of Leases    Section 3(c)
SECTION 1542    Section 4(h)
Seller    Preamble
Seller Closing Certificate    Section 5(a)(iv)
Seller Response Notice    Section 4(f)
Seller's Broker    Section 13(b)
Seller's Conditions    Section 5(b)
Seller's Designated Representative    Section 8
Seller's Representations    Section 4(h)
Survey    Section 4(e)
Title Company    Section 2(b)(i)
Title Objection Letter    Section 4(f)

Title Policy    Section 3(a)
to Buyer's knowledge    Section 9
to Seller's knowledge    Section 8
Updated Survey    Section 4(e)
Waiver Parties    Section 4(h)
Waste Materials    Section 4(h)(4)

EXHIBIT A

LEGAL DESCRIPTION

[to follow]

3285553_2

25

 
EXHIBIT B

FORM OF GRANT DEED

EXHIBIT B
-1-

./
-/5-2-19//

3285553_2

RECORDING REQUESTED BY AND 
WHEN RECORDED RETURN TO:

___________________________

___________________________

___________________________

MAIL TAX STATEMENTS TO:

___________________________

___________________________

___________________________

(SPACE ABOVE THIS LINE RESERVED FOR RECORDER'S USE)

The undersigned grantor(s) declare(s)

GRANT DEED

This transfer is exempt from the documentary transfer tax.

¨
þ The documentary transfer tax is $__________ and City Tax is $__________ and is computed on:

the full value of the interest or property conveyed.

þ
¨    the full value less the liens or encumbrances remaining thereon at the time of sale. 

Parcel Number: ________________________________________
The property is located in the City of San Jose, California

FOR  GOOD  AND  VALUABLE  CONSIDERATION,  receipt  and  sufficiency  of  which  are  hereby  acknowledged,  MNCVAD-
Graymark Ridder Park LLC, a Delaware limited liability company ("Grantor"), hereby does grant, bargain, and sell and convey unto
[__________________], a ____________________ ("Grantee"), the real property located in the City of San Jose, County of Santa Clara,
State  of  California,  described  on  Exhibit  A attached  hereto  and  made  a  part  hereof,  together  with,  all  and  singular,  the  tenements,
hereditaments,  easements,  rights-of-way  and  appurtenances  belonging  or  in  anywise  appertaining  to  the  same,  and  the  improvements
thereon (the "Property").

This conveyance is subject to all matters of record and any matters which could be ascertained by a proper inspection or survey of

such Property.

./
-/5-2-19//

3285553_2

[Signature page follows]

EXHIBIT B
-1-

MAIL TAX STATEMENTS AS DIRECTED ABOVE

./
-/5-2-19//

3285553_2

EXHIBIT B
-1-

IN WITNESS WHEREOF, Grantor has caused these presents to be executed as of this ___ day of _____, 20__.

Grantor:

MNCVAD-GRAYMARK RIDDER PARK LLC, 
a Delaware limited liability company

By:        

Name:     

Title:     

./
-/5-2-19//

3285553_2

EXHIBIT B
-1-

ACKNOWLEDGMENT

A notary public or other officer completing this certificate verifies only the identity of the individual who signed the document to which this
certificate is attached, and not the truthfulness, accuracy, or validity of that document.

State of California    )
County of ______________________    )

On _________________________, before me,     ,

(insert name of notary)

Notary Public, personally appeared     , who proved to me on the basis of satisfactory evidence to be the person(s) whose name(s) is/are
subscribed to the within instrument and acknowledged to me that he/she/they executed the same in his/her/their authorized capacity(ies),
and that by his/her/their signature(s) on the instrument the person(s), or the entity upon behalf of which the person(s) acted, executed the
instrument.

I certify under PENALTY OF PERJURY under the laws of the State of California that the foregoing paragraph is true and correct.

WITNESS my hand and official seal.

Signature        (Seal)

EXHIBIT A

LEGAL DESCRIPTION

EXHIBIT B

PERMITTED ENCUMBRANCES

EXHIBIT C

FORM OF BILL OF SALE AND ASSIGNMENT OF CONTRACTS AND INTANGIBLE PROPERTY

THIS BILL OF SALE AND ASSIGNMENT OF CONTRACTS AND INTANGIBLE PROPERTY (this "Assignment") is made
and  entered  into  as  of  this  _____  day  of  ________,  20___  (the  "Effective  Date")  between  MNCVAD-Graymark  Ridder  Park  LLC,  a
Delaware limited liability company ("Assignor"), and [______________________], a ____________________ ("Assignee").

FOR GOOD AND VALUABLE CONSIDERATION, the receipt and sufficiency of which are hereby acknowledged by Assignor
and  Assignee,  effective  as  of  the  Effective  Date,  Assignor  hereby  assigns  and  transfers  unto  Assignee  all  of  its  right,  title,  claim  and
interest, if any, in and under:

(A)    The "Personal Property" (as defined in that certain Real Estate Purchase and Sale Agreement dated as of __________, 20__

between Assignor and [Assignee] (the "Purchase Agreement"));

(B)    the "Assumed Contracts" (as defined in the Agreement) listed in Schedule 1 attached hereto; and

(C)    any other "Intangible Property" (as defined in the Agreement).

ASSIGNOR AND ASSIGNEE FURTHER HEREBY AGREE AS FOLLOWS:

1.        As  of  the  Effective  Date,  Assignee  hereby  assumes  and  agrees  to  perform  all  of  Assignor's  obligations  under  the  Assumed

Contracts, to the extent the same arise and accrue on or after the date hereof.

2.    Notwithstanding anything to the contrary in this Assignment, the Purchase Agreement or any of the other documents executed
and  delivered  by  Assignor  and  Assignee  in  connection  herewith  and  therewith,  Assignor  reserves  and  retains  any  benefits,  on  a  non-
exclusive basis, reasonably necessary under the Assumed Contracts and other Intangible Property to the extent that the same relate to any
matter  with  respect  to  the  afore-said  real  property  for  which  Assignor  may  continue  to  have  liability  from  and  after  the  Effective  Date
(including, without limitation, any liability under or pursuant to the Purchase Agreement). Assignee hereby agrees to reasonably cooperate
(at Assignor's sole cost and expense) with the reasonable requests of Assignor in enforcing its benefits under the Leases to the extent such
benefits are reserved by Assignor pursuant to the terms of the foregoing.

3.        This  Assignment  shall  be  binding  on  and  inure  to  the  benefit  of  the  parties  hereto,  their  heirs,  executors,  administrators,

successors in interest and assigns.

4.    This Assignment shall be governed by and construed in accordance with the laws of the State of California.

5.        Assignee  hereby  expressly  acknowledges  and  affirms  the  provisions  of  Sections  4(i)  and  14(m) and  (n)  of  the  Purchase
Agreement,  the  terms  of  which  are  incorporated  herein  by  reference  and  shall  apply  to  and  as  between  Assignor  and  Assignee  and  this
Assignment  as  they  apply  to  and  as  between  Seller,  Buyer  and  the  Purchase  Agreement,  respectively.  Inclusion  of  Section  4(i)  of  the
Purchase Agreement shall include all of the paragraphs and subparagraphs of such Section 4(i).

6.    This Assignment may be executed in any number of counterparts, each of which will be deemed an original, but all of which
taken  together  shall  constitute  one  and  the  same  instrument.  The  signature  page  of  any  counterpart  may  be  detached  therefrom  without
impairing  the legal effect of the signature(s)  thereon,  provided  such signature  page is attached  to any other counterpart  identical  thereto
(except for additional signature pages executed by other parties).

7.    To the extent allowed by law, Assignee shall indemnify, hold harmless, and defend the Assignor and its respective members,
partners, affiliates, parent business organizations, subsidiary business organizations, shareholders, officers, directors, beneficiaries, agents,
employees,  attorneys  and  representatives  and  their  respective  successors  and  assigns  from  and  against  all  Claims,  as  defined  in  the
Purchase  Agreement,  resulting  from  any  breach  by  Assignee  of  any  of  the  obligations  assumed  by  Assignee  hereunder.  Assignee's
obligations hereunder shall not apply to Claims to the extent caused by the willful misconduct or gross negligence of the party seeking the
benefit of this paragraph 7.

[Signature page follows]

IN WITNESS WHEREOF, Assignor and Assignee have executed this Assignment the day and year first above written.

ASSIGNOR:

MNCVAD-GRAYMARK RIDDER PARK LLC, 
a Delaware limited liability company

By:        

Name:     

Title:     

ASSIGNEE:

[_________________________], 
a ____________________

By:        

Name:     

Title:     

Exhibit A to 
Assignment of 
Intangible Property

Schedule 1 to 
Assignment of 
Intangible Property

Schedule of Assumed Contracts

[Insert]

EXHIBIT D

FORM OF ASSIGNMENT AND ASSUMPTION OF LEASES

THIS ASSIGNMENT AND ASSUMPTION OF LEASES (this "Assignment") is made this ______ day of _____________, 20___
(the  "Effective  Date"),  between  MNCVAD-GRAYMARK  RIDDER  PARK,  a  Delaware  limited  liability  company  ("Assignor"),  and
[____________________], a ____________________ ("Assignee"), who agree as follows:

1.    Assignment and Assumption. For good and valuable consideration including, without limitation, the terms and conditions of
that  certain  Real  Estate  Purchase  and  Sale  Agreement,  dated  _______,  20___,  between  Assignor  and  [Assignee]  (the  "Purchase
Agreement"), the receipt and sufficiency of which are hereby acknowledged by Assignor and Assignee, effective as of the Effective Date,
(a) Assignor assigns to Assignee all of its right, title and interest in, to, and under the Leases described on the attached  Schedule 1 (the
"Leases"), and (b) Assignee accepts the assignment and hereby assumes and agrees to perform, as a direct obligation to the parties to the
Leases described on Schedule 1 all the obligations and liabilities of Assignor as landlord under the Leases first arising and accruing from
and after the Effective Date, together with any and all obligations with respect to the repayment or credit for any security deposits under
such  Leases  to  the  extent  credited  to  Buyer  at  Closing.  Notwithstanding  the  foregoing,  Assignor  reserves  and  retains  any  benefits
reasonably necessary under the Leases to the extent that the same relate to any matter for which Assignor may continue to have liability
from  and  after  the  Effective  Date  (including,  without  limitation,  any  liability  under  or  pursuant  to  the  Purchase  Agreement).  Assignee
hereby  agrees  to  reasonably  cooperate  (at  Assignor's  sole  cost  and  expense)  with  the  reasonable  requests  of  Assignor  in  enforcing  its
benefits under the Leases to the extent such benefits are reserved by Assignor pursuant to the terms of the foregoing.

2.    Successors and Assigns.  This  Assignment  shall  be  binding  upon  and  inure  to  the  benefit  of  the  parties  and  their  respective

successors and assigns.

3.    Severability. If any provision of this Assignment shall be held invalid or unenforceable for any reason and to any extent, the

remainder of this Assignment shall not be affected, but shall be enforced to the greatest extent permitted by law.

4.    Law. This Assignment shall be governed by and construed in accordance with the laws of the State of California.

5.    Incorporation. Assignee hereby expressly acknowledges and affirms the provisions of Sections 4(i) and 14(m) and  (n) of the
Purchase Agreement, the terms of which are incorporated herein by reference and shall apply to and as between Assignor and Assignee and
this Assignment as they apply to and as between Seller, Buyer and the Purchase Agreement, respectively. Inclusion of Section 4(i) of the
Purchase Agreement shall include all of the paragraphs and subparagraphs of such Section 4(i).

6.    Counterparts. This Assignment may be executed in any number of counterparts, each of which will be deemed an original, but
all of which taken together shall constitute one and the same instrument. The signature page of any counterpart may be detached therefrom
without impairing the legal effect of the signature(s) thereon, provided such signature page is attached to any other counterpart identical
thereto (except for additional signature pages executed by other parties).

7.    Indemnity. To the extent allowed by law, Assignee shall indemnify, hold harmless, and defend the Assignor and its respective
members,  partners,  affiliates,  parent  business  organizations,  subsidiary  business  organizations,  shareholders,  officers,  directors,
beneficiaries, agents, employees, attorneys and representatives and their respective successors and assigns from and against all Claims, as
defined  in  the  Purchase  Agreement,  resulting  from  any  breach  by  Assignee  of  any  of  the  obligations  assumed  by  Assignee  hereunder.
Assignee's obligations hereunder shall not apply to Claims to the extent caused by the willful misconduct or gross negligence of the party
seeking the benefit of this paragraph 7.

[Signature page follows]

IN WITNESS WHEREOF, this Assignment has been executed as of the date first above written.

ASSIGNOR:

MNCVAD-GRAYMARK RIDDER PARK LLC, 
a Delaware limited liability company 

By:        

Name:     

Title:     

ASSIGNEE:

[_________________________], 
a ____________________

By:        

Name:     

Title:     

SCHEDULE 1 TO ASSIGNMENT AND ASSUMPTION OF LEASES

SCHEDULE OF LEASES

1.

1.

EXHIBIT E

SCHEDULE OF LEASES

EXHIBIT F

SCHEDULE OF CONTRACTS

EXHIBIT G

[INTENTIONALLY OMITTED]

EXHIBIT H

FORM OF FIRPTA AFFIDAVIT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 1445 of the Internal Revenue Code of 1986 (the "Code") provides that a transferee  of a U.S. real property interest must
withhold tax if the transferor is a foreign person. For U.S. tax purposes (including Section 1445 of the Code), the owner of a disregarded
entity (which has legal title to a U.S. real property interest under local law) will be the transferor of the property and not the disregarded
entity. To inform ____________________, a ________________, the transferee of certain real property located in [__________________]
that  withholding  of  tax  is  not  required  upon  the  disposition  of  such  U.S.  real  property  interest  by  the  undersigned  ("Transferor"),  the
undersigned hereby certifies the following on behalf of Transferor:

1.    Transferor is not a foreign corporation, foreign partnership, foreign trust, or foreign estate (as those terms are defined in the

Code and the regulations promulgated thereunder);

2.    Transferor's U.S. employer identification number is __________________;

3.    Transferor's office address is: c/o NYL Investors LLC, One Front Street, Suite 550, San Francisco, California 94111; and

4.    Transferor is not a disregarded entity as defined in §1.1445-2(b)(2)(iii).

Transferor  understands  that  this  certification  may  be  disclosed  to  the  Internal  Revenue  Service  by  Transferee  and  that  any  false

statement contained herein could be punished by fine, imprisonment, or both.

Under penalty of perjury, I declare that I have examined this certificate and to the best of my knowledge and belief it is true, correct

and complete, and I further declare that I have authority to sign this document on behalf of Transferor.

Date: ________________, 20___

MNCVAD-GRAYMARK RIDDER PARK LLC,

a Delaware limited liability company

By:        

Name:     

Title:     

EXHIBIT I

LIST OF DUE DILIGENCE DOCUMENTS

EXHIBIT J

FORM OF NOTICE TO TENANTS

Re:    [PROPERTY DESCRIPTION]

_________, 20___

VIA U.S. MAIL

[TENANT]

__________________________________

__________________________________

__________________________________

Dear __________:

This  letter  is  to  inform  you  that  the  above-referenced  property  has  been  sold  by  the  undersigned  to  _________________,  a
_________________ (the "Buyer") and the undersigned has assigned its interest in your lease. In connection therewith, Buyer is "Landlord" under
that certain ___________________ dated _________, by and between the undersigned, as landlord, and ________, as lessee (the "Lease"). In order
to receive credit for payments under the Lease, from and after the date hereof, all payments shall be made in accordance with the directions set forth
in this letter.

All future notices and other communication should be delivered to Buyer, c/o the building manager, at the following address:

________________________________
________________________________
________________________________
________________________________

Commencing with the rent and other charges due on or after the date hereof, all payments due under the Lease should be paid and delivered

as follows:

________________________________
________________________________
________________________________

Your security deposit, if any, has been transferred to Buyer

Please indicate your receipt and acceptance of the terms of this Notice by executing and returning the enclosed counterpart of this

Notice to Buyer. Thank you for your cooperation.

MNCVAD-GRAYMARK RIDDER PARK LLC,

a Delaware limited liability company

By:        

Name:     

Title:     

ACCEPTED AND AGREED TO:

,

a                     

By:                    
Name:                    
Title:                    

To:

Chicago Title Insurance Company

455 Market Street, Suite 2100

San Francisco, CA 94105

Attn: Terina J. Kung, Escrow Officer

Re:

Title No. __________

EXHIBIT K

FORM OF OWNER'S DECLARATION

Property: 1001 Ridder Park Drive, 1717 Fox Drive and 1751 Fox Drive, San Jose, California

1.    Lumentum Operations LLC, a Delaware limited liability company ("Buyer"), has requested Chicago Title Insurance Company
to issue its policy of title insurance insuring an interest in or title to real property described in Exhibit A (the "Property") pursuant to that
certain Commitment for Title Insurance prepared by Chicago Title Insurance Company effective as of __________ (the "Commitment")
without exception to or providing certain affirmative insurance against unrecorded matters.

2.    MNCVAD-Graymark Ridder Park LLC, a Delaware limited liability company, is the declarant hereunder ("Declarant").

3.    Declarant hereby affirms that to its knowledge there are no parties in possession of the Property or entitled to possession of the
Property under unrecorded leases other than those shown on Exhibit B and any sublessees or other parties whose rights derive from the
leases on the attached Exhibit B. The phrases "to its knowledge" or "to Declarant's knowledge" mean to the actual (and not constructive),
present knowledge of Andrew Jenkins.

4.    Other than as set forth on Exhibit C, during the period of ninety (90) days immediately preceding the date of this Declaration,
to Declarant's knowledge, no work has been done, no surveys or architectural or engineering plans have been prepared, and no materials
have been furnished in connection with the erection, equipment, repair, protection or removal of any building or other structure on the land
or in connection with the improvement of the land in any manner whatsoever for which payment has not been made.

This Declaration is made to induce Chicago Title Insurance Company to issue its policy of title insurance (the "Title Policy") to
Buyer with respect to the above-referenced order number. Chicago Title Insurance Company may rely on this Declaration for purposes of
issuing the Commitment and the Title Policy and for no other purposes whatsoever.

Executed under penalty of perjury on this ______ day of _______, 20___.

[Signature page follows]

DECLARANT:

MNCVAD-GRAYMARK RIDDER PARK LLC, 
a Delaware limited liability company

By:        

Name:     

Title:     

Exhibit A to Owner's Declaration

Legal Description

Exhibit B to Owner's Declaration

Tenant Roll

[insert]

Exhibit C to Owner's Declaration

Labor and Material Furnished

[insert]

Purchase    4

Deliveries    5

Review    5

Objections; Seller's Right to Cure    5

Interviews    8

Period    13

Agreement    13

Disclosures    13

1.Property Included in Sale    1

2.Purchase Price    2

3.Transfer of Title to the Property    4

4.Due

 Diligence

 Period;

 As-Is

(a)Due Diligence Period    4
(b)Due

 Diligence

(c)Further

 Document

(d)Contracts    5
(e)Title

 Matters;

 Buyer's

(f)Title Review    6
(g)Site Visits    7
(h)Discussions

 and

(i)As-Is Purchase    8
(j)Expiration of Due Diligence

(k)Termination

 of

(l)Natural

 Hazard

5.Conditions to Closing    14

(a)Buyer's Conditions    14
(b)Seller's Conditions    14

Seller    20

Matters    21

Buyer    22

Indemnifications    23

Deemed Modified    23

Closing    23

Assigns    26

Agreements    27

Dates    28

Limitations    29

Person    30

(c)Waiver of Condition    15

6.Remedies    15

7.Closing and Escrow    16

8.Representations  and  Warranties  of

(a)Status    20
(b)Authorization    20
(c)Litigation    20
(d)Condemnation    20
(e)Leases    20
(f)Contracts    21
(g)Compliance    21
(h)Environmental

(i)Non-foreign Person    21
(j)Non-foreign Assets    21

9.Representations  and  Warranties  of

(a)Status    22
(b)Authorization    22
(c)Proceedings    22
(d)Non-foreign Assets    22
(e)ERISA    22

10.Warranties

 and

(a)Seller's

 Representations

(b)Breach

 Prior

 to

11.Indemnity    23

12.Risk of Loss    23

13.Covenants    24

(a)Seller's Covenants    24

14.Miscellaneous    25
(a)Notices    25
(b)Brokers/Intermediaries    26
 and
(c)Successors

(d)Amendments    27
(e)Governing Law    27
(f)Integration

 of

 Prior

(g)Enforcement    27
(h)Confidentiality    27
 of
(i)Time

 the

 Essence;

(j)Severability    28
(k)Counterparts    28
(l)1031 Exchange    28
(m)Survival

 and

(n)Exculpation    30
(o)Designation  of  Reporting

(p)Headings    31
(q)Construction    31

./
-/5-2-19//

3285553_2

EXHIBIT B
-1-

LIST OF SUBSIDIARIES
LUMENTUM HOLDINGS INC.

AS OF JUNE 29, 2019

Name of Entity

Exhibit 21.1 

State or Other 
Jurisdiction of 
Incorporation or 
Organization

DOMESTIC

CCOP International Holdings Inc.

E20 Communications Inc.

Lightwave Electronics Corporation

Lumentum Inc.

Lumentum Operations LLC

Lumentum Optical Corporation

Lumentum Research LLC

Oclaro (North America), Inc.

Lumentum Fiber Optics, Inc.

Lumentum Optics Inc.

Oclaro, LLC

SDL PIRI, Inc.

INTERNATIONAL

Bookham International Ltd.

Bookham Nominees Ltd.

Lumentum Asia Limited

Lumentum (BVI) Ltd

Lumentum BC Research ULC

Lumentum Canada Ltd.

Lumentum Communication Technology (Shenzhen) Co., Ltd.

Lumentum d.o.o. Optièna vlakna

Lumentum HoldCo Limited

Lumentum HoldCo Limited - Taiwan Branch

Lumentum International (Thailand) Co., Ltd.

Lumentum International (Thailand) Co., Ltd. - Branch

Lumentum International Tech Co.

Lumentum Israel Ltd

Lumentum Japan Inc.

Lumentum K.K.

Lumentum Netherlands B.V.

Lumentum Netherlands B.V. - France Branch

Lumentum Netherlands B.V. - Germany Branch

Lumentum Netherlands B.V. - Italy Branch

Lumentum Netherlands B.V. - UK Branch

Lumentum Ottawa Inc.

Lumentum SK Limited

Lumentum Switzerland AG

  Delaware

  Delaware

  California

  Delaware

  Delaware

  Massachusetts

  Delaware

  Delaware

  Delaware

  Delaware

  Delaware

  Delaware

  Cayman Islands

  United Kingdom

  Hong Kong

  British Virgin Islands

  Canada

  Canada

  China

  Slovenia

  Hong Kong

  Taiwan

  Thailand

  Thailand

  Cayman Islands

  Israel

  Japan

  Japan

  Netherlands

  France

  Germany

  Italy

  United Kingdom

  Canada

  South Korea

  Switzerland

 
   
   
Lumentum Taiwan Co., Ltd.

Lumentum Tech LLC

Lumentum Technologies Limited

Oclaro (Canada) Inc.

Oclaro (North America), Inc. (branch office -- San Donato, Italy)

Oclaro Germany GmbH

Oclaro Innovations LLP

Oclaro Malaysia Sdn Bhd

Oclaro Technology (Shenzhen) Co. Ltd.

Lumentum Technology UK Limited

Oclaro Technology Limited (rep office-Hong Kong)

Oclaro Thailand Ltd.

  Taiwan

  Cayman Islands

  Canada

  Canada

  Italy

  Germany

  United Kingdom

  Malaysia

  China

  United Kingdom

  Hong Kong

  Thailand

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-228905, 333-215937, and 333-205918 on Form S-8 of our reports dated August 27, 2019,

relating  to  the  consolidated  financial  statements  and  consolidated  financial  statement  schedule  of  Lumentum  Holdings  Inc.  and  subsidiaries  (the  “Company”),  and  the

effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended June 29, 2019.

Exhibit 23.1

/s/ DELOITTE & TOUCHE LLP

San Jose, California

August 27, 2019

LUMENTUM HOLDINGS INC.
CERTIFICATION PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

Exhibit  31.1

I, Alan Lowe, certify that:

1. I have reviewed the Annual Report on Form 10-K of Lumentum Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d - 15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over
financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect
the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: August 27, 2019

/s/ ALAN LOWE

Alan Lowe
President and Chief Executive Officer
(Principal Executive Officer)

 
 
 
 
 
 
 
LUMENTUM HOLDINGS INC.
CERTIFICATION PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 31.2

I, Wajid Ali, certify that:

1. I have reviewed the Annual Report on Form 10-K of Lumentum Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d - 15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over
financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect
the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: August 27, 2019

/s/ WAJID ALI

Wajid Ali

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

 
 
 
 
 
 
 
 
 
LUMENTUM HOLDINGS INC.
CERTIFICATION PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32.1

In connection with the Annual Report on Form 10-K of Lumentum Holdings Inc. (the “Company”) for the year ended June 29, 2019 as filed with the Securities and
Exchange Commission (the “Report”), I, Alan Lowe, President and Chief Executive Officer (Principal Executive Officer) of the Company, hereby certify as of the date
hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1.                                      The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.                                      The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and
for the periods indicated.

Dated: August 27, 2019

/s/ ALAN LOWE

Alan Lowe

President and Chief Executive Officer

(Principal Executive Officer)

The foregoing certification is being furnished pursuant to 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, and it is not to be incorporated by reference into any filing of Lumentum Holdings Inc., regardless of any general incorporation language in such filing.

 
 
 
 
 
 
 
 
 
LUMENTUM HOLDINGS INC.
CERTIFICATION PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32.2

In connection with the Annual Report on Form 10-K of Lumentum Holdings Inc. (the “Company”) for the year ended June 29, 2019 as filed with the Securities and
Exchange Commission (the “Report”), I, Wajid Ali, Executive Vice President,
Chief Financial Officer (Principal Financial Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the
United States Code, that to the best of my knowledge:

1.                                      The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.                                      The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and
for the periods indicated.

Dated: August 27, 2019

/s/ WAJID ALI

Wajid Ali

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

The foregoing certification is being furnished pursuant to 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, and it is not to be incorporated by reference into any filing of Lumentum Holdings Inc., regardless of any general incorporation language in such filing.